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IN THE DISTRICT COURT OF THE FIFTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO, IN AND FOR THE COUNTY OF TWIN FALLS
VAUGHN SCHMECHEL, individually and as
surviving spouse and Personal Representative
of the Estate of Rosie Schmechel, deceased
and ROBERT P. LEWIS, KIM HOWARD
and TAMARA HALL, natural children of
ROSALIE SCHMECHEL, deceased,

)
)
)
)
)
)

CASE NO. CV 05-4345

)

Plaintiffs/Appellants,

)
)

VS

)

)

CLINTON DILLE, M.D., SOUTHERN
)
IDAHO PAIN INSTITUTE, an Idaho
)
)
Corporation, THOMAS BYRNE, P. A.,
and JOHN DOE and JANE DOE, I through X, )
)

Defendants/Respondents.

)
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VOLUME6
Appeal from the District Court of the Fifth Judicial District
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HONORABLE G. RICHARD BEV AN
District Judge
David Comstock
Byron Foster
199 N Capitol Blvd., Ste 500
P. 0. Box 2774
Boise, ID 83701-2774

Steven Hippler
J. Will Varin
601 W, Bannock Street
P. O. Box 2720
Boise, ID 83701-2720
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Case: CV-2005-0004345 Current Judge: G. Richard Bevan
Vaughn Schmechel, etal. vs. Clinton L Dille MD, etal.

Vaughn Schmechel, Robert P Lewis, Kim Lee Howard, Tamara Hall vs. Clinton L Dille MD, Southern Idaho Pain
Institute, Thomas J Byrne PA, John Doe, Jane Doe I -x
Date

Code

User

10/3/2005

NOAP

QUAM

Notice Of Appearance

QUAM

Filing: A1 - Civil Complaint, More Than $1000 No G. Richard Bevan
Prior Appearance Paid by: Mick Hodges
Receipt number: 5024920 Dated: 10/3/2005
Amount: $82.00 (Check)

COMP

QUAM

Complaint Filed

G. Richard Bevan

SMIS

QUAM

Summons Issued x 3

G. Richard Bevan

QUAM

Filing: 11 A - Civil Answer Or Appear. More Than
$ 1000 No Prior Appearance Paid by: Givens
Pursley, LLP Receipt number: 5027934 Dated:
11/712005 Amount: $52.00 (Check)

G. Richard Bevan

ANSW

QUAM

Answer To Complaint And Demand For Jury Trial G. Richard Bevan

HRSC

COOPE

Hearing Scheduled (Scheduling Conference
01/04/2006 01 :30 PM)

G. Richard Bevan

OSCO

COOPE

Order for Scheduling Conference and Order RE:
Motion Practice

G. Richard Bevan

12/19/2005

LETT

COOPE

Letter from David Comstock

G. Richard Bevan

12/2112005

HRVC

COOPE

Hearing result for Scheduling Conference held on G. Richard Bevan
01/04/2006 01 :30 PM: Hearing Vacated

12/30/2005

AFSV

NIELSEN

Affidavit Of Service

G. Richard Bevan

SMRT

NIELSEN

Summons Returned

G. Richard Bevan

FERCH

Filing: 17 A - Civil Answer Or Appear. All Other
Actions No Prior Appearance Paid by: Hall
Farley Oberrecht Blanton Receipt number:
6000440 Dated: 1/512006 Amount: $52.00
(Check)

G. Richard Bevan

NOAP

FERCH

Notice Of Appearance

G. Richard Bevan

ANSW

FERCH

Defendant Thomas J Byrne's Answer to plaintiffs
complaint and demand for jury trial

G. Richard Bevan

SMRT

NIELSEN

Summons Returned Clinton Dille, M.D.

G. Richard Bevan

SMRT

NIELSEN

Summons Returned Southern Idaho Pain Institute G. Richard Bevan

2/6/2006

NOSV

NIELSEN

Notice Of Service

G. Richard Bevan

2/14/2006

HRSC

COOPE

Hearing Scheduled (Scheduling Conference
03/06/2006 01 :30 PM)

G. Richard Bevan

2/15/2006

OSCO

COOPE

Order for Scheduling Conference and Order RE:
Motion Practice

G. Richard Bevan

2/2412006

NTSD

NIELSEN

Notice Of Service Of Discovery Documents

G. Richard Bevan

3/2/2006

STIP

COOPE

Stipulation for Scheduling and Planning

G. Richard Bevan

3/8/2006

HRVC

COOPE

Hearing result for Scheduling Conference held on G. Richard Bevan
03/06/2006 01 :30 PM: Hearing Vacated

HRSC

COOPE

Hearing Scheduled (Jury Trial 10/16/2007 09:00 G. Richard Bevan
AM) Excluding Mondays

HRSC

COOPE

Hearing Scheduled (Civil Pretrial Conference
09/24/2007 02:30 PM)

1117/2005

12/14/2005

1/5/2006

1/20/2006

Judge
G. Richard Bevan

G. Richard Bevan
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Case: CV-2005-0004345 Current Judge: G. Richard Bevan
Vaughn Schmechel, etal. vs. Clinton L Dille MD, etal.

Vaughn Schmechel, Robert P Lewis, Kim Lee Howard, Tamara Hall vs. Clinton L Dille MD, Southern Idaho Pain
Institute, Thomas J Byrne PA, John Doe, Jane Doe I -x
Date

Code

User

3/8/2006

HRSC

COOPE

Hearing Scheduled (Status/ADR 09/05/2007
01 :32 PM)

3/9/2006

NOJT

COOPE

Notice Of Jury Trial Setting, Pretrial Conf- Renee G. Richard Bevan
And Order Governing Further Proceedings

4/3/2006

NOTR

NIELSEN

Notice Of Preparation Of Transcript

G. Richard Bevan

4/6/2006

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum of
Defendant Clinton Dille, M.D.

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum of
Thomas Byrne, PA

G. Richard Bevan

NOSV

NIELSEN

Notice Of Service
04-17-06

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum of
Amber Zaccone

G. Richard Bevan

NOTC

RKLINE

Amended Notice Of Taking Video Deposition
Duces Tecum Of Thomas Byrne, PA

G. Richard Bevan

NOTC

RKLINE

Amended Notice Of Taking Video Deposition
Duces Tecum Of Defendant Clinton Dille, M.D.

G. Richard Bevan

5/10/2006

NTSD

NIELSEN

Notice Of Service Of Discovery Documents

G. Richard Bevan

6/9/2006

NOTR

NIELSEN

Notice Of Preparation Of Transcript

G. Richard Bevan

NOTR

NIELSEN

Notice Of Preparation Of Transcript

G. Richard Bevan

NOTR

NIELSEN

Notice Of Preparation Of Transcript

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum
(Timothy Floyd, M.D.)

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum
(Julian Nicholson, M.D.)

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum
(Records Custodian-Sun Valley Spine Institute)

G. Richard Bevan

NODT

NIELSEN

Amended Notice Of Deposition Duces Tecum
(Julian Nicholson, M.D.)

G. Richard Bevan

NODT

NIELSEN

Amended Notice Of Deposition Duces Tecum
(Records Custodian - Sun Valley Spine Institute)

G. Richard Bevan

3/30/2006

NTSD

NIELSEN

Notice Of Service Of Discovery Documents

G. Richard Bevan

7/3/2006

SUBR

NIELSEN

Subpoena Returned

G. Richard Bevan

AFSV

NIELSEN

Affidavit Of Service

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum
(Records Custodian - Spine Institute of Idaho)

G. Richard Bevan

SUBR

NIELSEN

Subpoena Returned

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Non-Service

G. Richard Bevan

7/13/2006

NOSV

MCMULLEN

Notice Of Service

G. Richard Bevan

7/14/2006

NOSV

NIELSEN

Notice Of Service

G. Richard Bevan

NOSV

NIELSEN

Notice Of Service

G. Richard Bevan

NTSD

NIELSEN

Notice Of Service Of Discovery Responses

G. Richard Bevan

NTSD

NIELSEN

Notice Of Service Of Discovery Responses

G. Richard Bevan

4/18/2006

5/1/2006

6/19/2006

3/26/2006

7/17/2006

Judge
G. Richard Bevan

1 r, r.w r:·
.J.\i ..J.J
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Case: CV-2005-0004345 Current Judge: G. Richard Bevan
Vaughn Schmechel, etal. vs. Clinton L Dille MD, etal.

Vaughn Schmechel, Robert P Lewis, Kim Lee Howard, Tamara Hall vs. Clinton L Dille MD, Southern Idaho Pain
Institute, Thomas J Byrne PA, John Doe, Jane Doe I -x
Date

Code

User

7/25/2006

SUBR

NIELSEN

Subpoena Returned

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Non-Service

G. Richard Bevan

9/8/2006

NTSD

NIELSEN

Notice Of Service Of Discovery Documents

G. Richard Bevan

9/29/2006

NOSV

NIELSEN

Notice Of Service

G. Richard Bevan

4/19/2007

MOTN

NIELSEN

Motion for Leave to Amend Complaint to Include
Claim for Punitive Damages
fax

G. Richard Bevan

4/20/2007

AFFD

NIELSEN

Supplemental Affidavit of Arthur G. Lipman,
Pharm.D.

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Arthur G. Lipman, Pharm.d.

G. Richard Bevan

MEMO

NIELSEN

Memorandum in Support of Plaintiffs' Motion for
Leave to Amend Complaint to Include Claim for
Punitive Damages

G. Richard Bevan

NIELSEN

Plaintiffs' Expert Witness Disclosures

G. Richard Bevan

HRSC

COOPE

Hearing Scheduled (Motion 06/18/2007 09:00
AM) to amend complaint to add punitive
damages

G. Richard Bevan

NOHG

NIELSEN

Notice Of Hearing Re: Motion for Leave to
Amend Complaint to Include Claim for Punitive
Damages

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum of
Kimberly Vorse, M.D.

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum of
David Verst, M.D.

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum $of
Juanita Peterson

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum of
Carl Peterson

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum of
Cindy Sheer

G. Richard Bevan

5/18/2007

NIELSEN

Defendant Thomas Byrne, PA's Disclosure of
Lay Witnesses

G. Richard Bevan

5/23/2007

NIELSEN

Plaintiffs' Lay Witness List
fax

G. Richard Bevan

NOSV

NIELSEN

Notice Of Service

G. Richard Bevan

NODT

NIELSEN

Amended Notice Of Taking Deposition Duces
Tecum of Carl Peterson

G. Richard Bevan

NOTC

NIELSEN

Notice of Vacating Deposition Duces Tecum of
Juanita Peterson

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum of
Kenneth Harris, M.D.

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum of
Julian Nicholson, M.D.

G. Richard Bevan

NODT

NIELSEN

amended
Notice Of Taking Deposition Duces Tecum of
Cindy Sheer

G. Richard Bevan

4/26/2007

5/11/2007

5/24/2007

Judge

1
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Case: CV-2005-0004345 Current Judge: G. Richard Bevan
Vaughn Schmechel, etal. vs. Clinton L Dille MD, etal.

Vaughn Schmechel, Robert P Lewis, Kim Lee Howard, Tamara Hall vs. Clinton L Dille MD, Southern Idaho Pain
Institute, Thomas J Byrne PA, John Doe, Jane Doe I -x
Judge

Date

Code

User

5/24/2007

NODT

NIELSEN

Notice Of Taking Deposition Ducas Tecurn
of Kent Jensen

G. Richard Bevan

NIELSEN

DefendantThomasByrne,P.a.'sSupplemental
Disclosure of Lay Witnesses
fax

G. Richard Bevan

5/25/2007

5/30/2007

NODT

NIELSEN

Amended Notice Of Taking Deposition Ducas
Tecum of Kimberly Vorse, M.D.
Fax

G. Richard Bevan

6/4/2007

AFFD

NIELSEN

Second Supplemental Affidavit of Arthur G.
Lipman, Pharm.D.

G. Richard Bevan

NOHG

NIELSEN

Notice Of Hearing

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Counsel in Support of Defendant
Thomas Byrne's Motion to Strike Portions of the
Affidavits of Arthur G. Lipman, Pharm. D.

G. Richard Bevan

MOTN

NIELSEN

Defendant Thomas Byrne's Motion to Strike
Portions of the Affidavits of Arthur G. Lipman,
Pharm.D.

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Keri Fakata, Pharm.D

G. Richard Bevan

NIELSEN

Defendant Thomas Byrne's Memorandum in
Support of Motion to Strike Portions of the
Affidavits of Arthur G. Lipman, Pharm.D.

G. Richard Bevan

NIELSEN

Defendant Clinton Dille, M.D.'s Joinder in Motion
to Strike Portions of the Affidavit of Arthur G.
Lipman Pharm. D.
fax

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Byron V. Foster

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Lorraine Shoafkadish BSN, RN

G. Richard Bevan

MEMO

NIELSEN

Plaintiff's Memorandum in Opposition to
Defendants' Motion to Strike Portions of the
Affidavits of Arthur G. Lipman, Pharm.D.

G. Richard Bevan

AFFD

NIELSEN

Affidavit of William Binegar, M.D. in Opposition to G. Richard Bevan
Plaintiffs' Motion to Amend Complaint to Add a
Claim for Punitive
Damages
fax

NIELSEN

Response to Plaintiffs' Motion for Leave to
Amend Complaint to Include Claim for Punitive
Damages
fax

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Counsel in Support of Defendant
Thomas Byrne, P.A.'s Memorandum in
Opposition to Plaintiffs' Motion for Leave to
Amend Complaint to Include Claim for Punitive
Damages

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Rodde Cox, MD
fax

G. Richard Bevan

6/6/2007

6/11/2007

1 r r:-: .,..,
j_ \.,1 ,_) I

Fifth Ju,
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Case: CV-2005-0004345 Current Judge: G. Richard Bevan
Vaughn Schmechel, etal. vs. Clinton L Dille MD, etal.

Vaughn Schmechel, Robert P Lewis, Kim Lee Howard, Tamara Hall vs. Clinton L Dille MD, Southern Idaho Pain
Institute, Thomas J Byrne PA, John Doe, Jane Doe I -x
Date

Code

User

Judge

NIELSEN

Defendant Thomas Byrne, P.A.'s Memorandum in G. Richard Bevan
Opposition to Plaintiffs' Motion for Leave to
Amend Complaint to Include Claim for Punitive
Damages

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum of
Stephen P. Lordon, M.D.

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Steven J. Hippler

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Bradford Hare, M.D.PH.D in
Opposition to Plaintiffs' Motion to Amend
Complaint to Add a Claim for Punitive Damages

G. Richard Bevan

3/13/2007

NOWD

NIELSEN

Notice Of Withdrawal of Plaintiff's Motion for
Leave to Amend Complaint to Include Claim for
Punitive Damages

G. Richard Bevan

3/14/2007

HRVC

COOPE

Hearing result for Motion held on 06/18/2007
G. Richard Bevan
09:00 AM: Hearing Vacated to amend complaint
to add punitive damages
motion to strike portions of affidavits of Arthur
Lipman

NOTC

NIELSEN

Notice of Vacating Deposition Duces Tecum of
Carl Peterson
fax

G. Richard Bevan

NOTC

NIELSEN

Notice Vacating Hearing
fax

G. Richard Bevan

NODT

NIELSEN

Amended Notice Of Taking Deposition Duces
Tecum of Cindy Scheer
fax

G. Richard Bevan

NOTC

COOPE

Notice Vacating Hearing
fax

G. Richard Bevan

NIELSEN

Plaintiffs' First Supplemental Expert Witness
Disclosures

G. Richard Bevan

NIELSEN

Defendant Thomas J. Byrne's Disclosure of
Expert Witnesses

G. Richard Bevan

NOTC

NIELSEN

Notice of Compliance
fax

G. Richard Bevan

NOTC

COOPE

Notice of Vacating Hearing

G. Richard Bevan

6/19/2007

NTSD

NIELSEN

Notice Of Service Of Discovery Documents

G. Richard Bevan

6/25/2007

SUBR

NIELSEN

Subpoena Returned
fax

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum of
Dennis Chambers
fax

G. Richard Bevan

RETN

NIELSEN

Return Of Service
6-16-7
fax

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum
fax

G. Richard Bevan

3/11/2007

3/12/2007

6/15/2007

6/18/2007

1 f'i f.~ 0
0 U
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Date

Code
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6/27/2007

NODT

NIELSEN

Amended Notice Of Taking Deposition Ducas
Tecum of Arthur G. Lipman, Pharm. D.
fax

G. Richard Bevan

NODT

NIELSEN

Amended Notice Of Taking Deposition Duces
Tecum of Stephen P. Lorden, M.D.
fax

G. Richard Bevan

NODT

NIELSEN

Second Amended Notice Of Taking Deposition
Duces Tecum of Kimberly Vorse, M.D.
fax

G. Richard Bevan

7/3/2007

MOTN

NIELSEN

Motion for Protective Order
fax

G. Richard Bevan

7/20/2007

SUBR

NIELSEN

Subpoena Returned

G. Richard Bevan

7/23/2007

NOTR

NIELSEN

Notice Of Preparation Of Transcript & Filing

G. Richard Bevan

NOTR

NIELSEN

Notice Of Preparation Of Transcript & Filing

G. Richard Bevan

NOTR

NIELSEN

Notice Of Preparation Of Transcript & Filing

G. Richard Bevan

NOTR

NIELSEN

Notice Of Preparation Of Transcript & Filing

G. Richard Bevan

8/2/2007

NTSD

NIELSEN

Notice Of Service Of Discovery Documents

G. Rithard Bevan

8/3/2007

NTSD

NIELSEN

Notice Of Service Of Discovery Documents

G. Richard Bevan

NTSD

NIELSEN

Notice Of Service Of Discovery Documents

G. Richard Bevan

NODT

NIELSEN

Amended Notice Of Taking Deposition Duces
Tecum of Cornelius Hofman

G. Richard Bevan

NOTC

NIELSEN

Notice of Vacating Deposition Ducas Tecum of
Dennis Chambers

G. Richard Bevan

NOTC

NIELSEN

Notice of Vacating Deposition Duces Tecum of
Shaiyenne Shindle

G. Richard Bevan

NOSV

NIELSEN

Notice Of Service

G. Richard Bevan

NOSV

NIELSEN

Notice Of Service

G. Richard Bevan

NODT

NIELSEN

Second Amended Notice Of Taking Deposition
Ducas Tecurn of Stephen P. Lorden, M.D.
(Change of Location)

G. Richard Bevan

NODT

NIELSEN

Amended Notice Of Taking Deposition Duces
Tecum of Jim Keller, M.P.H., PA-C

G. Richard Bevan

NODT

NIELSEN

Second Amended Notice Of Taking Deposition
Duces Tecum of Arthur G. Lipman, Pharm. D.

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Ducas Tecum
of Glen R. Graben

G. Richard Bevan

NODT

NIELSEN

Amended Notice Of Taking Deposition Ducas
Tecum of Glen R. Groben

G. Richard Bevan

NODT

NIELSEN

Second Amended Notice Of Taking Deposition
Duces Tecum of Glen R. Graben

G. Richard Bevan

NOTR

NIELSEN

Notice Of Preparation Of Transcript & Filing

G. Richard Bevan

NODT

NIELSEN

Amended
Notice Of Taking Deposition Duces Tecumof
Dennis Chambers
fax

G. Richard Bevan

8/6/2007

8/13/2007

8/22/2007

Judge

l'r·r)
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8/22/2007

NODT

NIELSEN

Amended
Notice Of Taking Deposition Duces Tecum of
Christopher Frey
fax

G. Richard Bevan

NODT

NIELSEN

Amended
Notice Of Taking Deposition Duces Tecum of
Shaiyenne Shindle
fax

G. Richard Bevan

8/27/2007

NTSD

NIELSEN

Notice Of Service Of Discovery Documents

G. Richard Bevan

8/29/2007

CONT

COOPE

Continued (Status/ADR 09/10/2007 11 :00 AM)
by phone with plaintiff's counsel to initiate

G. Richard Bevan

COOPE

Notice Of Hearing

G. Richard Bevan

NOSV

NIELSEN

Notice Of Service

G. Richard Bevan

NTSD

NIELSEN

Notice Of Service Of Discovery Responses

G. Richard Bevan

NIELSEN

Plaintiffs' Second Supplemental Expert Witness
Disclosures

G. Richard Bevan

HRHD

COOPE

Hearing result for Status/ADR held on 09/10/2007 G. Richard Bevan
11:00 AM: Hearing Held by phone with plaintiff's
counsel to initiate

LETT

COOPE

Letter from Byron Foster

CMIN

COOPE

Court Minutes Hearing type: Status/ADR Hearing G. Richard Bevan
date: 9/10/2007 Time: 11 :03 am Court reporter:
Virginia Bailey

NOTR

NIELSEN

Notice Of Preparation Of Transcript & Filing

G. Richard Bevan

NIELSEN

Plaintiffs' Third Supplemental Expert Witness
Disclosures
fax

G. Richard Bevan

NTSD

NIELSEN

Notice Of Service Of Discovery Documents

G. Richard Bevan

NTSD

NIELSEN

Notice Of Service Of Discovery Documents

G. Richard Bevan

NOSV

NIELSEN

Notice Of Service
fax

G. Richard Bevan

NOSV

NIELSEN

Notice Of Service
fax

G. Richard Bevan

NOSV

NIELSEN

Notice Of Service
fax

G. Richard Bevan

9/14/2007

NOSV

NIELSEN

Notice Of Service

G. Richard Bevan

9/17/2007

NTSD

NIELSEN

Notice Of Service Of Discovery Documents

G. Richard Bevan

9/24/2007

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum of
Marty Bright
fax

G. Richard Bevan

NODT

NIELSEN

Notice Of Taking Deposition Duces Tecum of
Valerie Bothof/
fax

G. Richard Bevan

8/30/2007
9/10/2007

9/11/2007

9/12/2007

G. Richard Bevan
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Date

Code

User

9/24/2007

NODT

NIELSEN

Second Amended
Notice Of Taking Deposition Duces Tecum of
Christopher Frey
fax

G. Richard Bevan

HRHD

COOPE

Hearing result for Civil Pretrial Conference held
on 09/24/2007 02:30 PM: Hearing Held in
Chambers

G. Richard Bevan

NIELSEN

Defendant Thomas Byrne, P.A.'s Exhibit List
fax

G. Richard Bevan

MISC

COOPE

Defendants Clinton Dille, M.D. and Southern
Idaho Pain Institute Trial Exhibit List

G. Richard Bevan

MISC

COOPE

Defendants Clinton Dille, M.D. and Southern
Idaho Pain lnstitute's Trial Witness List

G. Richard Bevan

9/25/2007

ORDR

COOPE

Pretrial Conference Order Pursuant to I.R.C.P.
16(d)

G. Richard Bevan

9/26/2007

MOTN

NIELSEN

Plaintiffs' Motion in Limine
fax

G. Richard Bevan

MEMO

NIELSEN

Memorandum in Support of Plaintiffs' Motion in
Limine
fax

G. Richard Bevan

WITN

NIELSEN

Defendant Thomas Byrne, P.A.'s Witness List
fax

G. Richard Bevan

WITN

NIELSEN

Plaintiffs' Witness List
fax

G. Richard Bevan

NIELSEN

Plaintiffs' Exhibit List
fax

G. Richard Bevan
G. Richard Bevan

Judge

3/27/2007

AFFD

NIELSEN

Affidavit of Counsel in Support of Defendant
Thomas Byrne, P.A.'s Motion in Limine Re:
Various Issues

3/28/2007

MOTN

NIELSEN

Defendant Clinton Dille, M.D. and Southern Idaho G. Richard Bevan
Pain Institutes' Motions in Limine
fax

10/1/2007

MEMO

NIELSEN

G. Richard Bevan
Defendants Clinton Dille, M.D. and Southern
Idaho Pain Institutes' Memorandum in Support of
Motions in Limine

MEMO

NIELSEN

Memorandum in Support of Thomas J. Byrne's
Motion in Limine Re: Various Issues

AFFD

NIELSEN

Affidavit of J. Will Varin in Support of Clinton Dille G. Richard Bevan
and the Southern Idaho Pain lnstitute's Motions in
Limine

NOSV

NIELSEN

Notice Of Service
fax

G. Richard Bevan

10/2/2007

HRSC

COOPE

Hearing Scheduled (Motion 10/11/2007 10:00
AM) Pretrial

G. Richard Bevan

10/3/2007

AFFD

NIELSEN

Affidavit of Counsel in Support of Defendant
Thomas Byrne's Motion to Quash Subpoenas
Duces Tecum
fax

G. Richard Bevan

G. Richard Bevan

., ...
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Case: CV-2005-0004345 Current Judge: G. Richard Bevan
Vaughn Schmechel, etal. vs. Clinton L Dille MD, etal.
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Judge

Date

Code
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10/3/2007

MEMO

NIELSEN

Defendant's Memorandum in Support of Motion to G. Richard Bevan
Quash Subpoenas Duces Tecum
fax

MOTN

NIELSEN

Defendant's Motion to Quash Subpoenas Duces
Tecum
fax

G. Richard Bevan

MOTN

NIELSEN

Defendant's Motion to Shorten Time
fax

G. Richard Bevan

NOHG

NIELSEN

Notice Of Hearing
fax

G. Richard Bevan

NIELSEN

Defendants Clinton Dille, M.D. and Southern
Idaho Pain lnstitute's Response to Plaintiffs'
Motion in Limine
fax

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Counsel in Support of Defendant
Thomas Byrne's Memorandum in Opposition to
Plaintiffs' Motion in Limine
fax

G. Richard Bevan

MEMO

NIELSEN

Defendant Thomas J. Byrne's Memorandum in
Opposition to Plaintiffs' Motion in Limine
fax

G. Richard Bevan

MOTN

NIELSEN

Defendant Thomas Byrne, P.A.'s Joinder in
Clinton Dille, M.D. and Southern Idaho Pain
lnstitute's Motion in Limine
fax

G. Richard Bevan

NIELSEN

Amended Plaintiffs' Exhibit List
fax

G. Richard Bevan

MEMO

NIELSEN

Memorandum in Response to Defendant's
Motions in Limine

G. Richard Bevan

MEMO

NIELSEN

Memorandum in Opposition to Defendant's
Motion to Quash Subpoenas Duces Tecum

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Byron V. Foster

G. Richard Bevan

AFFD

NIELSEN

Affidavit of J. Will Varin in Support of Clinton Dille' G. Richard Bevan
and the Southern Idaho Pain lnstitute's Response
to Plaintiffs' Motion in Limine

NIELSEN

Defendant Thomas J. Byrne's Supplemental
Disclosure of Expert Witnesses
fax

G. Richard Bevan

NIELSEN

Defendants Clinton Dille, M.D. and Southern
Idaho Pain lnstitute's Joinder in Defendant
Byrne's Motion to Quash and Response to
Plaintiffs' Opposition to Motion to Quash
fax

G. Richard Bevan

NIELSEN

Plaintiffs' Fourth Supplemental Expert Witness
Disclosure
fax

G. Richard Bevan

SUBR

NIELSEN

Subpoena Returned

G. Richard Bevan

AFSV

NIELSEN

Affidavit Of Service

G. Richard Bevan

10/4/2007

10/5/2007
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Date

Code

User

10/9/2007

HRSC

COOPE

Hearing Scheduled (Hearing Scheduled
10/11/2007 09:30 AM)

G. Richard Bevan

MEMO

NIELSEN

Pretrial Memorandum

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Byron V. Foster in Support of Plaintiffs' G. Richard Bevan
Pretrial Memorandum

MEMO

NIELSEN

Reply Memorandum in Support of Plaintiffs'
Motion in Lirnine

G. Richard Bevan

NIELSEN

Plaintiff's Proposed Jury Instructions

G. Richard Bevan

NIELSEN

Defendants Clinton Dille, M.D. and Southern
Idaho Pain lnstitute's Reply to Plaintiffs'
Response to Defendants' Motions in Limine

G. Richard Bevan

NIELSEN

Defendants Clinton Dille, M.D. and Southern
Idaho Pain lnstitute's Joinder in Defendant
Byrne's Motion in Limine

G. Richard Bevan

NIELSEN

Defendant Thomas J. Byrne, P.A. 's Proposed
Spcial Verdict Form

G. Richard Bevan

NIELSEN

Defendant Thomas J. Byrne's Trial Brief

G. Richard Bevan

NIELSEN

Defendant Thomas J. Byrne, P .A.'s Proposed
Jury Instructions

G. Richard Bevan

COOPE

Defendant's Thomas Bryne, P.A.'s Joinder in
Clinton DIiie, M.D. and Southern Idaho Pain
lnstitute's Reply to Plaintiff's Reponse to
Defendants' Motions in Limine

G. Richard Bevan

NIELSEN

Defendants' Joint Exhibit List
fax

G. Richard Bevan

NIELSEN

Defendant Clinton Dille' M.D. and Southern Idaho G. Richard Bevan
Pain lnstitute's Trial Brief

NIELSEN

Defendants Clinton DIiie, M.D. and Southern
Idaho Pain lnstitute's Jury Instructions

G. Richard Bevan

CMIN

COOPE

Court Minutes Hearing type: Motion in Limines
Hearing date: 10/11/2007 Time: 10:07 am Court
reporter: Virginia Bailey

G. Richard Bevan

CMIN

COOPE

Court Minutes Hearing type: Jury Numbering
Hearing date: 10/11/2007 Time: 9:42 am Court
reporter: Virginia Bailey

G. Richard Bevan

NOSV

NIELSEN

Notice Of Service
fax

G. Richard Bevan

MISC

COOPE

Jury Seating Chart

G. Richard Bevan

MISC

COOPE

Jury Seating Chart (Hand written)

G. Richard Bevan

HRHD

COOPE

Hearing result for Hearing Scheduled held on
10/11/2007 09:30 AM: Hearing Held

G. Richard Bevan

HRHD

COOPE

Hearing result for Motion held on 10/11/2007
10:00 AM: Hearing Held Pretrial

G. Richard Bevan

JTST

COOPE

Hearing result for Jury Trial held on 10/16/2007
09:00 AM: Jury Trial Started Excluding
Mondays

G. Richard Bevan

10/10/2007

10/11/2007

RSPN

Judge
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Case: CV-2005-0004345 Current Judge: G. Richard Bevan
Vaughn Schmechel, etal. vs. Clinton L Dille MD, etal.
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Date

Code

NIELSEN

Pocket Trial Brief Re: Hearsay Issue and Mrs.
Schmechel's Identification of Mr. Byrne
fax

NIELSEN

Supplemental Trial Memorandum Re: Dr. Lipman G. Richard Bevan
fax

NIELSEN

Second Supplemental Trial Memorandum Re:
Plaintiffs' Expert Jim Keller
fax

G. Richard Bevan

NIELSEN

Affidavit of Chris D. Comstock Regarding the
Parties' Motions in Limine

G. Richard Bevan

NIELSEN

Pocket Trial Brief Re: Hearsay Issue and Mrs.
Schmechel's Identification of Mr. Byrne

G. Richard Bevan

NIELSEN

Supplemental Trial Memorandum Re: Dr. Lipman G. Richard Bevan

NIELSEN

Second Supplemental Trial Memorandum Re:
Plaintiffs' Expert Jim Keller

G. Richard Bevan

NIELSEN

Defendant Thomas J. Byrne's Reply to Plaintiffs'
Pocket Trial Brief Re: Hearsay Issue and Mrs.
Schemchel's Identification of Mr. Byrne
fax

G. Richard Bevan

JUIN

COOPE

Defendants Clinton Dille, M.D. and Southern
Idaho Pain lnstitute's First Supplement Jury
Instructions

G. Richard Bevan

CMIN

COOPE

Court Minutes Hearing type: Jury Trial Day 1
Hearing date: 10/16/2007 Time: 9:18 am Court
reporter: Virginia Bailey

G. Richard Bevan

MISC

COOPE

Juror Questions Submitted by Defendants Dille
and Southern Idaho Pain Institute (in envelope
with answers)

G. Richard Bevan

MISC

COOPE

Jury Roll Call

G. Richard Bevan

MISC

COOPE

Peremptory Challenges

G. Richard Bevan

MISC

COOPE

Potential Jury Panel

G. Richard Bevan

ORDR

COOPE

Order Re: Motions in Limine

G. Richard Bevan

CMIN

COOPE

Court Minutes Hearing type: Jury Trial Day 2
Hearing date: 10/17/2007 Time: 8:45 am Court
reporter: Virginia Bailey

G. Richard Bevan

MISC

COOPE

Preliminary Jury Instructions

G. Richard Bevan

MISC

COOPE

Final Jury Panel

G. Richard Bevan

CMIN

COOPE

G. Richard Bevan
Court Minutes Hearing type: Jury Trial Day 3
Hearing date: 10/18/2007 Time: 9:09 am Court
reporter: Virginia Bailey Audio tape number: ct rm
1

JUIN

COOPE

Plaintiff's First Supplemental Proposed Jury
Instructions Filed

G. Richard Bevan

CMIN

COOPE

Court Minutes Hearing type: Jury Trial Day 4
Hearing date: 10/16/2007 Time: 9:00 am Court
reporter: Virginia Bailey

G. Richard Bevan

10/12/2007

10/15/2007

AFFD

MEMO

10/16/2007

10/17/2007

10/18/2007

10/19/2007

Judge

User

G. Richard Bevan
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Institute, Thomas J Byrne PA, John Doe, Jane Doe I -x
Date

Code
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10/19/2007

BREF

COOPE

Plaintiffs' Bench Brief RE: Proposed "Reckless"
Instruction

OBJC

COOPE

Plaintiffs' Objections to the Defendant's Proposed G. Richard Bevan
Jury Instructions

CMIN

COOPE

Court Minutes Hearing type: Jury Trial Day 5
Hearing date: 10/23/2007 Time: 9:00 am Court
reporter: Virginia Bailey

G. Richard Bevan

BREF

COOPE

Supplemental Bench Brief Regarding Jury
Instruction on Reckless Conduct

G. Richard Bevan

10/24/2007

CMIN

COOPE

Court Minutes Hearing type: Jury Trial Hearing
date: 10/24/2007 Time: 9:00 am Court reporter:
Virginia Bailey

G. Richard Bevan

10/25/2007

CMIN

COOPE

Court Minutes Hearing type: Jury Trial Day 7
Hearing date: 10/25/2007 Time: 9:10 am Court
reporter: Virginia Bailey

G. Richard Bevan

NOTR

NIELSEN

Notice Of Preparation Of Transcript & Filing

G. Richard Bevan

NOTR

NIELSEN

Notice Of Preparation Of Transcript & Filing

G. Richard Bevan

CMIN

COOPE

Court Minutes Hearing type: Jury Trial Day 8
Hearing date: 10/26/2007 Time: 9:10 am Court
reporter: Virginia Bailey

G. Richard Bevan

JUIN

COOPE

Plaintiffs' Second Supplemental Proposed Jury
Instructions Filed

G. Richard Bevan

OBJC

COOPE

Defendants' Joint Objections to Plaintiffs'
Proposed Jury Instructions

G. Richard Bevan

CMIN

COOPE

Court Minutes Hearing type: Jury Trial Day 9
Hearing date: 10/30/2007 Time: 8:47 am Court
reporter: Virginia Bailey

G. Richard Bevan

MISC

COOPE

Final Jury Instructions

G. Richard Bevan

OBJC

COOPE

Defendants' Joint Objections to Court's Proposed G. Richard Bevan
Final Jury Instructions

OBJC

COOPE

Defendants' Objectionto Plaintiffs' Proposed
Rebuttal Testimony of Dr. Lipman

MISC

COOPE

MISC

COOPE

Declaration of Counsel in Support of Defendants' G. Richard Bevan
Objection to Proposed Rebuttal Testimony of Dr.
Lipman
G. Richard Bevan
Special Verdict Form

10/31/2007

LETT

COOPE

Letter from Comstock and Bush

G. Richard Bevan

11/5/2007

JDMT

COOPE

Judgment

G. Richard Bevan

11/9/2007

JDMT

COOPE

Judgment

G. Richard Bevan

CDIS

COOPE

G. Richard Bevan
Civil Disposition/Judgment entered: entered for:
Byrne, Thomas J PA, Defendant; Dille, Clinton L
MD, Defendant; Doe, John, Defendant; Jane Doe
I -x,, Defendant; Southern Idaho Pain Institute,
Defendant; Hall, Tamara, Plaintiff; Howard, Kim
Lee, Plaintiff; Lewis, Robert P, Plaintiff;
Schmechel, Vaughn, Plaintiff. Filing date:
11/9/2007

10/23/2007

10/26/2007

10/30/2007

Judge
G. Richard Bevan

G. Richard Bevan
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Institute, Thomas J Byrne PA, John Doe, Jane Doe I -x
Date

Code

User

11/14/2007

AFFD

NIELSEN

Affidavit of Counsel in Support of Memorandum
of Costs

MOTN

NIELSEN

Defendant Thomas Byrne, P.A.'s Motion for Costs G. Richard Bevan

MEMO

NIELSEN

Defendant Thomas J. Byrne's Verified
Memorandum of Costs

G. Richard Bevan

MOTN

NIELSEN

Plaintiffs' Motion for New Trial

G. Richard Bevan

MEMO

NIELSEN

Memorandum in Support of Plaintiffs' Motion for
New Trial

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Byron V. Foster in Support of Plaintiffs' G. Richard Bevan
Motion for New Trial

HRSC

COOPE

Hearing Scheduled (Motion for Attorney fees and G. Richard Bevan
Costs 12/17/2007 09:00 AM)

HRSC

COOPE

Hearing Scheduled (Motion 12/17/2007 09:00
AM) for new trial -- Comstock

G. Richard Bevan

NOHG

NIELSEN

Notice Of Hearing re: Motion for New Trial
fax

G. Richard Bevan

ORDR

COOPE

Order Returning Property to Investigating law
Enforcement Agency

G. Richard Bevan

MOTN

NIELSEN

Defendants Clinton Dille, M.D. and Southern
Idaho Pain lnstitute's Motion for Costs

G. Richard Bevan

MEMO

NIELSEN

Verified Memorandum of Costs

G. Richard Bevan

NIELSEN

Defendant Thomas J. Byrne's Amended Verified
Memorandum of Costs

G. Richard Bevan

NOHG

NIELSEN

Notice Of Hearing
fax

G. Richard Bevan

11/28/2007

OBJC

NIELSEN

Plaintiffs' Objections to Defendant Thomas J.
Byrne's Verified Memorandum of Costs

G. Richard Bevan

11/30/2007

NOHG

NIELSEN

Notice Of Hearing

G. Richard Bevan

NIELSEN

Defendant Thomas J. Byrne's Memorandum in
Opposition to Plaintiffs' Motion for New Trial

G. Richard Bevan

NIELSEN

Affidavit Keely E. Duke in Support of Thomas J.
Byrne's Memorandum in Opposition to Plaintiffs'
Motion for New Trial

G. Richard Bevan

NIELSEN

Defendants Clinton Dille, M.D. and Southern
Idaho Pain lnstitute's Response to Plaintiffs'
Motion for New Trial

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Steven J. Hippler in Support of Clinton G. Richard Bevan
Dille and the Southern Idaho Pain lnstitute's
Response to Plaintiffs' Motion for New Trial

OBJC

NIELSEN

Plaintiffs' Objections to Defendant Clinton Dille,
M.D. and Southern Idaho Pain lnstitute's Verified
Memorandum of Costs
fax

G. Richard Bevan

NIELSEN

Defendant Thomas J. Byrne's Reply
Memorandum in Support of Motion for Costs

G. Richard Bevan

11/19/2007

11/20/2007

11/21/2007

11/23/2007

11/26/2007

12/3/2007
AFFD

12/4/2007

12/13/2007

Judge
G. Richard Bevan

'lr1r-fl
J.
I_, J )

Date: 9/11/2008

Fifth Ju(

Time: 09:38 AM
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12/13/2007

MEMO

NIELSEN

Reply Memorandum in Support of Plaintiffs'
Motion for New Trial

12/14/2007

AFFD

NIELSEN

Affidavit of J. Will Varin in Support of Defendants G. Richard Bevan
Clinton Dille, M.D. and Southern Idaho Pain
lnstitute's Reply to Plaintiffs' Objections to
Defendants Verified Memorandum of Costs

MEMO

NIELSEN

Amended Verified Memorandum of Costs

G. Richard Bevan

NIELSEN

Defendants Clinton Dille, M.D. and Southern
Idaho Pain lnstitute's Reply to Plaintiffs'
Objections to Defendants Verified Memorandum
of Costs

G. Richard Bevan

CMIN

COOPE

Court Minutes Hearing type: Motion for New trial G. Richard Bevan
and motion for atty fees Hearing date:
12/17/2007 Time: 9:00 am Court reporter: Virginia
Bailey

HRHD

COOPE

Hearing result for Motion held on 12/17/2007
09:00 AM: Hearing Held for new trial -Comstock

G. Richard Bevan

HRHD

COOPE

Hearing result for Motion for Attorney fees and
Costs held on 12/17/2007 09:00 AM: Hearing
Held Dille and Bryne

G. Richard Bevan

1/23/2008

OPIN

COOPE

Memorandum Opinion and Order RE: Plaintiffs'
Motion for New Trial

G. Richard Bevan

1/24/2008

OPIN

COOPE

Memorandum Decision and Order RE:
Defendants' Motions for Costs

G. Richard Bevan

2/14/2008

JDMT

COOPE

Amended Judgment

G. Richard Bevan

JDMT

COOPE

Judgment Nunc Pro Tune

G. Richard Bevan

3/3/2008

MISC

COOPE

Estimate Cost of Reporter's Transcript 2100
pages

G. Richard Bevan

3/5/2008

NTOA

COOPE

Notice Of Appeal

G. Richard Bevan

CCOA

COOPE

Clerk's Certificate Of Appeal

G. Richard Bevan

COOPE

G. Richard Bevan
Filing: T - Civil Appeals To The Supreme Court
($86.00 Directly to Supreme Court Plus this
amount to the District Court) Paid by: Comstock,
David E. (attorney for Schmechel, Vaughn)
Receipt number: 8006054 Dated: 3/5/2008
Amount: $15.00 (Check) For: Schmechel,
Vaughn (plaintiff)

COOPE

Miscellaneous Payment: For Making Copies Of
Transcripts For Appeal Per Page Paid by:
Comstock and Bush Receipt number: 8006055
Dated: 3/5/2008 Amount: $70.00 (Check)

G. Richard Bevan

COOPE

Miscellaneous Payment: Record Covers For
Appeals Paid by: Comstock and Bush Receipt
number: 8006055 Dated: 3/5/2008 Amount:
$30.00 (Check)

G. Richard Bevan

COOPE

Supreme Court Document Filed- Copy of Filing
Fee Receipt

G. Richard Bevan

12/17/2007

i

3/14/2008

SCDF

Judge
G. Richard Bevan
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3/14/2008

SCDF

COOPE

Supreme Court Document Filed- Filing of Clerk's
Certificate

SCDF

COOPE

Supreme Court Document Filed- Notice of Appeal G. Richard Bevan
(T)

REQU

COOPE

Defendant Thomas J. Bryne, PA's Request for
Additional Transcript and Record

REQU

COOPE

Defendants Clinton Dille M.D. and Southern Idaho G. Richard Bevan
Pain lnstitute's Request for Additional Transcripts
and Records

3/18/2008

CCOA

COOPE

Amended Clerk's Certificate Of Appeal

G. Richard Bevan

3/24/2008

SCDF

COOPE

Supreme Court Document Filed- Order Granting
Court Reporter's Motion for Extension of Time

G. Richard Bevan

SCDF

COOPE

Supreme Court Document Filed- Clerk's Record
& Transcript Due Date Reset

G. Richard Bevan

3/28/2008

SCDF

COOPE

Supreme Court Document Filed- Document{s)

G. Richard Bevan

4/2/2008

AFFD

NIELSEN

Affidavit of Byron W. Foster
fax

G. Richard Bevan

MOTN

NIELSEN

Plaintiff's Motion to Extend _Automatic Stay
fax

G. Richard Bevan

AFFD

NIELSEN

Affidavit of Taylor L. Mossman
fax

G. Richard Bevan

NIELSEN

Defendants Clinton Dille', M.D. and Southern
Idaho Pain lnstitute's Objection to Plaintiffs'
Motion to Extend Automatic Stay
fax

G. Richard Bevan

NIELSEN

Affidavit of Steven J. Hippler in Support of
Defendants' Objection to Plaintiffs' Motion to
Extend Automatic Stay
fax

G. Richard Bevan

COOPE

G. Richard Bevan
Miscellaneous Payment: For Making Copies Of
Transcripts For Appeal Per Page Paid by: Givens
Pursley Receipt number: 8009231 Dated:
419/2008 Amount: $100.00 (Check)

HRSC

COOPE

Hearing Scheduled (Motion 05/28/2008 02:00
PM) to stay execution and bond in interesting
bearing acct., by phone

G. Richard Bevan

NOTC

COOPE

Plaintifrs Notice of Posting of Cash Bond

G. Richard Bevan

MOTN

COOPE

Plaintiff's Motion to Stay Execution of Judgment
Pending the Appeal

G. Richard Bevan

BNDC

COOPE

Bond Posted - Cash (Receipt 8011835 Dated
518/2008 for 35603.64)

G. Richard Bevan

OBJC

NIELSEN

Defendants Clinton Dille, M.D. and Southern
Idaho Pain lnstitute's Objection to Plaintiffs'
Motion to Stay Execution of Judgment Pending
the Appeal

G. Richard Bevan

NOHG

COOPE

Notice Of Telephonic Hearing RE: Plaintiffs'
Motion to Stay Execution of Judgment Pending
the Appeal and Notice of Posting Cash Bond

G. Richard Bevan

3/17/2008

418/2008

AFFD

4/912008

5/812008

5/12/2008

Judge
G. Richard Bevan

G. Richard Bevan
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NIELSEN

Thomas Byrne, P.A.'s Joinder in Defendants
Clinton Dille, M.D. and Souther Idaho Pain
lnstitute's Objection to Plaintiffs' Motion to Stay
Execution of Judgment Pending the Appeal
fax

CMIN

COOPE

Court Minutes Hearing type: Motion Hearing date: G. Richard Bevan
5/28/2008 Time: 10:00 am Court reporter: Virginia
Bailey Audio tape number: ct rm 1

DCHH

COOPE

G. Richard Bevan
Hearing result for Motion held on 05/28/2008
02:00 PM: District Court Hearing Held
Court Reporter:
Number of Transcript Pages for this hearing
estimated: to stay execution and bond in interest
bearing acct., by phone

5/30/2008

ORDR

COOPE

Order Granting Plaintiffs' Motion to Stay
Execution of Judgment Pending the Appeal

G. Richard Bevan

6/9/2008

SCDF

COOPE

Supreme Court Document Filed- Document

G. Richard Bevan

SCDF

COOPE

Supreme Court Document Filed- Clerk's Record
and Transcript Due Date Reset

.G. Richard Bevan

SCDF

COOPE

Supreme Court Document Filed- Order Granting
Court Reporter's Motion for Extension of Time

G. Richard Bevan

SCDF

COOPE

Supreme Court Document Filed- Clerk's Record
& Transcript Due Date Reset

G. Richard Bevan

NOTC

COOPE

Notice of Balance Due on Clerk's Record

G. Richard Bevan

NOTC

COOPE

Notice of Balance Due on Clerk's Record

G. Richard Bevan

NOTC

COOPE

Notice of Balance Due on Clerk's Record

G. Richard Bevan

COOPE

Miscellaneous Payment: Personal Copy Fee Paid G. Richard Bevan
by: Comstaock and Bush Receipt number:
8016131 Dated: 6/24/2008 Amount: $61.70
(Check)

COOPE

Miscellaneous Payment: For Making Copies Of
Transcripts For Appeal Per Page Paid by:
Comstaock and Bush Receipt number: 8016131
Dated: 6/24/2008 Amount: $291.25 (Check)

G. Richard Bevan

COOPE

Miscellaneous Payment: Record Covers For
Appeals Paid by: Comstaock and Bush Receipt
number: 8016131 Dated: 6/2412008 Amount:
$30.00 (Check)

G. Richard Bevan

COOPE

G. Richard Bevan
Miscellaneous Payment: For Making Copies Of
Transcripts For Appeal Per Page Paid by: Hall,
Farley, Oberrecht & Blanton P.A. Receipt number:
8016139 Dated: 6/24/2008 Amount: $269.00
(Check)

COOPE

Miscellaneous Payment: Personal Copy Fee Paid G. Richard Bevan
by: Hall, Farley, Oberrecht & Blanton P.A. Receipt
number: 8016140 Dated: 6/24/2008 Amount:
$6.90 (Check)

5/21/2008

5/28/2008

6/13/2008

6/24/2008

G. Richard Bevan

Fifth Jue

Date: 9/1112008
Time: 09:38 AM

User: COOPE

l District Court - Twin Falls County
ROA Report

Case: CV-2005-0004345 Current Judge: G. Richard Bevan

Page 17 of 17

Vaughn Schmechel, etal. vs. Clinton L Dille MD, etal.
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COOPE

G. Richard Bevan
Miscellaneous Payment: For Making Copies Of
Transcripts For Appeal Per Page Paid by: Hall,
Farley, Oberrecht & Blanton P.A. Receipt number:
8016140 Dated: 6/24/2008 Amount: $47.50
(Check)

COOPE

Miscellaneous Payment: Personal Copy Fee Paid G. Richard Bevan
by: Givens Pursley Receipt number: 8016141
Dated: 6/24/2008 Amount: $62.00 (Check)

COOPE

Miscellaneous Payment: For Making Copies Of
G. Richard Bevan
Transcripts For Appeal Per Page Paid by: Givens
Pursley Receipt number: 8016141 Dated:
6/24/2008 Amount: $211.25 (Check)

LODG

COOPE

lodged Transcript Volume 1

G. Richard Bevan

LODG

COOPE

Lodged Transcript Volume 2

G. Richard Bevan

7/11/2008

SCDF

COOPE

Supreme Court Document Filed- Notice of
Transcript Lodged

G. Richard Bevan

8/5/2008

OBJC

NIELSEN

Defendants Clinton Dille, M.D. and Southern
G. Richard Bevan
Idaho Pain lnstitute's Objection to Clerk's Record
and Request for Additional Items

OBJC

NIELSEN

Defendant Thomas J. Byrne's Joinder in
G. Richard Bevan
Defendants Clinton Dille M.D. and Southern Idaho
Pain lnstitute's Objection to Clerk's Record and
Request for Additional Items
fas

8/6/2008

HRSC

COOPE

Hearing Scheduled (Motion 09/03/2008 09:00
AM) Objection to clerk's record

G. Richard Bevan

8/712008

NOHG

NIELSEN

Notice Of Hearing

G. Richard Bevan

8/12/2008

SCDF

COOPE

Supreme Court Document Filed- Document (s)

G. Richard Bevan

SCDF

COOPE

Supreme Court Document Filed- Clerk's
Record/Reporter's Trans. -Suspended-

G. Richard Bevan

STIP

NIELSEN

Stipulation re: to Clerk's Record and Request for G. Richard Bevan
Additional Items

ORDR

COOPE

Order RE: Objection to Clerk's Record and
Request for Additional Items and Stipulation RE:
Objection to Clerk's Record and Request for
Additional Items

HRVC

COOPE

NOTC

COOPE

G. Richard Bevan
Hearing result for Motion held on 09/03/2008
09:00 AM: Hearing Vacated Objection to clerk's
record
G. Richard Bevan
Notice of Balance due on Clerk's Record
(Supplemental)

SCDF

COOPE

Supreme Court Document Filed- Document( s)

G. Richard Bevan

SCDF

COOPE

Supreme Court Document Filed- Clerk's Record
and Transcript Due Date Reset

G. Richard Bevan

6/24/2008

7/8/2008

8/22/2008

8/27/2008

9/2/2008

G. Richard Bevan
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Keely E. Duke
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!SB #6044; ked@hallfarley.com

Chris D. Comstock
!SB #6581; cdc@hallfarley.com

HALL, FARLEY, OBER.RECHT & BLANTON, P.A.
702 West Idaho, Suite 700
Post Office Box 1271
Boise, Idaho 83701
Telephone: (208) 395-8500
Facsimile: (208) 395-8585
W:\2\2-404.53\Ncw Trlal Opp.doc

Attorneys for Defendant Thomas J. Byrne
IN THE DISTRICT COURT OF THE FIFTH WDICIAL DISTRICT
OF THE STATE OF IDAHO, IN AND FOR THE COUNTY OF TWIN FALLS

VAUGHN SCHMECHEL, individually,
and as Surviving Spouse and Personal
Representative of the Estate of ROSALIE
SCHMECHEL, deceased, and ROBERT P.
LEWIS, KIM HOWARD and TAMARA
HALL natural children of ROSALIE
SCHMECHEL, deceased,

Case No. CV-05-4345

DEFENDANT THOMAS J. BYRNE'S
MEMORANDUM IN OPPOSITION
TO PLAINTIFFS' MOTION FOR
NEWTRIAL

Plaintiffs,
vs.
CLINTON DILLE, M.D., SOUTHERN
IDAHO PAIN INSTITUTE, an Idaho
corporation, THOMAS BYRNE, P.A. and
JOHN DOE, I through X,
Defendants.

COMES NOW defendant, Thomas J. Byme (hereinafter "Mr. Byme"), by and through his

DEFENDANT THOMAS J. BYRNE'S MEMORANDUM IN OPPOSITION TO PLAINTIFFS' MOTION FOR
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counsel of record Hall, Farley, Oberrecht & Blanton, P.A., and submits this Memorandum in
Opposition to Plaintiffs' Motion for New Trial.
I.

INTRODUCTION

This was an action for medical malpractice wherein plaintiffs alleged Mr. Byrne and Clinton
Dille, M.D. (hereinafter "Dr. Dille") breached the applicable standard of care in their care and
treatment of Mrs. Schmechel. This case was tried before the Honorable G. Richard Bevan,
commencing on October 16, 2007. On October 31, 2007, the jury returned a w1animous verdict,
finding that defendants did not breach the standard of care in their care and treatment of Rosalie
Schmechel. Judgment for Mr. Bymewas entered on November 5, 2007 and judgment for Dr. Dille
was entered on November 9, 2007.
Plaintiffs' Motion for New Trial pursuant to Idaho Rule of Civil Procedure 59(a)(l)(3) and
(7) alleges four issues which they assert warrant a new trial in this matter. First, plaintiffs argue the
Court erred in precluding plaintiffs' experts from offering expert testimony regarding the Delegation
of Services Agreement and how such Agreement pertains to the standard of care. Second, plaintiffs
argue the Court erred in allowing defendants' expert, Dr. Smith, to testify at trial regarding his
opinion as to the cause of Mrs. Schmechel' s death based upon an alleged late disclos,ire of such
opinion. Third, plaintiffs allege the Court erred in not admitting the IDAPA regulations regarding
physician assistants into evidence or instructing the jury as to negligence per se based upon such
instruction. As a note, the Court did provide the jury with an instruction indicating the Court took
judicial notice of the IDAPA regulations, but did not admit the Regulations themselves. Finally,
plaintiffs allege the Court erred in biforcating the issue ofreoklessness. Plaintiffs' Motion for New
Trial should be denied on all grounds, as they are unable to establish any errors oflaw, irregularities
in the proceedings which prevented them from having a fair trial, or any surprises that could not have
DEFENDANT THOMAS J. BYRNE'S MEMORANDUM fN OPPOSITION TO PLAINTIFFS' MOTION FOR
NEWTRIAL-2

been prevented with ordinary prudence. The Court appropriately recognized the discretionary nature
of each of the above issues, and did not abuse such discretion with regard to any of its rulings.

II. STANDARDS
Plaintiffs' Motion for New Trial is based on Idaho Rule of Civil Procedure 59(a) whicl1 states
in pertinent part:,
A new trial may be granted to all or any of the parties and on all or
part of the issues in an action for any of the following reasons:
1. Irregularity in the proceedings of the court, jury or adverse party or
any order ofthe court or abuse of discretion by which either party was
prevented from having a fair trial.

***
3. Accident or surprise, which ordinary prudence could not have
guarded against.

***
i

En-or in law, occun-ing at the trial.

The Court has wide discretion in determining whether to grant a motion for new trial and a
trial cou1t' s decision will not be overturned unless the trial court abuses such discretion. Craig

Johnson Const., LLC v. Floyd Town Architects, P.A., 142 Idaho 797, 800, 134 P .3d 648,651 (2006).
Idaho appellate courts review the decision to grant or deny a motion for a new trial under an abuse of
discretion standard. Warren v. Sharp, 139 ldaho 599,603, 83 PJd 773, 777 (2003). On appeal, the
trial court's decision to grant or deny a new trial will not be disturbed absent a showing of manifest
abuse. Dyet v. McKinley, 139 Idaho 526,529, 81 P.3d 1236, 1239 (2003).
When considering whether to grant a new trial pursuant to I.R. C.P. 59( a)( 1), plaintiffs must
establish that an irregularity in the proceedings of the Court, j my or adverse party prevented
plaintiffs from receiving a fair trial. A comt' s determination of whether such an irregularity
DEFENDANT THOMAS J. BYRNE'S MEMORANDUM IN OPPOSITION TO PLAINTIFFS' MOTION FOR
NEW TRIAL- 3
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prevented plaintiff from having a fair trial is a matter of discretion. Myers v. A. 0. Smith Harvestore

Products, Inc., l 14 Idaho 432,440, 757 P.2d 695, 703 (Ct. App.,1988)
A motion pursuant to I.R.C.P. 59(a)(3) requires a showing 1hat the alleged accident or
surprise is one that "ordinary prudence could not have guarded against." LR.C.P. 59(a)(3). Hughes v.

State, Idalw Dept. ofLaw Er/forcement, 129 Idaho 558,562,929 P.2d 120, 124 (1996). Fur1her, the
moving party must establish that such accident or surprise caused prejudice. See Westfall v.

Caterpillar, Inc., 120 Idaho 918,821 P.2d 973 (1991).
Pursuant to Rule 59( a)(7), the trial court may grant a new trial for errors in law that occurred
during trial, but only if such error affects a substantial right of the moving party. Highland

Enterprises, Inc._ v. Barker, 133 ldaho 330,345,986 P.2d 996, 1011 (1999). The decision to grant or
deny a motion for new trial on this ground is wi1hin the sound discretion of the trial court, and the
trial court's decision will not be disturbed on appeal "unless it clearly appears to have been applied
unwisely and to have been manifestly abused." Davis v. Sun Valley Ski Education Foundation, Inc.,
130 Idaho 400, 404-05, 941 P.2d 1301, 1305-06 (1997) (quotingSherwpodv. Carter, 119 Idaho 246,
261, 805 P.2d 452, 467 (1991 )). The trial court is vested with "wide discretion" to grant or deny a
motion for new trial pursuant to Rule 59(a)(7) when the substantial rights of the movant are not
affected and that party is not entitled to a new trial as a matter ofright. Craig Johnson Const., LLC,
142 Idaho at 801, 134 P.3d at 652.
III. ARGUMENT
A. The Court Properly Precluded Plaintiffs' Experts From Offering Expert Testimony
Regarding the Delegations of Senriccs Agreement, as Plaintiffs Failed to Disclose
Such Opinions.

Plaintiffs argue they are entitled to a new trial based on the Court's ruling precluding their
experts from offering expert testimony regarding whether defendants had breached the Delegation of
DEFENDANT THOMAS J. BYRNE'S MEMORANDUM IN OPPOSITION TO PLAINTIFFS' MOTION FOR
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Services Agreement. Specifically, plaintiffs argue the 2003 Delegation of Services Agreement was
untimely produced, and that such late disclosure prohibited them from addressing this issue with
their experts prior to trial and supplementing their expert disclosures. As such, plaintiffs argue that
the late disclosure constitutes an irregularity in the proceedings and unfair surprise, and that the
Court's ruling to exclude their experts' testimony regarding the Agreement was an error in law.
However, as discussed below, plaintiffs' arguments fail for the following reasons: (1) the 2003 DOS
Agreement was produced as soon as it was discovered; (2) plaintiffs could have avoided any unfair
surprise by providing their experts with the earlier produced 2004 DOS Agreement, 2001 Job
Description and IDAP A regulations and disclosed whatever expert opinions they may have had; and
(3) plaintiffs had an opportunity to present rebuttal evidence regarding the 2003 DOS Agreement but
failed to do so and thereby waived their ability to argue such issue.

1. The 2003 Delegation of Services Agreement Was Produced As Soon As it
Was Discovered,
The disclosure of the 2003 DOS Agreement on October 10, 2007, does not constitute an
irregularity in the proceedings that would give rise to a new trial, as the disclosure did not prevent
plaintiffs from having a fair trial. For purposes of background, a copy of the 2004 DOS Agreement
as well as a copy·of a 2001 employment contract with Southern Idaho Pain Institute was produced at
Mr. Byrne's deposition on May 18, 2006.
On October 4, 2007, defendants received a letter from plaintiffs' counsel indicating a DOS
Agreement was required in 2003, and to "kindly supplement your response." (See Affidavit of Byron
Foster in Support of Plaintiffs' Motion for New Trial, Ex. D). After receiving this letter, counsel for
Mr. Byrne realized that at Mr. Byrne's May 18, 2006 deposition, a copy of the 2004 DOS
Agreement (not the 2003 Agreement) was produced. As such, counsel for Mr. Byrne asked Mr.

DEFENDANT THOMAS J. BYRNE'S MEMORANDUM IN OPPOSITION TO PLAINTIFFS' MOTION FOR
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Byrne ifhe could search his records for a copy of a 2003 DOS Agreement. (See Duke Aff., 12). Mr,
Byrne conducted a search of his records that were kept in storage and discovered the 2003 DOS
Agreement and provided it to counsel, who the~1 irnrnediately_produce_1 th~ do~um~nt to plaintiffs'
counsel on October 10, 2007. (See Defendant Thomas J. Byrne, P.A.'s Fourth Supplemental
Responses to Plaintiffs' First Set of Requests for Production of Documents, Foster Aff., Ex. E). An
assistant from plaintiffs' counsels' office emailed Mr. Byrne's counsel to examine the original
document, and Ms. Duke emailed back indicating "you can come over any time." (See Duke Aff.,
Ex. 2 (October I 0, 2007 email from Margie Rosenberg to Ms. Duke and return email from Ms. Duke
to Ms. Rosenberg). Plaintiffs' paralegal, Margie Rosenberg, inspected the original 2003 DOS
Agreement on October 11, 2007.
2: The 2003 and 2004 Delegation of Service Agreements are Nearly Identical.

Plaintiffs argue in their motion for new trial 1hey incurred unfair prejudice in that the 2003
DOS Agreement was not produced until October 10, 2007, and they did not have an opportunity to
address issues relating to the Agreement in regard to standard of care as a result. However, plaintiffs
had a copy of the 2004 DOS Agreement as of May 18, 2006, as well as a copy of the 2001 Job
Description. Plaintiffs crumot establish any unfair prejudice or surprise, however, as the 2004
Agreement is nearly identical to the 2003 DOS Agreement, and plaintiffs could have provided the
2004 DOS Agreement, the 2001 Job Description and the IDAPA regulations regarding physician
assistants in order to develop and disclose expert opinions prior to trial.
The 2003 DOS Agreement (Ex. 40) ru1d the 2004 DOS Agreement (Attached as Ex. 4 to the
Duke Aff.) vary in only very minor ru1d insignificant ways which are described below witb the

I1

changes underscored:

r·

''

1
"
1

I

l'
'
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The first sentence of the paragraph under heading Re-Evaluation:
o 2003 Agreement states: "The PA will be utilized in the re-evaluation of existing
patients for medication management, prescription renewal and recommendations
for further t·eatment within our facility."
o 2004 Agreement states: "The PA will be utilized in the re-evaluation of existing
patients for medication management & renewal and recommendations for further
treatment within our facility."
The second sentence of the paragraph under the heading of Minor Procedures:
o 2003 Agreement States: "These include but are not limited to: trigger point
injections, small joint injections, occipital injections, and laceration repair.
o 2004 Agreement states: "These include but are not limited to: trigger point
injections, small joint injections, occipital injections, and manipulations."
The second paragraph under the heading of"Direction and Control," second line:
o 2004 Agreement contains a typographical error that is not present in the 2003
Agreement ("they" instead of "the").
The 7th line under heading "Emergency Procedures":
o 2003 Agreement states a "primary or secondary physician will be available 24
hours per day ...
o 2004 Agreement states a "primary or secondary physician will be available 23
hours per day ... "
The third paragraph under the heading "Prescription Authority":
o 2003 Agreement states: "Current prescribing privileges, now include Schedule 2,
2N, 3, 3N, 4 and 5, after application and approval through the Idaho Board of
Medicine and Federal Drug Enforcement Administration Guidelines."
o 2004 Agreement states: "Current prescribing privileges, now include Schedule 2,
2N, 3, 3N, 4 and 5. This change came after application and approval through the
Idaho Board of Medicine and Federal Drug Enforcement Administration
guidelines."
The 6°1 line under heading "Care Review":
o 2003 Agreement states: "In addition, a secondary supervising physician or I will
be available 24 hours a day to provide the physician assistant with medical
guidance and supervision."
o 2004 Agreement states: "In addition l or a secondary supervising physician wilJ
be available 23 hours a day to provide the physician assistant with medical
guidance and supervision."
As evidenced in the line by line comparison of the 2003 and 2004 DOS agreements, the
substance of the two DOS agreements was not different-specifically, the portion that defendants
DEFENDANT THOMAS J. BYRNE'S MEMORANDUM 1N OPPOSITJON TO PLAINTIFFS' MOTION FOR
NEWTRIAL-7

lU?7

i

were primarily questioned on had to do with the paragraph entitled "Initial Evaluation of Patients."

l
iI
/

This paragraph is identical in both the 2004 and 2003 DOS Agreements:

l

The physician assistant employed with Southern Idaho Pain & Rehabilitation will be
utilized in the initial evaluation for patients seen in this facility. These patients stem from a physician referral base and also patient self-referrals. Patients will require a
full history and physical on initial visit. Pertinent findings will be documented and
recommendations made. The recommendations will be reviewed by the supervising
physician to confirm findings and determine a treatment plan.

ll

l

!f

3. Plaintiffs' Experts Testified at Deposition and Trial that Defendants
Complied with Idaho Law.

Interestingly, although the 2003 DOS Agreement was not produced to plaintiffs' experts until
at least October 10, 2007, plaintiffs' experts did not opine that defendants were in violation ofidaho
law for failing to have a 2003 DOS Agreement. Further, plaintiffs' experts testified at deposition
and trial that Mr. Byrne had the authority to perform a history, initial evaluation., determine a
with
treatment plan and prescribe
. Mrs. Schmechel medication, and that such authority complied
.
Idaho law.
Specifically, Dr. Lordon testified at trial as follows:
Q:

Let's talk about physicians assistants a little bit. You would agree that a
physician assistant is a physician extender?

A:

I would use that term.

Q:

Physician assistants evaluate and treat patients, and they do minor medical
procedures; correct?

A:

That is correct?

Q:

And that's all appropriate for them to do those things?

A:

Yes, it is.

Q:

It was certainly okay, in your opinion, for Mr. Byrne to prescribe
medications?
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A:

Absolutely.

Q:

That's something that Idaho law permits him to do?

A:

Yes.

Q:

And Idaho law also allows physician assistants to evaluate, plan, and
implement plans of care, and you have 110 problem with that; correct?

A:

I have no problem with that.

Q:

So you are in no way critical of the fact that Mr. Byme treated Mrs.
Schmechel; con-ect?

A:

No, none whatsoever.

Duke Aff., Ex, 5 (relevant portions of Dr. Lordon's trial testimony), pp. 66-67, IL S-6.
Plaintiffs' expert Mr. Keller testified in his deposition as follows:
Q:

But let me ask you this, it was okay, as I understand it, for Mr. Byrne to make
the decisions as a physician assistant to alter the medication, correct?

A:

Sure. That's by any state regulation and supervisory dlctorum that you have
and the relationship that you have with your supervising physician, a PA has
the authority to do that. Sure.

Q:

You are not critical of him doing that aspect of it?

A:

No, absolutely not.

(See Duke Aff., Ex. 6 (relevant portions of Mr. Keller's deposition transcript), pp. 55-65, II. I 9-3).

Further, Mr. Keller testified at trial as follows:

Q:

Btit with respect to what I have up there, a physician assistant, taking medical
histories., conducting physical examinations, prescribing medications,
counseling and educating patients, monitoring patients, ordering diagnostic
tests, performing minor surgery that's all within the scope of a physician
assistant's practice; correct?

A:

Their practice and their education, yes.

l

l

L

(See Duke Aff., Ex. 7 (October 18, 2007 testimony of Mr. Keller, p. 51, 11. 15-22)).
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Dr. Lipman testified in his deposition regarding Idaho physician assistant regulations as
follows:
Q:

Do you understand that physician's assistants in Idaho have, or did in 2003,
- have the authotity to see patients on initial evaluation and to prescribe a
course of treatment, including Schedule II narcotics?

A:

Yes.

Q:

Without a physician first approving that course of conduct.

A:

Yes. (Deposition ofDr. Lipman, p. 191, IL 8-16).

Dr. Lipman further testified in his deposition:
Q:

Is it your contention that Mr. Byrne or Dr. Dille violated any applicable
statute or rule of law in the state of Idaho?

A:

No.

(See Duke Aff., fx. 8 (Deposition of Dr. Lipman, p. 237, 11. 3-6)). The above testimony from trial

and depositicms,indicates that plaintiffs' experts had the opportunity to opine regarding the scope
and authority of a physician assistant as governed by Idaho law despite the production of the 2003
DOS Agreement in October 2007. Further, the above testimony reveals these experts felt Mr. Byrne
was within the scope of his allowable practice as outlined by Idaho law in his treatment and care of
Mrs. Schmechel.

4. The Timing of the Disclosure of the 2003 DOS Agreement Did Not Preclude
Plaintiffs From Disclosing Expert Testimony Regarding the Scope of Mr.
Byrne's Authority or Whether Defendants Had Complied With Idaho Law.
Plaintiffs argue that as a result of the late disclosure of the 2003 DOS Agreement, they were
precluded from disclosing their expert opinion regarding such Agreement. However, this argument
fails, as plaintiffs had access to the IDAP Aregulation indicating a DOS Agreement was requited, a

)

l

l
l
i

copy of the 2004 DOS Agreement and the 2001 Job Description as ofMay 18, 2006. Plaintiffs could
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have had their experts address the ID AP A regulations and their requirement that a DOS agreement
be in place in 2003 and that if no such DOS agreement existed, defendants were violating such
regulations.: or ~he ~g_11ag<:_ oft~e 2004 Agreement and 2001 Job Description. Plaintiffs faile~ to do
so. In fact, it appears plaintiffs did not provide these documents to their experts until after they were
deposed in this matter and just prior to trial. (See Plaintiffs' Fourth Supplemental Expert Witness
Disclosures, dated October 5, 2007).
Further, plaintiffs could have and should have supplemented their expert disclosures based
upon the 2003 Agreement prior to trial. The parties both engaged in supplementation of expert
witness opinions up to the time of trial. In fact, plaintiffs submitted their Fourth Supplemental
Expert Witness Disclosures on October 5, 2007. As the Court stated in sustaining the objection to
Dr. Lordon' s testimony regarding the 2003 Agreement:
I am going to sustain the objection. I dete1mine that, even though it wasn't disclosed
until last.week, that the nature of the inquiry and the circumstances surrounding this
testimony were known in advance sufficiently to allow this disclosure to have been
made. So I will sustain the defendant's objection.
(See Duke Aff., Ex. 5, p. 39, IL 14-20).
5, The Court Properly Excluded Plaintiffs' Experts Fram Offering
Undisclosed Expert Testimony Regarding the DOS Agreement.

Trial courts have "broad discretion in the admission.of evidence at trial, and [their] decision
to admit such evidence will be reversed only when there has been a clear abuse of that discreti-011.
The same standard applies to the admission of expe1i testimony." Karlson v. Harris, 140 Idaho 561,
564, 97 P.3d 428, 43 l (2004 ). It is appropriate to exclude from trial the opinion testimony of any
expert whose opinion was not disclosed pursuant to written requests for discovery. I,R.C,P. 26(e)(4);
C/arkv. Ratay, 1)7 Idal10 343,347, 48 P.3d 672,676 (Ct. App. 2002).
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Based on the foregoing, it is clear that the Court properly exercised its discretion in excluding
plaintiffs' experts from offering undisclosed expert testimony regarding the 2003 DOS Agreement,
as plaintiffs could have exercised ordinary prudence in avoiding any unfair surprise and disclosed
such any such opinions prior to trial. Further, it is important to note the Court similarly precluded
defendants' retained experts from testifying regarding their expert opinions as to whether Mr. Byrne
and Dr. Dille complied with the 2003 Agreement for failing to disclose such opinions prior to trial.
6. Plaintiffs Waived Their Right to Assert an Error by Failing to Address The
2003 DOS Agreement in Rebuttal Testimony.

At trial, the Court indicated it would consider allowing plaintiffs to address issues regarding
the 2003 DOS Agreement on rebuttal. However, plaintiffs did not attempt to address this matter on
rebuttal, and therefore failed to preserve this issue for appeal. By failing to attempt to offer rebuttal
testimony from their experts regarding the 2003 DOS Agreement, the parties cannot know whether
the Court would have allowed such rebuttal testimony. As such, plaintiffs failed to properly raise his
issue at trial, and are precluded from doing so now. See Lankfordv. Nicholson lvffg, Co., 126 Idaho
187,189,879 P.2d 1120, 1122 (1994).
ln conclusion, plaintiffs are unable to show an irregularities in the proceedings, unfair
surprise, or errors in law with regard to the Court's ruling to preclude plaintiffs' experts from
offering their undisclosed expert opinions regarding the 2003 DOS Agreement. As noted by the
Court, plaintiffs. had an opportunity to disclose such opinions prior to trial and failed to do so.
Further, plaintiffs waived any such argument by failing to attempt to address this issue on rebuttal.
B. Plaintiffs Were Not Unfairly Surprised by the Testimony of Dr. Smith.

Plaintiffs argue the Court erred in allowing Dr. Smith to testify on the grounds that his

,

,;

~-<O•

opinions regarding causation were not seasonably supplemented, and that plaintiffs were prejudiced

1
.t:
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in that based 011 the timing of the disclosures, they were not afforded an opporlunity to depose Dr.
Smith or seek out a cardiology expett of their own.
First, any alleged error in the admission of Dr. Smifi1' s testimony was harmless. Specifically,
Dr. Smith did n6t testify regarding standard of care. Rather, the objected to testimony of Dr. Smith
dealt exclusively with the issue of proximate cause. The jury unanimously decided that Mr. Byrne
and Dr. Dille met the applicable standard of care and, were not required to decide.the issue of the
cause of Mrs. Schmechel's death. InPeschke v. Carroll College, 929 P.2d 874,881 (Mont.,1996),
the court found the trial court erred in allowing defendant's videotape reenactment into evidence.
However, on appeal, the court held that such error was harmless, "[sJuch timing evidence goes to the

.i

I
!

issue of causation, which the jury did not reach, having determined that Carroll had not breached its
duty to warn and was therefore not negligent. Thus, we conclude that the court's error in this regard
was harmless." Id.
Regardless, plaintiffs are unable to show entitlement to a new trial, as discussed below,
because Dr. Smith's original opinions were timely disclosed and once Dr. Smith had an opportunity
to review the depositions of the pathologist, Dr. Groben, and the coroner, his supplemental opinions
were seasonably supplemented. Further, as noted by the Court in denying plaintiffs' objection to Dr.
Smith's testimony, plaintiffs had sufficient time to address Dr. Smith's testimony regarding
causation. Therefore, plaintiffs' argument that they were "stonewalled" is without merit and the
Court's discretionary ruling permitting Dr. Smith to testify a proper exercise of discretion.
Trial courts have "broad discretion in the admission of evidence at trial, and [their] decision
to admit such evidence will be reversed only when there has been a clear abuse of that discretion.
The same standard applies to the admission ofexpert testimony." Karlson v. Harris, 140 Idaho 561,

~ .....
~

"

I
~
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564, 97 P.3d 428,431 (2004). Further, in the event of an inconect ruling regarding evidence, "anew
trial is merited only if the eITor affects a substantial right of one of the parties." Id.
In ruling on the admissibility of Dr. Smith's testimony at trial, the Court appropriately
recognized its determination was a matter of discretion. Further, the Court noted in its ruling that
plaintiffs had sufficient time to address Dr. Smith's supplemented opinion regarding cause of death.
Therefore, plaintiffs cannot claim unfair surprise as they could have addressed Dr. Smith's opinions
through ordinary prudence.
Defendants disclosed Dr. Smith pursuant to the Court's Scheduling Order 011 June 18, 2007
in Defendant Thomas J. Byrne's Disclosure of Expert Witnesses. The disclosure stated in relevant
part that Dr. Smith would testify regarding the following subject matters "[a)pplicable medical
principals, causation and damages." (emphasis added). The disclosure went

011

to state, "It is

anticipated Dr. Smith will testify that the cause of Mrs. Schmechel's death is uncertain and that
another condition she had was just as, if not more, likely to have caused her death than methadone
and/or Hydrocodone." On June 20, 2007, counsel for the parties discussed scheduling depositions of
experts and counsel for Mr. Byrne sent a letter to plaintiffs' counsel indicating in part, that Dr. Smith
could be deposed after the deposition of Dr. Graben. (See Duke Aff., Ex. 9 (June 20, 2007 letter
. from Keely E. Duke to Byron Foster). Scheduling of depositions continued to be difficult, and on
Jnly 3, 2007, counsel for Mr. Byrne again wrote to plaintiffs' counsel attempting to schedule
depositions of experts and Dr. Groben, and again indicated that Dr. Smith would not be made
available to testify until "the pathologist in this case, Dr. Groben is deposed." (See Duke Aff., Ex. l 0
(July 3, 2007 letter from Keely E. Duke to Byron Foster)). The July 3, 2007 letter went on to state

i

efforts were being made to schedule Dr. Groben's deposition, and if Dr. Graben could be deposed

j
\

during the week ofJuly 30, 2007, that Dr. Smith would be made available for deposition on August
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NEWTRJAL- 14 ·

!

I
1

!
I

I•

I"

16, 2007. Id. On July 6, 2007, counsel for Mr. Byrne sent a letter to plaintiffs' counsel indicating
Dr. Groben was available for deposition on July 30, 2007, and Dr. Smith could be deposed

011

August 16, 2007. (See Duke Aff., Ex. 11 (July 6, 2007 letter from Keely Duke to Byron Foster)).
Dr. Graben was ·deposed on July 31, 2007.
On July 27, 2007, four days before Dr. Graben was deposed, plaintiffs' counsel sent a letter
to defense counsel stating "On further consideration, we will not be taking the depositions or (sic)
your respective experts. Therefore, please cancel the deposition dates for those individuals." (See
Duke Aff., Ex. i2 (July 27, 2007, letter from Byron Foster to Keely Duke and Steven Hippler)).
Therefore, despite the knowledge that Dr. Smith would be testifying regarding causation and relying
upon the deposition testimony of Dr. Graben, plaintiffs' counsel determined they would not depose
Dr. Smith, or any of defendants' respective experts in this case, prior to the time that Dr. Graben was
deposed.
Further, as testified to by Dr. Smith during trial, the deposition testimony ofMs. Shindle was
critical in forming his opinions as to causation, based upon the fact that she, and not Dr. Groben
determined the manner of death. As testified to be Dr. Groben:
Q:

And it's true, is it not, that actually you don't determine the manner of death?

A:

No, I do-not, well, on this case, I don't. Depends on where it comes from.

Q:

That would be in the coroner's office, in this case Ms. Now Anton, then
Shindle?

A:

Right. That's correct.

(See Duke Aff., Ex. 13 (trial testimony of Dr. Graben), p. 25, ll. 10-16)).

Defendants also faced difficulties in scheduling Ms. Shindle's deposition. Ms. Shindle was

.,

originally scheduled for deposition on July IO, 2007. (See Duke Aff., Ex. 14 {Notice ofTaldng

I

!'l
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Deposition Duces Tecum ofShaiyenne Shindfo, dated June 6, 2007)), On June 7, 2007, an assistant
from plaintiffs' counsel's office called indicating plaintiffs' counsel was not available for the July
I 0, 2007 deposition of Ms. Shindle which had previously been scheduled. (See Duke Aff., Ex. 15,
July 6, 2007, email from Ms. Pontakto Ms. Duke). Counsel for Mr. Byrne attempted to obtain dates
from plaintiffs' counsel to reschedule Ms. Shindle's deposition in late June 2007. (See Duke Aff.,
Ex. 16 (July 2, 2007 letter from Byron Foster to Keely Duke)). Due to unavailability of Ms. Shindle
and Dennis Chambers ( another Twin Falls County Coroner who was to be deposed), Mr. Byrne was
unable to get another available date for Ms. Shindle until September 5, 2007. Ms. Shindle was
deposed on September 5, 2007. Although Mr. Byrne had obtained records from Ms. Shindle, it was
not until her deposition, that her opinion that Mrs. Schmechel was awake when she died came to
light. Specifically, Ms. Shindle testified in her deposition that in her opinion Mrs, Schmechel was
awake just prior to her death based on numerous factors, (See Duke Aff., Ex. 17 (Deposition
transcript of Ms. Shindle), p. 44, 11. 1-4). Counsel received Ms. Shindle's deposition transcript on
September 24, 2007, (See Duke Aff., Ex. 1 (September 24, 2007 email from M&M to Keely E,
Duke). On September 26, 2007, Ms. Shindle' s deposition transcript was hand delivered to Dr. Smith
for his review and consideration. (See Duke Aff., Ex, 3, September 26, 2007, letter from Kathy
Savell to Dr. Smith).
Once Dr. Smith was able to review both of these depositions, Dr. Smith's supplemental
opinions were seasonably disclosed on October 4, 2007 and stated in relevant part, "It is anticipated
that Dr. Smith will testify that on a more probable than not basis, the likely cause of Mrs.
,l

Schmechel' s death was a cardiac death, likely a fatal dysrhythmia. He will testify that the
dysrhythrnia was caused by her 1mderlying cardiac and other co-morbid conditions."

(See

Defendants Clinton Dille and Southern Idaho Pain Institute's Supplemental Disclosure of Expert
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Witnesses, p. 2). This disclosure went on to indicate Dr. Smith's opinions regarding Mrs.
Schrnechel's cause of death were based in part upon the deposition of Dr. Groben, Dr. Groben's
autopsy rep01t and toxicology report and the deposition testimony of Shaiyem1e Shindle. Id.
Therefore, as of October 4, 2007, plaintiffs were fully aware of Dr. Smith's anticipated
testimony regarding the cause of Mrs. Schmechel's death. Further, prior to such time, and prior to
plaintiffs' determination to not depose defendants' experts, plaintiffs were aware that Dr. Smith
would be relying upon the depositions of Dr. Groben and Ms. Shindle in fom1ulating his opinions as
to causation. Plaintiffs could have opted to depose Dr. Smith and chose not do so. Therefore,
whatever surprise plaintiffs' allege resulted from Dr. Smith's testimony could have been guarded
against through ordinary prudence.
C. The Court Properly Excluded the IDAPA's from Evidence and Did Not Abuse its
Discretion in Not Giving a Negligence Per Se Instruction Regarding the IDAPA
Regulations.

Plaintiffs argue the Court erred in failing to give their proposed jury instruction regarding
negligence per se based upon an alleged violation of the IDAPA regulations and erred in not
admitting such regulations as exhibits. However, due to the fact that the JDAP A regulations failed to
define a clear standard of conduct, such regulations do not give rise to a negligence per se
instruction, and the Cornt properly exercised its discretion in not giving the requested instruction.
Further, the Court's ruling to the regulations from evidence was not an abuse of discretion, and the
Court allowed plaintiffs' counsel to question defendants regarding the regulations, read portions of
the regulations and to show pottions of the regulations to the jury during such examinations. As
such, plaintiffs cannot show that exclusion of the IDAPA regulations affected a substantial right.
1.

The Regulations Do Not Give Rise to Negligence Per Se.

The decision to include or exclude jury instructions is left to the discretion of the trial court.
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Highland Enterprises, Inc. v. Barker, 133 Idaho. 330, 986 P.2d 996 (I 999). The standard ofreview
for issues concerning jury instructions is limited to a determination of whether the instructions, as a
whole, fairly and adequately present the issues and state the law. Silver Creek Computers, Inc. v.

Petra, Inc., 136 ldaho 879, 882, 42 P .3d 672, 675 (2002). If the jury instructions adequately present
the issues and state the applicable law, no error is committed. Leazer v. Ki~fer, 120 Idaho 902, 904,
821 P.2d 957,959 (1991),

In the instant matter, the Comt's jury instructions fairly and adequately presented the issues
and stated the law. A negligence per se instruction regarding the regulations was not warranted,
because plaintiffs did not prove the necessary elements to establish that a violation of the IDAP A's
in question established a claim for negligence per se.
Negligence per se occurs where a person violates an ordinance or state law. Ahles v, Tabor,
136 Idaho 393,395, 34 P.3d 1076, 1078 (2001). A claim of negligence per se requires plaintiffs to
prove: ( 1) the statute or regulation clearly defines the standard of conduct; (2) the statute or
regulation was intended to prevent the harm caused by defendant's act or omission; (3) plaintiff is a
person of the class the statute or regulation was designed to protect; and (4)the violation must be a
proximate cause of plaintiffs alleged injury. O'Guin v. Bingham County, 142 Idaho 49, 52, 122
P.3d 308, 311 (2005). Negligence per seis a question oflaw for the court. Ahles, 136 Idaho at 395,
34 P.3d at 1078.
In Ahles v. Tabor, 136 Idaho 393, 34 P.3d 1076 (2001), the district court held that the
defendant was negligent per se for violation of LC. § 49-63 3 for passing the plaintiff's vehicle on the
right side and a subsequent collision. On appeal, the Idaho Supreme Court addressed each of the
,,~
fl

four requirements of negligence per se and determined that the statute did not allow for negligence

~·

Ii

per se. The Ahles court found that elements 2 and 3 were met as the statute was intended to protect

,,

!
I
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motorists and plaintiff fell within the protected category. However, the court held that "the standard
of conduct described in LC. § 49-633, ... is far from clear and requires statutory interpretation
including consideration of problematic definitions of terms used in the statute." Id. 136 ldaho at 396,
34 P.3d at 1079. The Ahles court held there were numerous questions as to certain terms in the
statute that were subject to interpretation, and that "[a]ll of these questions add to the complexity of
the statute and show that the standard of conduct derived from interpreting the statute is less than
clear and not easily asce1tained or applied." Id. As such, the Ahles court held that I.C. § 49-633 did
not satisfy the test with regard to the "description of a clear standard of conduct. Accordingly, the
alleged violation of the statute in this case cannot be deemed negligence per se." Id.
In the instant matter, the Rules for the Li censure of Physician Assistants and the Delegation
of Services Agreement are subject to interpretation and do not clearly define a required standard of
conduct. Specifically, Idaho Administrative Code 22.01.03.28 SCOPE OF PRACTICE, indicates
various items which a physician assistant may perform if included in the Delegation of Services
Agreement including, "Diagnose and manage minor illnesses or conditions" and "manage the health
care of the stable chronically ill patient in accordance with the medical regimen initiated by the
supervising physician." IDAPA 22.01.03.28.03 and 22.01.03.28.04.
The Regulations do not define minor illnesses or conditions or major illnesses or conditions
or what constitutes chronically ill, nor do the regulations define the term "manage." As such, what
constitutes a minor or major illness or condition is an1biguous and left to interpretation. In addition
what constitutes mruiaged care of a stable chronically ill patient is left to interpretation. If Mrs.
Schmechel's chronic pain was a minor condition (as testified to by Mr. Byrne) the Regulations
would allow Mr. Byrne to diagnose and manage such condition. Therefore, the IDAP A regulations
carmot give rise to a negligence per se instrnction as they fail to clearly define a standard of conduct.
DEFENDANT THOMAS J. BYRNE'S MEMORANDUM IN OPPOSITION TO PLAINTIFFS' MOTION FOR
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As stated above, the fourth element required to find that violation of a statute or regulation
equates to negligence per se is that "the violation must have been the proximate cause of the injury."

Ahles, 136 Idaho at 395, 34 P.3d at 1078. Plaintiffs cannot meet this requirement as Dr. Dille
testified in both his deposition and at trial, that witl1 regard to Mr. Byrne's treatment of Mrs,
Schmechef, he "could not see where [he] would have made any changes or done anything different
than what Mr, Byrne had." (See Duke Aff., Ex. 18 (Deposition of Dr. Dille), p. 29, 11. 17-21). Dr,
Dille testified at-trial that if anything, he would not have been as conservative as Mr. Byrne in his
Methadone dosing of Mrs. Schmechel. (See Duke Aff., Ex. 19 (trial testimony of Dr. Dille), p. 38, !!.
l 1-17). Because Dr. Dille would not have changed the treatment provided by Mr. Byrne to Mrs.
Schmechel, plaintiffs are unable to establish that any alleged breach of the Regulations was the
proximate cause of Mrs. Schmechel's death.
Further, as testified to by Dr. Lordon at trial after he had had an opportunity to review the
2003 DOS Agreement:
Q:

And Idaho law also allows a physician assistants to evaluate, plan, and
implement plans of care, and you have no problem with that; correct?

A:

I .have no problem wiili mat.

Q:

So you are in no way critical of the fact that Mr. Byrne treated Mrs.
Schmechel; correct?

A:

No, none whatsoever.

(See Duke Aff., Ex. 5, pp. 66-67, !1. 25-6).
In conclusion, the IDAPA regulations did not set forth a necessary and required clear
standard of conduct and therefore do not meet the requirements for a finding of negligence per se if
such regulations are breached. As such, the .court did not commit error in not giving plaintiffs'
requested jury instruction regarding negligence per se.
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The Court Did Not Err In Excluding the IDAPA Regulations From
Evidence.

I

i

l

Trial courts have "broad discretion in the admission of evidence at trial, and [their] decision

l

l

to admit such evidence will be reversed only when there has been a clear abuse of that discretion."

Karlson v. Harris, 140 Idaho 561, 564, 97 P.3d 428,431 (Idaho 2004). In the case of an incorrect

I

ruling regarding evidence, a new trial is merited only if the error affects a substantial right of one of

'l

~
]'

the parties. Id; I.R.C.P, 61. In ruling on the admissibility of the Regulations, the Court noted that
they were not clear enough to give rise to a per se jury instruction. Further, as made clear tln·oughout
the trial, the Regulations themselves were confusing and ambiguous and would likely have misled
the jury had they been admitted into evidence. As such, the Court properly exercised its discretion in
excluding the Regulations from evidence.
Even if such ruling was in error, plaintiffs are not entitled to a new trial as they are unable to
establish such ruling affected a substantial right or that they incurred any unfair prejudice.
Specifically, the Comt took judicial notice of the ID APA Regulations, allowed plaintiffs' counsel to
question defendants regarding the Regulations, read portions of the regulations, and show portions of
the Regulations to the Jury during examination. Further, the Court indicated it would allow plaintiffs
to use the Regulations during closing argument. As the Fifth Circuit noted in Alexander v.

Conveyors & Dumpers, Inc, when a party is allowed to read a safety code to the jury and question
witnesses with the document the complaining party does not suffer any prejudice because it was not
provided to the jury. Alexander v. Conveyors & Dumpers, Inc., 731 F.2d 1221, 1229 (5th Cir. Miss.
1984) ("Secondly, no substantial right of Alexander's was affected by the failure to admit the Code as
an exhibit because the relevant sections had already been read and shown to the jury.")
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D. The Court's Bifurcation of Recklessness was Not an Abuse of Discretion.

Defendants' objected to Dr. Lipman offering any testimony as to whether Mr. Byrne or Dr.
Dille were reckless. Defendants' objections were ovenuled and Dr. Lipman was allowed to testify
regarding the issue ofrec!<lessness. Defendants expressly reserve and do not waive those objections
in addressing this issue for purposes of the instant motion.
The decision to include or exclude jury instructions is left to the discretion of the trial court.

Highland Enterprises, Inc. v. Barker, 133 Idaho. 330, 986 P.2d 996 (1999). The standard ofreview
for issues concerning jury instructions is limited to a dete1mination of whether the instructions, as a
whole, fairly and adequately present the issues and state the law. Silver Creek Computers, Inc. v.

Petra, Inc., 136 Idaho 879, 882, 42 P.3d 672, 675 (2002). If the jury instmctions adequately present
the issues and state the applicable law, no error is committed. Leazer v. Kiefer, 120 Idaho 902, 904,
821 P.2d 957, 959 (1991). Reversible error occurs when an instruction misleads the jury or

prejudices a party. Howell v. Eastern Idaho R.R., Inc., 135 Idaho 733,740, 24 P.3d 50, 57 (2001).
Plaintiffs argue a new trial is warranted pursuant to Idaho Rule of Civil Procedure 59(a)(I)
and (7) as a result of the Court bifurcating the issue of recklessness. Specifically, plaintiffs argue
they were prejudiced by not including a reckless instruction in two ways. First, plaintiffs argue they
elicited significant testimony from Dr. Lipman regarding the recklessness of Mr. Byrne's care, and
that by not submitting a reckless instruction to the jury, such testimony was rendered "meaningless"
or that is served to mislead or confuse the jury.
Second, plaintiffs appear to argue the jury could have found Mr. Byrne recl<less "without ever
reaching the question of whether the Defendant was negligent." (Memorandum in Supportatp. 13).
Although identified as separate issues, the question for purposes of the motion is whether the CoUit
ened in not providing the reckless instruction.
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Plaintiffs' argument that the jury could have found recklessness without finding negligence
defies common s_ense as well as the state of the law. The face of plaintiffs' proposed jury instruction
even makes it clear "reckless" conduct is conduct bearing a higher degree of culpability than
negligent conduct. Plaintiffs' proposed instruction on recklessness stated:
The words "reckless conduct" when used in these instructions and when applied to
the allegations in this case, mean more than ordinary negligence. The words mean
acts or omissions under circumstances where the actor knew or should have known
that the acts or omissions not only created an umeasonable risk ofhann to another,
but involved a high degree of probability that such harm would actually result.
(Emphasis added).
Under Plaintiffs' own definition ofrecklessness, if Mr. Byrne was not negligent, he could not
be reckless. Mariy Idaho cases recognize the distinction between "negligence" and "recklessness."

See e.g. Athay v: Stacey, 142 Idaho 360,365, 128 P.3d 897,902 (2005); Galloway v. Walker 140
Idaho 672,676, 99 P.3d 625,629 (Ct. App. 2004). Even Black's Law Dictionary recognizes the fact
recklessness embraces a higher standard than negligence and states in its definition of recklessness
that, "Recklessness involves a greater degree of fault than negligence but a lesser degree of fault than
intentional wrongdoing." Black's Law Dictionary, 7th ed. (West 1999).
Plaintiffs' argnrnent makes even less sense when considered in light ofidaho Code Sections
6-1012 and 6-1013, which govern medical malpractice claims. These sections require plaintiffs "[i]n
any case, claim or action for damages due to injury to or death of any person ... on account of the
provision of or failnre to provide health care or on account of any matter incidental or related
thereto" to prove through direct expert testimony that the defendant "negligently failed to meet the
applicable standard of health care practice of the community in which such care allegedly was or
should have been provided ... " (Emphasis added). Under these sections therefore, plaintiffs had to
prove negligence to recover for medical malpractice, and their argument that a finding of
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recklessness without negligence could have been sufficient must be rejected.
Plaintiffs sought to instruct the jury on recklessness so they had a basis to pierce the statutory
non-economic damages cap of [dal10 Code § 6-1603 if the jmy found the defendants negligent and
returned a damage award above the cap. The issue of the statutory non-economic damage cap was
only relevant if the jury found that defendants breached the standard of care, that such breaches were
a proximate cause of Mrs. Schmechel's death, and awarded non-economic damages in excess of the
cap. In fact, the.statute specifically provides the jury should not be info11ned of the cap during its
deliberations. See LC. § 6-1603(3) "(If a case is tried to a jury, the jury shall not be informed of the
limitation contained in subsection (1) of this section.").
Finally, instructing the jury on recklessness and allowing plaintiffs' connsel to argue Mr.
Byme was reckless would have greatly prejudiced the defendants, particularly when the issue of
recklessness only applied to Mr. Byrne. There was no allegation or expert opinion offered that Dr.
Dille or the Southern Idaho Pain Institute were reckless. Inserting inflammatory language, such as is
contained in the reckless jury instruction, would have been particularly prejudicial to Dr. Dille and
the Southern fdaho Pain Institute. The jury could easily have confused the parties to whom the
recklessness standard applied and improperly applied the instructions.
The Court considered the arguments of counsel with regard to the giving of the reckless
instruction, including arguments of defendants that giving such instruction prior to a finding of
damages in excess of the cap was mmecessary and m1duly prejudicial. The Court then appropriately
exercised its discretion and bifurcated the recklessness issue. Plaintiffs caimot establish that such
decision was an error, or that it caused them undue prejudice. Therefore, plaintiffs' motion should
be denied.
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IV. CONCLUSION
Based on the foregoing, plaintiffs have failed to establish a right to a new trial pursuant to
idaho Rule of Civil Procedure 59(a)( I )(3) or (7), and Mr. Byrne respectfully requests the Court deny
plaintiffs' Motion for New Trial, and allow the well-reasoned verdict of the jury to stand.

.
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DATED this_.;---_ day of December, 2007.

HALL, FARLEY, OBERRECI-IT
& BLANTON, P.A.

By~ML'!:-";f::~~~~<.4-~----Keely E uke - Of the Firn1
Attorneys for Defendant Thomas J. Byrne

DEFENDANT THOMAS J. BYRNE'S MEMORANDUM IN OPPOSITJON TO PLAINTIFFS' MOTION FOR
NEW TRIAL - 25

11 r1\; ('
.:, C.,_}

CERTIFICATE OF SERVICE

,,1

I HEREBY CERTIFY that on the-=3 day of December, 2007, I caused to be served a true
copy of the foregoing DEFENDANT THOMAS J. BYRNE'S MEMORANDUM IN
OPPOSITION TO PLAINTIFFS' MOTION FOR NEW TRIAL, by the method indicated below,
and addressed to each of the following:
David Comstock
Law Offices of Comstock & Bush
199 N, Capitol Blvd., Ste. 500
P.O. Box 2774
Boise, Idaho 8370 I

Lu.s. Mail, Postage Prepaid
Hand Delivered
__ Overnight Mail
__ Telecopy

Attorney for Plaintiffs

Fax No.: (208) 344- 772 l
Steven J, Hippler
GIVENS PURSLEY
601 W. Bannock ST.
POBox2720
Boise ID 83701-2720

/4s. Mail, Postage Prepaid
Hand Delivered
__ Overnight Mail
__ Telecopy

Attorneys for Clinton Dille, MD. and·
Southern Idaho Pain Institute

Fax No.: (208) 388-1300
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Keely E. Duke

BY----"'~----=,-,---

!SB #6044; ked@hallfarley.com

CL[f<Y1

Chris D. Comstock
JSB #6581; j:dc@hallfarley.com

HALL, FARLEY, OBERRBCHT & BLANTON, P.A.
702 West Idaho, Suite 700
Post Office Box 1271
Boise, Idal10 83701
Telephone: (208) 395-8500
Facsimile: (208) 395-8585
W:\2\2-404.53\New Trlal Opp.Byrne.KED.doc

Attorneys for Defendant Thomas J. Byrne
IN THE DISTRJCT COURT OF THE FIFTH JUDICIAL DISTRICT
OF THE STATE OF IDAHO, IN AND FOR THE COUNTY OF TWIN FALLS
'

' ,.,_,

V AUGE-IN SCHMECHEL, individually,

and as Surviving Spouse and Personal
Representative of the Estate of ROSALIE
SCHMECHEL, deceased, and ROBERT P.
LEWIS, KIM HOWARD and TAMARA
HALL natural children of ROSALIE
SCHMECHEL, deceased,
Plaintiffs,

Case No. CV-05-4345

AFFIDAVIT KEELY E. DUKE IN
SUPPORT OF THOMAS J.
BYRNE'S MEMORANDUM IN
OPPOSITION TO PLAINTIFFS'
MOTION FOR NEW TRIAL

vs.

CLINTON DILLE, M.D., SOUTHERN
IDAHO PAIN INSTITUTE, an Idaho
corporation, THOMAS BYRNE, P.A. and
JOHN DOE, I through X,
Defendants.
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)

County of ADA
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KEELY E. DUKE, being first duly sworn on oath, deposes and states as follows:
J.

I am an attorney with the fom Hall, Farley, Oberrecht & Blanton, P.A., the attorneys

for defendant Thomas J. Bryne and, in that capacity, I make the following affidavit based upon my
own personal knowledge and belief.
2.

I was not present at Mr. Byrne's May 18, 2006 deposition in this case. I was under

the misimpression that Mr. Byrne's relevant Delegation of Services Agreement had been produced at
his deposition. I did not look into the matter until I received a letter from plaintiffs' counsel on
October 4, 2007, indicating they had not received a copy of the 2003 Delegation of Services
Agreement. I had not looked into this matter because an issue regarding the Delegation of Services
Agreement or lack of one had not been raised. After receiving the October 4, 2007, letter, I
contacted Mr. Byrne and asked him to search through his records for a copy of the Agreement. Mr.
Byrne was able to locate a copy of the Agreement within records he had in storage. I then
immediately produced a copy of the Agreement to opposing counsel
3.

Attached hereto as Exhibit 1 is a true and correct copy of a September 24, 2007 email

from M&M to Keely E. Duke attachlng an electronic copy of Ms. Shlndle's deposition transcript
4.

Attached hereto as Exhibit 2 is a true and correct copy of an October 10, 2007 email

from Margie Rosenberg to Keely E. Duke and a return email from Keely Duke to Ms. Rosenberg.
5.

Attached hereto as Exhibit3 is a true and correct copy of a September 26, 2007, letter

from Kathy Savell to Dr. Smith, enclosing a copy of Ms. Shi11dle's deposition transcript.
6.

Attached hereto as Exhibit 4 is a true and correct copy of the 2004 Delegation of

Services Agreement.
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7.

Attached hereto as Exhibit 5 is a true and correct copy ofrelevantportions of Stephen

Lordon, M.D. 's trial testimony transcript.
8.

Attached hereto as Exhibit 6 is a true and con-ect copy ofrelevant portions of James

Keller's deposition transcript.
9.

Attached hereto as Exhibit 7 is a true and correct copy of portions of James Keller's

trial testimony transcript.
10.

Attached hereto as Exhibit 8 is a true and cotTect copy of relevant portions of Arthur

Lipman, PHARM.D.'s deposition transcript.
11.

Attached hereto as Exhibit 9 is a true and correct copy of a June 20, 2007, letter from

Ms. Duke to Byron Foster .
.12.

Attached hereto as Exhibit 10 is a tmeand correct copy of a July 3, 2007, letter from

Ms. Duke to Mr. Foster.
13.

Attached hereto as Exhibit 11 is a true and correct copy of a July 6, 2007, letter from

Ms. Duke to Mr. Foster.
14.

Attached hereto as Exhibit 12 is a true and correct copy ofaJuly27, 2007 letterfrom

Mr. Foster to Ms. Duke and Mr. Hippler.
15.

Attached hereto as Exhibit 13 is a true and correct copy of portions of Glen Graben,

M.D. 's trial testimony transcript.
16.

Attached hereto as Exhibit 14 is a true and correct copy of the June 6, 2007 Notice of

Taking Deposition Duces Tecum of Shaiyenne Shindle.
17.

Attached hereto as Exhibit 15 is a trne and correct copy of a June 7, 2007, email from

Ms. Pontak to Ms. Duke.
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18,

Attached hereto as Exhibit 16 is a true and correct copy of a July 2, 2007, letter from

Mr. Foster to Ms. Duke.
19.

Attached hereto as Exhibit 17 is a bue and correct copy ofrelevant portions of the

deposition transcript of Shaiyenne Shindle.
20.

Attached hereto as Exhibit 18 is a true and correct copy of relevant portions of

Clinton Dille, M.D.'s deposition transcript.
21.

Attached hereto as Exhlbit 19 is a true and correct copy of relevant portions of

Clinton Dille, M.D.'s trial testimony transcript.

FURTHER YOUR AFFIANT SA YETH NOT.
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I HEREBY CERTIFY that on the _2-:::_ day of December, 2007, I caused to be served a true
copy of the foregoing AFFIDAVIT KEELY E. DUKE IN SUPPORT OF THOMAS J.
BYRNE'S MEMORANDUM IN OPPOSITION TO PLAINTIFFS' MOTION FOR
NEW TRIAL, by the method indicated below, and addressed to each of the following:
David Comstock
Law Offices of Comstock & Bush
. I 99 N. Capitol Blvd., Ste. 500
P.O. Box2774

/U.S. Mail, Postage Prepaid
Hand Deli vercd
__ Overnight Mail ·
~Telecopy

Boise, Idaho 83701
Attorney for Plaintiffs
Fax No.: (208) 344-7721
Steven J. Hippler
GIVENS PURSLEY
.601 W. Bannock ST.
PO Box 2720
Boise ID 83701-2720
AttorneysforC!inton Dille, MD. and
Southern Idaho Pain Institute

,,........- U.S. Mail, Postage Prepaid
Hand Delivered
__. Overnight Mail
__ Telecopy
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Cathy A. Pontak
From:

-----------------------------Cathy A. Pontak

Sent:

Monday, September 24, 20071:38 PM

To:

Kathy A. Savell

Subject:

FW: Dennis Chambers, Shaiyenne Anton depos

Attachments: current.zip

'~~-

~

. .,-..,-<

From: M & M {Asuka Tada) [mailto:asuka@qwest.net]
Sent: Monday, September 24, 2007 1:27 PM
To: Keely E. Duke; Cathy A. Pontak
Subject: Dennis Chambers, Shaiyenne Anton depos
M & M COURT REPORTING SERVICE, INC 208-345-9611

800-234-9611

The following transcripts can be downloaded online at the end of this business day:

DATEfTIME: 9/5/2007 11:00:00 AM
WITNESS: Dennis Chambers, Shaiyenne Anton
CAPTION: Schmechel v. Dille
CASE#: CV 05-4345
.
VENUE: Twin Falls County, Idaho
LOCATION: Tolman & Brizee, 132 Third Avenue East P.O. Box 1276, Twin Falls, ID 83303-1276
M & M JOB No: 15129B4, 1513084
*'NOTE: WE ARE FORWARDING THIS NOTIFICATION TO ALL PARTIES FOR USER NAME AND PASSWORD
INFORMATION. IF YOU DID NOT ORDER, PLEASE DISREGARD, HOWEVER YOU MAY USE THIS LINK TO ORDER
AT A LATER DATE.

_Your user name is: Duke

Double-click on the following address. If you are not able to reach the website by double-clicking, copy and paste the http
info into the browser address: https:!icp1 .courtpages.net/loqon.asp?TB=&companyid=-1829437679
Once you have accessed the site, you can change the password. All work will be posted at the end of the business day.
If immediately needed, please reply and it will be promptly posted,

You may view your proceeding calendar, download your transcripts, view invoices, schedule proceedings, or order
products. Our online repository is always up to date with all the latest information for all your proceedings and/or invoices
you have with our company. You may visit our website for additional seNices and information at: https://www.mmservice.com (Boise) or https:l/www.mmcourt.com (Coeur d'Alene). For scanning information, programs and software,
please access M & M's Accuscan site: https:/lwww.accuscan.org.

SERVICES AVAILABLE - M & M COURT REPORTING
REALTIME COURT REPORTING; SCANNING; VIDEOTAPErfRANSGRIPT SYNCHRONIZATION; SOFTWARE

12/3/2007

Page 2 of'2
VENDORS; COURTROOM TRIAL PRESENTATION; IDAHO JURY INSTRUCTION PROGRAM; IDAHO INDUSTRIAL
COMMISSION PROGRAM

No virus found in this outgoing message.
Cheeked by AVG Free Edition.
Version: 7.5.488 /Virus Database: 269.13.30/1027 - Release Date: 9/24/2007 1!:27 AM

12/3/2007
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Cathy A. Pontak
From:

Sent:

To:
Cc:
Subject:

Keely E. Duke
Wednesday, October 10, 2007 5: 16 PM
'mgr@comstockbush.com'
'decomstock@comstockbush.com'; 'byron@bvfoster.com'; Cathy A Pontak;
Kathy A. Savell
Re: Schmechel

I have it at my office. You can come over a~y time, just coordinate with Kathy
Savell.
Keely

Original Message-~--From: Margie Rosenberg <mgr@comstockbush.com>
To: Keely E. Duke
Cc: David Comstock <decomstock@comstockbush.com>; Byron Foster
<byron@bvfoster.com>
Sent: Wed Oct,10 15:28:47 2007

Subject: Schmechel
Hi Keely,

Thank you for the 2003 Delegation of Services Agreementr produced today in
response to Plaintiffs' First Request for Production of Documents, Request No,
9 propounded June 29 2006. We would like to have an opportunity to examine
the original document as soon as possible. Please contact us today to make
those arrangements.
1

1

Thank you.

Margie Rosenberg

, -, rl ·'· _,
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ATTORNEYS

HALL, FARLEY, OBERRECHT & BLANTON, P.A.
702 WESTIDAHO $TREST,

surrn 700

RICHARD E. HALL
DONALDS. FAtu.SY
PIULLW S. OUE.R.REC!-IT
J. Cl{A.IU.8$ BLANTON

KEY FTNANC[AL CENTER.
BOfSE, IDAHO 83702

POST OFFICE BOX 127 l
BOISE, lDAHO 83701

RAThfOND D. !'OWE~

KeaYE.DUKE
JAMES S, TiiOMSON, lI
rm.'/ AN A. N1CKBLS
CHIUS t'I. COMSTOCK
l'ORTIAL. JEHKlNS

CANDYW AGANOJ:i: DALE

KAREi~ 0. SHEEHAN

J.KEl/tNWBST

KYLE M. YEARSLEY

OAltr W. BARWOOD

DANA M, HERBER.HOLZ
MARK J. Ol~t.EI'.
IEffREY !l. TOWNSEND

JOfil! l. BURkE
KEVIN 1. SCANLAN

TELE-PHONE {208) 395,8500
FACSIMILE (2011) 395-8585
W:\2\2.-.404.53\Ex:perts\SmiUi 07 .doc

TAMSEN L. LEACHMAN

6-MAIL: conta<::!@h-al!far!ey.com
WEB PAGE; www.baUforley.com

Wilh ,!ltcrnt}'S Admitletf IQ Proctic,, J;.m,.• in
(dalw, Oregon, Washl11gmn and Uu,h

September 26, 2007

CONFIDENTIAL COMMUNICATION
VIA HAND DELIVERY
· James Smitb, M.D.
Boise Heart Clinic
287 W. Jefferson
Boise, ID 83 702
Re:

Claimant
HFO&B File No.

Vaughn Schmechel, et al.
2.404.53

Dear Dr. Smith:
Enclosed for your review are the following depositions:

l.
2.

3.

De1mis Chambers
Shaiyenne Anton
Stephen Lordon, M. D., part 2

Kathy Savell, Paralegal

KAS/cp
Enclosures
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ATTORNEYS
HALL, FARLEY, OBERRECHT & BLANTON,

P.A.

702 WEST lDAHO STREET, SUITE 700
KEY FINANCIAL CENTER
BOISE, IDAHO 83702

IUCHARD lo. [{ALL
OONALDJ. FARI.EY
PHILLll' S. 08EllRf:C!ff
J. CHAR.LES "BLANrON

RAYMOND D. POWERS

POSTOFFICEllOX l27l
BOISE, IDAHO 8370t

CANDY WAGAH0f1" DA.LL\

I. KBVTNWEST
OART W. HARWOOD
JOHN J, DURKE.

TELEPHONE(208) 395-8500
f A.CSJM!LE (208) 395-8585
W:\2\2-404.53\Foslcr 19.doc

KEVIN J. SCANLAN

TAMSENL. LEACHMAN

E-MAIL: conuict@haUfarley ,com
WEB PAGE: www.ha1lfur1ey.corn

KEELY £. DUKE
Jf,MES S. THOMSON, U
OR.YAN A. NlCKEt.S
CHRIS D. COMSTOCK
1'0RTIA L. .ffiNKlNS
KAREt-f 0. SHEEHAN
DANA M. HE!<.BERflOt..Z
MARK J, ORLER

1Eff'REY k.. TOWNS&ffi
ROBERT A. DErutY

MEOAN E. MOONEY

With At1on1t)'S.Ad111/1r;;d 10 Proclict Law in

/dahn, Or~g,:.m, Warhi11g1m,and Ulah

October 11, 2007

VIA FACSIMILE
Byron Foster
David Comstock
Law Offices of Comstock & Bush
199 N. Capitol Blvd., Ste. 500
P.O. Box 2774
Boise, Idaho 8370 I
Re:

Schmechel v. Byrne, et al,,
HFOB File No.: 2-404.53

Dear Dave and Byron:
Enclosed is Defendants' Exhibit 276.

Kathy Savell, Paralegal
KAS/cp
Enclosure
cc: Steve Hippler (via fax w/encl.)
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DELEGATION OF SERVICES AGREEMENT
DELEGATION OF SERVICES AGREEMENT

A OelegaUon or Services Agreement Is !o be malnlalned at each practice site \11\d avaltable to the Board upo~ request. The
Dalegatlon ol Services (DOS) Agreement ts a written docu!mlntnwtually a~reed Ull0) and slgried and dated bylhe physlcian
essl$tant and suparvlslng physician that defines 1he working relati0!18hlp and delegation or duties b<!lween the supervising
physician and Uie physlclrul asslslant as specified by Board rule, The Board of Medlolne may review the written Delegation of
Servloes Agreement, Job dascrlpllons, policy statements, or other documents 1hat define tha responslbllltl<:>s of the ph)'slclan
assistant In l!ie practlca oottlng, and may requl/e such changes es noodod to achieve compliance with these rules, nod to
safeguard Ille publlc,

u••

,r

Tllo roll owing lnlo,m~Uon muol t,o leglbt&,
addlllonal oho els no...,ary. DO Nar SUBMIT YOUR DEL!;GATION OF SER·
VICES AGREEMENTS TO Tl-II; SOARD WITH YOUR APPLICATION FOO LIOENSUAc,
l'hyalclan Asslolanl Name:
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Supeivilllng Physl<:lan Name:
a
Alternate Suparllolng Phyok:lan(i} Nama{s): _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __

PRACTICE SO'E(S):

1, Natll-OofFaclllly:
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Delegation of Seni= Agreement,

¥

Each licensed physician ..,,;smnt shall maintain acunoot oopy of1he Dclegalion of Services (j)OS).
Agreelnoot between the physlclanassis1antaru! each ofbis or her supervising physicians. This as=ent
$ball nut be sent to a., Board, but roust be roaintainoo on file at each 1"""1ion in which the physician
nssfatant is practicing. This ag,=nent ,hall be made immediatoly avrulable to the Board upon ooqu,:at aru!
shall ioolude:

•
Activity 11nd Location
A listi,,g of1ho specific aotMties, which wUJ be perfunncd by the phy,;ician assislant>md !Ile llj!OCific
lccalloru; mid lncllitres in which the physician assisuuit will function.

Location of Practice
Souiliem [daho Pain aru! Rehabilitation
236 Martin St
Twin Falls, Idaho 833-01

8outhem Idaho Poin and Rehabilitation
496 ll. Shoup Ave. Wes!
Twin Falls, ID 8330!

Specific Dulle,; -Activities

ll

loltw B~aluation of Patients

The physician assi- ernployed with Soothom Idaho Pain & Rcllahilibllion will be utilized in the initllll
.-valuation fur p:ui- seen in thls facility, These pati- stem from a physi<i>n referral base and also
patlcnl sclf-referrals. Pati"11s
roquire • full lll,tozy and physical on initial visit Pertinont fiadin(!S will
bedocumeatcd and rocommendaliom made. The =nunerulatioos will berevwwed by the supo,vising
pbysician to eonfnm find!ll/!S and dotennlne a trorrunent plan.

wm

RB-Ewluatlon

The PA will be utilized in the i,;,,,va[uat!on of e:dsfu,g patients fur medication management;, pre=ip!ion
renewal and rocommendatiom for further treatment within our fu<,Uit:y. The l'A will perform appropriate
aystem eKruDS based on the p,,liant'• ohlefecmyloint. [/pon thisoxam, will =nnnond the type oftlwrapy
ond/or procedure that is needed. Tue snporvislng physicion will m'iew and porll,rm prooedurcs as
indicaiod.

SuJ:mcal Assistant

=

The pbyslcuw assislant will assist U1e supervising physician wilh oases preacnred in our surgery =re,.
Thooe
will include but ore tw! limited to, opldun,l prooedlll'ell undor fiuorosoopy, epiduroll"'=,
disoo$[M1s, stellate g,u,gllon blocks, lumber sympathetic blocks and Mcd!l:nnlc intrathecat trials. The
supeNislng physician will train. the PA to assist him on all of the above procod...,,,
Minor Prgco<!wes
Tho PA will pcifunn several small office based procedures based on thcmcdi""1 ftndings on clinical exam
within this iacilit:y. These include, but are not limited to: friggcrpolot injections, small joint i,,je<lloos,
occipital injections, and laceration «pair.

:rb.l'.Dllll:

The FA will assist in llUllll\glng and cval.tu!ling patient, forvhysical therapy withln our fucilit:y.

General QuldeHnes
Tho Physician ,¾s!stonts tral.aing, backe,ound and experience make him qualified to funcrion in thls
· capacity. Hlspraoticowill l>e®gmented by:24,oou,baokup "1ld support from lili, desigmwd prim,uy and
secondary supervising Physician.

2

t
j

l

Direction and Control
The methods lo be used tD insure responsible direction and COO!rol of !he ru:tivifies of the physician
assistant which $hall prov!db fur an on-slre m!t ot I~ moothly, regularlyocliedulcd confuronces betwocn
the aupe,vislog phy,kiflll and the physicinnassi,tan~ and availability of the oopmislng physiclaa to the
pbysfoian as.sistant in per,on or bytclephooo.
PlO!lS<l describe how 1hfa will be a<o0mplished ot this pra,(lil:e site:
As the physician assistant'• sup.&Vislug pbysicina twll!Jl'o aVililabl,, for ooosµlbltion, guidance, and
supovmim> on most Im<= days, in lllY infrequent ab= a -,ndory mipervlslng physlclJm will be
avoilab!e.
l will perfurm ot !ea>t monthly poriodfo ohart and C>lOOrovicw.s, and will work witl1 wy phy,;lcian llSS!stant
to cstabl!sh and maintain mutually agreed npon practlre prowool, & guidolJne,_
·

Emergency l'ro~nres

-t

Avait.bilcy ofthe supervising pby,ician to the physician assistnntio poraon or by Mcphone an.cl
proc«lures furprov:ldlng baclrup for the physician assistant in omergency situations·
Please descn'be how this will oooooomplished ot this practio• site.
Wru,n a seriously ill or iajm<:d paffont
to Sou them I<laho !'sin and Relmbilitation the ph)"'lcian
assistant will initiato stabilizing care and maintain !l4icl adheroru» to ACLS, ATLS, and PALll guideline&.
Tho physician assistant
move c,qx,ditiously to ttansfer the we of the patlent to an oppropriate
pbysiehm or p!iysician ,peoiall,~ A prima,y or ,eoondary pilyslcinn wlll be availab!o 24 houm por day to
provide consultation, guidance and supervision to the pl1ysiclan assismnt.

wm

Addressing Situations Outside the Scope or Praetlee
Proccdutes for ru!dresaing situations outside the ,oope of practice of the ph)'llician assmtant.
Pkruiedoocribe bow this will bo a<C(}tnpll,hed at this practice silo.
Should a sltualion ocour truit is outside the scope ofp..,,,ti<x, fur the pby,;foian assistant ho will lmmcdiotely
<>ontact. a primazy or =•dary l!llj>OrVi:;ing physician forronsultation, guidai= and insftucuon. Tho
patle,it's
will be e<ped!eoUy tnmsfertcd to rux approprlote physician.

°""'

Pre$crlptlon Authority
A physician ..,,istant Who wiskes ro apply for prescrlplion writi.og oofuorlly shall submit an application for
such purpose to tho Board of Medkiru,.
The drug cotegorles or spcoitfo legend d,ugs and eotllrol!ed drugs, Schedule ll through V Ula! will bo
~ proridcd that the legeru! d,ugs and OODJrolloo d,ugs shall be COllJlistcnt wilb Ute regular
prescriptive prooticc of the supervising physlclan.

Current prosoriblng privileges, oow include Sonedule 2, 2N, 3, 3N, 4 and 5, afte; appUcotlon and approval
through tho Idaho Board of Medicine and Fei!om! Drug &.fo1<:emeoi Administre!ion gul<lcllnes,
DEA ii l-,IJ.l041!098l
ls!.11ed 8/14/02 _
!lxpire,; 7/31/05
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CareRemw
l'eriodic review of• reprosen1al:ivo sample of rocon!s and a perlodio review of lhe mt<lical scrvire,, being
provided by the physlciao oslllSWll This review shall also mchulc an ev;iluation ofrulherence to the
delegation of services agreement.

l'lcased<:saibo how1his wlll be acrompllsbed ot lhls pm<rtioo locanon:

As the pnn,,uy supervising physici11l!, l will pctfunn pcriodlcooan reviews arul csse evaluarloru, ofpafu,ils
...u by the physician ssal-t ln addiuon, a """"""'1y supe,vlsb,g physician or I will be available 24
hours • day to provide tho plzysiclrui asmstant wifumroical guidanoe awl supervision.

'

1

S4Jnatutes:
(Phyalelan Assistant)

(Superruing Physician)

~)fA5:I~~

(Date)

(;76

(Altemnte Supervising Physici,n) _ _ _ _ _ _ _ _ _ _ (Datc) _ _ _ __
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IN 'l'HE OISTRWT COURT OF 'l'HE FIFTH JUDIClAL DISTR1CT OF
THE $Tl\TE OF IDAHO, IN AND FOR THE COUNT¥ OF TWIN FN.,LS

VAUGHN SCHMECl-!BL, fodividudly I

)

and as Surviving Spouse and

)

Personal Representative of the
Estate of Roaalie Schmechel,
Deceased, and ROBERT P. LEWIS,

)
l
)

KIM HOWARD and TAMARA HALL,

)

Natural Children of. ROSAL!E
SCHMECHEL, Deceased,

}
)

CASE NO, CV 2005·4345
11:li!POll.'rER' S 'l'RANSCRl !?'r

P1ainti f fa.,

)
)
)

CLINTON DILLE, M.D., SOUTHE:RN

J

10
11
12

!DAHO Pll.IN INSTI'.l;'UTE, an Idaho )
Corporation, THOMAS BYRNE, t' .A., j
and JOHN DOE' 1'. t:hrol.lgh X,

Defeildanta,

)

13

)
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DISTRICT JUDGE, PRESIDI~G
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WEDNESDAY, OCTOBER 17, 2007,
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THERON WARD JUDICIAL BUILDJNG,
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. 425 SHOSHONE STREET NORTH, TWIN FALLS j
COUNTY, TWIN FALLS, IDAHO.
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i
STEPHEN PATRICK LORDON, M.D.
produced as a wilness, being first duly sworn, was
examined and testified as follows:
DJRECT EXAMINATION
,,
BYMR.FOSTER:
Q. Hi, Dr, Lordon. Before we get started, the
last time we talked, you indicated there was something
that you wanted me to tell the jury, I think I'll just
!i
let you tell them, and then we'll get started,
'J
A, Okay. I think there are basically two things
ti
;1
rwanted to tell them. One is that I have stuttered
~
ever ~ince I can remember, okay, probably since age two
and three; and I've learned to deal with it, and l'm
very relaxed with it, and sometimes it comes out, its
ugly head, and sometimes r do just fine. Doesn't mean
that I'm particularly nervous or anxious. It just comes

'
t
i
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Page 2
1
2

3

APPEARANCES OF COUNSEL:
MR, BYRON FOSTER, Attorney at Law, and
MR. DAVID COMSTOCK, Attorney nt Law,

Boise, Idaho,
·
appeared on behalf of Plaintiffs.

4

s

MR. STEVEN HIPPLER, Attorney at Law, and

MR, WILL VARIN, Attorney at Law,
6
7

Givens Pursley LLP, Boise, Idaho,
appeared on behalf of Defendant Dille &
Southern Idaho Pain InS1itute.

8
9

10

MS, KEELY ELIZABETH DUKE, Attorney at Law, and
MR. CHRIS COMSTOCK, Attomey at Law,
Hall, Farley, Oberrecht & Blanton, PA,
Boise, Idaho,
appeare(l on behalf of Defendant Thomas Byrne, P.A.

11

12
13
14

15
16
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18
19
20
21
22
23
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2
And the other thing I wanted to say is that
3 1his is the first time that I have ever done something
4 like this before and, please, bear with me.
5
Q. Okay. Dr. Lordon, you're a medical doctor?
A. Correct.
6

1l

I
l

Q. You practice in Salt Lake City?

!.

A. Actually in Murray, Utah, which is a suburb
of Salt Lake City,
10
Q, And you're an anesthesiologist pain
8
9

11

~

ij

ft

1 out.

7

~

1

management expert; correct?

12
A. Correct.
13
Q, And you have been -- first of all, I'll go
14 back to your education. You've got a degree in, I'm
15 assuming, some kind of science at U.C. Davis in 1978?
16
A. It was a bachelor or science in biochemistry
17 in l 978, and I graduated with honors.
18
(Discussion held off the record.)
19
THE WITNESS: My name is actually Stephen
20 with a P-H, middle name is Patrick, last name is Lorden,
21 L-O-R.-D-O-N.
22
MR. FOSTER: Sorry about that. Okay.
23 BY MR. FOSTER:
24
Q. And then in, after graduating from U,C. Davis
2 5 in '78 and '79 and '80, vou started a 2raduate nroeram

j
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Arthur Lipman
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it's truly an interdisciplinary service.
Q. But from the standpoint of the physical
examinations of patii,nts, that's done by other
ri,edical professionals, and you have the benefit
through the notes of their work-ups?
A. Absolutely. I certainly could do this if
necessruy. Advanced practice pharmacists, pharmacotherapists frequently do that. But since it's
already done, there's no need for me to do that.
Q. All right. And as I understand it, you do
not provide medical diagnoses for a patient's
condition?
A. Frequently I will come up with
identification of drug treatment or drug-induced
adverse effects, or I will identify problems witl1
sleep hygiene, for example, which ln my note will
explicitly recommend that this be evaluated by the
psychologist, or I will. identify the patient
presenting with what sounds like myofascial trigger
points, in which case refer the patient to the
physical therapist to inanage that.
So frequently . l'm identifying patient
problems. Diagnosis, again, is a term of art. We
refer to it more as an assessment. But it's all
really the same thing;; and that's all shared in the
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physician, No, that's not correct. [n my examination
I found such-and-sucb, which is -- which rules out
what you're looking at as a potential diagnosis. So
final diagnoses typically come out of the team
setting rather than one individual.
Q. Okay. With respect to treatment, do you
actually initiate pharmacotherapy treatment to a
patient, or do you make a recommendation to a medical
provider with respect to the initiation of a therapy?
A. Both. I will very frequently change the
patient's medication regimen. I will frequently
recommend additional medications, in which case I go
to the responsible physician, discuss the case, and
recommend that the physician write the appropriate
prescriptions, which almost invariably is done.
But quite commonly I will change the
patient's dosing schedule based on the pharmacokinetics of the medication and the patient's reaction
to it, write the note accordingly, instruct the
patient, and then inform the physician, for which the
response is invariably, Thank you, that helps a lot.
Q. Okay. And so you actually will adjust a
patient's medication without first getting approval
from the attending physician?
A, Well, I do this in collaboration with the
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interdisciplinary team staffing, which, as I
mentioned, is held each morning.
Q. Okay. But with respect to a specific
diagnosis for a patient as to whether they're
suffering from fibromyalgia, I mean, is that a
diagnosis that you make, or is that made by someone
else within your interdisciplinary treatment team?
A. That's a very. interesting question and
it's not a yes or no question because fibromyalgia is
a very complex syndrome. So it might not be the best
example. But I woUld often identify because of what
the patient shares with me particular behaviors which
would be more suggestive of, for instance, a
somatization disorder or an affective disorder as
opposed to a physical disorder. And because of what
patients share with us and because of the training
that we have and the ,_ what's often referred to in
our terms of art as role blurring that occurs since
patients determine what they're going to tell to
which clinician, I often will be identifying key
issues that will contribute to the final diagnosis.
The diagnoses are not made by one
individual in this setting. They're actually made by
the interdisciplinary team at team staffing. And not
infrequently the physical therapist will say to the
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attending physician.
Q. Well -A. Chronic pain is not a medical emergency
that you -- for which you intervene quickly. It's
clinically important to move step-wise and closely.
I will frequently a,J,;ise the patient of a change to
be made. [ will then advise the physician what I've
told the patient.
Q. And that's where I'm getting to is the
timing of that.
A. And the physicians explicitly ask me to do
that. And the reason they refer patients to me -one of the main reasons they refer patients to me to
see the patients is to make those adjustments.
Q. That's what I'm getting to -A. Correct.
Q. -- is wilh respect to those adjustments,
those aren't something that you go to the physician
and say, Hey, before I tell the patient that I'm
going to do this, I want to run it by you first. Or
there are times when you do that, there's times when
you don't do that?
A. The latter is co,rect.
Q. Okay.
A. There are times that it's ve,y impo,tant
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1
CROSS EXAMINATJON
2 BY MS. DUKE:
3
Q. Dr. Lordon, good afternoon.
4
A. Good afternoon.
5
Q. Just to clear up a couple of things that l
6 want to make certain we're all on the same page, you
7 certainly do not feel that Mrs. Sclunechel was
8 drug-seeking; correct?
9
A. That is correct.
10
Q. Meaning that she was not trying to switch
11 providers and to try and get medication when she should
12 not have been.
13
A. There's no evidence of that whatsoever.
14
Q. And there's also no evidence in the record
15 that, or in Dr. Vorse's records, that she was
16 noncompliant with her CPAP therapy; correct?
17
A. That is corTect.
18
Q. l think Mr. Hippler asked you this. But as I
19 understand it, you are, -- you do not feel that edema is
20 something that would be a side effect of Methadone or
21 any other opioid; correct?
22
A. Methadone, no. Other opiates, yes. When
23 they are delivered, especially into the spine; they can
24 cause lower extremity edema. But in this case, no.
2s
Q. Right. Not Methadone?
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A. Not Methadone.
Q. You also agree with the principle that there
can be multiple treatment options that a provider can
use that would be within the standard of care and it's
up to the medical provider to use his or her judgment in
detennining a treatment?
A. Absolutely.
Q. Let's talk about physicians assistants a
little bit. Yon would agree that a physician assistant
is a physician extender? Does that sound like a proper
term to you?
A. [ would use t_hat term.
Q. Physician assistants evaluate and treat
patients, and they do minor medical procedures; correct?
A. That is correct.
Q. And that's all appropriate for them to do
those things?
A. Yes,itis.
Q. l\ was ce1iainly okay, in your opinion, for
Mr. Byrne to prescribe medications?
A. Absolutely.
Q. That's something that Idaho law permits him
to do?
A. Yes.
O. And Idaho law also allows ohvsician

l

assistants to evaluate, plan, and implement plans of
care, and you have no problem with_ that; correct?
A. I have no problem with that.
I
Q. So you are in no way critical of the fact
)
that Mr. Byrne treated Mrs. Sclunechel; correct?
ij
A. No, none whatsoever.
I
Q. And actually, when we took your deposition,
l
switching gears a little bit on you here, we were
talking about Dr. Vorse'$ change in the OxyContin from :.:
40 milligrams to 60 milligrams on September 16th. Do
you recaU that?
,\.i
A. Yes, I do.
•
Q. And in that testimony, do you recall also
l
saying that you felt, given that there was a 50 percent
l
increase, and Mrs. Sclunechel was complaining of IO out l
of 10 pain a couple of days later, that you really had
[
to question whether or not OxyContin was the appropriat i
drug; correct?
,
A. There were two answers, if! recall. There
I
'I
was either it was the appropriate drug or the right
dose.
l
Q. You certainly agree that if Mr. Byrne spoke
l
with Mrs. Schmechel about how she was to take the
!,
Methadone, that would have been within the standard of
care; correct?
}

!
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I

A. Oh, absolutely.
Q. And I assume you also agree that
Mrs. Schmechel wouldn't have seen the dictated history j
and physical; correct?
,
A. There's no reason for her to have done that.
,
"
Q. That's not something you do in your practice?
A. Very rarely.
Q. And she also wouldn't have seen the
handwritten notes that Mr. Byrne made in the medical
cha.rt; correct?
A. Are you referring to Exhibit 1O?
Q. No. I'm referring to just the chart notes he
makes in the chart itself, not to Exhibit 10.
A. Oh, l see what you're saying. No, there's no
reason for her to have seen those.
Q. And obviously, Exhibit 10 is the handwritten
note that she did receive?
A. That's my understanding.
Q. As I also understand it, you believe that
Mr. Byrne complied with the standard of care -- well,
strike that.
As l understand it, you believe it's within
the standard of care to use Methadone?
A. Absolutely.
Q. And vou certainlv would not be critical with

17 (Pages 65 to 68)
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IN Tllfi: DlS'tRicr COU"R'r' OF THE FlPTH JUDICIAL DISTRICT
OP Tl\8 STA.TE OF lDAttO, IN AND FOR THB COUNTY OF TWIN FALLS
Case No. CV-05-4345

VAlJGHN SCHM8CHE:r,, individually, and i!l.ll Surviving Spouse and
Person<'l-1 Representative'· of the Bstat.e of ROSA.LIB SCHMEC!!BL,
deceased, and ROBBR'J' P, LEWIS, KIM 110\'IARO, and ,TIJANt'l'A
PETERSON natural c!tildren of ROSALlE SCHEMECHEL, deceaGed,

Plaintiffs,

·

vs.

CL!N'J'ON DH,LE, M.D.' SOUTHl3RN [DAHO PA.IN rNSTI'l'IJTB, an
Idaho corporation, THOMAS BYRNE, P.A. and JOHN DOE r
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APPEARANCES:
BYRON V. FOSTER, Attorney at Law, 199N. Capitol
Boulevard, Suite 500, Boise, [daho 83701, appearing on
3 behalf of the Plaintiffs.
KEELY E. DUKE, Attorney at Law, from the Law Firm
4
of Hal!, Farley, Oberrecht & Blanton, P.A.) Key Financial
s Center, 702 West Idaho Street, Suite 700, Boise, Idaho
83701, appearing on behalf of Defendant Thomas Byrne, P.A.
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STEVEN J. HIPPLER, Attomey at Law, from the Law
Firm of Givens PurSley, LLP, 601 W. Bannock, Boise, Idaho
83701, appearing on behalf of Defendants Clinton Dille,
M.D. and Southern Idaho Pain Institute.
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WHEREUPON, the following proceedings were he~
pursuant to the Idaho Rules of Civil Procedure:
1
JAMES KELLER
f
having been duly sworn to state the whole truth, testified !
as follows:
I
EXAMINATION
.!;
BY MS. DUKE:
l
Q. Mr. Keller, my name is Keely Duke. We were jus I
introduced off the record. lam one of the attorneys that :i
is representing T.J. Byrne, the PA that provided care to
Ms. Scbmechel in September and October of 2003,
"
You are here today for your deposition. And this \'.
deposition is being taken pursuant to the Idaho Rules of 1
Civil Procedure.
[fyou could please state your name for the
·i.·
record,
A. My name is Jimmie with an i-e, middle initial E. l
Keller, K-e-1-1-e-r.
l
Q. Have you had your deposition taken before?
AQ.. For this case?
i.'.
No, any case?
n

j

i
l

A . Y es,

1:

Q. So you're familiar with basically the process we
2 4 are about to go through today?
25
A. Y a

23

li
'

!

•
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because of her obesity I would kind of expect that because
of the surgery she had on her knees, maybe on her back, I
would assume that.
But if it is getting worse -- and particularly I
think her son Robert said she wasn't mentally alert on one
of those weekend days, those are red flags to me that
Mr. Byrne should have been aware of and seen her or
whatever.
The phone calls, again, the phantom phone calls
over the weekend or the documented phone calls that he says
in his note that she was doing okay, what does okay mean?
Did he ask her specifically, are you having any trouble
breathing?
The sleep apnea is a huge concern by using any
narcotic whether it be Oxycontin, hydrocodone, oxycodone or
methadone it has a potential affect. And then when you add
them together and someone with a comorbid condition such aE
sleep apnea, my goodness, you're decreasing the respiratory
drive no matter what. And with her sleep apnea her
respiratory drive is diminished anyway. And patients who
use C-PAP are usually anywhere from 30 to 50 percent of
them by literature are noncompliant because I hate to sleep
in that stuff at night. Jt_is not very comfottable,
So was she using·it on the couch1 I doubt it.
There is no record ofit. Should she have been? Yeah,

l
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The other thing, with the edema that go back to what you
l
said about the cardiomeglia and other kinds of things, tl1e
2
concern that I have is what were her kidneys doing because 3
we don't know.
4
Only, again, I'm going by an assumption ofa
5
patient similair to Ms. Schmechel being obese, hypertensive 6
and 60 years old by literature from the age of30 or 40
7
depending upon the individual's other comorbidities, wear 8
los]ng anywhere from 3 to 10 percent of our kidney functio 9
every decade over time.
io
And when you add medications or other conditions
11
such as hypertension that C"'1 affect the renal function -12
and she was obviously retaining fluid from something, wha 13
was her kidney function? Don't know. Did that have a
14
contributing factor? Possibly. Don't know that, but that
15
is something that should have been monitored by Mr. Byrn ,16
Dr. Dille, somebody, in my opinion, should have rnonitore< 1 7
that.
18
And I feel that if Mr. Byrne had talked to
19
Dr. Vorst or obtained those records that he would have
2o
hopefully -- there would been a lot of red flags about how 21
he treated Ms. Scluneche!.
22
The other thing was in a complicated patient, l
23
would have probably talked to Dr. Dille. He was my
24
supervising physician and said, this is my plan, what do
25

Q. You are not critical of him doing that aspect of
it?
A. No, absolutely not.
Q. And what I understand you to be saying is once a
physician assistant initiates that therapy, at some point
after he's initiated that therapy you would like to see he
or she talk with their supervising physician and say, here
is what I did with Ms. Schmechel, is that all right with
you?
A. There is the science of the medicine and there is
the art of medicine and there is the practice of medicine.
All ofus who deal with medicine spend a lifetime or X
number of years perfecting our practice in medicine,
Science will always change. We learn something new about
diseases and illnesses every day,
So you have to keep up on the science aspect of
it. And there is some basic principles in science or
pharmacokinetics and things that don't change, but you find
out more about them. Like the knowledge of methadone toda
is much different than it was, say, five or ten years ago.
Q, ·Or even in 2003 versus now?
A. Correct. But the practice of medicine, the art of
medicine is knowing' when you have limitations and knowing
when you're stepping -- you're on a boundary here that
maybe you don't know everything about this patient but you
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1 you think. Because here is Ms. Schmechel, never seen her
2 before but) gosh 1 look at what all she has, what should we
B
g
3 do? Should we consider this or not?
~
4
Q. Let me stop you there just real quick to follow up
,
5 with a question. Do you know whether Mr. Byrne ever talked ij
6 to Dr. Dille about Ms. Schmechel's treatment?
1
7
A. I can only go by what is in the depositions, and I
{
B don't think there was anything that Dr. Dille signed off on
i
9 anything in his chart.
i
10
Q, lfDr. Dille were to testify in his deposition
/
11 that Mr. Byrne in fact did talk to him on that Monday after
j
12 Mr. Byrne did initiate the methadone therapy 1 wouldn't you (
13 agree that would have been appropriate?
f. l,
H
A, For him to ta!k to him?
,
15
Q. Correct.
~
~~
16
A. Yes. For the treatment, I still don 1t agree .with
17 the treatment. If Dr. Dille had any input in that
1B treatment, I don't think she was followed adequately,
19
Q. But let me ask you this, it was okay, as I
20 understand it, for Mr. Byrne to make the decisions as a
21 physician assistant to alter the medication, correct?
22
A. Sure. That's by any state regulation and
23 supervisory dictorum that you have and the relationShip
24 that you have with your supervising physician, a PA has the
25 authority to do that. Sure.
.
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should consult. I tell my students it is when the little
2 hairs on the back of your neck stand up. It just doesn't

2007
Page 59 U

1

3Mri~

3~~~~
4
·1 would assume that you agree that Mr. Schmechel

4

s
6

7
s
9
10
11
12
13
14
15
16
17
18
19
2o
21
22
23
24

25

This is a patient whose hairs stood up on the back
of my neck. Whether I was seeing her in a general practice
clinic for the first time or whether I was Mr. Byrne seeing
her in a pain medicine clinic. Hairs stood up on the back
of my neck. This lady had problems, As l said, whether-ifhe talked to Dr. Vorst, that would have been perfectly
fine and said this is what I'm doing, she is a pain
medicine specialist. That's an opinion and you work on
opinions.
And Dr. Dille, from what I understand in reading
the testimony and so forth, he signed off -- as soon as he
signed that chart, he concurred with Mr. Byrne's treatment.
That's the way it works, Docto1· Shirar in my practice and
any PAs practice does not see every patient l see. And
that is understood.
But implicitly as they read the chart and they
review my chart or whatever and they say, you know, we
should have done this, we should have altered this type of
treatment, that is how we do it. Ot· I'm going to call her
up or l'm going to go in the next room, depending upon ho1
we are working that day, and say, I've got this patient I
need you to take a look at. This is what I'm thinking

2 efficient way here to do that. Let me ask you a couple of i

5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
2O
21
22
23
24
25

I

i

''

was not drug seeking, correct?
A. I agree. Nothing that I can find in anything ·
would lead me to believe that she was a drug seeker.
Q. l would also assume that there's nothing -- well,
strike that.
l would also assume that you are not saying she
wasn't a truthful, honest reporter of her condition to
Mr. Byrne, correct?
A. Again, nothing that I can find that would say that
she was not.
Q. And you would certainly agree, as I understand
from your last statement, that it is very important for a
patient to be honest and accurate with their medical
provider?
A. Yes.
Q. Is that part of their contract to the medical
provider?
A. Yes.
Q. Aod a provider such as a physician assistant has
to be able to rely oit what the patient is telling he or she
with respect to the patient's conditions?

I.•.
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J
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1 aboutdoing,whatdoyouthink? Wouldyoucomeandlooka
2 them and consult.
3
That is what physicians do. Physicians don't know
4 evetything. That is why you have specialists. So you
5 consult either telephonically or in person or you refer a
6 patient to them.
7
That is, again, part of the implied contract that
8 a provider has with a patient. The implied contract you
9 have with a patient is that the patient is going to tell
10 you everything you need to know to make a good, presumptiv
11 differential diagnosis and treatment plan.
12
The co11tr.act the provider has with the patient is
13 you're going to find out everything you need to know and
14 you are going to do the right thing to the best of your
15 knowledge.
16
I think that's all I have to add right now tltat_ I
17 can think about of what I was going to say based upon what
18 you asked me about in that disclosure and clarification.
19
Q. As l understand it, have you articulated now all
20 of the opinions that you hold in this case?
21
A. I believe so.
22
Q. Obviously rm going to foHow up with you on some
23 things.
24
A, I expect that is -- that is why I'm here. I
25 expect that,

''j

Q. Sure. I'm just trying to think of the most

1

l
~

1

1
A Yes Let
·ust let
t Uy uwhatlteach
2 my first ye~r stu'.;;,~ls. !-~on't~~o: "· ':,,can to sound
3 flippant, because it is not. It's any easy way for me to
j
4 get some levity when l teach them this but also to hone in ',
5 what I think is important in the practfce of medicine
6 across the spectrum of medicine and surgery.
j
7
The first rule I go by is there are dumb people
j
8 born to dumb parents. That is, again, what did the patient j
9 hear. What are they capable of understanding that you're !
10 telling them and what is their ability to tell you the
I
11 information you need to know. And it's incumbent as far al
12 that contract goes of that provider to glean out as much
13 information from the patient as they are capable. And if
14 they're not, either their family member, their guardian or I
15 another provider.
16
The second thing is that patients lie. rt ls not
17 that they always lie intentionally, some do. Some will lie ;

I
l

i
!
l
j

18 to get secondary gain such as. you mentioned earlier, drug ia
19 seekers or whatever other kinds of things it may be.
;
20 But they ·don't always lie intentionally, they just omit
I
21 things because either they didn1t think about it, you
~
22 didn't ask the right question or whatever it is. So it is
;
I
2 3 incumbent again on that practitioner to ask the right
>
1

24
25

questions) open-ended questions so it leaves it for
discussion or get other infonnation from other mec1ns> as I

I
It
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mentioned earlier.
1
The third thing is that if you don't find it, it's
2
not there. That is that when you do a physical exam or y, u 3
do history taking and all you have are negatives, well, yo• 4
assume everything is normal. Well, it may not be, but if 5
it ain't there you assume, working on that diagnosis, that 6
everything is okay.
7
And the final thing is that the conditions that
8
are there, whatever is there, I'm too stupid to find it,
9
because I didn't look right. I didn't do the right test.
1o
I didn't ask the right person. I didn't ask the right
11
question. I didn't do the right physical exam. I didn't
12
order the right test. !'didn't order the right diagnostic
13
study, whateveritis..
14
So those four rules kind of encompass the practice 15
of medicine in my mind and in a case like this somewher< 16
along those rules were violated. One way or the other
17
between Ms. Schmechel and Mr. Byrne or Mr. Byrne and 18
Dr. Vorst or Dr. Dille or whomever, Ms. Sclunechel, inn v19
opinion, didn't get the care that she should have.
20
Q. And going back kind of where we started -21
A, Sure.
22
Q. -- before you just provided that answer, you are
23
certainly not saying that there is anything that you've
24
read or observed with respect to Ms. Schmechel that wou d2 5

4
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i
!

Dr. Vorst's records. With respect to the records that you
have reviewed, is there anything contained in those records i
that you believe would have caused Mr. Byrne to alter his
course of treatment for Ms. Schmechel?
1,
A. I don't have an opinion. I can't say. I don't
i!
know. I don't know what he would have done. I wou!d ha ~
just felt comf011able in him taking a whole history of it.
Again, going back to not knowing her on that Friday
j
afternoon. Was she compliant? Was she drug seeking? I
don't know. That is one thing I would have asked
Dr. V orst.
,,
Q. But you don't know ofanything as you sit here
J.,
today that was contained within Dr. Vorsfs records that
~
would have or should have changed Mr. Byrne's treatment ,'f
Ms. Schrnechel) correct?
!
A, Not that rm aware of.
ti
Q. With respect to Dr. Harris -- strike that.
With respect to Dr, Hanis, I don't understand you
B
to be saying that you believe Mr. Byme depa,ted from the E
,a
standard of care in not obtaining Dr. Harris' records. I
!i
undersfand you to be saying it is something he could have j
done but you are not critical of him in that regard?
g
A. Correct. Doctor Harris was the general
I
practitioner, the general family medicioe physician for
Ms. Schmechel. Be had a whole history of her. Jt is just ,

l

!

I

I

j

1
Page 64 ,

Page 62

1
2
3

2007

l

indicate that she was not capable and able of providing as 1 another reference that was there, ifnecessary. You know,
2 as an example, could he have called Doctor Vorst and not i
best she knew it an accurate histoiy of her condition?
3 got in contact with him, could he have and called
ij
A. To my knowledge that is correct.
4 Dr. Harris and said, hey, could you give me a background,~
Q. There is certainly nothing that -- well, strike
that.
5 Ms. Schmechel here. But, sure, it is another resource that j
Ms. Schmechel reported to Mr. Byrne what
6 should have been considered before the treatment started, f;
medications she had been 011 1 correct?
7 in my opinion.
j
A. Yes.
8
Q. But it's not a breach of the standard ofcare for
Q. And did so accurately, conect?
9 him not to obtain those records or called Dr. Harris,
,
A. Yes.
1 o correct?
Q. She also reported to Mr. Byrne that she had
11
A. Not a standard of care -- breach of care. l
,
obstructive sleep apnea?
12 wouldn't call it a breach of care.
:, _
A. As in his written note, yes. Not in that dictated
13
Q. Now, with respect to the records that Mr. Byrne
note,
14 did obtain, are you aware of any prior treating physician
Q. But it's in the records?
15 records that he obtained with respect to Ms. Schmechel? I
A. It is there, yes.
16
A. None that I'm aware of. I don't know of any than l
Q. And she was using her C-PAP machine and was 1 7 what I have reviewed.
!
compliant with it, correct?
18
Q. Are you aware that she was seeing an orthopedic
A. As far as I know,
19 surgeon with respect to her arachnoiditis?
;
Q. WitbrespecttoDr. Vorst,lunderstandthatitis
20
A, Yes.
,,i
your opinion that Mr. Byrne should have done one thing, (21
Q. As I understand it, you're not aware that he in
g
another thing. And that is he either should have obtained 2 2 fact received those records from the orthopedic surgeon? j
her records or picked up the phone and called Dr. Vars\? 2 3
A. No, not that I'm aware of.
I
A. That is correct.
24
Q. You would not be critical of him obtaining those

!
_:,i

j
j
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1 standard of care that would be applicable to a physician
A. Critical of him obtaining or not obtaining?
2 assistant practicing chronic pain management medicine in
Q. Of obtaining the orlhopedic surgeon's records to
3 Twin Falls, Idaho, in September and October of 2003,
3 determine if there is a surgical component to her pain?
4 correct?
A. Again, as I said earlier, I think any resource
4
A. That's correct.
5 that you can use to enhance yom knowledge of the patient 5
6 is going to be eventually good for both parties, the
6
Q. And you certainly understand the concept that you
7 patient and the provider.
7 have standard of care. That doesn't mean you can't go
Q. That brings up a good point that you and
8 above tl1e standard of care, but there is a standard of care
8
9 Mr. Foster are discussing there. Are there any documents
9 that you need to meet as a minimum threshold, correct?
10 that you have just seen but you don't have copies of that
10
A. Yes.
11 are not contained within your file?
11
Q. With respect to your knowledge of the standard of
A. Yes. Correspondence between Dr. Verst, the
12 care in Twin Falls, Idaho, as it existed in September and
12
13 orthopod, and Dr. Vorst, the pain management physician, ir 13 October of 2003, for a physician assistant practicing pah1
14 reference to Ms. Schmechel and her arachnoiditis.
14 management medicine, what have you done to fan1iliarize
15
Q. Anything else?
15 yourself with that standard of care'/
A. Other than what I told you that arrived at my
16
A. I talked to a pain management physicillll assistant
16
1 7 house today that l haven't seen.
17 by the name of Tom Robe.
18
Q. Okay. With respect to seeing her on a Friday
18
Q. Rambo?
19
MR. FOSTER: Rambo?
19 afternoon and. changing her treatment, l understand that
20 that is something that you are critical of; is that
20
A. Rambo, sorry,
21 correct'?
21
Q. (BY MS. DUKE) When did you speak to Mr. Rambo·
22
A. Yes, ma'am.
22
A. I spoke to him on two occasions. The last time
;
23
Q. ls that something that you're saying constitutes a
23 was last Thursday afternoon August 2nd.
'
24 breach of the standard,of care?
24
Q. When was the first time you spoke to him?
A. I would not call it a breach of standard of care.
25
A. Again, I don't remember. Mr. Foster may have a
l
25
l-----,------------------P-a_g_e_6_6--+-----...:'-'-------------=--P-a_g_e_6_8-fl
1

2

j

1 It is -- as I mentioned to you, it is a flexibility of the
2 practice ofa medicine that a provider can do. ln my
3 learned years as Jim Keller being a PA for 31 years, I've
4 just learned that there ·are things that you just don't do
5 and this is one of them. Because of Schwartz laws, as I
6 mentioned earlier, It if it is going to go bad it is going
7 to go bad over a weekend or a time that you don't have
B access to that patient in a way that would be -- optimized
9 the care to that patient. I think it was a poor decision
10 on Mr. Byrne's pait.
11
Q. But not a breach of the standard of care, correct?
12
A. The standard of care for Jim Keller, yes.
13 Standard of care in general, no.
14
Q. And while we're on that topic with respect to
15 standard of care, what.do you understand that phrase to be,
16 sta11dard of care?
17
A. It's a pretty open phrase. But generally it is
18 what a prudent practitioner in the same like practice or
19 general knowledge or same profession, i.e., PA physician o
20 whatever it may be would do in a similar situation, That
21 can be either local, state, national, international,just
22 depends.
·
23
Q. Okay. And you understand that the standard of
24 care that we're dealing with here is obviously not the
2 5 standard of care that you imply to yourself. It is the
,~;wa;, ,w;·-"1).r.:::c,:c~·--="''"'"'~''"'"~'~··" ,, ~ ·""'",.,.."'

I

l

1 better idea than lhat. It was to qualify my expe,t
2 testimony in talking to someone that had a like practice as ,
3 Mr. Byrne did and that was Tom. And l apologize to you,
4 just don't remember the date.
I
5
Q. Was that amonlh ago, two months ago, back in
)
6 March when you were contacted on this ease, just a genera j
7 time frame?
8
A. Time frame I think was May or June of this year.
i
9
Q. And let's take the first time that you spoke to
10 him, whether it was May or June of this year.
,;t
11
A. Hang on a minute. The letter tliat you have, the
j
12 exhibit, what date is that letter?
j
13
Q. I have April 4.
,.g
14
A. Okay. It was that time frame then because the
,
15 telephone conversation says an hour long, that was a
l
16 combination of conversations I had with Tom at that time j
1 7 and Mr. Foster. So that should have been April.
18
Q. So sometime prior to April 4, 2007?
i
l19
A. That's correct.
20
Q. But between March 3rd or 6th) whenever you were ~.:,"~
21 retained in 2007?
.
22
A. That is correct. Mr. Foster told me he needed the
23 qualifications for legal purposes for the standm·d of care.
24
Q. In that first conversation that was either in late
;
2 5 part of March of 2007 or early part of April 2007, what wa, j
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APP EA.RANCBS OF COUNSBL:
MR. BYRON FOSTER, Attorney at law, and
MR: DAVID COMSTOCK, Attorney ;:it law,
3
Boise, [daho,
appeared on behalf of Plainttffs,
l
2

l

2
3

4
5
6

4
5

6

7

MR, STEVEN HIPPLER, Attorney at L'lW, and
MR. VllLL VARIN,Auomcy at law,
Givens Pursley LU1 , BoL-re, Idaho,
appeared on behalf of l)cfendant Dille &
Southern Idaho Pain lnstitule.
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MS. KEELY ELIZABETH DUKE1 Auomey at Law, and
MR. CHRIS COMSTOCK, At!omey at law,
Ha11, Farley, Oberrecht & Blanto11, PA,
Boise, Idaho,
appeared on behalf of Defendant Thomas Byme, P.A
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25

Q. And can you tell us a little bit aboul

3

4
5
6

THURSDAY, OCTOBER 18, 2007,
TIIERON WARD JUDICIAL BUIWING,
425 SHOSHONE STREET NORTil,
TW1N FALLS COUNTY, TWIN FALLS, IDAHO.
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8
JIMMIE ELLIS KELIBR,
9 produced as a witness, being first duly sworn, was
10 examined and testified as follows:
11

Page 5 ;

5

7

DIRECT EXAMINATION
BY MR. COMSTOCK:
Q. Mr. Keller, good morning. You are a
physician assistant practicing presently lhat trade in
Colorado, and we have asked you to review materials in
this case, study depositions, speak with PAs from the
state of Idaho, ,n order to form opinions as to whether
or not Mr. Byrne, the PA in this case, fell below the
standard of care in his treatment of Rosie Schmechel.
Before we get into that, though, and your response about
that, would you just take a moment, start first by
introducing yourself and staling your full name for the

20
21
22
23 record.
24
A. My name is Jimmie, J-I-M-M-1-E, Ellis,
25 Keller, K-E-L-L-E-R.
....,,=~,·

"· -~=-~,,,_.,.,,--_.,. .. ,..,,. 'v.,,... ,,.~, ....

I

yourself personally, where you presently live, what you
are doing currently, and perhaps a little about your
~
family'!
A Sure. I am currently the Program Director
~
Por tlie Physician Assistant Program al Red Rocks
w
Community College in Lakewood, Colorado. Also, work .,'j
part time in a rural health clinic that we established
!
through a grant two yean; ago in Idaho Springs,
~
Colorado, I work there on Tuesday afternoons as a
~
family practice PA.
~
~
~
l grew up in North Carolina, had intentions
ti
of becoming a physician. Economically, things didn't
work out, so I enlisted in the Uniled States Army in
1967, lo get the GI bill to go back to school.
1was in Viet Nam. I was as medic in Viel
'
Nam, in 1969 to 1970, with two infantry battalions in
the 9th lnfantry Division in the Delta, Viet Nam.
"il
After I completed that tour of duty, I was at
.,f
Fitzsimmons Army Medical Center in Denver, Colorado. I
was an assistant ward master on an orthopedic ward,
f
taking care of returnees from the war.
"g
And then I went lo teach in a program that I
had gotten additional training, !here at Fitzsimmons,
orior to ,roin,r a Viet Nam, that's equivalent to a
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licensed practical nurse. The Army calls it a clinical
specialist. I applied to and was selected in the sixth
class of the United States Army Military Physician
Assistant Prograrn, in association with Baylor
University, went there in 1964, graduated in 1976 with
honors.
After that I was the first physician
assistant assigned to Fort Jackson, South Carolina,
where I took care of active duty soldiers, male and
female, training at Fort Jackson.
Did a tour of duty in Germany for
three years, from 1979 to '82, with the 3rd Infantry
Division.
After that I did assignments for physician
assistants in the Army Surgeon General's personnel
office. And then I was selected to serve as the first
Army physician assistant in the White House Medical Unit
with President Reagan and at that time Vice President
George W. Bush from 1984 until 1988.
After that I was selected to be the ombudsman
for the Surgeon General of the United States Army as his
physician assistant consultant and helped transition
physician assistants from being warrant officers at that
point in time in the Army to commissioned officers.
1retire<l in 1999. I went to &st Carolina
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in a pain mruiagement practice?
A. I do.
Q. That he was managing people's pain?
A. I do.
Q. And that he was making decisions each and
every day with respect t.o what he would do with a
chronic pain patient?
A. I understand that, yes.
Q. You are certainly not agreeing with the
following:
First of all, you agree that physician
assistants perform many of the same functions as medical
doctors?
A. That's correct. We practice medicine.
Q. And physician assistants deliver a broad
range of medical and surgical services?
A. All the things you see here that we are
allowed to do by law in any state, territory of the
United States, and elsewhere, is a negotiated autonomy.
What that means is, is that we have autonomy of
independent decision-making as far as deriving and being
able to do all those things that you see, deriving a
treatment plan and so forth; but we are dependent
practitioners, that is, that every PA is educated to
this knowled e in ever PA ro am that exists toda . I
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supervising physician never even sees the patienLs that
you see; correct?
A. Thal is correcL
Q. And that's okay?
A. That's okay.
Q. You are not here testifying that, with
respect to a c,iuse of death type opinion, are you?
A. I'm not an expert. I'm not a pathologist. I
do have an opinion, though.
Q. But you agree you're nol a pathologist?
A. No.
Q. You're not a toxicologist?
A. No.
Q. And when I took your deposition in Denver,
O:,!orado, you told me you were not going to provide an
opinion with respect to what caused Mrs. Scl1mechel's
death?
A. At that time I did.
Q. Second, you're not critical of Mr. Byrne
changing Mrs. Schmechel's Hydrocodonefrom 7.5
milligrams to lO milligrams, are you?
A. I am not.
Q. You are certainly not here saying that she
abused her Hydrocodone, are you?
A. Nol that I can -- not b an indication that
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1 was. Mr. Byrne was. We all are. That when you reach a

1 I have researched, no.
2
Q. TI1ere is absolutely no evidence of that;
3 correct?
4
A. None that I can find.
5
Q. You're not critical that Methadone was used?
6
A. That was a choice he made. As I said
7 earlier, I would not have made that choice; but since he
8 did, he used it.
9
Q. Sure. And it was not a breach of the
1 0 standard of care for him to use-Methadone; correct?
11 Just the Methadone in and of itself.
12
A. From my understanding, in his practice with
13 Dr. Dille, that they use Methadone in substitution for
14 the other long-acting opioids such as OxyConlin, yes,
15 that was part of their practice.
16
Q. And that was within the standard of care to
17 do?
18
A. It was in their standard of care, their
19 standard of care.
2o
Q, You agree that most practitioners are not
2 1 experts in the phannacokinetics of Methadone, including
2 2 -- or excuse me -- the pharmacokinetics -- pardon me.
2 3 ['m going to start that over.
24
You agree that most practitioners are not
2 5 experts in the phannacokinetics of medicines, including
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point of where you're unsure or the complication of a
ease or patient is beyond your scope, then that's a
point in time that you need lo consult with your
supervising physician and/or refer to a specialist in a
field, a consultant.
Q. And thank you for that.
A. And that's the same thing for physicians,
loo, in their expertise,
Q. And thank you for that, Mr. Keller.
When you are unsure, as a physician assistant
or as a physician, that's a time when you need to go to
talk to somebody?
That is correct.
But with respect to what [ have up there, a
p
·an assistant, taking medical histories,
ting physical examinations, prescribing
lions, counseling and educating patients,
ing patients, ordering diagnostic tests,
p
·ng minor surgery, that's all within the scope of
a
ian a.~sistant's practice; correct?
Their practice and their education, yes.
You yourself have a supervising physician?
I do.
And there are times, many times, where your

II
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Arthur Lipman
lN THE DtSTRlCT COUfl.T OF THE FIPTH JUDICII\L OISTR1~7
OP THE STATE OF IDJ:\HO,

m

11.ND FOR THE: COUNTY OF

VAUGHN SCHMECHEL,
individually, and as
surviving Spouse and
Personal Representative of
the Estate of ROSALIE

nirn

f,'Al,!,S

) De.poeition of:
)

6

) ARTHUR G, LIPMAN,

7
8
9

SCttMEC!ili!L, deceased, and
ROBERT P, LE:\'/lS, KIM HOWARD

) PW\RN.D,
)
)
)

SCHM!i:Cl'IEL, deceased,

) Case No. cv-05-4315
)

8 More: current CV of Dr. Lipman

)
VS,

CLINTON DILLf, M.D.;
SOUTHERN IDAHO PAIN
INSTITUTE, an Idaho
corporation; THOMAS BYRNE,
p. A., I and DOES X through X'

l

250

~

11

)
)
)

'

9 Medical records re: Rosalie Schmeche! l 00

Ii

12

)

10 Handwritten instJ~ction from BJ. Byrne
~3
given to Rosalie Schmechel
150
14 11 Earlier version of notes of Dr. Lipman
Re; Schmecbel case
185

J
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)
)
)
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DESCRIPTION
!'AGE
NO.
4
I Notice of Deposition
4
2 Curriculum Vitae of Dr, Lipman
4
3 Affidavit of Dr, Lipman
4
4 Supplemental Affidavit of Dr. Lipman
5 Second Supplemental Affidavit of Lipman 4
4
6 Typed notes ofDr. Lipman
7 6/7/05 !etter to Dr. Lipman from Margie
Rosenberg
4
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and JUANITA P~ERSON,
natural children of ROSALIE
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APPEARA~CES

2 FOR THE PLAINTIFFS:
3
Byron V, Foster, Esg,
LAW OFFICES OF COMSTOCK & BUSH
'1.
199 N. Capitol Boulevard, Suite 500
P, 0, Box 1584
5
Boise,ldaho83701-JSS4
208.336.4440
6
Fax 20&.344,772[
7 FOR THE DEFENDANT l?RYNE:
B
Keely E. Duke, Esg.
HALL, FARLEY, OBERRECHT & BLANTON, P.A.
9
702 West Idaho Streei, Suite 700
P. 0. Box 1271
10
Boise, Idaho 83701
208,395,8500
11
Fax 208.395,8585
12 FOR THE DEFENDANTS DlLLE nnd SO!JTI{ER.N lDAHO PAIN
INSTITUTE:
13

14
15
16

Steven J. Hippler, Esq.
GIVENS PURSLEY
60 J W. Bannock Street
P. 0, Box 277.0
Boise, Idaho 83701-2720
208.388, ! 200
Fax 208.388.!300
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PROCEEDINGS
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INDEX
ARTHUR G, LJP!YiAN, PHARM,D.
Examination by Ms, Duke
·
'1 Examination by Mr. Hippler
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ARTHUR G. LIPMAN, PHARM.D.,
called as a witness, being first duly sworn, was
examined and testified as follows:
EXAMJNATION
BY MS.DUKE:
Q. Dr. Lipman, good morning, My name is
Keely Duke. We were just introduced off the record.
We're here to take your deposition today. And that
deposition will be taken""
MS. DUKE: r assume, Counsel, we can
stipulate it will be taken pursuant to the Idaho
Rules of Civil Procedure?
MR. FOSTER: Yeah.
Q. (BY MS. DUKE) If you could state your
full name for the record.
A. Arthur G. Lipman.
Q. And where do you reside?
A. Salt Lake City.
Q. How long have you lived here?
A. Be 30 years next month.
Q. As I understand it when we were talking

• ;";" .,. ., ..,.~,,.~,~...-""~ '"""'"""'····;_"""'"""'~"-~"... ;, . --- "·-· - .....,,
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Arthur Lipman

July 5, 2007
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through conversation?
A. Yes.
z
Q, Is it your contention that Mr. Byrne or
3
4 Dr. Dille violated any applicable statute or rnle of
5 law in the state ofldaho?
A. No.
6
7
MR. FOSTER: I'm going to object to the
8 form.
Q. (BY MR. HIPPLER) One of the reasons that
9
1 O methadone is sometimes used is because it's felt to
11 be an efficacious medication to give for neuropathic
12 pain, correct?
A. Yeah. There's not evidence to suppo1t
13
14 that. Tb ere were a number of speculations on that,
15 and I've actually published in this area also, It's
16 a very-- one of the isomers of the molecule is a
17 weak NMDA antagonist. We know that NMDA antagonist
18 are useful in managing neuropathic pmn. There's
19 absolutely no real evidence that methadone is any
2 o better th,m any other opioid for that purpose. There
21 was a speculation to that effect in the literature in
22 the late 1990s which could have influenced people
23 using it in 2003. Thinking that it's a better drug
24 than morphine or oxycodone or any other opioid is not
25 valid, ft's just as good as the other drugs,
1

j

1

2
3
4
5

6
7
B
9

1o
11
12
13
14
15
16
17
18
19

2o
21

22
23

24
25

methadone or the selection of the methadone. It's
the way that it was used that I fault.
Q, And that relates, again, to the once-a-day
upward titration?
A. Correct,
Q. Are you knowledgeable enough about the
scoring of sleep apnea to know whether her scores
qualified her for severe or moderate sleep apnea?
A. No.
Q, You said you had a discussion with
Dr. Vorse. Did she indicate to you a belief, not
with respect to the dosing now, but just a belief
that this patient should not have been on methadone?
A. Not that I recall.
Q. And when you talked with the physician in
Lewiston whose name I can't remember -MS. DUKE: Flinders.
MR. FOSTER: Flinders.
Q. (BY MR, HIPPLER) -- Flinders, did you
talk with him generally about the standard of care in
Idaho, or did you talk specifically about the
standard ofcare in 2003?
A. The majority of the conversation on the
standard of care was between Dr. Flinders and
Dr. Lordon since they're both practicing
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however, so there's no reason not to use it.
Q. Okay.
A. And it's cheap.
Q. It certainly wouldn't have been
inappropriate in 2003 for.Mr. Byrne working in a pain
management clinic to think that methadone might be a
good drug of choice for neuropathic pain?
A. There's no reason to think it's a drug of
choice. ft's certainly a reasonable alternative
opioid. I have no problem with the selection of
methadone. I've been very clear on that. I think it
was a reasonable choice,
Q, I take it you don't feel it was necessary
for him to first try to increase her OxyContin to see
if that worked better?
A. She was already-- she was not taking a
large dose. She was only taking 20 milligrams three
times a day, But that's still a reasonably expensive
drug, and methadone is a lot cheaper. So for
economic reasons it would certainly be reasonable to
try her on methadone.
Q. It's at least, at a minimum, a matter of
judgment, professional judgment?
A. Yeah, Neither I nor anyone else on either
side of this case, to my knowledge, faults the use of
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anesthesiologists. I certainly concurred with what
they said. I don't remember much more detail about
it.
Q. So you don't remember whether it was a
general discussion or specific discussion related to
2003?
A, l suspect it was both.
Q, Okay. And do you recall what Dr. Flinders
indicated, if anything, about what his knowledge of
the standard of care in Twin Falls, Idaho was in
2003?
A. I don't recall.
Q. Or what his basis of -- or how much
coutact he had with providers in 2003 from the Twin
Falls region?
A. That may )iave been part of the
conversation. Again, I don't have a recollection. I
do recall that he felt that there was fairly
consistent standard across the state ofldaho, and
that it was consistent between Idaho and Utah.
Q. Okay. Do you know whether he practiced in
Utah?
A. I think he trained here.
Q, Okay. Do you know when that was?
A. I don't recall.
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HALL, FARLEY, OBER.RECHT & BLANTON, P.A.
RICHARD 1:-. HALL

702 WEST IDAHO STREET, SUITE 700
KF.Y FINANCIAL CENTER
BOISE, IDAHO 8Jnl2

DONALO S, f"IJU..F.Y"
!'lllLLU> S. O:BI:RRECHI'
1. CHARLF.$ IIU.ITTON
RAYMOND D, POWERS
C'I.NPYWAdo\UOffDAL"e
J. K!:MN W!',S"f
B,ui:r W. llMWOOD
JOHN J. BllR,KE
KEVINJ.SC/INl...l'IN
TAMSE,N L. LUACWMN

POSTOFPICE BOX 1271
B0l$E. IDAHO .8370!

TELEJ>HONE. (208) 395-3100
FACSil\fil..E (208) 395-8:SSS:
W:\2\2-40453\Ctnm.sel OS.dot
&MAIL: contat1@hallfadey.com
WEB PAGE: www.hallforley.com

KEl?LY £.. DUKB
JAMc.S S. THOMSON, JI

BRYAN I>-. NIC'KEU
CHlUSD. COMSTOCK
JILL M. 'IWEDT
PORTIA L, 18'NKINS
KMEN'O,SI-II!E.IU),;
KYLHM, i'EI.RSLEY
DANA M. frelUIERHOU
MAAA.1, ORi..£!1'
W'liR$'l Il TOWNSEND

WIOr.AfJamt:pklmlrr«f1', Pra,:/1CCMW in
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June 20, 2007

VIA FACSIMILE
Byron Foster
Law Offices of Comstock & Bush
199 N. Capitol Blvd., Ste. 500
P.O. Box 2774
Boise, Idaho 83701
Re:

Schmechel v. Byrne, et al.,
HFOB File No.: 2--404.53

Dear Byron:
Thank you for discussing the deposition schedule in the above-referenced matter with Steve
and I today. As we all agreed, Dr. Lipman's deposition wlll be held on July 5, 2007 in Salt Lake
City, Utah at 11:30 a.m. As such, we wlll send out an amended notice of deposition duces tecum
with the new 1 l :30 a.m. start time. In addition, you indicated that you wlll talk to John Bush to see
ifhe can cover Jim Keller's already scheduled deposition on July 19. With respect to Dr. Lordon,
you indicated that given the trial you and Dave have from July 9 through potentially July 31, you
need to move Dr. Lordon' s currently scheduled July 20 deposition. As such, you are checking to see
if Dr. Lordon can be deposed on August 2, 8, 9 or 13-17. Obviously, the earlier we can depose Dr.
Lordon the better, given that Rich and I will be unavailable for depositions in this case from August
20, 2007 through September 14, 2007 due to a medical malpractice trial we have in Rexburg, Idaho.

We also discussed getting the pathologist and Dr. Vorse scheduled for deposition. Currently,
Dr. Verse's deposition is scheduled for July 25, but understand from you that is not a deposition Mr.
Bush will able to cover, as such, please provide us dates for Dr. Verse's deposition. fn addition, we
need to get Dr. Graben scheduled. My office will contact his office to find a date and then work with
your office to schedule the deposition.
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June 20, 2007
Page2

In the event we are able to get Dr. Vorse, Dr. Lordon, Dr. Graben, Dr. Lipman, and Mr.
Keller deposed prior to August 3, we will Wk to our experts about seeing who can be deposed during
the week of August 13th through the 17th. As we indicated today, we will likely not be able io get
all of our experts scheduled that week, but will do our best to do so, If we are unable to get the
individuals listed above deposed before August 3, then 1he majority ofour experts' depositions will
need to occur during the week of September 17 (as long as they are available). We would be willing
to have you depose our toxicologist and Dr. Jim Smith during the week of August 13, even.if we m:e
unable to complete Dr. Lordon's depo by August 3.
On a final note, we agreed to extend the lay witness and expert witness depositions currently
set by the court to an indefinite date. As for plaintiffs' disclosure of rebuttal experts, we will not
agree to extend that deadline beyond July 18 due to your refusal to accommodate our request to
extend our expert disclosure from June J 8 lo a laier date.
Again, we appreciate you taking the time to have this phone call. Please let us know the
availability of your witnesses as soon as possible so we can finish up the discovery in this case.
Very truly yours,
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KEFil.YE.DUKE
JAMES S, THOMSON, ll
BRYAN A. NICKELS
CHRIS D. COMSTOCK
JlI.L M. TWEDT
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MARK J. ORLER
JEf'FREY R.. TOWNSEND

Willi A.t1onmys Ar/milled to Prwtlce Law In
Idaho, Or~g1m, Wa.;hington mid Ulah

July 3, 2007

VIA FACSIMILE
Byron Foster
Law Offices of Comstock & Bush
199 N. Capitol Blvd., Ste. 500
P.O. Box 2774
Boise, Idaho 83701
Re:

Schmechel v. Byrne, et al.,
HFOB File No.: 2-404.53

Dear Byron:
We are in receipt of your letter ofJuly 2, 2007 regarding the scheduling of depositions in this
matter. As you are aware, our office first requested depositions for plaintiffs' experts on April 24,
2007. After hearing nothing from plaintiffs' counsel with respect to those depositions we sent
another letter requesting the depositions on May 9, 2007. Again, having not heard from plaintiffs'
counsel, we sent a third letter, dated May 23, 2007, requesting your experts' depositions. On May
24, 2007, plaintiffs' counsel finally responded with proposed dates for plaintiffs' experts'
depositions (with the exception of Dr. Lordou). As such, we scheduled the depositions as follows:
Deponent
Arthur Lipman
Kimberly Vorse, M.D.
Cornelius Hofman
Jim Keller
Stephen Lordon, M.D.

Date
July 5, 2007
June 15, 2007, moved
to July 25, 2007
August l, 2007
July 19, 2007
July 20, 2007

Location
Salt Lake City
Ketchum
Boise
Denver
Salt Lake City

f,
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However, you contacted us a week and a half ago indicating your office needed to reschedule
all but one of those depositions. As such, we have worked with your office over the last week to
obtain additional dates. Currently, the expe1t depositions scheduled in this case are scheduled as
follows:
Deponent
Arthur Lipman
Kimberly Vorse, M.D.
Cornelius Hofman
Jim Keller
Stephen Lordon, M.D.

Date
July 5, 2007
August 1, 2007
September 18, 2007
August 8, 2007
August 2, 2007

Location.
Salt Lake City
Ketchum
Boise
Denver
Salt Lake City

Unfortunately, we learned form your office on June 27, 2007 via e-mail from your assistant to
my assistant that your office is no longer able to keep the July 19, 2007 date for Mr. Keller's
deposition and that the first available date for his deposition is August 8, 2007. Given that your
primary standard of care expert is not being deposed until August 8, 2007, we. are unable to provide
our standard of care experts for deposition (Dr. Cox and Mr. Kottenstette) until they have had an
opportunity to review and analyze Mr. Keller's deposition. As such, the depositions of Dr. Cox aud
Mr. Kottenstette will need to beheld the week of September 17, 2007. If you are able to find a date
that works for our office (such as July 19, 2007) for Dr. Keller's deposition, we will be able to
schedule Dr. Cox's deposition the week of August 13, 2007. As for Mr. Kottenstette, he has been on
vacation and we have been unable to reach him with respect to his availability, but anticipate we will
speak with him in the next week or so.
As we explained in our June 20, 2007 telephone conference, Dr. Phillips and Dr. Smith are
not available for deposition until the pathologist in this case, Dr. Graben, is deposed. Unfortunately,
Dr. Groben indicated he was available on August 14 and 15, 2007 for his deposition. However, our
office has left another message with his office asking ifhe could attend a deposition sometime the
week of July 30, 2007. In the event we are able to have Dr. Groben's deposition taken the week of
July 30, 2007, we are able to have Dr. Smith deposed on August 16, 2007 (we have not yet reached
Dr. Phillips with respect to his availability). If Dr. Groben is unable to provide us a date earlier tha11.
August 14 or 15, 2007, that works foryouroffice, Dr. Smith's and Dr. Phillips' depositions will also
need to occur the week of September 17, 2007 so that they both have time to receive and review Dr.
Graben' s deposition tTanscript.
With respect to Dr. Fakata, she is available for her deposition on August 17, 2007 in Salt
Lake City, Utah.
We are frustrated with respect to the timing ofmauy of these depositions but unfortunately,
given your office's request to reschedule all but one of your experts' depositions, our experts'
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depositions have to be pushed into September. Please let us know if you can move Dr. Keller's
deposition back to July 19, 2007, as that will resolve a number of these scheduling issues.

KED/cp
cc: Steve Hippler

'

'4]001

HALLFARLEY

07/03/2007 17:19 FAX 2083968585

'

'******************************
*** MULTI TX/RX REPORT ***

i

$$$~***********Z$****~****$***

0411
4

TX/RX NO
PGS,
TX/RX INCOMPLETE
TRANSACTION OK

( 1)

93447721

(2)

93881300

ERROR INFORMATION

LAW OFFICE

HALL, FARLEY, OBERRECHT & BLANTON, P.A.
Telephone: (208) 395-8500

702 W. ldaho, Suite 700
Post Office Box 1271
Boise, Idaho 83701

Facsimile: (208) 39%585

FACSIMILE COVERSHEET
July 3, 2007
TO:

David E, Comstock

FAX: (208) 344-7721

Byron Foster

Steven J. J:iippler

FROM:

Keely Duke

RE:

Schmechel v. Byrne, et aL
HFOll Fifo No.: 2-404.53

(208) 388-1300

MESSAGE: Please see attached letter
PAGES : including cove; page: 4

BARD COPY TO FOLLOW: No.
Sent by:

Cathy Pontak

'i
~
t
"t

!. 11,
l1 ,;...

·1

I

EXHIBIT ull"

A!TGRN£Y$

HALL, FARLEY, 0BERRECHT & BLANTON, P.A.
KEY FINANCfAL CENTER

DONALD 1. FARLEY

BOISE, IDAHO 83702.

f'Hll.Lll' s. ODlltlRfiCHT

KEELY a DI.IKB
JJ\.MCS S. THOMSON, n
Dll,YAN A. NICKELS

l CHAllES l!LANfON
RAYMOND D. POWERS

CHlUS D. COMSTOCK
JILL M. TWEDT

CANDY WAGAfiOFF DALE

l'ORTrA L. JENKINS
KAREN 0. SHEEHAN
KYLE M. YaARSLBY
DANA M. HE.RDERHOJ...Z
MARK J. ORLElt
JE.FfREY R. TOWNSBND

702 WES! IDAHO STilEE'r, sum~ 700

IUCf-wlD E. HALL

POSTOFFICBBOX 1271
BOISE. IDAHO 83701

J.KEVI.NWESl
BAATW, HARWOOD

JOHN J. BURKE

TELEPHONE (208) 395-8500
FACSIMILE (208) 395-8585
W:\2\2..-404 .53\Fo~tcr -03.doc

KEVIN 1. SC/\NLAN

TAMSElfL. LEACHMAN

E~MAIL: conlac(@haUfarfoy.com
WEB PAGE: www.hal!for!ey.com

With Attomcys Adtriilkd(o ProGlici law hi
Jduho, Ot<J<)Qf'r, li'ash1J,[;U»1 w,d Utah

July 6, 2007

VIA FACSIMILE
Byron Foster
Law Offices of Comstock & Bush
199 N. Capitol Blvd., Ste. 500
P.O. Box 2774
Boise, Idaho 83701
Re:

Schmechel v. Byrne, et al.,
HFOB File No.: 2-404.53

Dear Byron:
Dr. Groben is available for his deposition on July 30, 2007, after 5:00 p.m. Ifwe are able to
have Dr. Groben's deposition taken on July 30, 2007, we are able to have Dr. Smith deposed on
August 16, 2007. Please Jet us know as soon as possible ifthls will work.
Very tmly yours,
Dictated by Keely E. Duke and Sent
Without Signature lo Avoid Delay

Keely E. Duke
KED/cp
cc: Steve Hippler

- . - . ·=·- - - - - - - - - - - -

Q.] 001

JlALLFARLEY

07/06/2007 15:56 FAX 20S395S58~

.***************************$:*$

<•

***

MULTI TX/RX REPORT

**•

**********i**$********$*******
TX/RX NO
PGS.
TX/RX INCOMPLETE
TRANSACTION OK

0421
2

93447721
93881300

(1)

{2)

ERROR INFORMATION

LAW OFFICE

RALL, :FARLEY, OBERREC.Il.1' & BLANTON, P.A.
702 w. Idaho, Suite 700
Post Office Box 1271
Boise, Idaho 8370 l

Telephone: (208) 395-8500
Facsimile: (208) 395-8585

FACSIMILE COVERSHEET
July 6, 2007

TO:

David E, Comstock
Byroll Foster
Steven J. Hii:ipler

FROM:

FAX: (208) 344-7121
(208) 388-1300

Keely:Ouke
Sc!nnechel v. Byrne, et al.

HFOB File No.: 2-404.53
MESSAGE: Plei:wc see attached corrected letter regarding Dr. Groben's deposition.
·PAGES: including cover page: 2

HARD CO:l'YTO FOLLOW: No.
Sent by:

Catliy Pontak

"ii

1.

--;

..~

'i

J_ ·':::. .J

EXHIBIT "12"

Byron V. Foster
Attorney at Law
199 N. Capito! Blvd., Suite 500
POSoxi5M

le!eµhone: (208} 335-4440
Facaim11c-: (208) 344-n21

Boisa, ID 83701-1584

July 27, 2007
Via Facsimile: (208) 395-8585

Keely E. Duke
HALL FARLEY OBERRECHT & BLANTON. PA
702 West Idaho, Suite 700
PO Box 1271
Boise ID 83701
Via Facsimile: (208) 388-1200

Steven J. Hippler
GIVENS PURSLEY, LLP
601 W. Bannock St.
POBox2720
Boise, ID 83701-2720
RE:

Schmeche/ v. Dille, M. D, et al.

Dear Counsel:
On further consideration, we will not be taking the depositions or your respective
experts. Therefore, please cancel the deposition dates for those individuals. If you have any
questions, please -feel free to contact me.
Yours very truly,

BVF/skp

/7,

lZLL·vv£-SOZ

Hsns

~

)IJ0lSH0J

t

r!
Byron V. Foster
Attorney at Law
100 N. Oapllo.! Blvd., Suite 500

Telephone; (2:08} 33G-4440
Pacs\mlle.: (208} 344~77?.1

POBox1564

Bo1se, ID 83701-1584

FACSIMILE COVER SHEET

TO:

Keely Duke

395-8585
FROM:

Byron V. Foster

DATE:

July 27, 2007

CC:

Steven J. Hippler

388-1300

RE:

Schmechel v. DI/le, et al.

COMMENTS:

Please see the attached correspondence of today's
date.

Including this cover sheet, this facsimile contains

L

page(s).

FAX RECEIVED

JUL 2 7 2007
HALL, FARLEY.
OBERRECHT & BLANTON
CONFIDENTIALITY NOTICE
The infonnatlon In this facsimile is confidential and intended only for !he use of the addressee. The data
transmitted is attorney privileged and may be exempt from disclosure. Do not copy or distribute to anyone
other than the addressee. Reliance on this data by other than the Intended recipient Is prohibited. Please notify
us Immediately if you have received this communication ln error. Upon notification we will arrange for return of
the faK copies to Comstock & Bush. Additionally, if you do nol receive all of !he pages of this facsimile, please
notify our office as soon as possible. Thank you for your cocperatlon. lf you have any problems receiving this

fax, please contact the operator at (208) 336-4440.
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Schmechel v Dille

&

Testimony of Dr. Glen Robert Groben

Byrne

October 23, 2007

CV 2005-4345

3

Page 1
IN THE DISTRICT COURT OF THE FIFTH JUD:r.cnu. DISTRICT OF
THE STATE OF IDAHO, 1N AND FOR THE COUNTY OF TWIN FALLS

1

VAUGHN SCHMECHEli, Individually, I

3
4
5

and as surviving Spouse and
Personal Representative of the
Estate of ~osalie Schmechel,

l

Deceased, u.nd ROBERT P. t,r,!WXS,

)

KIM HOWARD and TAMARA HALL,
Natural Children of ROSALIE

I
I
l
l

SCHMECHEL, Deceased,

Plaintiffs,

I

l

CASE NO. CV 2005-1345
REPOR'l'ER' S 'rRANSCRI PT

l
vs.

I

I

14
15
16

I
I

OCTOBBR 23, 2007

17
J. 8

PARTIAL REPORTER'S TRANSCRIPT

JURY TRIAL - DAY 5

19

TESTtMONY 0~ DR, GLEN ROBERT GROBEN

2o
HON, G. RICHARD B'.E!VAN
DISTRIC1 JUDGE, PRESIDING

21
22
23

24
25

Reported By
VIRGINIA M, BAILEY, RPR, CSR. No. 262

official Court Renorter

ij

I

l

7

13

l
Defendants,

i
i

6

11
12

CLINTON DILLE, M.D., SOUTHERN
)
IDAHO PAIN INSTITDTE, an Idaho )
Corporation, THOMAS B¥RNE, P.A.'}
and JOHN DOE, r through X,
l
.

2

8
9
10

)

1

TUESDAY, OCTOBER 23, 2007,
Page
THERON WARD JUD[CIAL BUILDING,
•
425 SHOSHONE STREET NORTH,
TW!N FALLS COUNTY, TWIN FALLS, IDAHC

~
~

g

GLEN ROBERT GROBEN,
i
produced as a witness, being first duly sworn, was
examined and testified as follows:
l
DIRECT EXAM!NAT!ON
~BY MR. COMSTOCK:
Q. Dr. Graben, good morning, You are a medical
physician and a forensic pathologist, and the jury has
heard your name, and we have been referring to an
autopsy report that was prepared by yourself regarding
the probable cause of Rosie Schrnecbel's death.
Before we get into those matters and your
work and your conclusions in this case, would you take a
moment, introduce yourself to the court, spell your last
name for our court reporter and, if you wouldn't mind,
review your background and your education that qualifie:
you to do what you do for a living.
A. All right. My name is Glen Robert Graben.

I

Page 4

Page 2

12
13
14

1 My last name is spelled, G-R-O, B, as in boy, E-N, I am
2 a forensic pati1ologist. l work at the Ada Coun1y
3 Coroner's Office.
4
I have a medical degree from the Universi1y
5 of Colorado Health Sciences Center in Denver, Colorado
6 in 1990. Following that J did a five-year residency in
7 general pathology at the same institution in Denver,
8 where [ studied basically all aspects of pathology,
9 which includes forensic pathology, Following that I did
1 O a one-year fellowship in forensic pathology where I
11 specifically worked in a medical examiner's office, and
12 that was the office of the Chief Medical Examiner in
13 Richmond, Virginia, So I worked there for a year doing
14 autopsies and studying under the medical examiners
15 there, Then following that, I went to work, and I went
16 to Texas, worked for three years, before coming here in

15
16

17 2000.
18

17

19 doing since 2000 for a living, and explain if you can,

1
2
3

APPEARANCES OF COUNSEL:
MR. BYRON FOSTER, Attorney at Law, and
MR. DA VlD COMSTOCK, Attorney at Law,
COMSTOCK & BUSH, Boise, ldaho,
appeared on behalf of Plaintiffs.

4

s
6
7

MR. STEVEN HIPPLER; Attomey at Law, and
MR. WILL VARIN, Attorney at Law,
GIVENS PURSLEY, LLP, Boise, Idaho,
appeared on behalf of Defendant Dille &
Southern Idaho Pain Institute,

8

9
10

MS. KEELY E. DUKE, Attorney at Law, and
MR. CHRJS COMSTOCK) Atlomey at Law,
HALL, FARLEY, OBER.RECHT & BLANTON, l'A, Boise, Idaho,
appeared on behalf of Defendant Thomas Byrne, P.A,

ll

18
19
20
21
22
23
24

25

2O

Q. Can you explain sort of what you have been
during that process, how it is that you got involved,

21 even though you're primarily in Boise, in tenns of doing

an autopsy for the coroner here in Twin Falls County?
A. Well, I've been working at the Ada County
Coroner's Office since June of 2000. We do all of the
2 5 autopsies for that county. And in that county I

22
23
24

1 (Pages 1 to 4)
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Testimony of Dr. Glen Robert Groben

Byrne

October 23, 2007
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Page 27 ~

MR. HIPPLER: I'd be impressed if you were
able to do it from up there.
THE COURT: I would, too.

2
3

BY MR. HIPPLER:

4

Q. Mr. Comstock, well, before we get to that,
the page we're at there on the second highlighted line,
says, I'm of the opinion that findings, cause, and
manner death, as follows. Do you see that?
A. Yes, I do.
Q. And it's true, is it not, that actually you
don't determine the manner of death?
A. No, I do -- not, well, on this case, I
don't. Depends on where it comes from.
Q. That would be in the coroner's office, in
this case Ms., now Anton, then Shindle?
A. Right. That's correct.
Q. Now, Mr. Comstock touched on this, so I won't
go into too much of it; but Mrs. Schmeche! had an
enlarged heart, or what you medical folks call
cardiomegaly; correct?
A. That's right.
Q, And it's true that cardiomegaly, as
Mrs. Schmeche\ had, can in and of itself cause a fatal
arrhythmia in a person?
A. That's possible, yes.

5
6

1
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1

I

A, That's right.

Q. And obviously, long-tenn hypertension or high j
blood pressure, including to the extent of causing
!
granulation of the kidneys can be indicative of coronary!
artery disease'I
l
A. Well, they can happen either/or. But
l
certainly they can happen together.
i
Q. Sure. And in fact, in this case you found
g
what you indicated was coronary artery disease that was j
I think you indicated, moderate to severe but trending j
into the severe; correct?
:l
A. That1s right.
~
Q. And that would include a 75 percent occlusion l
of -- is it the left descending main coronary artery?
A. It's the left anterior descending coronary
,
artery.
i
Q, And like you said, that's one of the three
U
important vessels; correct?
A. Yes, it is.
,
Q. And you found a 50 percent occlusion, or
i
narrowing or stricture of the right coronary main
aitery; correct?
l
A. Yes, I did.
j
0. And I presume in your position as a
1

'

1

I
j

.,
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1
2

3
4

5
6

7
B
9

10
11
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14
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Q. In fact, there are times where you will get a
body, and you'JJ do an autopsy, and you won't find other
causes of death, you'll find an enlarged heart, and
you'll call it a fatal arrhythmia, secondary to a
cardiac -- cardiomegaly; correct?
A. That's right.
Q. And if they have a fatal arrhythmia from
cardiomegaly, there's no finding other than the enlarged
heart itself that you typically will be able to find
that shows you that that's what killed them; correct?
A. That's right.
Q. Now, Mr. Comstock had asked you about various
parts of the report and had you point them out.
lfyou turn to page five of, what we've
numbered page five, on our document, under paragraph
number four, gastroi1\testinal system. Pardon me. !
take that back. Number five. Sorry.
And under number five, one of the things that
you looked at was the kidney; correct?
A. That's right.
Q. And one of the things that you found in the
kidney was granulation of the kidney; correct?
A. That's right.
Q. And granulation of the kidney is consistent
with long-term hypertension or high blood pressure, is

1
2
3

4
5
6
7
8
9

10
11
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pathologist, you'll have patients who have similar
findings in their heart, and you'll conclude that that
is the cause of the death, that is, their severe
i
coronary artery disease may have caused a sudden cardia ~
death; correct?
!
A. If there's nothing else, yes.
j
Q. And a sudden cardiac death might be an
,
arrhythmia, and it might be a sudden fatal heart attack? j
A. That's right.
J
~l
Q. If we have, for example, a sudden fatal heart
attack, often times on pathology, there won't be a sign .\
of that other than the coronary artery disease that you
see; correct?
A. That's correct.
Q. And just so that I am understanding
correctly, that I understand what you're saying with
respect to Methadone, but if we had the same patient
"
with just the Hydrocodone and her other underlying,
we've been using the term comorbid conditions -- and yo\ j
understand what comorbid conditions are; correct?
1
A. Yes.
i
Q. If we had the other underlying conditions,
such as her heart disease, such as her high blood
l
pressure, such as her cardiomegaly, that you would have
1
found that it was her severe coronary artery disease
1!

I

l

j
!

!

1

7

(Pages 25 to 28)

Virginia M. Bailey, RPR, CSR No. 262
a1 e261 e0wf340-4 e71 w802.0w803f4dada807

,
1

>;. n.)

I

EXHIBIT "14"

Richard E. Hall

i[_
1
j

ISB # 1253; reh@haJ!farley.com

Keely E. Duke
ISB #6044; ked@hallfarlcy.com

HALL, FARLEY, OBERRECHT & BLANTON, P.A.
702 West Idaho, Suite 700
Post Office Box 1271
Bolse, Idaho 83701
Telephone: (208) 395-8500
Facsimile: (208) 395-8585
W:\2\2~404,53\NOD SHfNDLB.DOC

Attorneys for Defendant Thomas J. Byrne
IN THE DISTRICT COURT OF THE FIFTF! JUDICIAL DISTRICT
OF THE STATE OF IDAHO, IN AND FOR THE COUNTY OF TWIN FALLS

VAUGHN SCHMECHEL, individually,
and as Surviving Spouse and Personal
Representative of the Estate of ROSALIE
SCHMECHEL, deceased, and ROBERT P.
LEWIS,K!MHOWARD and JUANITA
PETERSON natural children of ROSALIE
SCHMECHEL, deceased,

Case No. CV-05-4345

NOTICE OF TAKING DEPOSITION
DUCES TECUM OF SHAIYENNE
SHINDLE

Plaintiffs,
vs.
CLINTON DILLE, M.D., SOUTHERN
IDAHO PAIN INSTITUTE, an Idaho
corporation, THOMAS BYRNE, P.A. and
JOHN DOE, l through X,
Defendants.

YOU WILL PLEASE TAKE NOTICE that defendant Thomas J. Byrne, P.A., by and thTough
his counsel of record, Hall, Farley, Oberrecht & Blanton, P.A., will take the deposition of
NOTICE OP TAKING DEPOSITION DOGES TECVM OF SHA!YENNE SHINDLE -1

!
'I

SHAIYENNE_ SHINDLE at the Twin Falls County Courthouse, }ury Room, 425 Shoshone St. N.,
Twin Falls, Idaho commencing at 9:00 a.m. on July 10, 2007, and continuing from time to time
until completed, at which place and time you are invited to appear and take part in such deposition as
you deem proper.
The deponent is required to bring with her the following:
1)

All medical records, charts, reports or other documents reviewed by you or in

your possession pertaining to the medical care and treatment of Rosalie Schmechel.
2)

A copy of any and all correspondence, medical records or other materials

provided to you by plaintiffs or plaintiffs' counsel or which you provided to plaintiffs or plaintiffs'
counsel.
3)

All documents, notes, writings, correspondence, recordings or reports,

produced, created or written by you, including any p1ior testimony or statements given by you,
whether recorded stenogtaphically or otherwise, which reflect your opinions in this case or relate to
the issues in this case.
4)

A copy of your curriculum vitae.

The above deposition will be conducted pursuant to the Idaho Rules of Civil Procedure
before a Notary Public, or such other officer authorized by law to administer oaths.
DATED this .f;!!ctay of June, 2007.

HALL, FARLEY, OBERRECHT
& BLANTON, P.A.
.By~~

,f,..,
Q •'

Richru:d E. Hall " Of the Firm
Keely E. Duke- Of the Finn
Attorneys for Defendant Thomas J. Byrne

NOTICE OF TAKING DEPOSITION DUCBS TBCUM OF SHAIYENNE SHINDLE" 2

·t

i
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n,

J. ;:. .) ..

CERTIFICATE OF SERVICE
I HEREBY CERTIFY that on 1he ~Jdyday of June, 2007, I caused to be served a true copy of
the foregoing NOTICE OF TAKIN DEPOSITION DUCES TECUM OF SHAlYENNE
SHINDLE, by the method indicated below, and addressed to each of the following:

/4s.

David Comstock
Law Offices of Comstock & Bush
199N. Capitol Blvd., Ste. 500
P.O. Box 2774
Boise, Idaho 83701
Attorney for Plaintiffs
Fax No.: (208) 344-7721

Mail, Postage Prepaid
Hand Delivered
__ OvemightMail
__ Telecopy

Steven J. Hippler
GlVENS PURSLEY
601 W. Bannock ST.
POBox2720
Boise ID 83701-2720
Attorneys for Clinton Dille, MD. and
Southern Idaho Pain Institute

~ S . Mail, Postage Prepaid
Hand Delivered
__ Overnight Mail
__ Telecopy

t

M&M Court Reporting via email

in,~~

T5 . '

Keely E. Duke

NOTICE OF TAKING DEPOSITION DUCES TECUM OF SHAfYENNE SHJNDLE. 3
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EXHIBIT "15"

Cathy A. Pontak
From:
Sent:

To:
Cc:
Subject:

Cathy A. Pontak
Thursday, June 07, 2007 9:50 AM
Keely E. Duke; Richard E. Hall; Chris D. Comstock
Kathy A. Savell; Kay L. Moorhouse; Cathy A. Pontak
Schmechel v. Byrne 2-404.53

Sarah from Dave Comstock's office called. She said Dr. Lordon is ohly available on Fridays and we have
tentatively set his deposition for July 27 in Salt Lake. Also, Sarah said that their office is not available for
the depositions of the coroners on July 10th as they are in trial. We are going to keep those on calendar
for now, in case their case settles.

l
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EXHIBIT "16"

.,.,,,·

Byron V. Foster
Attorney at Law
199 N, Capitol Blvd,, Suite 500
PO Box 1604
Sols~ 10 83701-1584

July 2, 2007
Via Facsimile: (208) 395-8585
Keely E. Duke
HALL FARLEY OBERRECHT & BLANTON, PA
702 West Idaho, Suite700
PO Box 1271
. Boise ID 83701
Via Facsimile: (208) 388-1200
Steven J. Hippler
GIVENS PURSLEY, LLP
601 W. Bannock St.
PO Box2720
Boise, ID 83701-2720

RE:

Sohmeohel v. Dille, M.D, eta/.

Dear Counsel: .
Last week, Ms. Duke's assistant, Cathy, emailed my assistant regarding
scheduling/rescheduling the depositions of Mr. Hofman, Dr. Nicholson, Dr. Groben, Mr.
Chambers and Ms. Shindle. In reviewing Ms. Duke's letter of June 20, 2007, it is indicated that
if we were able to schedule Drs. Vorse, Lordon, Lipman, Groben and Mr. Keller prior to August
3, 2007, we would discuss deposing your experts the week of August 13. Given 1hat we have
set the majority of these depositions, Dr, Lipman on July 5, Dr. Vorse on August 1, Dr. Lordon
on August 2 and gave proposed dates far Mr. Keller of either August 8 or 9, we would like to
schedule your experts' depositions during the week of August 13, 2007. I feel it Is unreasonable
to wait to schedule your experts' depositions until Dr. Groben's deposition has been taken.
Therefore, please provide our office with your experts' avallabllity including, but not limited lo,
.Mr. Kottenstette, Dr. Binegar, Dr. Cox, Dr. Fakafa, Dr. Smith, Dr. Phillips, Dr. Hare, and Dr.
O'Donnell.
Yours very truly,
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Byron V. Foster
Attorney at Law
199N. CaplloJ l;IlvO,, S!Jlle 600
POBox1584
,
Boise, JD 83701-1584

Telaphone,: {208) 336-4440
F1tCG.lm!l11: {208) 344-7721

FACSIMILE COVER SHEET
TO:

l

Steven J. Hippler

i

388-1200

,

i ..

.

-I

Keely Duke
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395-8585
FROM:

Byron V. Foster

DATE:

July 2, 2007

RE:

Schmeche/ v. Dflle, et al.

COMMENTS;

Please see the attached correspondence of today's
date,

Including this cover sheet, this facsimile contains
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other than the addressee, Relianoo on this data by other than the intended recipient Is prohibited. Please notify
us Immediately If you have received 1hls communlcatlon In error. Upon notlfioatlon we will arrange for return of
th• fax copies to Comstock & Bush. Additionally, If you do not receive all ofthe pages of tills facs1m!le, please
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fax, please contact !he operator at (208) 336444-0.

zn:

Hsna '8 )l'.JOlSWO'.J

EXHIBIT "'17"

I

1
l

,,.,r~(,¥
.JI..
'

J. ._,'
. J

,'.

Pagel
IN THE DISTRICT COURT OF THE FIFTH JUDICIAL DISTRJCr
OF THE STA.TB OF IDAHO, IN AND FOR 'rHS CO\JNTY ()F ·rwrn PALLS
VAUGHN SCHMF.:Cl-iE:t,, individually,

)

and as surviving Spouse and

)
)

Pe:i.:sonal Representative of the
Estate of nosALI8 SCHM8CHEL,
deceased, and ROBERT P. LEWIS,
KIM HOWARD and JUANITA PETERSON'

natuzal cl1ildzen of ROSA.LIE
SCHMECHEL,, deceased,

PlaintiCfs,

3
4
5
6
7

I
)

)
)
)

"·
CLINTON

L, D!LLE, M,D., SOU'J'IH?RN
IDAHO PAIN INSTITUTE, an Idaho
corpor.?ttion, THOMAS BYRN£, P ,A.,
and JOHN bOES, I through X,
Deferidanta.

case No, CV 05-4345

)
)

I

7

SEPTEMBERS, 2007

J\NTON

31
~

j

For the Defendant
Hall Farley Oberrecht & Blanto, l
Th01nas J. Byrne:
BY: KEELY E. DUKE
j
1
702 West Idaho, Ste. 700
P.O. Box 1271
'
1,
Boise, Idaho 83701-1271
fl.

For the Deponent:

10

)

------D~EPO~s~,~r~,o~.-o~,~sHA=I"YBNNE
Cll,.THERlNE PAVKOV, CSR NO, 658
Nota-ry Public

APPEARANCE S (Cont.)

B

9

)
)

REPORTED BY:

1
2

)

)

Page

Twin Falls County Prosector's j
i
Office
-~

11

BY: MATTHEWD. PEMBER

.1

12
13
14
15
16
17
18
19

P.O. Box 126
Twin Falls, Idaho 83303-0126

·1

'

f

i

''

I
~

[

!
!

20

21

/,
f;
~
¥.

22

23
24
25

i
l

1--------------------P-a_g_e_2+---------------------P-a_g_e_4-ll
TI!E DEPOSITION OF SHAIYENNE ANTON was tal<e1 1
INDEX
2 on behalf of the Defend.ant Thomas J. Byrne at the
2
3 law offices of Tolman & Brizce, 132 Third Avenue
3 TESTIMONY OF SHAIYENNE ANTON:
4 East~ Twin Falls, Idahot commencing at 12:00 p.m.,
4 Examination by Ms. Duke
5
5 on September 5, 2007, before Catherine Pavkov,
5 Examination by Mr. Hippler
96
6 Certified Shorthand Reporter and Notary Public
6 Examination by Mr. Foster
105
7 within and for the State ofldaho, in the above7 Further Examination by Ms. Duke
127
8 entitled matter.
8 Further Examination by Mr. Foster
132
9
9 Further Examinatn by Mr. Hippler
l 33
10
APPEARANCES:
10
11
11 For the Plaintiffs:
Comstock & Bush
12
12
BY: BYRONV.FOSTER
EXHIBITS
13
P.O. Box 2774
13 I
Second Amended Notice of Taking
15
14
14
Boise, Idaho 83701-2774
Deposition Duces Tecum of Shaiyenne
15
15
Shindle
16 For the Defendants
GIVENS PURSLEY, LLP
16 2
CD of photographs
134
17 Clinton Dille aud
17
BY: STEVEN .l. HIPPLER
** To be provided later
18 Southern Idaho Pain ,601 West Bannock Street
18 3
Twin Falls County Coroner's Office
19
19 Institute:
P.O. Box 2720
19
Autopsy Report with Attached Record
20
Boise, Idaho 83701-2720
20
of Death
21
21 4
Twin Falls County Coroner's Office
19
22
22
Autopsy Report
23
23 5
Reeord of Death
28
1

24

24

25 (Appearances continued to next page)
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1 (Pages 1 to 4)
(208)

345-9611

M & M COURT REPORTING SERVICE,

INC,

(208)

345-8800

(fax)

Page 41

Page 43 "

j

1
2

find any signs of struggle, bodily fluids,
1
Q. Rather, why don't you describe for
sickness, anything like that. You know, just to
2 me in your own words what you believe, you know,
'
3 indicate to me if she'd been sick prior to her
3 happened immediately prior to her death, at least
4 death. And I didn't find anything to that effect.
4 from the standpoint of you being able to observe
s
Q. Okay. With respect to your
s the scene.
6 investigation of the area surrounding her, could
6
A. Okay. I believe from what I saw at
7 you tell whether she had released her bowels or
7 the scene and what I later heard, you know,
8 ber bladder at that point?
8 speaking with witnesses that were there, later
9
A. I believe at that point, no. I
9 with Mr. Schmechel, the little bit I was able to
1 O couldn't tell. It was later when we had moved her
1 o speak with him, he had seen her earlier that
11 and was back at the mortuary that I noticed that.
11 morning, that she had been sleeping. I believe he
12
Q. And it's also my understanding that
12 stated she was even snoring.
13 the TV had been on when Mr. Lewis had come to the 13
By the way, the family members
14 scene but that it had been subsequently turned
14 stated, you know, she didn't leave dishes in the
15 off?
15 sink. She didn't leave the ashtrays. Those are
16
A. Correct. And I can't recall what
16 things she did in the morning, part of her day.
1 7 The bird cage wasn't taken off. The dog wasn't
1 7 time, when in the time Officer Andrae told me
18 that, but he did say that when he got there the TV
18 outside. Those are things that she did, you know,
19 and cable was on. I remember him telling me that
19 throughout the morning, I was told. That since
2 o he did turn the cable off.
20 those things weren't done, I believe it was
21
Q. So the TV and cable were off at the
21 sometime during the morning that maybe she woke
2 2 time?
2 2 up, you know, possibly had a cigarette or the -:
23
A. Correct. Uh-huh. Or I believe the
23 the coffee wasn't started or made, which they said
I
24 cable was off or they were having difficulty with
24 was one of the first things that she did, I don't
j
2 5 something that had turned on while I was there,
2 s think she'd been awake very long.
!
f------"-------------P-a-'ge-4~2--l------------------------'---_c.,"-----P-a-ge_4_4--!j
!

1
1

j

1
2

3
4
5
6
7
8
9
10
11
12
13

14
15
16
17
18
19
20

21
22

23

but he stated to me that he had turned them off.
Q. But it's your understanding that
when he came upon her, prior to calling,
obviously, nine-one-one, that the TV had been on?
A. Correct.
Q. And as I understand it, you didn't
find any signs of any kind of other person unknown
or trauma?
A. Right.
Q. No sign of struggle?
A. Correct.
Q. And so you ruled this to be an
accidental death?
A. Correct.
Q. Is it fair to say that based on the
fact that the TV was on, the fact that there was a
lit cigarette that obviously fell to the floor,
and that it appeared Mrs. Schmechel slumped over,
that immediately prior to her death she had been
sitting up?
A. Correct. :Yes. I believe so.
Q. And so it's not your opinion based
upon your investigation that she bad been asleep

2 4 at the time of her death,· is that con-ect?

25

A.

I don't believe so, no.

l

2
3
4

5
6

7
8
9
10
11
12
13

14
15
16
17
18

19
20

21
22

23

Q. But you do think at the time of her
death she was awake?
A. Correct, yes. And I believe that
dne to the fact with the cigarette, lit cigarette.
Q. Right. And I would assume that you
also believe that just given the posture of her
body looking as if it kind of slumped to the
right, that she had been in a sitting position?
A. Yes.
Q. And then something occurred and she
slumped to the right and that's where you found
her?
A. Correct, yes,
Q. All right. So after you performed
this investigation that brought you into the room,
did you notice that there was a CPAP machine in
the room anywhere? ·
A. Not that I recall, no.
Q. Do you remember anybody talking
about a breathing device which she would use if
she was asleep?
A. No.
Q. Do you recall any photos of that

2 4 device at all 7

25

A.

Not to my knowledge, no.
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EXHIBIT "18"

1

OP ~~/~~A~iiS~li~J\~g~liI/!~~:I~ ~~~~/~I~ ~k:
VJIUGUN SCIIMECU&L, individually, and a13
Surv.Lv.fog Spo1rne llnd Pe:rsonal

:~~:~~~~t~:~e~:el~e_._~~t;;:E~f
:~s~~~~s.
KlM !IOWARP and T.MIJIJ'!.1i. IUILL, natural

1
2

)
)

3
No, cv-os~4.34.!

4

children of ROSALIE SC'HMSCHEL, dece.ised,

v,,

5

Plaintiffs,

6

Cl,lm'ON D'ILL'E, M.D., SOUTHERN lDAIIO l.'AlN
INSTITUTE, 1111 ld"'ho (lOt:poration, TJIOMAS
BYRNE, P-.h,' and JOHN DOE and JANE DOS,

7

I through K,
VWSO'l'J\PEO OEPOSl'l.'lON OF CLINTON l.J>.MAR PlLL£, M,D,
JUNE :l, 2006

REPOR.'T'ED B'f 1

G!'..ODO\o!SKI, CSR

i•

BY: Richard E. Hall
702 West Idaho
Suite 700
Boise, Idaho 83701

1.·

I
I

!
I

8

De.Cenda~ta.

w,nu. n.

Page 3 ;
i
APPEARANCES (continued):
!
· For Defendant Byrne:
Hall, Farley, Oberrecht 8
Blanton, PA
:

No. ns, RPR

Also Present: John Glenn Hall, Videographer
9
10
11

Nota1.y P\iblic

12
13
14
15
16
17
18
19
20
21
22
23
24

I

~-----------------+-----------------11~
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Page 2

l

TIIEVIDEOTAPED DEPOSITION OF CLfNTONLAMAR DILLE, M.t,

Page 4

1

INDEX

!
!

;i:

2

was tak!'n on belrnlf of the Plaintiffs at the offices of

2

3

Q;v,os Pu,sley, LLP, 60l West Bannock Stree, Bdse,

3

WITNESS CLINTON LAMAR DILLE, MD.

4

Idaho, commencing at 9:15 a.m. on Friday, June 2, 2006,

4

Examination by Mr. Comstock

s

before Maria D. Glodowski, Certified Shorthand Rc:port¢r

5

~

6

and Notary Public within and for1he Stn.te ofldnho, in

6

~

7

the abovi::-entitled mutter.

l:

7

DEPOSITlON EXHIBIT NO.

8

8

1, Southern Idaho Pain and Rehabilitation

9

9
10

lo

APPEARANCES:

PAGE!,:.~.
~
;

9

PAGE

~

ij

through DILLE002S

11

2, Curriculum Vitae of Clinton Lamar Dille, M.D.

12

3, Hand-written note by T.J, Byrne

13

199 North Cnpitol Boulevo.rd

11

14

Suite 500

14

15

Boise, ldid10 83701

15

Comstock & Bush

For P!l)lntiffs:

12

16

16

17

FotDefendnnts Dille and Give11s Pursley, LLP

18

Southern Jdaho Pain

19

lnstituic::

20
21

BY: Steven J. Hippler

601 West Bannock Street
Boise, Idaho 83701-2720

17
18

39

t4

~

i\

I
"I

I

1
f

19
20

21

22

22

23

23

"

"

25

f,

Instilute chart, Bates stamped DILLEOOO l

BY; Dnvid E. Comstock

11

i
~

5

25
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Page 31

death?

09:56

1

09,56

2

5
6
7

A I think as physicians you always want to know
if any of your therapies or medications are involved, and
given that, then I was concerned,
Q. Did you go back and look at her chart?
A. Yes, I did.
Q. Why did you do lha17

09:57

7

09: 54

8

A. I wanted to review a!! the records and review

()9:57

8

09: 54
09:54

9
10

the care that had been provided by Mr. Byrne.

09: 5?

9
10

11

09:57

11

o9: 54

12

Q. Diel you speak with Mr. Byrne?
A. Yes, l did.
Q. Tell roe about that conversation. And this
would be a conversation after learning about
Mrs. Schmechel's death.
A. And the.review of the chart.
Q. Sure.
A. After my review of the chart1 I told T.J. tha1
it appeared that he had handled Mrs. Schmechel in an
excellent fashioO and that I could not see where I would
have made any changes or done anything different than wh;

09:57

09;54

09:57

12

09: 53
09: 53

1
2

09: 53

3

09: 53

4

o 9 : 53
09, 53
09, 53

0 9 : 54 13
o9 : 5 4 14
09:54

15

09;54

16

09,54

17

o 9 : 54

18

09,56

3

09:57

4

09: 57

5

09:57 . 6

I

A. I do not know that.
I
Q. Do you know whether Mr. Byrne had obtained any ~
records of her sleep apnea tests that they conduct to
determine whether or not your sleep apnea is mild,
moderate, or severe?
A. He had not.
;
Q. Okay. After reviewing the record once you
!earned Mrs. Schmcchel had died, and after talking lo
s
Mr. Byrne~- and you've just related to me that
rt
conversation, correct?

I

I
i
"rr

A. Correct.

:$

09: 57

13

09,57

14

Q. I note from the record whk:h ls Bates stamped
iI
'~
page 10 ofExhlbit l, that you wrote 1o the Twin Falls
County coroner on November 4th of 2003. Why did you d

09: 57

15

that?

o 9 1 s 7 16

f·
'

1

09,57

17

A. It's a standard procedure when we have patients
who die unexpectedly and that have an autopsy, tha1 we

o 9 : 57

18

would like to obtain that for her med -- completeness sake

I!

21
09: 54 22
09: 54 23

Mr.Byrnebad.

09:58

21

And, in fact, I thought Mr. Byrne had done an
excellent job of obtaining the history and pulling out the

09: 58
D9: ss

22

of her medical records.
~
ii
Q, So you wrote to the·- what caused you to write
'!
to the coroner? Was that just routine practice, or did
f
you hear something about her death that caused you to mak~

23

that request?

j

09: 54 24
O9 : 54 2 5

fact that she has obstrnctive sleep apnea when she didn't
put it on her init_\al .intake, and that he was able to

o 9: 58
o 9 : 58

24
25

A. We did not hear anything about her death.
That-~ it was a routine practice.

i,:.

09 : 5 5

09: 5 8
09, 58

1
2

09, 58

3

09:58

4

09: 58

5

09: 54

19

o9 ; 54

2o

09:54

09: 58

19

to 9 : 58

2o

~

1------~-----'---------------1--------------------------1~
Page 32 ii
Page 30
09:55

2

09, 55

3

09, 55

4

09, 55

5

address that and fonnulate a plan and to follow up with
it, and with his concern, also, had made appropriate
telephone calls and follow up with the patient J thought
that Mr. Byrne had done an excellent job.
Q. Why i& obstructive sleep apnea a significant

09, 55

6

piece of her history when providing this type of

09:58

6

09: 55

7

Schedule II narcotic treatment?

09, 58

7

09: 55

8

A. Because if the patient has obstructive s[eep

09: 59

8

09,55

9

09, 59

9

09:55

10

apnea that's not appropriately treated, it could -- the
narcotics, not just methadone, but any narcotics, could

09,59

10

o 9 : 55
09:55

11

cause some respiratory depression and increase the -- the 09 : 5 9

11

12

09:55

13

09:55

14

09,59 12
chance of an -· of an adverse outcome.
Q, Did you !earn from T.J. Byrne whether or not he 09,59 13
had - be had attempted to contact Dr. Vorse to determine 09:59 14

09:56

15

the extent of Mrs. Sc;:hmechel 1s sleep apnea disturbances? 09,59

09,56

09: 56

A. I did not ask him that question. However, I
17 don't think thattilat's particularly relevant since the
18 patient was already being treated with potent long acting
19 narcotics that have essentially the same side effects as
2 O methadone, and that tbe patient was being treated with
21 CPAP.
22
Q, From your discussions with Mr. Byrhe, do you

O9 : 5 6

23

have an understanding as to whether or not

09: 56

24

09: 56

25

09:56

09,56
09 : 56
O9 : 56
09, 56

1

16

15

09, 59

16

09, 59

17

O9 : 5 9

18

09,59

19

09,59

20

09,59

21

09:59

22

09,59

23

Mrs. Schmechel's sleep apnca was by history mild,

09,59

24

moderatei or severe?

10:00

25

~

1
Q. Did you subsequently receive a copy of the
~
toxicology report relative to her autopsy?
1
A. I beHeve so.
Q. Did you review that?
A. I have reviewed it.
~
Q. Did you place a copy of what you received into J
Mrs. Schmeche!'s chart? I'll represent to you, Dr. Dille, .
ill
that it ls not part of the chart that has been produced to if
me, and that's why I ask the question 1 did you put a copy!
of her toxicology autopsy report-into her chart?
fl
A. I am not sure about that.
3

~

i

'

Q. ls tliere some kind of separate chart being kept
relative to RosaJic Schmechel in your office?
.
A. We have a-- probably a folder that relates to
"
ongoing legal issues related to her that we've received
from my attorney, as well as T.J.'s attorney.
Q. Okay.
l
MR.,H!PPLER: A11d -, and, Counsel, for lhe
record1 it was my understanding when I obtained the
~
records from Ms. Davies, that the cha.ti was in there and
it may be a -- just a matter of my staff having separated i\
that out when they gave me what they thought was tbe f,
record when they went through it, but you're welcome tO :(
look at the original chart at some point to see whether '·
it's in there?
f_~_

"

Ii
!
j

'
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.1 '

r' r·

·'· '._,j ·)

Schmechel v Dille

Testimony of Dr. Clinton Dille
October 25 1 2007

Byrne

&

CV 2005-4345

Page 3 1
,

Page 1
IN THE DISTRICT CO~RT OF THE PIPTH J\JDlCIAL DISTRICT OF'
TH8 STATS OF IDAHO,

IN AND l'OR 'rHE COUNTY OP TWIN FALLS

VAUG!:IN SCHMECl-iEL, Individually' I
and as Surviving Spouse and
I
Personal Representative of the I
tstate ol: Rosalie sclimechel,
I
Deceased, and ROBERT I?, UEWlS,
KIM HOWARD and 'l'AMAAA HALL,

)

Natural Children of ROSALIE
SCHMECHEL, Deceased,

)
)

3
4
CASE NO, CV 2005-4345

)

REPOR'l'E:R' S TRANSCIUl?T

8

)

Defendants,

I

i,,

* * * * * * * **

11

12
13

)
)

I

14

15
16

OCTOBBR 25, 2007

PARTIAL REPORTER'S TRANSCRIPT
,JURY TRIAL - DAY 7

17
18

TESTIMONY OF DR. CLINTON DILLE

1~

20

0

HON, G, RICHARD BEVAN
DISTRICT JUDGE, PRESIDING

23
24
25

Reported By
VIRGINIA M. BAILEY, RPR, CSR No, 262
Official Court R0porter

APPEARANCES OF COUNSEL:
MR. BYRON FOSTER, Attorney at Law, a,1d
MR. DAV!D COMSTOCK, Al1orney at Law,
Boise, Idaho,
·
appeared on behalf of Plaintiffs.

4

s

6
7
8

9

10

I

li
~

~

''
~

A. I was born in Jerome, spent much ofmy youth
in the Magic Valley and graduated from Murtaugh High
School. r was involved and worked on our family farm
after high school; and my father died, and so things
Page 4

Page 2

3

Il

DIRECT EXAMINATION
BY MR HIPPLER:
Q. Dr, Dille, could you introduce yourself to
the jury and spell your name, including your last name
for the court reporter?
A. My name is Clinton Lamar Dille. That's
spelled C-L-1-N-T-O-N, L-A-M-A-R, last name, Das in
David, l-L-L-E.
Q. And Dr, Dille, could you take some time to
introduce yourself to the jury in terms of where you

21 grew up, where you 1re from?
22

2

I

1

-----------'

1

I:

CLINTON LAMAR DILLE,

10 examined and testified as follows:

CLINTON DILLE, M.O., SOUTHERN
)
IDAHO PAIN INSTITfJTE, ao Idaho )
Co:qioration, THOMAS BYRNi, P,A,,)
and ,JOHN DOE, I through X,

J

9 produced as a witness being first duly sworn, was

)
)
)

vs.

5
6

THURSDAY, OCTOBER 25, 2007,
,
THERON WARD JUDICIAL BUILDING,
425 SHOSHONE STREET NORTH, TWIN FALLS i
COUNTY, TWIN FALLS, IDAHO.

7

)

PJ.aintiffs.,

1
2

MR. STEVEN HJPPLER, Attorney at Law, and
MR. WILL VARIN, Attorney at Law,
Givens Pursley LLP, Boise, Idaho 1
appeared on behalf of Defendant Dille &
Southern Idaho Pain Institute.
MS, KEELY E. DUKE, Attorney at Law, and
MR. CHRIS COMSTOCK, Attorney at Law,
I-fol!, Farley, Oberrechl & Blanton, PA, Boise, ldaho,
appeared on behalfofDefondanl Thomas Byrne, P.A.

11

12
13

14
15
16

17
18
19

20
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changed on the farm, and I went to college. I went to
Brigham Young University and obtained a bachelor's of
3 science degree and 1hen went to medical school at the
4 .University of Washington in Seattle. Because I was an
s Idaho resident, Idaho has an agreement with University
6 of Washington to educate ldaho students, and it's called
7 the WAMI Program, which stands for Washington, Alas
8 Montana, and Idaho; and in 1his program, the first year
9 is, of education, is performed in your home state, and
10 so the first year ofmy medical education was performed
11 at University ofldaho in Moscow as well as at
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Washington School of Medicine in Seattle, where l
graduated with a medical degree.
Q. And what year did you graduate from medical
school?
A. 1985.
Q. Okay. And are you married?
A. Yes. rm~~ I've been married to Anna, my
wife, for 30 years.
Q. And do you have any children?
A. I do. I do. I have six children.
Q. What are their names and ages?
A. The oldest is Brock; he's 28. He lives here

1
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Q. Okay. And we talked earlier about what you
understood the conversion starting dose to be, and I
think you indicated it was 30 milligrams or 15
milligrams twice a day; correct?
A. Yes.
Q, And you understand that Mr. Byrne, from his
testimony, as well from your review of the records, had
elected to conservatively initiate her into that
conversion starting dose; is that right?
MR. COMSTOCK: Objection, Your Honor.
Leading.
MR. HIPPLER: Setting up another question,
Your Honor.
MR. COMSTOCK: It is leading, Your Honor.
THE COURT: It is leading, counsel. Would
you try to 1·ephrase it?
MR. HIPPLER: Okay, Sure.

19 BY MR. HIPPLER:
20
Q, How would you describe Mr. Byrne's dosing of
21 Mrs. Schmechel with respect to her conversion starting

2 2 dose and the doses below that?
23
A, I think that the conversion starting dose of
24 30 milligrams was -- was conservative and was a
2 5 reasonable conversion starting dose. l think that he
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to do what he did with Mrs. Schmechel?
MR. COMSTOCK: Objection, Your Honor. Call
for this man to make a legal conclusion as to what's
;
required by the Board of Medicine.
]
THE COURT: Overruled. The question
I
1
referenced his understanding of what he believed the
i
agreement would require rather than what the law would
require, I'll allow that.
1,
THE WITNESS: Our intent was to allow
1
Mr. Byrne to practice medicine and to do the things that j
he had been trained for and was obviously authorized to I
perform by the State of Idaho, the Board of Pharmacy, as ,
well as the DEA; and in that respect, we had no intent I
of trying to limit Mr. Byrne's ability to practice. I
j
think that our intent was to try to meet the Board of
a
Medicine's requirement that we have this agreement,
j
which is a general outline and the contents of which are j
not specified by the Board of Medicine.
s
W11at is important here is that I recognize
j
that [ am his primary physician who is supervising him, ,
and Mr. Byrne recognize that I am his supervising
physician, and that I recognize if there are anything
j
that I do not want Mr. Byrne to do that I think is
I
outside his scope of medicine, and our intent here was l
not to limit Mr. Byrne on this -- on this piece of
I

l
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took it even more conservative and started the patient
with a decreased dose, which, from my review of the
charts, appears to be 5 milligrams twice a day, which he
was trying to elicit if the patient had any adverse side
effects from the medication, that, with the long
half-life of this medication, it would be best to have a
small amount on boa;d and have an adverse reaction than
to have a larger amount on, on board. And so he was
starting with a smaller starting dose and was working
the patient into the starting conversion dose.
Q. Did you have any problem or concern with
that?
A. No. 1-- l may have done things differently.
I may have started the patient right on 15 milligrnms
twice a day or 10 milligrams three times a day. But
that was very a reasonable and conservative approach to
the medication management that Mr, Byrne approached.
Q, And you were here yesterday; correct?
A. Yes, I was.
Q. And you had. -- you've seen the job
description and the delegation of services what were in
effect in 2003; correct?
A. Yes.
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paper.
BY MR. HIPPLER:
Q. Okay. Was this something that you guys would
have out on your desk and look at every day in tem1s of
the exact wording ofit?
A. I don't think I ever saw this again until
this trial.
Q. Okay. And there was something raised in
opening. I just want to cover it real quick. Ms. Duke,
can you pull up the signature page of the delegation of
services agreement? I believe that's Exhibit 40 in the
jury notebook.
Doctor, I don't mean to embarrass you about
your handwriting, Do you see where you signed under,
supervising physician?
A. Yes.
Q. And you dated it?
A. Yes.
Q. Can you read your handwriting?
A. Yes.
Q. What does it say for the date?
A. 4/15/03.
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Steven J. Hippler ISB #4388
J. Will Varin !SB #6981
Givens Pursley LLP
601 W. Bannock Street
P.O. Box 2720
Boise, Idaho 83701-2720
Telephone: 208-388-1200
Facsimile: 208-388-1300
sjh@givenspursley.com
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Attorneys for Defendants, Clinton Dille, M.D. and Southern Idaho Pain Institute

IN THE DISTRICT COURT FOR THE FIFTH JUDICIAL DISTRICT OF THE
STATE OF IDAHO, IN AND FOR THE COUNTY OF TWIN FALLS

VAUGHN SCHMECHEL, Individually, and :
as Surviving Spouse and Personal
Representative of the Estate of ROSALIE
SCHMECHEL, deceased, and ROBERT
P. LEWIS, KIM HOWARD and TAMARA
HALL, natural children of ROSALIE
SCHMECHEL, deceased,
Plaintiffs,

Case No. CV 05 4345

·. r

AFFIDAVIT OF STEVEN J. HIPPLER
IN SUPPORT OF CLINTON DILLE
AND THE SOUTHERN IDAHO PAIN
INSTITUTE'$ RESPONSE TO
PLAINTIFFS' MOTION FOR NEW
TRIAL

Vs.
CLINTON DILLE, M.D., SOUTHERN
IDAHO PAIN INSTITUTE, an Idaho
corporation, THOMAS BYRNE, P.A., and
JOHN DOE and JANE DOE, I through X,
Defendants.

STATE OF IDAHO )
)ss.
County of Ada
)
STEVEN J. HIPPLER, being first duly sworn upon oath, deposes and states as
follows:

AFFIDAVIT OF STEVEN J. HIPPLER IN SUPPORT OF CLINTON DILLE AND THE SOUTHERN
IDAHO PAIN INSTITUTE'S RESPONSE TO PLAINTIFFS' MOTION FOR NEW TRIAL -1

1. J. G8

1.

I am an attorney in good standing licensed to practice law in the state of

Idaho. I am one of the attorneys for Defendants Clinton Dille, M. D. and Southern Idaho
Pain Institute in the above-referenced action and have personal knowledge of the facts
of the matters contained herein.
2.

I represented my clients at the May 18, 2006 deposition of Mr. Byrne. A

true and correct copy of Mr. Byrne's deposition is attached hereto as Exhibit A. Prior to
the deposition, Mr. Byrne's counsel, Mr. Hall, asked if I could provide him with any
documents responsive to the Plaintiffs' duces tecum deposition notice for Mr. Byrne that
were in my clients' possession.

In reviewing my clients' records, I found a job

description for Mr. Byrne dated 2001. A Delegation of Services Agreement dated 2004,
was also produced at the deposition. ·· Copies of these documents were then provided to
Mr. Cor:ns.tock at the deposition pursuant to the duces tecum notice.
3.

During Mr. Byrne's deposition, Mr. Com,;tock, sought to question Mr.

Byrne on the 2004 Delegation of Services Agreement.

I interjected an objection to

clarify the record and in an attempt to clarify everyone's understanding of these
documents and their purpose. It was my understanding that the version of IDAPA §
22.01 .03 et seq in effect in 2003 required a written document defining the working
relationship between the supervising physician and physician assistant. It was further
my understanding from my client that the 2001 job description fulfilled this function as
they had no copy or record of a "form" Delegation of Services Agreement until 2004, the
first time that the Board of Medicine prescribed a specific form and required the
Agreement to be submitted to the Board for review and for the Board to maintain a
copy. At that time, my client believed he and Mr. Byrne had been using the 2001 job

AFFIDAVIT OF STEVEN J. HIPPLER IN SUPPORT OF CLINTON DILLE AND THE SOUTHERN
IDAHO PAIN INSTITUTE'S RESPONSE TO PLAINTfFFS' MOTION FOR NEW TRIAL· 2

description to serve as their "Delegation of Services Agreement" until 2004 when the
Board of Medicine provided a required form Agreement and required it to be filed with
the Board. This is what I communicated to Plaintiffs' counsel at the deposition. (See
Exhibit A at p. 32, I. 1 - p. 33, I. 23.) This, however, was merely an objection and a
good faith expression of my understanding of the facts and the _requirements that were
in effect at the relevant time.
4.

Later in the deposition, Mr. Comstock sought to question Mr. Byrne with

the IDAPAs that became effective in 2004, after Mrs. Schmechel's death. Your affiant
objected to these questions to the extent they were based upon a document not in
effect in 2003 (Exhibit A, p. 95, II. 12-22). Mr. Comstock replied that his questions were
not based upon the actual IDAPAs; but rathsir were .general questions that utilized
language that mirrored language from.the·post 2003 IDAPA regulations.
5.

On October 4, 2007, Defend~nts ·received a letter from plaintiffs' counsel

indicating that based upon his understanding of the IDAPAs, a Delegation of Services
Agreement was required in 2003, and requesting a copy of that document (See Affidavit of
Byron Foster in Support of Plaintiffs' Motion for New Trial, Ex. D). After receiving this letter,
your affiant again inquired of Dr. Dille's office whether they had an Agreement other than
the job description and then inquired of Mr. Byrne's counsel whether Mr. Byrne knew of any
purported 2003 Agreement other than the job description. It is my understanding that Mr.
Byrne's counsel again inquired of Mr. Byrne whether he had a copy of a 2003 Delegation of
Services Agreement. It is my understanding Mr. Byrne then conducted a search of his
records in storage and discovered the 2003 Delegation of Services Agreement and
provided it to his counsel, who then immediately produced the document to Plaintiffs'
counsel on October 10, 2007.

(See Defendant Thomas J. Byrne, P.A.'s Fourth

AFFIDAVIT OF STEVEN J. HIPPLER IN SUPPORT OF CLINTON DILLE AND THE SOUTHERN
IDAHO PAIN INSTITUTE'S RESPONSE TO PLAINTIFFS' MOTION FOR NEW TRIAL" 3

Supplemental Responses to Plaintiffs' First Set of Requests for Production of Documents,
Foster Aff., Ex. E).

As such, the 2003 Agreement was produced to Plaintiffs upon its

discovery. Indeed, Mr. Byrne's counsel produced it to Plaintiffs prior to your affiant ever
seeing the document.
6.

Attached hereto as Exhibit B is true and correct copy of Mr. Byrne's 200i

job description and the 2004 Delegation of Services Agreement between Dr. Dille and
Mr. Byrne, which was Exhibit 4 of Mr. Byrne's deposition and which contain identical
language to the 2003 Delegation of Services Agreement that was found and produced
to Plaintiffs prior to trial.
7.

Attached hereto as Exhibit C is true and correct copy of the deposition of

Dr. Lipman.
8.

Attached hereto as Exhibit D is true and-,correct copy of the deposition of

Mr. Keller.
9.

Attached hereto as Exhibit E is true and correct copy of the trial testimony

of Mr. Keller.
10.

Attached hereto as Exhibit F is a true and correct copy of the trial

testimony of Dr. Lordon.
11.

Attached hereto as Exhibits G and H are a true and correct copies of the

October 19, 2007 and the October 24, 2007 trial testimony Mr. Byrne.
12.

Attached hereto as Exhibit I is a true and correct copy of the trial testimony

of Dr. Dille.
13.

During the depositions of all of Plaintiffs' experts, Defendants' counsel

asked to, and did, review every document the experts had received and relied upon in
developing their opinions. None of Plaintiffs' experts had a copy of, or had been sent a
AFFIDAVIT OF STEVEN J, HIPPLER IN SUPPORT OF CLINTON DILLE AND THE SOUTHERN
IDAHO PAIN INSTITUTE'S RESPONSE TO PLAINTIFFS' MOTION FOR NEW TRIAL. 4

copy of any IDAPAs (regardless of year) or the 2001 job description or the 2004
Delegation of Services Agreement and its attachments. Further, none of the experts
relied upon any of the IDAPAs, Idaho statutes or other regulations, job description, or
Delegation of Services Agreements in forming their opinions.

None of the experts

opined that Mr. Byrne and Dr. Dille should have had a Delegation of Services
Agreement in 2003 or that either of the Defendants violated the standard of care with
respect to the scope of Mr. Byrne's authority under Idaho law or otherwise.

Further your affiant sayeth naught.

Dated this~ day of December, 2007

SUBSCRIBED AND SWORN TO before me, a Notary Public, this
December, 2007.

Notary Public fo~o
Residing at
, J
My Commission Expires:

.3~

day of

JD

Y;x,t.) '3 1 &Pl\
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CERTIFICATE OF SERVICE

I hereby certify that on this~ day of December, 2007, I caused to be served a
true and correct copy of the foregoing by the method indicated below, and addressed to
the following:

David E. Comstock
COMSTOCK & BUSH
199 N. Capitol Blvd. #500
P.O. Box 2774
Boise, ID 83701-2774
Attorneys for Plaintiff
Richard E. Hall
Keely E. Duke
. Hall Farley Oberrecht & Blanton PA
702 W. Idaho Street
P.O. Box 1271
Boise, ID 83701-1271
Attorneys for Defendant, T. J. Byrne P.A.

_ _ U.S.Mail
- ~ Overnight Mail
__:;;;,_ Hand Delivery
- - Fax 344-7721

_ _ U.S.Mail
_ _ Overnight Mail
Y:, Hand Delivery
Fax 395-8585
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I.

IN THE DISTRIC'f COURT OF TH:E FIF'TH JUDICIAL DISTRICT
OF THE STATE OF IDAHO, IN AND FOR THE COUNTY OF TWIN FALLS

VAUGHN SCH:MECHEL, individually,

)

and as Surviving Spouse and

)

Personal Representative of the

}

Estate of ROSALIE SCHMECHEli,

)

deceased, and ROBERT P. LEWIS 1

)

KIM HOWARD and TAMARA HALL,

)

natural children of ROSALIE

)

SCHMECHEL, deceased,

)

Case No. CV-05-4345

Plaintiffs,

)

VIDEOTAPED DEPOSITION OF

VS,

)

THOMAS J. BYRNE, P.A.

CLINTON DILLE, M.D,, SOUTHERN

)

MAY 18, 2006

IDAHO PAIN INSTITUTE, an Idaho

)

corporation, THOMAS BYRNE, P.A., }
and JOHN DOE and JANE DOE, I

)

through X,

)
Defendants.

REPORTED BY:

)

EMILY L. NORD, CSR No. 695, RPR, Notary Public

EXHIBIT

A
(208)

345-9611

M & M COURT REPORTING SERVICE,

INC,

(208)

345-8800

(fax)

Page 4

Page 2
THE VIDEOTAPED DEPOSITION OFTHOMAS J, BYRNE,

1

2
3

P.A., was taken on bchnlfofthe Plnintiffs at
the offices of Hall, Farley, Obcrrechl & B!;m!on,

<!

PA, 702 W. rdaho, Suite 700, Boise, Idaho,

5

commencing at 9:26 a.rn, on Thursday, May 18,

IN DEX

1

2

TESTfMONY OF THOMAS J, BYRNE, P.A.
Examination by Mr. Comstock
6

J

'5

6

2006, before Emily L. Nord, Cenified Shorthnnd

6

7

Reporter and Notary Public within nnd fur the

7

8

Smic of Idaho, in r1w al>OY1H::n1J1Jw.J mailer.

8

EXHIBITS

9

9

APPEARANCES

10

NO, DESCRTPTION

10

J. Index of Medical Records,

11

11

12

13

MARKED/PAGE
I

Rosalie Schmeche!; Tabs I through 6

Por the

Law Office$ of Comstock & Bush

12

2. Handwritten nofatlons/inslructions

S

Plainiif'fs:

BY MR. DAVIDE. COMSTOCK

13

3. Rules for the Licensure of Physici~n

5

14

199 N. Capitol Boukva.rd

14

15

Suite 500

15

16

P.O. Box 2774

16

17

Boise, 1D 83701-27/4

19

For Defendan1

20

Thomas J. Byme, & Bltmton, PA

21

P.A.:

4. Provider Contrnc1 1 dated 1!/14/2001;

BY.MR. RICHARD~- HALL

22

702 West fdaho

22

23

23

24

Suite 700
P.0. Box !27 l

25

Boise, ID 83701-IZ:71

2$

32

Job Description for PA Services;

Delegation of Services Agreement

17

Hall, rarley, Oberrccht

5. Medication and Dosing sliect, with

47

additional documents/con-espondence

6, Curriculum Vitae of Thomas J. Byrne,

24

APPEARANCES (Continued)
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5
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Southern Idaho
Pain Institute:

Givens Pursley, LLP
BY MR, STEVEN J, HIPPLER
601 W.BannockStreet
P.O. Box 2720
Boise, ID 83701-2720

Also present:

Christy Davies

For Defendants
Clinton Dille,
M.D., and the

8
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2
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Videographer:

100

Physician Assistant/Athletic Trainer

Page 3
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Assistants
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PAGE

John Glenn Hall

3
09: 26: 10 4
09:26:39 5
09: 26: 40 6

09:26:44 7
09:26:47 8
09:26:50 9
09:26:5310
09:26:5711
09:27:0112
09:27:0613
09:27:0814
09:27:1015
09: 27: 14 16
09:27:1717
09:27:1818
09:27:1919
09:27:2120

09:27:2521
09:27:2622
09:27:2623
09 :27: 2924
09:27:3125

22

23
24
25

PROCEEDINGS
(Exhibils I through 3 marked,)

THE V1DEOGRAPHER: On the record.
MR. COMSTOCK: For the record, today's •
date is May 18th of 2006. My name is David
Comstock, I represent the Schmechel family,
Mr. Byrne, and we are here today to take your
c,
deposhion with regard to medical care) or the
;;
provision of medical care, that came from the
f
Southern Jdaho Pain Institute between September
26 of200} and Rosalie Schmechel's death on
October 2nd of 2003,
Before we do that, though, I would ask
each of the counsel here to represent, for the
record, who they arc and who they represent.
MR. HALL: I'm Rich Hall. I represent
Mr.Byrne,
MR. HIPPLER: I'm Steve Hippler. l
represent Dr. Clinton Dille and the Southern
Idaho Pain Institute.
MR. COMSTOCK: Mr. Byrne, in order to .'.
get this process sta,ted> we first of a!I need to
have the court reporter give you the oath, and
we'll do that al this time.

2 (Pages 2 to 5)
(208)

345-9611
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&

M COURT REPORTING SERVICE, INC,

(208)
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(fax)
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THE WTTNESS: Okay.

09:27:33 l
2

3
4
5

THOMAS J. BYRNE, PA-C, ATC,
first duly sworn to lei! the truth relating to
said cause, testified as follows:

6

7
8
09:27:43 9
09 : 2 7: 4 5 10
09: 2 7 : 4 7 l l
09 :27: 50 12
09 :27; 5413

09:27:5814.

09:28:0115
09:28:0316
09: 28: 08 17

09:28:1018

09:28:1419
09:28:1520
09;28;1621

09:28:1922
09:28:2123
09:28:2224

09:28:2425

EXAMINATION
QUESTIONS BY MR. COMSTOCK:
Q, Firstofal!,Mr.Byrne,ifyou
wouldn 1t mind, would you introduce yourself to
the record, and to whoever is going to watch this
at some point, by stating your full name, {elling
us where you presently live, an<l telling us what
you are presently doing for a living?
A. Yes, sir. My name i$ Thomas Joseph
Byrne. I !ive in Post Falls, Idaho: 5120 West
Hedgewood Avenue. And I work in Spokane Valley,
in the Valley Hospital Emergency Department.
Q. What are you doing in the emergency
department?
A Twork as a physician assistant there.
Q, You have been a physician's assistant
for appl'oximately how long?
A. l graduated from physician assistant
school in l 995 and have been a practicing PA

l?age 8

09:29:46 l
09:29:47 2
09:29:52 3
09:29:55 4
09:29:59 5
09:30:02 6
09:30:05 7
09:30:08 8
09:30:11 9
09, 3 o, 111 o
o9 , 3 o , 15 11
09:30:1812
09:30:2213
09:30:2414
09:30:2715
09:30:3116
09:30:3417
09,30:3618

trainer, and I was there a little over five

years. I went to Portland State Univer.dty from
there; and then frotrl Portland State, went to
Brigham Young University, again as an athletic
trainer. And then I went back into -- back to PA ,;
school from Brigham Young University,
.:;_
Q. Whal motivated you to go to PA school,
having been an athletic trainer for all those
years?
A. Oh, I guess I wanted a professional
challenge, and had met a couple of physician
I''
assistants in my interaction with team -- our
team physicians; and it seemed interesting and
challenging professionally, and! liked the idea
of working closely with the physician and the
·experience that it enabled.
Q, Describe for me, ff you can, the PA
program that you went through.

A,

It was about a 28-month bachelor's of

09:30:3819
09:30:4320
09: 30, 47 21

science program. Tbe first year of the program

09:30:53 22
09:30:5523
09:31:0124
09:31:0325

the majority of the time. And the second year is
out in the ~- doing clinical rotations out in the
different settings; family practice, emergency
medicine) pediatrics, psychiatry, internal

is clinical didactics; you 1re in the classroom

Page 9

Page 7
09:28:27 l

09:28,28
09:28:31
09:28:34
09:28:36
09:28:39
09:28,42

2
3
4
5
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09:28:48 B

09:28:52 9
09,28:5510
09 :28: 5911

09:29,0112
09:29,0113
09:29:0414
09:29:0715
09:29:1216
09:29:1517
09:29:1818
09:29:2019
09:29:2420
09 :29: 3121

09:29:3422
09:29:3723

09:29:4024

09 :29: 4225

since that time.
Q. Would you review for me your education
leading up to graduating frorn physician
assistant's school?
A. I went to Boise State University. I
graduated there with a bachelor of science degree
in 1980 in physical education/athletic training.
I went on and got a master1s degree at Brigham
Young University> and l finished that in l 982,
And that was !n exercise physiology) also with an
emphasis in athletic training and sports

medicine.
Then J worked as an a!hletk trainer

09:31:09
09:31:10
09:31:13
09:31:13
09:31:15
09:31,18

1
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09:31:21 7
09:31:23 8
09:31:24 9
09:31:3110
09:31,3411
09:31:3712
09: 31, 4013
09:31:4314

for about 17 years, and then went to PA school at
09: 31: 4615
Travecca College in Nashville, Tennessee, from
09:31:5016
1993 to 1995. Okay.
Q. Working as an athletic trainer1 can you
09: 31: 5217
review that employment for me? Who did you wort09: 31: 5618
for, and what did you do during those years?
09: 32: 02 19

A,

Sure, I finished my degree in '80 and

then worked at a graduate assistantship as an
athlet!C trainer at Brigham Young Univer.sity,
until I finished my degree th~re.
Then I went to southern California and
worked al Pepperdine University as an athletic

I

09: 32, 05 20
09:32:0721
09:32:0822
09:32:1123
09: 32: 14 24
09:32:J,625

medicine, those settings.
Q. And in what year did you graduate from
PA school?
A.
Q.

1995.

And from that point forward, up to your
employment at the Southern Idaho Pain lnstitutc, ,
can you summarize for me the jobs that you've
held?
A. Sure. ln 1995, I went to Gooding,
Idaho, and was employed by Gooding County
Memorial Hospital & Associates in Family
Practice, and I worked in family practice in the
emergency room at Goodjng Hospital. And I wm
there, I think, roughly two years and then went
to the Twin falls Clinic and Hospital in Twin
Falls, where I also worked as a physician
<1sslstant in family practice, internal medicine,
and emergency room. And then I let\ that
facility to work with Dr. Dille.
Q. In what year did you st.art working with
Dr. Dille?
A, l believe that was in January of 200 I.
Q. And you left employment with Dr. Dille
when?

A.

October of2004; September or October
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of 2004.
Q. for what reason?
A. I just was ready for a change. My wife
and l had property in northern Idaho, and we
wanted to relocate. And we had stayed in
southeastern Idaho primarily until our two older
boys bad graduated from high school, and when
that was ~- when -they had finished school, we
felt like we wanted to make a change. My wife
has family in northern Idaho, eastem Washington

09:35:05

l

09:35:09 2
09:35:15 3
09:35:21 4
09:35:2< 5
09:35:27 6
09:35:29 7

09:35:34

B

091351.:-7 9

09: 35: 4210
and we wanted to get up to thal area.
09: 35': 45 11
Q, In the PA program under which you were 09: 35 t 50 12
trnincd 1 was there any aspect of that program
09: 35; 53 13
that afforded you some type ofsubspecialty, if
09:36: oo 14
you will 1 in pain management or administration o · 09: 36: 07 15
narcotic medications for management of pain?
09: 36: 0816
A. In the didactic training, we had a
09:36: 10 17
semester of pham1acology training. And then in 09: 36: 17 1a
each ofrny clinical rotations -- family practice,
09: 36: 20 19
internal medicine, and emergency medicine-09: 36: 24 20
there was ample experience in the prescription of O9: 3 6: 26 21
pain medications. It wasn't exclusive to a pain
09: 36: 32 22
management practice,
09: 36: 35 23
Q. So in other words, the PA program that
09: 36, 42 24
you attended waS not a program specialized or
09: 36: 45 25

experience and/or training in the medical process
of converting a pain management patient from an
OxyContin-based pain con1rol to a methadone-based :
pain control?
A. I don't have specific recollection, you
know, of specific patients. But during the
course of my work leading up to my employment at
Southern fdaho Pain fnstitute, J certainly had
patients that 1 worked with who were on those-on those medications. However, at that time in
my career, l did not prescribe those medications.
Q. Did YO\! have training, education, or
experience with opioids, such as mcthadone1
during the period of time of your PA trai11ing?
A. Yes.
Q. Explain that to me.
A. Through my training in my program of
pharmaceutical training, in our program we
learned about al! of the opioids, including the
long-acting opioids,
Q, What is your understanding as to the
uses to whlch methadone has been put over the
years in terms of the management of patients?
A. Its multiple uses, or are we talking
just specifically abou1 pain management here?

r
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designed to graduate PAs who are golng to go into
pain management medicine?
A. No.
Q, It was more general than that; is that
correct?
A. That's co1Tect.
Q, When yoo wenl lo work with Dr. Dille,
was it your understanding that the area of
m~dicine that you were going to be working in was
going to be in the area of pain management?
A. Yes.
Q. Was thai an area of interest for you,
and did you seek that out? Or how is it that you
got that job?
A. l knew both Dr. Dille as well as
Christy Davies, his office manager, through my
years in Twin Falls, and had had opportunity to
meet Dr. Dll!e on many occasions and found him to
be an interesting physician and was intrigued and
interested by the work that he was doing at his
-~ in his practice. And the opportunity came up
for inc to move into his practice, and I took the
opportunity.
Q, Priol' to going to work within
Dr. Di!le's practice, did you have clinical
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Q. That's a good point. Multiple uses
first.
A. Okay, I know of its use in the
withdrawal of patients from illicit drugs and
so~called n1ethadone programs that are available
within 1 you know1 most large metropolitan areas,
Pve never been involved in one of those program
or patticipated in one of those programs, but l
know that1s one of the uses of methadone.
And then methadone has become a widely
prescribed medication within prima1y carcj famil,
practice, internal medicine, as well as pain
management centers for the use of chronic pain,
in treating patients with chronic pain,
Q. By September of 2003, when Rosalie
Schmechel came to lhe Southern Idaho Pain
I
Institute ~~
A. Yes.
Q. -- for care, had you familiarized
yourself with the statistics relative to the
rising number of deaths that occuffed following
the initiation of methadone pain management
therapy?
MR. HALL: Object to the fonn.
MR. Hil'PLER: Join; assumes facts.

Ii
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THE WITNESS: I was aware of the risks
of all of the long-acting opioid medications and
hn<l made a concerted effort to work closely wilh
Dr. Dille t_o familia1fae myself with the
medications in that drug class.
Q.

ifany,didyouhavc,asofSeptemberof200J,

o9 : 3a :35 B
09 :38 :44 9

rcla1ive to the rising number of deaths that were

09;39:1518
09;39:1719

09:39:2220
09:39:27 21
09:39:28 22
09 r39:3123

09:39:3524
09:39:4025

09:41:11 5

(BY MR. COMSTOCK) What understanding, 09,41:11 6

09:38:30 7

09:38:IJ.710
09: 38: 48 11
09: 38: 4 9 12
09:38:5113
09:38:5614
09 :38: 59 15
09:39:0516
09:39:0817

09:40,55 1
09:40:59 2
09:41,02 3
09,41,07 4

occurring with the initiation of methadone
therapy?
MR. HALL: Object to the form again,
MR. HIPPLER: Ponn and foundation;
assumesfacts.
THEWITNESS; Again,lwasawareofthe
risks of long-acting opioids and familiarized
myself with those medications and, I think, had a
good understanding of those risks.

(BY MR. COMSTOCK) You understand, or
understood in September of 2003, that methadone
Q.

was a long-acting pain medication?
A. Yes,
Q, You understood that it was a powerful
pain medication with a long half-life?
A. Yes.
Q, And you understood a!so that methadone

09:11:15 7
09,41:21 8
09 :41: 2-5 9

09:41:3010
09: 41: 34 11
09: 41: 38 12
09:41:4113
09:41:4214

09: 41: 45 15
09,41,4716
09:41:5217

09,41,5518
09:41,5719
09:42,0120
09,42:0421
09:42,0622
09, 42, 1123
09,42:17 24

1

does accumulate in rhe patient s system. And
that1 in essence, is why the medicine is

effective and valuable as a long-acting opioid
pain medication, because it does stay in the
system.
And as the patient1s level of methadone
is safely and slowly elevated, the medication
hopef1-1lly has a benefit of decreasing their pain,
and once that pain level has decreased to an
acceptable level, then the dose of the methadone :·
is then leveled off and -- and possibly even
•··
lowered, depending upon how the patient is
responding,
Q, ls there a risk, because of its long
life and because of the fact that it can
accumulate, that a patient will get levels that
are too high and dangerous to the patient?
A. There's a level there are tisks with
w~

all of the !ong.. acting opioids, whether it1s
OxyContin or methadone, certainly; but ln
methadone -w in the case with methadone, in

pa1tlcular1 you have to be aware of that
characteristic; and for that reason, a gradual,
slow progression in the dose of the medication,
09:42:2125 · again 1 to a level ·ofimprovem·ent in pain for the
Page 17
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had the capability of gradually increasing its
level of toxicity. if you will, in your system as
you administered it'?
A. Yes.
Q. And is that because of its long
half.life?
A. Yes, it is.
Q. What risk, if any, does that present to
a patient who is being converted from a
short-acting pain medication, like OxyContin, to
a longer"acting pain medication, like methadone,
with a long half-life?
MR. HIPPLER: Object to the fo1111 and
foundation.
MR. HALL: Join.
THE WITNESS: I guess I'd want you to
clarify the question for me, if you could,
please.
Q. (BY MR. COMSTOCK) What is the
significance of the fact that methadone, with its
long half~Hfe, can accumulate within your
system 1 in terms of patient risk?
A. Okay. Methadone, by its
characteristics, has a long halfwlife, as you
have stated, and as a result of that) over time
.... ,,

09:42:28
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patient.

(Ms. Davies enters deposition room,)
Q. (BY MR. COMSTOCK} ls the risk to the
patient ofdeveloplnga toxic level of methadone
increased during the period of time that they are
titrating up the dosage to get to a therapeutic
level?
A. I don't think that a general
characterization can be made such as that. I
think that if the practitioner is aware of the
characteristics of methadone and takes that into
account and makes it, again) a gradual, slow
titration with close monitoring of the patient,
making sure that, A, their pain level is
decreasing and they're not developing any
problems, then il1s ...
Q. When converting a patient from an
OxyContinMbased pain management program to
methadone, is it incumbent upon the practitioner
monitoring that to do so slowly?
MR. HIPPLER: Object to the form.
MR. HALL: Join.
THE WITNESS: And are you referring to
the titration of the methadone, or the removal of
the OxyContin?
.
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(BY MR. COMSTOCK) !'m referring to -I didn'l understand.
Q. rm refen·ing to the titration of the
methadone, and 1 apprecii::ite the clarification,
A. TI)e again, I would just go back to

09:46:13 1
09:46,17 2

the same thing tha1 I said before, It is
impo1iant to monitor, obviously, and I guess it
would be impo11anl to start at what would be
considered safe early doses; and again, elevating
the dose as indicated by the patient's pain level
and how the patient feels subjectively.
Q. Long-acting opioids, like methadone,
have 1 do they not, a risk inherent in them in

09:46:31 6
09:46:35 7
09:46:37 8

terms of their capacity to decrease respiratoi·y
drive?
A Yes. I ,would like to also say that

09:46,5614

that's not ex.elusive to methadone, All of the
long-ac1i_ng opioids in that drug class -including OxyContin, MS Contin, which is a

09,47,0817

morphine-based, long-acting opioid -- ail have
!-hose same characteristics,
Q. Then we agree that the characteristic
can be that it will decrease respiratory drive?
A. Of that drug class, yes.
Q. And that1s one of the risks that are

09,47:1620

Q.
A.

~w

09:46:23 3
09:46:25 4
09:46:27 5

09:46:38 9
09:46,4110
09:46:4611
09,46,5012
09:46:5313
09:47,0015
09:47,0416
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09, 47: 18 21
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09:47,2723
09,47:3024
09 :47 :32 25

decrease respiratory drive. So that1s inherent
within the narcotic class in general.
Q. What are the symptoms that you would ••
you mentioned that, during this process of
titrating up, when using methadone as a means o
pain management, you need to do that slowly,
carefuily, and monitor it; correct?
A. Yes.
Q, And in the process of monitoring, what
are you doing?
A. Essentially describing, prior to
prescribing the medication to the patient, the
potential side effects of the medication as well
as the risks of medications. And again, these
are risks that are inherent to a!! of the
opioids, but in particular, you know, with
methadone, discussing the -- as that was -- your
question is specific to methadone; is that right?
Q. Yes.
A. Discussing, again, the long hatf-life
of the medication and its risks of respiratory
depression, as well as other side effects 1 which
could include dizziness, headache, nausea 1
potentially vomiting, There's an abundant numbf '.
of side effects with all of the opioids.
·
l?age 21 ;
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09:47:36 1
inherent when you arc titrating a patient up in
09:47:42 2
lerms of their dosage of methadone, is it not?
09 :47 ,45 3
A. Yes.
09:47:48 4
Q. And because of that risk that's known,
09:47:51 5
it's incumbent upon the practitioner who is
09:47:52 6
monitoring this medication to understand the
09:47:56 7
baseline that this patient brings to the tab{e,
09:47:58 8
if you witl, in terms of their capacity to
09:48:02 9
breathe?
MR. HIPPLER: Object to the form.
09, 48, 0510
MR. HALL: Join.
09, 48, 0911
11-lEWITNESS: Yes.
09:48,1112
Q. (BY MR. COMSTOCK) So, for example, i 09 ,48, 1413
09,48:1814
you have a patient who has decreased respiratory
09,48,1915
drive during their sleep, such as a sleep apneic
09,48,2216
patient, 1hat's something the practitioner should
09,48:2517
be keenly aware of when titrating up their
09,48:2818
medication such as methadone?
09:48:3119
A. Yes.
09,48,3520
Q. Why is that?
09:48,4121
A. Again, as with all of the narcotics in
09:48:4222
the long-acting drug dass, as well as the
09,48:4323
short-acting opioids, for that matter, that is
09:48:4524
one of the charactcristicB in the drug class in
09: 48: 48 25
general, is that they tend to potentially

Q. What side effects would be present if a
patient were developing a dangerous level of
methadone in their body?
A. You know, I think that really would be
depending-· dependent upon a1 you know1
case-by-case basis. Each individual responds
differently to different medications, and to
generalize would be fairly difficult, r think.
Q. If a patient 1 during the process of
titrating up methadone, ex.pressed to you that
they were having problems with their mentation
and their thinking1 would that be one of the
symptoms that you as the practitioner would wan;'.
to know about and be concerned with?
A. I think that potentially would be a
concern with any of the long-acting opioids, or
the opioids in general 1 yes.
Q. Same question with respect to reduced
breathing, if they were having difficulty
breathing.
A. I1m not sure I understand your
question.
Q, ff1 in fo Bowing a patient that you're
titrating up, the patient says to you, 'You know,
ljust 11 -- 11 I'm not breathing very wel\.u
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A. Uh-huh,
Q. Is that something that you as a
practitioner would want to be concerned about?
A.

I would certainly want to be aware of

any potential complaints that the patient had,
certainly.
Q. How about swelling or edema in the
lower extremities?
A. Yes.
Q. ls swelling in the lower extremities or
edema in the lower extremities a symptom of

09:51:40 1
09:51:44 2

09,51,49
09,51,52
09,51,54
09,51,56
09,51,58
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7
09:52:02 8
09,52,05 9
09,52,0810
09: 52: 13 11
developing toxic or dangerous levels of opioid or 09,52,1612
09,52,2013
methadone in your system?
09,52,2214
A. You know> J don't have specific
knowledge of that as an exclusive side effect or 09,52,2615
adverSe effect. I would assume that somewhere h 09,52,3216
09,52,3317
the -- it's been reported that~- I don1t know
09,52,3518
that it1s exclusive to methadone or the opioids.
09,52,3619
Q, lf a patient reported to you -- and
09,52,37 20
again, this is a patient that you were titrating
09,52,3921
up their methadone to get to therapeutic levels
09,52,4122
~" repo1ted to you that they had experienced
09, 52, 42 23
swelling in their feet and a discoloration of
09,52,45 24
their feet are you telling me that that is not
09,52,5125
something that you would equate to acoumulatillf

qualified your answer to uin 2003." Has there
been some information disseminated since 2003
that would lead you to believe that methadone ma)
be contraindicated for use in a patient with
severe sleep apnea?
A. No. I just wanted to make sure that J
was talking about the circumstance in 2003 with i:
Mrs. Schmechel.
Q. In September of 2003, you were
practicing as a PA at the Southern Idaho Pain
Institute in Twin Falls! Idaho; is th&t correct?
A.
Q.

That is correct.

And during that time frame, you were
employed by the Southern Idaho Pain Institute?
Or by Dr. Dille? How did that work?
MR. !IlPPLER: Object to the form; calls
for a legal conclusion, You can go ahead and
answer.
MR. COMSTOCK: l don't know if it's a
legal conclusion, by whom you're employed, but
MR. !IlPPLER: Well ••
THE WITNESS: I guess -· yeah, I guess
I would say I considered them the same. I worked {
with and for Dr. Dille, who, for all intents and
purposes, I guesst. is Southern I~al~o Pain
M
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dangerous levels of methadone?
A. And we're talking about a hypothetical
situation here, then?
Q, Sure,
A. Okay. If this was a new problem that
the patient reported with the prescription of a
new medication and they reported it to me,
whether it was methadone or OxyContin or a higl
blood pressure medication, I certainly think at
that point that you would want to involve their
primary care provider to determine whether or no
there was another issue> medical issue with that
particular person that potentially could be
contributing to the edema, as well as the
medication 1 certainly.
Q. Is methadone contraindicated fol' use
with patients who have a hislory of severe sleep
apnea?
A. And we're talking about in 2003?
Q, Yes.
A. Not-· not to my knowledge,
Q. How about thereafter?
A. I don 1t have specific knowledge of a

09: 51: 37 24

contraindication, no.
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Institute,
Q, (BY MR. COMSTOCK) Your checks, when
you would get paid, were your checks on Southern i.;
Idaho Pain 1nstitute format, or was it
Dr. Dille1s check to you?
A. I think it was Southern Idaho ·Pain.
Q. I'm going to talk to you somewhat about
standard of care applicable to PAs practicing in
Twin Falls, Idaho, in September and October of
2003; and 'f:'hen·J use the phrase 11standard of
care, 11 I'm talking about the standard of
healthcare practice applicable to a PA in the

community of Twin Falls in September of 2003,
A.

Okay.

Q. Do you understand that?
A. Yes, I do.
Q. Would you agree that the standard of
care, when taking a new patient into the Southern
Idaho Pain Institute for potential management of
their pain problem, required~~ required you to
obtain a complete histo1y from that patient
before a~ministrntion of opioid medication?
MR. HALL: Object to the form.

MR, HIPPLER: Join.
THE WfTNESS; Yes, it was our routine
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Page 26
09:54:09 1
09:54:14 2
09:54:19 3

09:54:21 4
09:54:24 5
09:54:27 6
09:54:30 7
09:54:33 8
09:54:37 9
09:5'1:4110
09;54:4511
09:54:4812
09; 54: 53 1-3
09: 54: 54 14
09:54:5615
09:54:5816
09:55:0017
09:55:0218
09:55:0619
09:55:1120

09,55:1221
09:55:14 22

09:55:1723
09:55;2124
09:55; 25 25

09:56:49 1
to take a comprehensive history of the patient on
09:56:53 2
their initial visit to the facility.
Q. (BY MR. COMSTOCK) And in that process, 09:56:54 3
09:56:55 4
you would want to obtain an accurate history so
09:56:59 5
that you understood what the patient was actually
09:57:01 6
bringing to your plate to manage; correct?
09:57:05 7
A. Yes, to the best ofmy ability,
09:57:08 8
Q. In that process, and before changing a
09:57:13 9
long~~enn fonn of pain mi:magcment 1 did the
09:57:1710
standard of care c11ll for you to consult with any
09:57:2211
pain management physicians who had been caring
09:57:2612
for this patient before coming to the Southern
09 :57:3013
[daho Pain Institute?
09: 57 :3314
A, Did il call for me to do that? ls that
09: 57 :3715
what you asked me?
09:57:4016
Q. Was that the standard of care?
09:57:4417
A. No.
09:57:4618
Q, Why no!?
09 :57 :5419
A. Why not ... l guess, could you just
09:57:5520
rephrnse
09:57:5821
Q. Why is it not the standard of care lo
09:58:0422
contact the physician, who has been managing the
09:58:0723
pain of this patient for a number of years,
09:58:1124
before implementing a change in the long•tenn
09:58:1525
management protocol?
¥•

A, Are we talking specificaHy now about
Mrs. Schrnechel?
Q, Sure.
A. Okay. I felt, in my process of

interviewing Mrs. Schrnechel during her-· the
history taking and the time that I spent with
her, that she was able to articulate to me, both
in a written and verbal fonn, her chief
complaint, her past medical history, her current
medication regimen, her medication allergies, he
again, her chief complaint un<l her pain !eve! 1
her satisfaction with her current treatment
program in terms ofits ability to control her
pain, and her quality of life.
Q. And under those circumstances, you're
telling me the standard of care for a PA
practicing in Twin Falls, Idaho, in September of
'03 would allow for the PA to not contact the
w.

physician who had been providing the pain
management for years?
A.
Q.

Yes.
Did the standard of care call for you,
as the PA intaking a new patient, to obtain the
prior medical records before changing the pain
management protocol?

Page 29

Page 27
09:55:27
09:55:31
09:55:34
09:55:41
09:55:42
09:55:46

1
2
3
4
5
6

09:55:50 7
09:55,53 8
09,55:56 9
09:56:0310
09:56:0511
09:56:081:J
09: 56: 1413
09: 56: 1614
09:56:1915
09:56:2116

09:56:2617
09:56:2918
09:56:3119
09:56:3420
09:56:3821

09:56:4122
09: 56: 44 23
09:56:4624

09: 56: 4725

A. Again 1 it's really relatively a
case~by-case situation based on the patient's
circumstance and what their individual situation
is.
Q. In what circumstance would you, as the
PA intaking a new patient) believe it would be
incumbent upon you to contact the prior care
physician who had been managing their pain for

09:58:19
09:58:21
09:58:21
09,58:23
09:58:26
09:58:32
09:58:34

1
2
3
4
5
6
7
8

09:58:35
09,58:39 9
years?
A. I don't know when it would be incumbent 09,58:4210
09:58:4611
upon me to do that. Again, it would just be an
09:58,4912
individual decision with an individual patient.

Q. Well, if, for example 1 you had a
patient who had been under the care of a
well--trained and qualified pain management
physician for five or six years and they came to
you saying, "You know, you're closer to me than
they are, and I'd like to come for pain
managemcnt,1' and you decided that you wanted t
change the pain management protocol; under that
circums!.ance, would the standard of care call for
you to at least consult with the prior physician
before doing that?
A. No.
Q. And why not?
......,.,,,.. , .,..,.,., ..... "

'"•'

-,·.;,·.-.·:.

,,,,.. _.,.... ,._ •..

"""' ,........_.,,.,__,.,, ......... ·.·

A. Coul<l you state that for me once more,
please?
Q, Sure. Did the standard of care call
for you, as the PA taking ln a 11ew patient for
pain management) to obtain the prior records of
the patient before changing the pain management
protocol?
A. No, I don't believe it did.
Q, Would it be effective~- an effective
and efficient way for you to familiarize yourself
with a patient1s past pain management to obtain
the records?

A I think the most effective and
efficient method of attaining that information is
to interview the patient, who is an excellent
,,
09:59:0116 historian, was lucid, and was able to communicate}
09,59:0517 that information to me, Tiie patient was there
09:59:0818 and was able to communicate those -- that
09:59,1319 Information quite effectively to me.
09:59:18 20
Q, Does !'he standard of care call for the
09:59:2421 PA to carefully consider any change in pain
09:59:33 22 management when ii involves narcotic medication :
09:59:36 23 such as methadone?
09!59:37 24
A. Yes.
09:59:4025
Q. Does the standard of care cal! for the
...... ., .,,, .,,...
'""'""'"' ·-· .... ,,.. ,.... . .... ,.... ~,·: ,.
. ._,, ...,..,.,,,,., , ........ , "· .. ,.,,_,,.,,
09:58:5013

09:58,5314
09:58:5615
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Page 30

09:59:55 3

10:02:27 1
P A to consult with the supervising physician
before implementing a change in the narcotic pait 10:02:28 2
10:02:35 3
management for a new patient coming into the

09:59:57 4

clinic?

10:02;37 4

09:59:58 5

A. Again, case by case, depending upon the
patient and their circumstances; sometimes yes,
sometimes no.
Q. In Rosalie Schmechel's case, did you
consult with Dr. Dille prior to implementing the
change in her pain management program?

10:02:40 5
10:02:52 6

09:59:45 1
09:59:51 2

10:00:01 6
10:00:06 7
10:00:09 8
10:00:12 9
10:00:1810

10: 02: 53 7
10: 02: 54 8

9
10: 03: 04 10

10:00:2111

A.

No,ldidnot.

10:00:2412

Q.
A.

Why not?

10: 03:

I was confident in my experience with

10: 03: 12 13

10:00:3214

-- in pain management and with my previous

10: 03: 1914

10:00:3615

10: 00: 53 20

prescribing of medications that Mrs. Schmechel
was prescribed, as well as the medications that
she had been prescribed previously1 to make thos.
adjustments without consulting Dr. Dille on that
day.
Q. We'll be going through the chart here

10 :00 :5521

in a little bit --

10: 00: 2713

10:00:4116
10:00:4417
10:00:4818
10:00:5219

10:00:5622
10:00:5723
10:00:5924
10:01:0325

A.
Q.

10:03:0511

Okay.
-- and at some time later on, did you

actually consult with Dr. Dille relative to
Rosalie Schmechel?

oa 12

10: 03: 2115
10: 03: 22 16

10: 03: 24 17
10: 03: 29 18
10,03:3419
10: 03, 3 7 20
10:03:4421
10:03:4922
10:03:5523
10:03:5624
10: 03: 57 25

MR. COMSTOCK: l'vejust received a
five~page ·- a four•page doc- -- a five-page
document from Mr. Ha!!, and ['rn going to have
that marked as Exhibit 4 to the deposltion, if
you will.

(Exhibit 4 marked.)
Q. (BY MR. COMSTOCK) Mr. Byrne, l've just
handed you what's heen marked as Exhibit 4 .. ,
(Interruption.)
Q. (BY MR. COMSTOCK) l'vejust handed you
What's been marked as Exhibit No. 4, and is this
a copy of the agreement that was in effect
between you ond the Southern ldaho Pain &
Rehabilitation Institute .•
A. The··
Q. •• in September of 2003?
A. The top copy is a contract, an
employment contract. The second pnge ls a -kind of a rough job description. And then the
rernalnder of the documen! is the Delegation of
Services Agrnement document that is provided for
the Board of Medicine, as required.
MR. HJPPLER: Counsel, if I can
interject here-~
MR. COM STOCK: Sure.

l?age 31
10:01:04 l
10:01:05 2
10:01:06 3

10:01:08 4
lO!Ol:16 5
10:01:21 6
10:01:24 7

10:01:26 8
10:01:30 9
10:01:3510

10:01:3911
10:01:4312
10:01:4413
10:01:45 H
10:01:4615

10:01:4916
10:01:5317
10:01:5518
10:01:5519
10:01:57 20
10;02:0021
10: 02: 02 22

10:02:0623
10:02:1224
10:02:13 25

Page 33

10:04:5921

MR. HIPPLER: •• I ,night be able to
help out. Jusr so the record is clear, because
Mr. Byrne didn 1t have possession of these
documents, in order to facilitate this deposition
! nonetheless acquired them through my client for
today's deposition.
I want to point out that, with regard
to the Delegation of Services Agreement, this was
not in effect in 2003, as the Board of Medicine
did not require them in until 2004. But we
produced the one that was in effect thereafter.
And in addition to the docmnents that
you have ~wand perhaps Mr. Hall 1s assistant can
make a copy of it -- on the delegation it says
"Sec atrnchcd,11 and I have the pages that are
supposed 10 be attached that go with the 2004
delegation agreement.
MR. COMSTOCK: Okay. So you have just
handed me three more pages lhat are the
attachment to the Delegation of Services
Agreement that you're representing was in effect

10:05:0222

in 2004?

10:05:0423

MR. HIPPLER: Correct.
MR. COMSTOCK: Would you mind if! mark :
these three pages -·

A.

10:03:58 1

Q,

10:03:59 2

Yes, I did.
We'!! get into that later.
A. Okay.
Q. Would the standard of care require a
physician's assistant to work under the
supervision of a physician?
A. Yes.
Q. In that regard, did the standard of
care call for the PA and the physician to have an
agreement relative to the duties and obligations
between the two of them, and the supervision?
A. Yes.
MR. HIPPLER: Object to the form.
Q. (BY MR. COMSTOCK) Did you have a fonn
of an agreement with Dr, Dille during the period
of time that you were providing medical services
to Rosalie Schmechel?
A. Yes.
Q. Was it in a written fonn?
A. Yes.
Q, Have you brought that document with you
here today to produce as part of this deposition?
A. Yes.
MR. HALL: {Handing document to
Mr, Comstock.)

10:04:01 3

10:04:03 4
10:04:06 5
10:04:10 6
10:04:11 7
10:04:13 8

10104:16 9
10:04:2010
10: 04: 25 11
10:04:3112

10:04:3513
10:04:3814
10:04 :4115

10:04:4316
10:04:4617

10:0'1:5218
10:04:5319
10:04:5620

10: 05: 06 24
10:05:0825
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10:05:4214

MR. HIPPLER: That's fine.
MR. COMSTOCK: -- or add them -- I'm
going to add these three pages to Exhibit 4 so we
don't have so many multiple exhibits.
MR. HIPPLER: That's fine.
Q. (BY MR. COMSTOCK) Mr. Byrne, because
of that clarification r want to get·~ back up
just a little bit. First ofal!, did you have a
Delegatioti of Services written agreement between
yourself and Dr, Dille and the Southern Idaho
Pain Institute in effect in September of2003
when you were providing PA services to Rosalie
Schmechel?
A. ! believe there was a job description,

10:05:4715

which is enclosed.

10:05:5316

Q. But in terms ofa Delegation of
Services Agreement, such as the one that's
attached to Exhibit No. 4, was there such an

10:05:09 1
10:05:09 2
10:05:10 3

10:05:12 4
10:05:15 5
10:05:21 6
10:05:21 7
10:05:24 8
10:05:26 9

10:05:2810
10;05:3311

10:05:3612
10:05:3813

10:05:5617
10:05:5818

10:06:0419

10:06:06 20
10:06:0921
10: 06 :10 22

10,06,13 23

10:06:1524
10:06:18 25

agreement 1 in writing, in effect in September of
2003 between yourself and the Southern Idaho Pain
InsHtuteand Dr. Dille?
A. l think there was a-~ was some
documentation that was with the Board of
Medicine, bui not necessarily a Delegation of
Servkes Agreement.

Page 36
Q. And Rosalie Schmechel, r take it, was
not a patient, at least on September 26 of 2003
when she first came in the clinic and you changec
her pain management regimen, that you believed
you needed to talk to Dr. Dille about?
A. I didn't believe that I needed to talk
lo him about Mrs. Schmechel on that day. Bul I
did review the case, her case with him
subsequently.
Q. Did you review her case with him after
she <lied?
A. No, before.
Q. And again, we'll go through the chart
and perhaps you can help me with when that
occurred.
A, Okay,
Q. Getting back to standard of care
questions, would you agree that the standard of
care called for the PA to carefully instruct a
patient whose paifl management was being shifte J
from OxyContin to methadone?
A. Yes.
Q. And would that include an obligation lo
carefully instruct relative to any increases in
f:J
the dosage that were going to take place over the /

10:07:41 l

10,07,43
10,07,47
10,07,50
10,07,53
10,07,58
10:08,00
10,os,04
10,08,09

2

3
4

5

6
7
8
9

10,os,1010
10,08,1311
10,08,1412
10, 08, 1813
10, 08: 20 1.4

10: 08: 2215
10: 08: 2316
10: 08: 24 1 7
10: 08: 2518
1 D: 08 : 3 2 19
10: 08: 39 20
10: 08: 42 21
10: 08 :44 22
10: 08: 45 23
10: 08: 48 24
1 O : O8 : 51 2 5

Page 37

Page 35
10,06,19
10,06,21
10,06,28
10,06,33
10,06,36
10,06,41

1
2
3
4

5

6
10,06,45 7
10,06:52 8
10:06,54 9

10: 06: 58 10
10, 07, 00 11
10, 07, 02 12
10:07:03 13

10:07:0814
10:07:1115

10,07,J,616
10,07,1717
10,07,2018
10,07,2219
10:07:25 20
10,07,26 21
10,07,28 22
10;07:3123
10,07,3624
1 0 : 07 : 3 7 2 5

There was, at some point during 1hat
period, a change in the board 1s recordkeeping

10:08;54 l
10:08:55 2

10:08:55 3
process, per se. So documentation was with and
through the Board of Medicine rather than tl1rough 10:0B:5B 4

the office, So the documents went to the Board

10:09:00 5

of Medicine rather than ~. the documentation was
kept with the Board of Medicine in -- Boise?
Q. I'm trying to get a little better
understanding of how you and Dr, Dille worked
together with respect to any particular patient
in September of 2003.
A. Okay.
Q. You 1ve told me that the standard of
care didn't necessarily require you to consult
with Dr. Dille before irnpl~menting a change in
chronic pain management?
A, On a casewby-case basis.

10:09:02 6

Q, Was that understanding in writing
anywhere between you and Dr. Dille?
A. No,
Q. A11d ls that the pt'actice that you and

Dr. Dille had engaged in from the time you
started as a PA up to September of 2003?
A.

To the best of my recollection, we

communicated regularly about patients.

10:09:06 7

subsequent days?
A. Yes.
Q. And we call that 11 titrating it up";
correct?
A. l'm sure that that is a tenn that can
be used. There1s probably other terms that can
be used as we!!.

Q.

10:09:07 8
10i09:09 9

1 o : o9: 14 10
10: 09: 18 11
10: 09: 22 12
10:09:2513
10:09:2514

Would you agree that !n this process of

converting a patient from OxyContin to methadone
and titrating it up, the standard of care called
for the PA to follow that patient closely in
order to monitortheir symptoms and their
progl'ess?
MR. HALL: Object to the fonn.

10:09:2815

MR. HIPPLER: Join.

10:09:3116

THE WITNESS: Yes.

10:09:3217
10:09:33 18

10:09:37 19
10:09:42 20

10:09:49 21
10:09:52 22

10: 09: 57 23
10: 09: 59 24
10; 10; 01 25
..,_ ... ,,, ....,...,. ,.....

Q. (BY MR. COMSTOCK) Would you agree tba1
the slandard of care also would reguire the PA to
change the regimen of pain management in the face
of any reported syrnp!oms that would evidence a
dangerous level of methadone accumulating within
the patient's system?
A. r guess I'd need you to clarify the
question. Are we talking specifically about

Mrs. Schmechel now?
.

..~,. .............,., .... -.. -.
,
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Page 38
10:10:03 1
10:10:06 2
10:10:07 3
10:10:07 4
10:10:09 5
10:10:10 6
10:10:10 7
10:10:12 8
10:10:16 9
10:10:1610
10:10:19J.1

Q. J'm talking about any patient and
standard of care.

10:12:25 1
10,12,32 2

A.

Okay.
If you're in the process of converting
a patient -A. Okay.
Q, •• from OxyContin to methadone; you're
in those days where you 1re titrating it up.
A, Okay,
Q, As part of your following with them,
it's reported to you symptoms that would lead yot
Q.

10:12:39 3
10:12:45 4
10,12:49 5
10,12:52 6
10:12:57 7
10,13:00 8
10,13,02 9
l.O: 13: 0710
10:13:1211

10:10:2112

to believe that perhaps this patient is

l.0:13,1312

10:10:2313

developing a toxicity or a dangerous level or a
dangerous accumulation of methadone; does the
standard of care require for you to change that
regimen immediately?
A. I would certainly want to get all
infonnation available from the patient that -their concerns and prob!ems 1 and determine, to
the best of my ability, whether or not it sounds
like a side effect from the medication that had
been prescribed; or, again, if this patient had
other medical problems that could potentially be
producing_those side effects, that the patient
may need to be seen by their primary care

10,13:1613

10:10:2714
10:10:2915
10:10:3216
1.0:10:3417
10:10:3518
10:10:4019
10: 10: 44 20
10: 10: 4 7 21
10: 10: 50 22
10:10:5423
10:10:5924
10:11:0125

Page
10:11:04 1
10:11:07 2
10:11:12 3
10:11:16 4
10:11:l9 5
10:11:22 6
10,11:25 7
10: 11: 26 8
10:l.l:26 9
10:ll.:3010
10:11:3411
10:11:3612
10:11:3913
10:11:4314
10:11:4515
10:11:4616
10,11:4917
10:11:5318
10:11:56i.9
10:12:0220
10:12:0621
10:12:0922
10:12:1523
10:12:1924
10:12:2325
.

··

...

10:13:1814
10,13:2215
10:13: 2316
10:13:2417
10:13,2518

10:13:3019
10:13:3220
10,13:3521

10:13:3922
10:13:4123
10:13 :4724
10:13:4725

And the predominant factor in making a
change at that time was her expression of pain,
but also her concerns that her existing pain
management program, though it had been adjusted
within the last month, was not providing her with
adequate pain control, and that it was affecting

her quality of life; her ability to sloop, her
ability to function 1 her bi!- -- abil- -ability, rather, 1o perform her activities during
the course of the day,
Q. (BY MR COMSTOCK) If, during the
process of obtaining this history from
Mrs, Schmechel, you learned from Mrs. Schmeche! >
that her pain was a 10 on a scale of 10 --10
over 10 -A. Yes.
Q. -- that is something you would chart,
is it not?
A. The documentation that she provided for
me indicated that she -- that was her pain
rating, and she expressed it to me.
Q. In talking with her, would you have
written that down because of its significance to
you?
A. I may or may not have. It was

39

physician or in the emergency department at the
local hospital for evaluation in the interval
between their next visit.
Q. With respect to Rosalie Schmeche!, it's
fair to say that on September 26 of 2003, the
first day she came into the pain institute and
met yo\l -A. Yes.
Q, -- ym1 made the decis'ion to change her
pain management control, did you not?
A. Yes.
Q, And you changed part of it, at least,
from OxyContin to methadone; correct?
A. Yes, I did.
Q, Give me each and every reason why you
did that.
MR. HIPPLER: Object to the form.
THE WITNESS: During the course ofmy
history with Mrs.·· of Mrs. Schmechel, she
expressed to me her reason for being at Southern
Idaho Pain Institute and her chief complaint as
being ongoing chronic pain, and that was her
priority for being in our facility, was that she
was having ongoing pain lhat she rated a 10 over
IO on the pain scale.

Page 41
10,B:50 1

communicated to me in a verbal and a written fom ·.

10:13:54 2

by the patient,

10,14;00 3
10:14:02 4

Q. What consideration did you give, if any
at a11, to Rosalie Schmecbel's history of sleep
apnea and the fact that she was using a CPAP
during hei· sleeping hours?
A. What consideration did J give to it?
Q. In making your selection of methadone.
A. I) during the course of my history
taking, again, and her past medical history, she
indicated to me that she did have obstructive
sleep apnea, and that this had been diagnosed and
had been treated by Dr. Kimberly Vorse, and that
the patient had been prescribed CPAP and that she
was compliant with her CPAP and used it as she
had been instrncted by Dr. Vorse.
Q, Other than that, did you have any
information relative to how severe her apnea
I
events were during her sleeping hours?
A. The patient indicaled to me 1hat she
had obstructive sleep apnea and that she was
compliant with her medication. That was the
informaiion {hat I needed.
Q. Did the standard of care call for you
to determine whether or not her sleep apnea was

10:14,06 5
10:14'12 6
10,14:15 7
10,14:17 8
10:14:22 9
10:14:2410
10:14:2811
10,14,3012
10:14:3313
10:14:3714

10:14. :44 .15
10:11 :4616
10:14:5117
10:14:5218
10,14 ,5719
10:15:00 20
10:15:02 21
10,15:0522
10:15:0823
10:15:1024
10:15:1125

11 (Pages 38 to 41)
(208)

345-9611

"i.

M & M COURT REPORTING SERVICE, INC.

(208)

345-8800 (fax)

Page 44

Page 42
10,15,15 l
10,15,18 2
10,15,20 3
10,1s,23 4
10,15,27 5
10,15,30 6
10,15,32 7

mild, moderate, or severe, before changing from
OxyContin to methadone?
A. No. Her pain ~" her sleep apnca was
being managed, according to the patient1s
history) effectively, and she was compliant with

10:17:49 1
10:1•7:52 2
10:17:56 3
10:18:02

•

10:18:03 5

her treatment.
Q. Based on the history that you took of

10:18:05 6

10,15,34 8
10,15;38 9
10,15,4210

Rosalie Schmechel 1 <lid you conclude that she wa
a patient who was fairly knowledgeable about her
ongoing condition and the medications t!1t1t she

10,18:13 8

10; 15, 4511

had been treated with?

10:18:22 11

10, 15; 4812

A. She appeared Lo me to be alert and
lucid and communicated effectively, both in a
written as well as a verbal fonnat, her past
medical history, her CUJTent family/social
situation, her current pain level, and her

10:18:2712

10: 15: 5113
10, 15, 5414
10, 15, 5815
10, 16, 0216
10;16,0617
10,16,0718
10, 16, 10 19
10,16,1420
10,16,1721
10,16,1822
10, 16, 20 23
10: 16: 24 24

10:16:2725

current treatment.
Q. And because of that, you chose to rely
upon her history rather than contacting Dr. Vorse
who had been her pain management physician for
the past number of years; correct'!
A. I felt the infom1ation that

Mrs. Schmechel provided for me was -- was clear
accurate, and was what I needed.
Q. Did you at that time know Dr. Vorse?

10:18:09 7
10:18:15 9
10:18:1B 10

10:18:3013
10:18:3114
10:18:3215
10:18:3416
10:18:3517
10:18:4418
10:18:'1819
10:18:5020
10:18:53 21
10: 18: 55 22
10: J.9: DO 23
10: 19: 0124

10: 19: 07 25

MR. HIPPLER: Object to the fom1;
asked and answered.
THE WITNESS: Yes, I did.
Q. (BY MR. COMSTOCK) If you had contacted
Dr. Vorse and said, "You know, Dr. Vorse, I've
got one of your patients here; she's in our
clinic becnuse it's closer to her home than Sun
Valley, and l want to change, you know, the basis
of her pain management from OxyContin to
methadone," and Dr. -Vorse had indicated 10 you
that she would not recommend that, would you have
done lt?
MR. HIPPLER: Object to tl1e fonn;
foundation.
MR. HALL: Join.
THE WITNESS: l guess (hat would be
speculation. f don'l have the infonnation that l
would need-to -- you know, to make that decision.
l didn 1t contact Dr. Vorse and didn't fee! that
it was at that time necessary for me to contact
her to ma~e the changes that were made based on
my pl'evious experience with these medications.
Q. (BY MR. COMSTOCK) Prior to Rosalie
Schmechel's death on October 2nd of 2003, had you
experienced the death of any other patients that

Page

Page 43
10,16,31 1
10,16,34 2

I did not know Dr. Vorse personally. I
had never met her. I had seen communications,

10,16,38 3

written communications, chart notes and such,
from -- from other patients, but I don 1t believe
that I had ever met her or talked to her.
Q. A( that time did you know -- did you
know of Dr. Vorse and what her specialty was?
A. Yes, I did.
Q. So when you made the decision to change
Rosalie Schmeche!1s chronic pain management
regimen, you knew that Rosalie had been undertht
care of Dr. Vorse, a pain management specialist

10,16,41

•

10,16,44 5
10,16,47 6

10,16,51 7
10,16,55 8
10,16,56 9
10,16,5910
10,17,0211
10:17:0812

10,17,1213
10,17,1414

10:17:1715
10,17,2116
10:17:2517

10:17:2818
10:17:2919

10:17:3120
10:17:3521
10,17,3522

10:17:3823
10,17,42 24

10: 17: 46 25

A,

10,19,11 1
10,19,16 2
10,19,17 3
10,19,19 4
10,19,23 5
10,19,25 6
10,19,26 7
10,19,30 8
10,19,35 9
10;19,4910

you were treating with methadone?
A, Yes.
Q, Tell me about that.
A. Do you have a specific question?
Q. Howmany?
A. One.
Q, Under what circumstances?
A, It was alleged that one individual had
-- had died from the use of methadone,
Q. I'm going to hand you what we have

10: 19: 5111

marked as Exhibit No, I, Mr. Byrne1 and Jld ask

10,19,5612

you just to flip through that quickly.
A, (Examining document,) Okay.
Q. There1s an index and some tabs 1 but
other than the index and the tabs and the Bates
stamp numbers, does that exhibit appear to
comprise the chart, if you will, from the

practicing in Sun Valley; correcl?
A. During the course of my history taking,
Mrs. Schmechc! indicated to me verbally that she

10,20,0713

bad been under the care of Dr. Vorse for her
chronic back pain and her obstnictive sleep
apnea.
Q. And you knew at that time that Dr.
Vorse practiced in the area of pain medicine;
correct?
A. Yes, I did.
Q, Yet you chose not to contac1 Dr. Vorse
before making a change from the OxyContin-base<
mode of therapy to methadone; correct?

10:20:2716

10,20,2014
10,20,2215
10,20,3117
10,20,3518

Southern Idaho Pain Institute relative to Rosalie

10,20,3719

Schmechel?
A. Yes.
Q. Have you had a.n opportunity to review
that chart prior to the deposition here today?
A. Yes.
MR. HIPPLER: And, Counsel, for the
record 1 I will note that the chart that you had

10,20,42 20

10:20:43
10; 20, 45
10: 20: 49
10: 20: 57
10: 20: 58

21
22

23
24
25
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10,21:00 1
10:21:03 2
10:21:08 3
10:21:14 4
10:21:15 5
10:21:17 6
10:21:18 7
10:21:19 8
10,21:23 9
10:21:2710
10:21:2911
10:21,3112
10: 21:31 U
10:21:3414
10:21:3815
10:21:4016
1.0:21:4317
10:21:4418
10:21:4719
10: 21: 49 20
10:21:5121
10:21:5422
10:21:5623
10:21:5824
10:22:0025

Page

46

prodticed previously, which J1m assuming is the
same one, was not complete and identical to the
chart that I have for the institute,
MR. COMSTOCK: Well, then, perhaps
sometime you can get me a complete and accurati
chart.
MR. HIPPLER: I did give Mr. Hall a
comp!ete copy of it. l think he has that
available.
Q. (BY MR. COMSTOCK) As pa11 of the ••
MR. HALL: Just a second -Q, (BY MR. COMSTOCK) As part of the
deposition notice, Mr. Byme, we asked you to
bring with you a copy ofRosa!ie1s chart or any
notes you might have with respect to Rosalie.
Have you done so?
MR. HALL: I've got a copy of the
chart, I believe.
MR. HIPPLER: And again, Mr. Byrne is
not in control of that chart. As a courtesy,
however, J did provide that to Mr. Hall.
MR. COMSTOCK: !'m not whining about
it, but Mr. Hall is now in control of it, so l
gather I can get it.
MR. HIPPLER: Yes.

10:23:18 1
10:23,20 2
10:23:25 3
10:23:25 4
10:23:27 5
10:23:28 6
10:23:30 7
10:23:33 8
10:23,36 9
10:23:4210
10:23,4711
10:23:5012
10:23 :5213
10:23:5514
10:23,5615
10:23:5616
10:23:5817
10:24:0018
10:24:0119
10: 24: 03 20

10:24:0421
10:24:0722
10:24:0723
10:24,1024
10:24:1225

48

Yes, sir.
And the subsequent page behind it,
which is 6 -A. Okay.
Q. -- so we1ll refer to those two pages,
What are those two pages?
A. These are handwritten notes from
Southern Idaho Pain Institute that are dated 9126
of 2003, in reference to Rosalie Schmechel; and
in particular, lhis is her part of the document
from that day's visit.
Q. And the first day she came to the
institute was September 26th of 2003; is that
correct?
A. Yes.
Q. And on that day she was seen by
yourself; correct?
A Yes 1 she was,
Q. Was she seen by Dr. Dille on that day?
A, No, she was not,
Q, Was she seen by anybody else on that
day?
A. She was seen by our front office staff,
who see all of our patients 1 as well as one of
our medical ·assistants who wrote the area just up ·
A.
Q.

t----------------------t--·--------------------1
Page 47
Page 49
MR. HALL: Sure. That's why we brought 10: 24: 1 7 1

10:22:01 1
10:22:03 2
10,22:09 3
10:22,09 4
10:22,11 5
10,22:14 6
10:22:26 7
10:22:26 8
10:22:27 9

~

10:24:21 2

MR. COMSTOCK: So that we have a
complete record, Mr. Byrne) rm going to go ahea
and mark this as Exhibit 5, what has just been
produced.
(Exhibit 5 marked.)
TI1E WITNESS: So -Q. (BY MR. COMSTOCK) If you wouldn't

10:22:2810
10:22:2911

A.

10:22:3012

Q. We're going to rcferto Exhibit l,

10,22:3213
10:22:3514
10:22:3715
10,22:4016
10: 22: 4117
10:22:4418
10:22:4719
10 :22: 5520
10: 22: 58 21

10 :23: 0222
10:23:0423

-- when we refer to~- which copy?

because there are things l want to ask about
documents that are contained in Exhibit I. But
just for a moment -- and bear with me -- if you
would just look through Exhibit 5 and tell me if
you recognize that as being the complete chaii
from lhe Southern Idaho Pain Institute for
Rosalie Schmechel,
A. Yeah, to the best that I can tell, it
appears to be the complete document.

Q, Now, getting back to Exhibit I, would

10:23:0824

you refer to, under the first tab -- there's
Bates stamps in the lower-right-hand comer of

10:23:1025

the documents·- would you refer lo CD 00005.

10: 24: 25 3

10: 24: 28 4
10 :24:32 5
10:24,33 6
10:24:36 7
10:24,39 8
10, 24: 42 9
10:24,4610
10:24:4811
10:24:5112
10:24:5513
10: 24: 5714
10:25:0115
10:25:0116
10:25:0317
10:25:0818
10:25: 1019

10 :25: 13 20
10: 25: 16 21
10:25:1922
10:25:2023
10:25:2224
10:25:2525

above1 which is in her handwriting) as well as
the vital signs section that1s up there.
Q, Okay. So the initial paragraph, which
begins '1Paticnt is a 60-year-old female" was
written by?
A, Sharon Willmore1 medical assistant.
Q. How about the vital sign information
above that and to the left. where it has Rosalie
Schmechel's name and the weight of 203 and the
pulse and the blood pressure. ls that written by
her as well, or is that written by you?
A. No 1 those are written by Ms, Willmore.
Q. The writing on the right-hand upper
side, 11 OxyContin, 11 "Lortab," is that handwriting 1·
yours'?
i.:
A. That is my writlng 1 where it says
OxyContin, 20 milligrams, Q8; and Lortab, 5 to (
per day.
Q. When you wrote that down, was that
because that's what you were infonned
Mrs. Schmechel had been taking under the care o
Dr. Vorse?
·.
A.

Yes. fn talking to her, r}ust wrote

that up there so 1 wou Id know specifica!!y what
the dose was on those meds, as it didn't indicate
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10:25,28 1
10:25:32 2
10::0:5:35 3

it specifically in the medication !ist that was
written by Ms. Willmore.
Q. All right. Approximately how long did

10:25:3-9 4

you spend with Rosalie Schmechel that day'?

10:25:42 5
10:25:47 6
10::0:5:50 7
10:25:52 8
10:::ZS:58 9
10:26:0110
10:26:04 11
10:26:1012
10126:1313
10:26:1414
10:26,1715
10:26:2116
10:26:2217
10:26:2318

10:26:2619
10:26:2620
10:26:2821
10: 26: 3 2 22

10:24:33 23
10,26,34 24
10:26:3825

A.

[ would say probably 60 to 70 minutes.

Q, And during that 60-to-70-minute period
of time, I'm assuming therets some verbal history
taking that you do, but what else did you do?
A. A fairly extensive discussion with the
patient in tenns of her chief complaint, her
medical history, family/soCial histo1y, as well
as a physical examination which was performed by
myself.
Q. The writing on this page from the top
all the: way down to near the bottom where it says
9/30/03 -A. Yes.
Q.

-- is all from September 26th; ls that

cmTect?
A. That1s correct; up to the point where
it says 9/30, patient phone cal! advised; that's
from a different day.
Q. And that's your initial off to the
far-right-hand side just above that?
A. That is correct.

Page 52
10:27:57 1
10,28,00 2

10:28:03
10:28:07
10,28:11
10:28:12
10:28:14

written.

5

Q. In the pain questionnairc 1 when it gets
to the section of "Level of pain" -- I see it on
00008?
A. Yes, sir,

6
7

Q, There's a circle around '1 10." Did you
place that circle, or did Mrs, Schmechel place

3

4

10:28:16 8
10:28,16 9
10,28:2010
10:28:2311
10:28:2612
10:28,2913
10:28:3214
10:28:3815
10:28:4116
10:28:4517
10, 29: 0418
10 :29, 0719
10:29:1120
10,29:1621
10!29:1722
10:29:1923
10:29:2024
10:29:2025

that?

A. No, that was placed by the patient.
Any docurnen1ation that l made on this chart would'.,:
be off lo the side. I think there's only really
one -- one spot where I wrote -Q. And on what page is that?
A. 009, on the surgical hislory,just
clarifying that she had arthroscopic surgery in

'03 of her right knee, and that Dr. Widell had
done her back surgery.
Q. The inforn,ation that you wrote down by
hand on September 26th also became part of a
dictated char! note, did it not, for that day?
A. Yes.
Q, And l want to foHow that process for _a

minute.
A.
Q.

Okay.
You meet with Mrs. Schmechel; you're

Page 51
10:26:38 1
10:26:41 2
10:26:43 3
10:26:43 4
10,26:44 5
10:26,46 6
10:26:47 7
10:26:52 8
10,26:54 9
10 ,26, 5710
10:27:0111
10,27:0512
10,27:0913
10:27:1314
10:27,1615
10 ,27: 1916
10,27:2517
10:27:2918
10:27:3219
10:27:3620
lo: 2 7: J 9 21
10:27:4122
10:27,4423
10,27,4824
10,27,5125

Page 53

10:29:21 1
Q. And so these are the handwritten notes
writing notes while you meet with her; you
l0:29:24 2
that you took during !"he course of talking wlth
develop a plan for her care.
10,29:26 3
A. Yes.
Rosalie Schmechel?
10:29:26 4
A. Yes, sir.
Q. And implement that plan. After she has i.
10:29,30 5
gone, and al the end of the day, did you sit down ;
Q. And doing your examination and
10:29:32 6
and dictate what had gone on that day with
evaluation?
10,29:35 7
A. That's correct.
respect to Mrs. Schmechel?
10,29:37 8
A. [ -- my typical routine was to dictate
Q. I don 11see anywhere in here that she
was complaining to you that her pain was a 10 on 10:29:40 9 · the patient's chart after I saw the patient, in
10:29:4310 order to keep it fresh in my mind and try to be
a scale of 10, do you?
10:29:4611
as accurate as possible,
A. Additional document- -- on the initial
10:29:5012
visit, the patient also was asked to fi!I out a
Q. If we look at page. I under lab 1 of
pain questjonnaire form, tlrnt 1s a comprehensive 10:29:5613 Exhibit 1, that's a dictzited note for September
10:30:0214 26th, is it not? It's page l and page 2.
fom1 that the patient fills out in reference to
10,30,0515
their reason for being al the institute. That1s
A. That is correct.
00007, which was completed by Mrs. Schmcchel. 10:30,0616
Q. ls that what you dictated on September
10:30:0917 26th?
And during the course of my interview
A. Yes.
·;
·
process and history taking with Mrs. Schmechel, 10,30:1018
had this fom1. with me and wa,; reviewing it while 10:30:1319
Q. Now, with respect to the process of
10:30:1520 getling lhat document back, the typed document, .
I was talking to her, and actually confi1111ing a
10,30:2021
how long did that typically take at the Southern
lot of the information that was on here, as there
10,30,2422 Idaho Pain Institute?
are some notes that I made on th.is document in
A. It was variable; several days,
addition to the notes that she had made on there 10,30,2523
10,30:2824 typically, by the time the recording went to the
us well; and again, to clarify, from my
perspective, maybe what she meant or what was 10:30:3625 transcriptionist and came back.
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Page 54
10:30:39 l.
10:30:43 2
10:30:47 3
10:30:49 4
10:31:00 5
10:31:02 6
10:31:08 7
10:31:13 8
10:31:16 9
10:31:1910
10:31:2211
10:31:2512
10:31:2613
10:31:3014
10:31:3315
.10:31:3716
10:31:4217
10:31:4618

10:31:4919
10:31:52 20
10:31:56 21
10:31:5722
10:31:59 23
10:32:03 24

10:32:14 25

Q. Is there any way we can determine when
the typewri1ten chart note actually came back to

!he institu\·e7
A. Not to my knowledge.

Page 56
10:34,14 1
10,34:18 2
10:34:21 3

10:34:26 4
10:34:29 5
10:34:31 6
26th of2003 was a Fridayi and again, wi!h
respect to what you remember being typical during 10:34,35 7
10:34:36 8
thal time frame, would it have been typical for
10,34:39 9
the transcription to come back the following
Monday if you had dictated it on Friday, or would 10:34:4410
10: 34 :48 11
it have been several day~ after that?
10:34:5512
A. I don't have specific recollection of
when it came back. It cou Id have been Monday; it 10: 34: 5813
10:34:59H
could have been !ater. I don't recall.
10:35:0315
Q. I do note on page 2 thel'e are
10:35:0716
signatures there for yourse!fand Dr, Dille on
10,35,1717
the typewritten document; and ccln you (eli me,
10:35:2118
from looking at this document or any other
10,35,2419
document, on what day those signatures were

Q.

Let me represent to you that September

actually placed on the typed chart note?

A.

I dont
Q. Fair to say )t would have been several
days after September 2<5th?
A. Yes.
Q. Going back to your handwritten note of

10:35:2620
10:35:2921
10,35,3022
10,35:3123
10: 35: 33 24
10:35,3525

instructions that we had set forth, which was
initiating the methadone at five milligramst and
theni with my instruction, advancing the medicin
as determined by her -- her level of pain.
And we also at that time discussed the
use of a short-acting pain medication for
breakthrough pain.
And in addition to that as well, we
discussed the lowering of one of her medications '.!
that she was on, which potentially could produce
some sleepiness, as well as its ineffectiveness1
essentially, and I felt that we needed to lower
that dose,
So the methadone was discussed at
length with her in reference to the dosing -- the
dose, the dosing interval, the changes, how they
would be made, and as well as, again, we~- 1
focused on talking to her about the potential
problems with th.e medicine.
Q. Was the prescription that she was given
for ten~rnilligram tablets?
1-A. That's correct.
Q. And so if you wanted her to rake five
mil\igrams 1 you instructed her to break one of
them in half? ls that what you did?
Page 57

Page 55
10:32:17
10:32,33
10,32,38
10,32:42

1
2
3

4
10:32:49 5
10:32,53 6
10:32:56 7

10:33:02 8
10,33:07 9
10:33,1110
10:33:1411
10:33,l'/12
10,33:2213
10:33,2814
10,33:3115
10:33:3416
10:33:3917
10:33:4518
10:33:4819
10,33,5120
10,33:5721
10:34:0122
10,34:0423
10:34:0724

10:34:1125

that day, look at the plan, and can you just tell
me whal the plan was for methadone?
A. Yes. The plan was to initiate
methadone at five to ten milligrams every 12
hours.
Q. And how was that explained to Rosalie
Schmechel?
A. l explained to Mrs. Schmechel in detail
after we had spoken at length in the early palt
of her history and physical examination in
reference to her chief complaint of ongoing pain,
and her interest in changing her pain managemen1
program and the ineffectiveness of her existing
program had suggested that we try different
medicaticins, and she was amenable to that.
I then discussed with her at lenglh the
medication methadone, its characteristics as we
had -- you an.d l had discussed earlier in the
deposil!on, in terms of its long-acting nature
and its use in chronic pain and its risks and lts
benefits. And we discussed those al length.
And then prior-~ after discussing
those things and noting lhat she understood those
completely, I then discussed with her the
necessity tO be compliant with the dosing

10,35:37 l
10:35:38 2
10:35,41 3
10:35:44 4
10:35:46 5
10:35:48 6
10:35:50 7
10:35:52 8
10:35:54 9
10:35:5510
10:35:5611
10:35:5'/1,
10:35:5913
10:36:0014
10:36:0315
10,36:0316
10,36:0517
10:36:1018
10,36,1219
10,36:1720
10:36:2021
10:36:2022
10:36:2423
10:36:2624

10: 36: 3125

A. Yes.
Q. And was she to start lhat day, start
off with five rni11igrams?
A. Yes,
Q. And is that how this is written?
A. Yes.
Q. Explain that to me. This looks to me
Hke it's ten milHgrams ~A. -- one-half -Q. -- hyphen, one-half -A. -- to one -Q. -- to one~,
A. -- POQ 12 hours.
Q, And that means every 12 hours; correct,;:
A. Correct.
Q. So isn't this written that she could
take as much as one whole pill, or ten
milligrams, right off the bat?
A. No. She was instructed to take a half.
Q, ls that instrnction written down here
anywhere?
A. Right there, one-half to one.
Q. But when you write one-half lo one,
doesn1t that indicate to you that she can take
one-half of one or one?
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10:36:34 l
10:36:36 2
10:36:39 3
10:36:45 4
10:36:50 5
10:36:55 6
10:36:59 7
10:37:00 8
10:37:04 9
10:37,0910
10: 3 7: J.4 11
10:37,1612
10:37:1713
10:37:2214
10:37:2815
10:37:3116
10:37:3117
10:37:4318
10:37:4519
10:37:4820
10 :37 :5.121
10:37:5522
10 :37, 58 23
10:38:0824
10 ,38 :1025

A. The chart itself, both in the
handwritten notes as well as the dictated forrn,
are notes that I made essentially for myself, for
completeness in the patient1s treatment program,
as well as to~¥ so I would understand and
remember what treatments were rendered for the
patient.
So in ils entirety, the chart was a
document for me and for Dr, Dille to understand
the initial evaluation and treatment of the
patient.
Q. So it was her inst1uction, according to
you 1 to take five milligrams as soon as she
picked up the prescription?
A. Can J review the document?
Q. Of course.
A. Okay, thank you. (Examining document.)
The dictation, as we!! as the written note,
indicate that I gave her inslruction in reference
to the initial starting dose being at five
milligrams, and then gave her an idea of what we
would be doing in tenns of titrating the
medication up to control her pain.
Q. It being a Friday when the change was
implemented --

10:39:19 1

10:39,22 2
10:39:24 3
10:39:26 4

10,39:28 5
10,39:33 6
10:39:36 7

10:39:38 8
10:39,39 9
10:39:4210
10:39:4611
10,39,4812
10:39:4913
10,39:5014
10: 39: 5315
10,39,5616

10:40:0217
l.0,40:0418
10:40:0819
10:40:1220
10:40,1621
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Q. And it s your testimony that she was
clearly instructed on that?
A Yes, she was.
Q. With respect to the hydrocodone, which
is the short-acting, if you will, you changed
that somewhat from what she had been taking undc ,
the direction of Dr. Vorse, did you not?
A, Yes,ldid.
Q. Dr, Vorse had her taking what?
A. Dr. Vorse had her on -- and you want to
know just specifically the short~acting
medication~Q. Yes.
A. -~ right now? L01iab, which is one of
the trade names for hydrocodone; and she was
taking a 7.5 500 Lortab,
Q. What does that mean?
A. 7.5 indicates the millig1·am amount per
pill of the narcotic, which in this particular
1

case is hydrocodone. The 500 indicates the

amount of acetaminophen that is in the same pi!l.
So it 1s a combination pill using hydrocodone and
acetaminophen.
Q. And she was to take it on what
intervals, according·to Dr. Vorse?

i:
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A.

Vh-huh.

Q. -- were you giving Mrs. Schmechel the
pem1ission to go up to as much as one tablet or
ten m.illigrams every I 2 hours over the weekend?
A. I believe so, yes.
Q. And what were her instructions relative

to doing that? l mean, did you tell her that if
you're not getting any pain relief, just go ahead
and take more?
A. Well -Q. What did you tell her about that?
A. One of the factors with any medication
is a slow elevation in the dose, and so we wanted
to make sure that, A, she didn 1t have any
immediate side effects of nausea or anything sud
as that; and we talked about those things, as l
alluded to earlier.
And then as her understanding of
methadone and how it was dosed and her previou•
level of substantial amounts of long-acting
opioid OxyContin, the five to ten milligrams
twice a day would cer1ainly be an appropriate
initialdose. Tenmi!ligramstwiceadaywou!d
probably be a reasonable starting dose, but I
wanted to go a little lower than that initially.
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A. I believe the record indicates
Mrs. Schmechel told me she took five to six per
day.
'·
Q, And so what was your pre.scrjptiqn
relative to hydrocodone? You changed it to 10
slash 500?
A. That1s correct.
Q, So that would be increasing the amount,
would it not?
A. Increasing the amount of the
hydroeodone per pill from 7.5 to JO milligrams,
Q, And how about the dosage, as to when
she could take it?
A. Every four to six hours, one pill.
Q. So you were giving her instruction that
she could actually take more hydrocodonc than ,
what she had been under the care of Dr. Vorse; '
correct?
A, The dose pet pill was, in fact,
increased, yes.
Q. Now, you had her decrease the
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amitriptyline. Why was that?

10, 41, 3 3 24
10: 41: 3 5 25
..

"

A. Probably the single most jmportant
reason was that this medicine really wasn1t
giving her any benefits that she could tell. It
........ ,...c"".,-.-.,·c; ,.. ,,..,, ..,..,.··
.... ..,., ._,,._..,._,,....~.,.,,.,."·"·'
,
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wasn't benefitting her sleep, a:nd it didn t seem
to be benefitting her pain.
So my determination on that day was
that ifit wasn1t working, then I wanted to
decrease it to avoid potential side effects;
sedation, dry mouth, those types of things. But
most importantly, because it just wasn 1t
effective,
So there wasn't, in my mind, a reason
to maintain the substantial dose of(he
amitripty!ine that she was taking.
Q. You wa11ted her to continue the Bextra;
correct?
A. Yes.
Q. At the same doses; correct?
A. I did not make any changes to the
Bextra.
Q. Discontinue the OxyContin?
A. T)mCs correct.
Q. Did you give her any kind of
handwritten instructions relative to the
medications she was to take when she left your
office that day?
A. [ don't have a specific recollection of
a handwritten riote 1 but! did, on some occasions)
1

Page 64

10:44:17 6

Exhibit No. 2?
A, Yes, that is my -- my handwriting.
Q, And that's handwriting on a Pfizer pad,
is it not'!
A. That's correct. No intended
advertisement there. It 1sjust what I had in

10:44:20 7

hand.

10:44:22 8

Q, I understand, Let me represent to you
that this is something that Mrs, Sch~ncchel had al
home; and Vaughn Schmechel, her husband, kep1 i ):
and gave it to me.
A. Okay.
Q, Do you recognize this as a-~ as the
instructions that you gave her in writing when
she left your office on September 26th?
A. I would say that is, correct.
Q. And ifl read it correctly, on
methadone it says one-half to one piff every I2
hours; correct?
A. Thafs correct.
Q. And it doesn 1t say fake only five
milligrams initlally?
A. It says one-half to one pill every 12
hours. Five milligrams is a half a pH!.
Q. Right. Looking at the -- what's marked

10:43:59 1
10:44:00 2
10:44:07 3
10:44:12 4

10:44:14 5

10:44:23 9
10:44:2610
10: 44: 2911
10:44 :3012
10,44 :3113
10:44:3414
10:44 :3615
10:44:3716
10:44:4117
10:44:4418
10:44 :4719
10,44 ,4920

10: 44: 5121
10: 44: 53 22
10: 44, 56 23
10:44:

5924

10: 4 5: 02 25

Page 63
10:42:44 1
10:42:46 2
10:42:53 3

10:42:56 4
10:42:59 5
10:43:00 6
10:43:03 7
10:43:05 8
10:'13:07 9
10:43,0810
10:43:1011
10 :43, 1312
10: 43, 16 13
10: 43: 20 14
10:43:2315
10:43,2816
10:43,2917
10:43,3218
10:43,3519
10:43:38 20
10:43:4221
10:43:4822
10:43,5023
10:43:5124
10:43:5725

write -- write down some instructions for rny
patients just so they understood dosing and the
medication. I don 1t recal1 1 you know)
specifically if I did on that day with
Mrs. Schmechel.
Q. And your handwritten note would have
clearly said just take five milligrams initially?
A. I don't have a recollection of the
handwritten note,
Q. But it was your intent, though, that
she only take five milligrams initially?
A. At least ti1e first day, yes.
Q, On the first day -- would it have been
your intent that on the first day, September
26th, that she take only five milligrams? On
that day?
A. I don't have specific recollection of
-- of.the amount, but five to ten milligreim$
certainly was a reasonable starting dose in a
patient who was on a substantial amount of
another long-acting opioid medication.
Q. I'm going to hand you what I've marked
as Exhibit No. 2.
A. Okay,
Q. Do you recognize the handwriting on

Page 65
10:45:24 2

as Exhibit No. J , • ,
MR. HWPLER: We've been going for a

10:45,25 3

while. Can I take a break?

10:45:21 1

MR. COMSTOCK: Sure.
THE V!DEOGRAPHER: Off the record.

10:45:27 4
10:45:29 5

10,52,0613

(Recess held.)
THE VJDEOGRAPHER: On the record. ,,
Q. (BY MR. COMSTOCK) Mr. Byrne, we're
back, having just taken a short recess to stretch
our legs. I'd like to refer you to what's under
tab 3 of Exhibit l; Ws page 1l.
A. Okay.
Q. Just for a moment. Do you recognize

10:52:0814

tha1 document?

10:52:0915

Yes, l do.
What is it?
A. It is essentially a medication !og
that's kept in our office, which a!!ows us to
keep a running track of the patient's date of
visit, refills, an<l'.what medications were
prescribed.
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A.

Q.

Q.

Is the handwriting on this log yours?

A. The mc.dications, tbeir dosages, amounls
written, arid !'he date are mine, The name is.not
my handwriting.
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Q. So if I read this correctly,
Mrs. Schmechel was given a prescription for 90
tabs of methadone?
A. Yes.
Q. And those are the ten-milligram tabs;
is that correct?
A. That*s correct.
Q. And then you write n1 Q 12." What does
that mean?
A. One te1Hnilligram tablet every 12
hours.
Q. And what's thew~ what's written
undemealh the number 90?
A. No refills.
Q. And hydrocodone is l Oslash 500, and
we 1ve talked about that before; correct?
A. Yes.
Q. And what's written under the number70?
A. One refill.
Q. And I gather the prescription that she
was given al the time she came in to see you on
September 26 called for 70 of the hydrocodones t
be deliver1;;d to her? The number 70?
A. Yes.
Q. Does that mean she can get 70 of those
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Q. Otheiwfse no significant leg pain;
correct?
A. Correct.
MR. HALL: Well, you left out part of
the first sentence.
Q. (BY MR. COMSTOCK) You continue: "Her':
pain is typically constant, worse wllh lying down
and has disrupted her sleep"; correct?
A. Yes,
Q, Did you write <mywhere in here tha( her
painisal0ona !0?
A, No, but in the documentation of her
intake form, she ex.p1essed to me at th.it point,

10:55:1914

in a written fonn as well as verbally, that her

10:55:2315

10:55:4924

pain was a 10 over 10.
Q. You write: "She also has increasing
pain with activities. 11 And then 1 "If she gets in
a flexed position) her pain improves"; correct?
A. Correct.
Q. So with some manipulation of her spinal
column, her pain is improved?
A. Yes, She indicated that if she bent
forward, and when she was lying down, If she bent
forward a lilt!e bit, she could get a Uttle more

10:55 :5125

comfortable that way.
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pills at one time?
A. Right.
Q. All right. Let's get back to page 1 of
Exhibit l, which is the transcribed typewritten
note for September 26 of 2003.
A. Okay,
Q. I want to go through the history that
you dictate there. And this is your dictation,
is it not?
A. Yes, it is.
Q. You write, under "Chief Cornplainf1 '.
"Her chief complaint at time of presentation is
central low back pzdn status post two surgeries,
the last of which was 199 ! "; correct?
A. Yes.
Q. And then you have a history section
where you discuss the pain that you and she
talked about; is that correct?
A.
Q.

Yes.

Q.

Occasionally gets numbness and a duU

And it indicates that she rarely gets
pain in her leg; correct?
A. Yes.

ache in her left thigh; co1Tect?
A.

Yes.
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Q, You did not include, in the Past
Medical History section, any information relative
to her sleep apnea and the use of a CPAP; is tha1
COlTeCt?

A. I would consider the dictated document
as well as foe handwritten document the same in
terms ofmy - my record and my recordkeeping.
It's documented in the written por1ion.
Q. The reason I ask it, it's not here in
the typed portion, is it?
A. No, it's not.

Q. And the reason I ask it is that
Dr. Dille signs off on the typed portion, bul Ito
didn't sign off on your handwritten notes. So
did you tell Dr. Dil!e that this was a woman who
had a history of sleep apnca and was on CPAP
therapy at some point in time?
MR. HALL: Object to the form,

:;
conversation, but I do recall speaking to him at
length in reference to Mrs. Schmechel, because he
was going 1o be seeing the patient in follow-up,
and I wanted him to know that I had seen ber and !_
........... ,... ,,,.·., ,....... ,, .. ,,
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what had been done.
Q. (BY MR. COMSTOCK) And as you sit here
today, you can't recall if you actually talked
with him about her CPAP therapy and her sleep
apnea?
A. I can 1t recall.
Q. Let's look at the Physical Examirn.1tion
portion of your dictated and typed chart note.
A. Okay.
Q, What I don't see in this section, under
Musculoskelcta!, ls anything that would indicate
to me that you are finding that her pain is
severe. Do you see anything that would indicate
to you in tllis section that her pain is severe?
A. You know, I1m assessing clinically her
range of motion and pain, and her pain complaint
is a-~ ls a subjective thing that she relayed to
me verbally as well as in a written format.
Q. But is there anywhere in here relative
to your physical examination of her
muscu!oskeletal system that would indicate to
someone reading il, Hke Dr. Dille, that she was
indicating that she had pain on a~¥ al a 10 on a
scale of IO?
A You know, there's indications that she
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with minimal radicular symptoms.!J There's
nothing in that section to indicate to the reader
that this is a patient who has severe ongoing
back pain, is there?
MR. HIPPLER: Object to the form.
MR. HALL: Join.
THE WITNESS: Again, you know, the
patient indicated to me that she <lid have ongoing -'.
back pain, and the record indicates that
Q. (BY MR. COMSTOCK) Under the Plan
section, there1s some discussion here about why
she came to you.
A. Uh-huh.
Q. And it reads: "The patient has been
under the care of Dr, Kimberly Vorse to this
point but feels like it is more convenient for
her to come to Twin Falls for her pain
management, and she also wants some new
information in reference to pain management. 11
Did she come to you for you to actually
take over her care, or did she come to you just
for a second opinion and some information
relative to what else could be done in terms of
pain management'?
A. She came to us to establish for pain
Page 73
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had limited range of motion in her back as well
as palpable lenderness,
Q. So the answer to my question is, there
is no indication here that she had s~vere pain or
pain on a -- at a 10 on a scale of 10?
A. There is -~
MR, HWPLER: Object to the form.
THE WITNESS: .. an indication in the
intake form where the patient indicated to me in
a written as well as, later on in the evaluation,
in a verbal form that she was still having
cum;lanl pain.
Q. (BY MR. COMSTOCK) I understand your
answer, Mr. Dille~- or Mr. Byrne, but this
document, which is your typed dictated note for
the visit of September 26th, and looking under
thls section, doesn't say that, does h?
A. It does not, but I would also again
stale that this -~ the document, the written, the
transcribed, as we!! as the intake form, was
something that was considered as the entire chart
·and was used for our reference, and and for
that purpose, the information is there.
Q. Under Assessment, you write:
"Postlaminectomy/fusion ongoing !ow back pain
M~
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management.
Q. Did you make any statements to her
relative to Dr. Vorse and your view of whether
Dr. Vorse was adequately carjng for her chronic
pain patients?
A. Could you repeat the question 1 please?
Q. Yeah. Did you make any comments to her
about Dr. Vorse which would be construed as
negative comments in terms of her ability to
treat chronic pain patients?
A. No.
Q. What was the new information that she
wanted?
A, If you read on, it basically says that
"She feels like her medicines arc currently not
working 11 well -- as we!! as they should-~ as
they used to. And that's not the quote, "She
feels like her medicines are currently not
working as well as they should or they used to. 11
And that was the information that she
wanted, what other options were there for her in
terms of improving her pain and her.quality of
life, in addition to the convenience of seeing a
pain management provider in Twin Falls which wa~
closer to her residence than driving to the Wood
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Page 76

River Valley.
Q. Again, with September 26 being a
Friday, did you expect that by the following
Monday, that this patient would have titrated up
to as much as one and one-half pills every 12

11: 04: 16
11: 04: 19
11; 04 :21
11 : 04 : 26
11: 04: 29

l
2
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hours?

11:04:32 6

A. No. I very clearly instructed her that
len ml!ligrams twice a day would be the maximum

11:04:38 7

dose. And that's indicated on the note dictated
on 9/29, that 11 1 spoke to Ms. Schmechel today in

11:04:42 9

reference to her medication change to methadone.
She was doing wel!. 11 I advised her that she
could go ahead and increase to methadone, ten
milligrams twice a day 1 and continue the program
and recheck as schcdl!!ed, So ..
Q. Your handwritten note to her-, however,
which is marked as Exhibit 2, says "may increase
to maximum of one and onewhalf pills every 12
hours.'1
A. The patient ••
Q, Does it no!?
A. It does Indicate that, but what was
indicated to the patient verbally was that she
would sta1t at five milligrams, up to ten
milligrams:,

11 :04 :4611
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argumentative and misstates his testimony.
THE WITNESS: The patient had verbal
instructions that were very clear; and I felt, in
talking to the patient in fo!low-up, that she was
following those instructions closely, five to ten
milligrams every 12 hours.
Q. (BY MR. COMSTOCK) But you would agl'Ce
that your note that you gave to her isn't the
same thing as what you told her verbally?
A. lt is -MK HALL: Asked and answered.
THE WITNESS; -~ the same thing. It
says a half to one pill every ! 2 hours.
Q. (BY MR. COMSTOCK) But it does go on,
Mr. Byrne, to say, "May increase to maximtlm of
,.
one and one-half pills every 12 hours," docs 'it
not?
A It states that, but the patient was
given instructions that sl1e obviously was
following tha1 indicated the appropriate time
frame for the titration from five to ten
milligrams; and then another note that's in the
chart that indicates the titration beyond ten
milligrams.
Q. Did you talk to this patient at any

,.
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11;03:28 4
11:03:29 5
11:03:31 6
7

8
11:03:35 9
11:03:3610

11:03:3611
11:03:4012

11:03:4213
11: 03: 45 14
11:03:4715
11:03:5116

11:03:5917
11:04:0018
11,04,0119

11: 04 : 03 20
11: 04: 06 21
11: 04: 06 22

11: 04: 08 23
11: 04:10 24

11: 04: 15 25

Q. Well, if 1 take your handwritten note
literally, you were giving the patient pennission
to go up to as much as 30 mil!igrams over a
24-hout' pel'iod?
MR. HIPPLER: Object to the form;
argumentative, asked and answered,
Q. (BY MR. COMSTOCK) Correct?
MR. HALL: Join.
THE WITNESS: No,
Q. (BY MR. COMSTOCK) Isn't that what "May
increase to maximum of one and onew!ialfpi!!s
every 12 hours" eqlmlcs lo?
A. I think it's all about the time frame
Lhat is not necessarily specifically indicated on
the written note but was very clearly indicated
to the patient when l talked to her.
And is also
Q. So you-·
A. And is also pretty clear in the note on
9/29 as far as the dose that she was taking at
that time.
Q, So would you agree with me, then, that
your handwritten note that the patient left your
office with is incorrect?
MR. HIPPLER: Object to the fonn. ft 1s
w~

Page 77
11:05;18 1
11:05:20 2
11,05,23 3
11,05:26 4
11:05:28 5
11,05,29 6
11:05:32 7
11:05,34 8
:!,1:05:39 9

11:05:5410
11:05:5611
11, 05: 5912

point in time over the weekend?
A. No.
Q. Did Dr. Dille telephone and talk to
thls patient at any point in time over (he
weekend?
A. Not to my knowledge.
Q. lfthat had occurred 1 would there be a
no1e in your chart to that effect?
A. Yes.
Q. From your review of the chart, when did
you next have contact with Rosalie Schmcchel?
A. I spoke to Mrs. Schmechel on 9/29 of

11,06:0313

1

11: 06: 04 14

And if we -- that would be a Monday;
correct?

11, 06, 07 15
11,06,0716
11:06:0917
11:06:1218
11:06:1819
11,06'19 20
11:06:2121

03.
Q.
A.

Q.
of patient contact, again under tab 11 page 5 -A. Yes.
Q.
I don 1t see uny entry in there
reflecting patient contact on 9/29 of'03, do
WW

11:06:28 24

you?
A. No; and the reason is, I initiated that
contact and called Mrs, Schmeche! pcrsonaUy, and'.

11:06,3125

for that reason, as soon as I hung up the phone,

11:06:25 22
11,06,25 23
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11:06:35 1
11:06:48 2
11:06:51 3
n,o6,s4 4
ll,06:57 5
11: 06: 59 6

11:07:03 7
11: 07: 06 8
11:07,08 9
11:07:1010

11: 07, 1411
11: 07: 1712

11,09,14 J.
I dictated this note, that J had spoken to her.
11,09'16 2
Q, All right, but on 9130 there's another
phone conversation that bas, not only a dictated 11:09:20 3
note, but also a corresponding handwritten note? 11,09:23 4
11:09,25 5
A. Correct.
11:09:26 6
Q. So is the practice, when you call a
J.1:09:27 7
patient, you don 1t enter a handwritten note but
11:09:30 8
rather just a dictated note?
11:09:32 9
A. I think that there was no specific
11: 09, 3510
practice, but it was availability of the chart at
11:09:3711
the time. When I spoke to her on the phon_e, I
may not have had the chart in front ofme on the 11,09,4512

11:07:2013

29th when I decided lo dictate the note in terms

11:07:2514

of efficiency.
Q. The chart notes -- the dictated note of
9129 of'03, which is Monday, indicates that
Mrs, Sohmechel was doing well. It doesn't
indicate. however, what doses ~he was taking,
does it?
A. !fl advised her to go ahead and
increase the methadorn~ to ten ml tligrams at
bedtime and ten milligrams daytime, then I wouk
say she was ,taking less than len milligrams twice
a day.
Q. And that is what you advised her, was

11:07:3015
ll,07:3216

11' 07: 4017
11:07:4318
11: 07: 4719
11: 07: 5120
1.l:07,5321
11.:07,5622
ll,07:5823
1l: 08: 0124
11: OB, 02 25

Page 80

11'09:4813
11,09,51.14
11:09,5715
11, 09, 5916
11:10:0317

11: 10: 05 18
11:10:0919
11: 10: 1620
11:10:2021

11:10:2422
11:10:2823
11:10:3024

11:10,3425

A. My intent was to check with her on
Monday.
Q. And on Monday the 29th, it's your
te...i:;timony that you called her?

A.

That's cort"ect.
From the office?
A. That's correct.
Q. In the office when you would contact
;:;
patients 1 did you use a ceH phone or did you use
what we call a landline?
A. It would have been the office !andline.
Q, How do we know and how do you know th, this is a contact from you to Mrs. Schmechel as
opposed to Ivfrs. Schmechel caHing you?
A. I don't specifically know 1 other than I
just~~ 11 1 spoke to Ms. Schrnechel today."
Q, It doesn 1t say
A. I have a recollectioh of calling her on
Q.

~M

9129,
Q, Why did you eleet to increase the
methadone, if you will 1 to ten milligrams at

bedtime and ten milligrams daytime?
A, Based on the information that she had
given me on the phone, that was the next logical
step in the management of her pain.

Page 79
11,08:04 1
11,08,07 2
11:08,08 3
11:08:12 4
11:08:12 5
11:08:14 6

11: 08, 18 7
11:08:20 8
11:08:24 9
11: 08: 2610
11:08,3011
11:08:3212
11:08,3413
11:08,3814

Page 81

the ten milligrams at bedtime and ten milligrams 11:10:40 1
in the daytime?
A. That1s correct, every 12 hours.

(Clearing thrnat.) Excuse me.
Q. So would it be your understanding that
she started that protocol on Monday the 29th?
A. She may have been taking five
milligrams on one dose and ten milligrams on
another dose, I don 1t have specific recollection
of that, but I indicated to her that at that
point she could take ten milligrams twice a day.
Q. At that time was she to continue the

11:10:'13 2

11:10:46 3
11:10:51 4
11:10:51 s

11:10:52 6
11:10:53 7
11:10:56 8

11,10:59

9

11:11:0010

11,11,0111
11: 11: 03 12

hydrocodone as you had previously prescribed to 11:11:0613
11:11:0914
her?

11:08:5618

11:11:1115
A. As needed for breakthrough pain.
Q, When you met with her on September 26 11:11:1616
ll;ll:2117
of 2003, did the two of you depart with an
11:11:2418
understanding that you wou)d contact her over th

11:08:5919

weekend?

11:08:3915

11:08:4816
11: 08: 5017

11:09:0020
11,09: 02 21
11:09:0322
11:09:0723
11:09:0924
l.1'09:1325

A.

11:1112719

No.

11: 11: 30 20

Q. Did you have an understanding as to
11: 11: 34 21
when you would next communicate so that you, a 11: 11: 36 22
the PE, could continue to -- the PA, could
11: l l : 3 9 23
continue to monitor the progress of her titration
11: 11: 4 0 24
of methadone?
11: 11: 41 25
..

'""'

Q. When Mrs. Sclunechel was speaking to
you, was she under the impression that you were a
medical doctor, or a physician 1s assistant, or do
you know?
MR. HALL: Object to the fonn.
Q. (BY MR. COMSTOCK) You may not know.:
what wa$ in her mind, but did she ever reference
you as 11 Dr. Byrnen and those kinds of things?
A. In my presence?

Yes,
She did not reference. me as
nor. Byrne. 11 It was my routine, typica!ly upon
presenting to a patient in an exam roorn, lo
introduce mysetfas HTJ Byrne, physician
asslstant. 11 And I also wear -- wOre a name badge
which also indicated my name as well as my title.
I believe at that time it said "Physician
assistant, <.1th!etic trainer."
Q. {n your experience in taking care of
patients, you know, wherever, and including the
Southern Idaho Pain Jnstitute, th~y often would
Q.
A.

confuse whether or not you were a doctor, would
!hey not?
MR. HIPPLER: Object to the fonn.

MR. HALL: Join.

.. , . "·".-'''·· ·... -., , ..
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Page 82
11, 11: 42 1

11:11:43 2
11:ll:4.5 3

11:11:47 4
.11,11,54 5
11,11,56 6
11:11'59 7
11,12,00 B
11,12,04 9
11: 12, 0610
11, 12: 0811

11:12:0912
ll :12, 1113

11:12:1414
11:12,1715

11 :12: 2016
11:12:2817
11,12,3218
11:12:3419
11:12,3620
11,12,3821
11,12,1022
11:12,4223

11:12:4424
11,12,4925

THE WITNESS: I don't have specific
recollection about Mrs. Schmeche!, but certainly

I've had patients on occasion who would refer to
me as "Doctor/' And when possible1 I would try
and correct them and make sure they understand m
role and duties.
Q. (BY MR. COMSTOCK) Thank you. In thi
note of September 29 of'03, you end it by
saying: "She will continue with this program
until we recheck as scheduled."

A.

Uh-hub.

Page 84
11:14:16 1
11:14:20 2
11,14:22 J
11:14,24 4
11: 14, 27 5

,11:14:45 9

record, though, is it?
A, No,
Q, Let1s turn next to the your office
note of September 30, '03.
A. Okay.
Q. And first of all, let's go to the

i:

11: 14: 47 10

handwritten note on page 5 of tab 1 of Exhibit 1.

-f

11,14:37 6
11:14:40 7
11:14:42 8,

11,

Q. So at that point in time, did she have
a scheduled follow-up appointment?
A. I don't know a specific date, but it
was my intent for her to be seen in follow-up two
weeks from the original vi.sit with Dr. Dille.
Q, As of September 29th, which is Monday,
had you consulted with Dr. Dille?
A. I believe I spoke to Dr. Dille on
Monday,
Q, Before or after you had this
conversation with Mrs, Schmeche!?
A, I don 1t recall specifically.
Q. Under your practice with Dr, Dille,
would you have had the authority to increase her

Mrs, Schmechel s information to him, and he
agreed,
Q. That's not anywhere in the written
1

l.4: 54 ll

11: 14: 57 12

11: 14; 59 13
11: 15: 02 14
11: 15; 04 15
11: 15: 07 16
11: 15: 08 17
11: 15: .1. O 18
11: 15: 13 19
11: 15: 18 20
1:l.: 15: 22 21
11: 15: 25 22
11: 15: 26 23
11: 15: 33 24
11 : 15 : 3 6 2 5

-P

That's your handwriting there, is it not?
A. That's correct.
Q. And would you read that handwriting for 1,
me so that I know what all ls writ!en there,
\
because there's -- in parentheses there1s an
11
crr01J 1 and things of that -A. Right. Essentially [1ve written here,
npatient phone caH, advised methadone, 5 to 10
to 15 milligrams a.m. 1 5, 10, 15 milligrams p.m." -:
And then I made an error1 and so 1 initialed that 1,,
I wrote 11 error,'1 that I had crossed something out
and initialed it.
nDecrease Elavi1 1 mlnimize hydrocodonei
call Monday for any problems. 11
Q. What was the enor?
1

1----------------------,----------------------I
Page 83
Page 85.;
11: 12: 54 1
11: 12: 59 2
11:13,02 3
ll: 13: 03 4
11,13:07 S
11,13,12 6
11 :13: 17 7
11 ,13: 21 8

methadone to ten milfjgrams at bedtime, ten
milligrams at daytimet without first consulting

with Dr. Dille9
A. Yes, I would.
Q. Was it Dr. Dille1s practice to come
back and initial chart notes where medication

11:15,39 1
11, 15, 40 2
11:15,45 3
11,15:55 4
11:15:57 5

11'16: 00 6
changes were made to show that he was supervisin, 11:16:03 7

11:13:25 9

your actions and activities?
A. f don 1t have a specific recollection of

11:13:2610

that.

11, 16, 13 10

11: 13: 28 11
11: 1313012

Q. And the reason I ask that question ls,
as I look at 1he chart note for September 29, I
see your inhials on it, and assuming it takes
several days to come back -A. Right.
Q. -- after being typed up 1 you initial
it; but f don 1t see an initial there for
Dr. Dille, Do you see one?

ll:16:1611
11,16,1812

11,13,3413
11:13:3714
11: 13, 3815

11:13 :3816
11,13:4017
11,13,4318

11:13:4419
1.1:13:5420
11:13:5721
11:14:0022
11:14:0423

11, 14: 08 24
11: 14, 13 25

A.

I do not.

Q. How, Mr. Byrne, am 1 to develop an
understanding from this record as to whether or
not Dr. Dille approved of your increase in the
methadone on September 29th of '03?
A. I spoke lo Dr. Dille at an interval
after her initial visit and relayed

11:16:07 8
11:16,10 9

11:16,20 13
11:16:2514
11,16:2615
11:16,2916
11:16:3217
11:16:3618
1,1:16:39 19
11:16,4120
11:16:46 21
11, 16, 48 22
11:16:53 23
11:16,57 24
11:17:0125

A.

I don't specifically remember. I think

maybe I wrote the wrong mifligrams behind it or:,

something. I don't -- I don't recall.
Q, I mean, I can't tell from looking at
this what's been crossed out1 can you?

A.

I don't. It's-milligrams and then my

initials behind that, where I signed, so -- its
5/10/15 ~~ and I may have written -- I dodt know·;:
what I wrote, but it was an error and it was
crossed out, and I initialed -~ wmte llerror'i and
initialed my -~ put my initials there to make
j'.
sure that it was understood that it was an error 1
that I had made in the ~- a clerical error that I
had made there.

When did you make that change?
At the time that I wrote the note.
And how do we know that?
A. Because there's no other date on it
If I would have done it on a differeni time,
Q.
A.
Q.

whjch isn't likely, I would have written a date.
But certain[y once this is written_, I wouldn1t
make a change.
Q. You write here 11 minlmlzc hydrocodone," :

Why that change'/
A. My anticipation with the patient on

22
(208)

345-9611

M

&

M COURT REPORTING SERVICE, INC.

(Pages 82 to 85)
(208)

345-8800

(fax)

·

Page 88

Page 86

11: 17: 03 1
11: 17: 06 2
11:17:11 3
11:17:H 4
11:17:20 5
11:17:25 6
11:17:28

7

11:17:32 B
11:17:37 9
11:17:4110
11:17:44 11
11:17:46 12
11:17:48 13
11:17:50 14
11: l 7; 53 15
11:17:5416

11:17:58 17
11: 18: 02 18
11: 18: 07 19
11:18:08 20
11:18:10 21
11: 18: 14 22
11: 18 :20 23
11:18:23 24
11:18:27 25

long-acting medicine, as the dose increc1ses and
her pain level improves, is that the necessity
for the short-acting medicine for breakthrough
pain is decreased, and so less medication is
needed.

Q. Again, with respect to your typical
practice 1 would it be your testimony that on this
day, September 30th, you wrote the handwritlen
note that we see on page Bates stamp 5, and then
on that same day you dictated the transcribed
note that we see on page 4?
A. Yes.
Q. But it would be several days later that
the transcribed note comes back and you initial
it?
A. Yes.
Q. In the transcribed note, it slmis off,
0
Mrs. Schmechel called in as instructed.n
A. Okay.
Q. And what J don 1t see in the note from
the day before, September 29 1 '03, was that
Mrs. Schrnechcl was instructed to call in; other
limn the line that says '*Follow up sooner if
there are problems." So was Mrs, Schmechel
instructed to call in on September 30th, even in

Page
11:18:30 1

11:18:32 2
11:18:35 3
11:18:39 4
11,18,42 5
11:18:45 6
11:18:49 7
11:18:53 8

11:18:57 9
11, 19, 03 10
11:19:0911
11,19,1512
11:19:2213
11:19:2614

11:19:2815
11:19:3316
11:19:3617
11,19:3618
11,19:3819
11:19:42 20
11:19:44 21
11:19:45 22
11:19:48 23
11:19:52 24

11:19:56 25

·11,19,5B 1
11:20:02 2

11,20,06 3
11: 20: 11 4
.ll: 20: 14 5
11, 20: 15 6
11,20:16 7
11:20:23 8
11,20,30 9
.11,20:3510
11,20:3711
11,20:4112
11 :20:4413
11:20:4714
11: 20: 5515
11:21:0016

11: 21, 0617
11:21,0918
11,21,1219
11: 21, 15 20

11, 21, 16 21.
11,21:1722

11 :21, 1823
11,21,2924
11: 21: 33 25

Yes, it does.
So is this note an indication that
Mrs. Schmechel was taking five more milligrams ir
the p,m. than you had authorized her to the day
previously?
A. You know, I think that she understood
the mode of increase with the methadone and that
certainly with the low starting dose of the
methadone at five mil1igrams, again, a ve1y I
would actually consider probably a low dose of
the methadone at ten milligrams, with t11e
substantial amount of the long-acting opioid
OxyContin that she had been taking prior to that,
that those medicine doses were fine.
Q. Well, if she had 1 on her own. gone up
to one and a half pills or 15 milligrams al
night, that would be consistent, would it no1,
with your handwritten note to her that you gave
her on September 26th?
MR. HALL: Object lo the fonn.
,.
MR. HIPPLER: Join.
Q. (BY MR. COMSTOCK) Conect?
A. Yes. But again, I think it was
understood by the patient the gradual, slow
increase in the medication, that 1he initial
A.

Q,

~w

87

the absence of problems?
A. I oftentimes asked m>1 patients to call
in and check in with me and let me know how they
were doing.
Q. Why did you change the methadone
protocol on September 30th from that which you
had prescribed for her on September 29th?
A. She just seemed to be doing better, was
tolerating the medicine well; and a safe, gradual
increase again ln the methadone to, again> try
and improve her underlying pain complaint and to
reduce the amitriplyline an<l the ::.hort~at:ting
hydrocodone. (Clearing throat) Excuse me.
Q. I'm a little confused, and maybe you
can help me here, but on September 29th you ~~
you wrlte in your dictated, typed note~¥
A. Uh-huh.
Q. ~- she is to go ahead and increase
methadone to ten milligrams at bedtime, ten
milligrams a1 daytime.
A. Okay.
Q. On September 30th your transcribed note
says, 1'She is taking 10 milligrams a.m., 15
milligrams p.m.," and does that reference
methadone?

Page 89

11:22:2716

doses were low intentionally, and that a
significan·t period of time was taken to gradually
increase the dose of the methadone with a good
dosing interval in between the two doses.
Q. What I don 1t understand 1 Mr, Byrne, is
that·- and maybe I'm just thick-headed, but what
l don 1t understand is that you write on September
29th that it's ten milligrams in the morning and
ten milligrams at night, at bedtime, and that
nshe will continue this program until we recheck
as scheduled/ and you1ve testified that that
would be several weeks down the road. And the1 ,:
the next day··
A. I don 1t think I said several weeks down
the road. I said from the day that she was seen
by myself on Friday the 26th, that she would sec

11:22:3117

Dr. Dille In two weeks.

11,22:3218

Q. Right
A. Okay.
Q. I didn 1t mean to misrepresent anything
on that.
A. No prnblem.
Q. My question, though, is that il looked
to me like you were planning, at 1east on
September 29th, that she would slay al l Oand l 0

11,21:37 1
il:21,44 2
11 ,21 :48 3
11:21:51 4
11:21:56 5
11:21:58 6
11:22:01 7
11: 22: 03 8
11,22:08 9

11: 22: 12 10
11:22:1611
11: 22: 1812

11:22:2013
11 ,22 ,2214
11:22:2315

11:22:3219
11,22:3320
1L22:3521
11:22:3522
11:22:3723
11 :22 ,39 24
11:22,4225
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Page 90
11,22,45

l

11,22,49 2
11:22,52 3
11:22:54

4

11:22:57

5

11,23:0l

6

11,23,04 7
11:23,07 8
11,23,12

9

11:23:1510
11:23:2111
11,23,29 12

11, 23, 33 l3

mil Iigrams, and then on September 30th you 1re

11:25:56 l

telling her to go ahead and up it to 15 and 15,
if she chooses?
A. Again, the patient was tolerating the
medication well; her pain was improving; there
was no other, you know, concerns about the
medicine at that point; and she understood how
the medicine worked and our intent in the dosing
schedule. She was doing well,
Q. Again, with respect to your
conversations with Mrs. Schmcchel 1 was lt ever
reported W you by Mrs. Schmeche! that she was
having cdcrna in her legs and pain in her legs?

11:25:59 2
11:26:02 3
l:l.:26:04 4
11:26:07 5
11:26:10 6
11:26:13 7
11:26:J.8 8
11:26:20 9
11:26,2510

l.l, 26, 3111
ll,26,4012
ll:26:50J.3

11,24,13 23

11:26 ,5314
No.
11:26:5615
ls h your testimony that you never
11: 27: 00 16
talked to her on Sunday the 28th?
11 ,27, 0217
A. I did not.
11:27:0618
Q. After talking with Mrs. Schmechel on
September 30th of 2003, did you speak with her 11, 27, 1219
11:27,1420
again?
11:27:1721
A. No, I did not.
11:27,2022
Q. In talking with her on September 30th
11:27:2623
of 2003, is it fair to say that you had given her

11:24:18 24

the authority to take up to 30 milligrams of

11:27:2824

ll:24:2125

methadone in a given 24Nhour period?

11:27 :3125

11:23,4014
11:23.:4415

11,23:4616
11:23:50 17
11,24,00 18
11:24,02 19
11:24:07 20
11,24,07 21

11, 24, 11 22

A.

Q.

Q, Having done so, do you have an
understanding as to wha~ the cause of her death
was?
A. 1n reading the autopsy report, it was
alleged that lt was combined
methadone/hydrocodone poisoning, l believe, was

how it was -- it was inte:rpreted.
Q. Do you have any reason to disagree with
that finding?
A. rm not a forensic pathologist or a
toxicologist. I don 1t have specific information
as to what her cause of death was.
Q. From your review of thal document and

from your dealing with Mrs. Schmechel) do you
have an opinion, one way or the other~ over
whether or not Mrs. Schmechel had been following·;
your instructions with respect to the taking of
methadone?
A. I feel like she was following my
instructions in the dosing of methadone.
Q, How about with respect to the taking of
the hydrocodone?
A. I'm not sure that she was following my
instruc1ions in reference to the hydrocodone.
Q. And why do you say that, Mr. Byrne?

Page 91

11:2~:1311

A. Yes. It also indicates in the note
that on -· on the handwritten note on the 30th,
that !:'\he could call Monday if there was any
problems. She also understood that she could
call at any time if she had any concerns.
Q. And I had one question about that, that
writing, "CaU Monday for any problems." We know
from the calendar that September 30th was a
Tuesday, and that this handwritten note refers to
September 30 as Tuesday, and then at the end of
that note it says, "Ca!) Monday for any

11: 25: 15 12

problems."

11:24:21 l

11:24:37 2
11:24:40 3
11:24:45 4
11:24:50 5
11:24:52 6

11:24:56 7
11:24:59 8
11:25:05 9

11:25;1010

11: 25:

11: 25; 19 14

11:25:2115
ll:25;2416
11:25:2517
11!25:2818
11:25:3119
11:25:3520

11:25:3921

11:25:44 22
11:25:4623

11:25:5224

11:25:5325

....

11,27,34 l
11,27,37 2
11,27,41 3
11:27:42 4
11,27:44 5
11,27,47 G
11:27:50 7
11,27:52 B
11,27,54 9

11: 27: 57 10
11: 28: 00 11

A. The·· I would have to •• can l look at
that record as well? Do we have that?
Q. You know, I didn't bring that with me
here today) Mr. Byrne.
A. I would probably need to read that and
review it in order to answer that question.
Q. But when you did read it, there was
something about the information contained in
there that caused you to wonder whether or not
Mrs. Schmechel had followed your instructions
relative to the hydrocodone?

11, 28: 0112

What was the significance of Monday?

16 13

Page 93

Was there going to be a vacation that you were
going to have and you weren't going to be back
until Monday? Or. , .
A. No specific significance. !n
communicating with Mrs. Schmechel from the onset,
she understood that we were always accessible and
iha1 she could call us with problems jf

necessary.
Q. At any point in time, hllve you reviewed

the iiutopsy report with respect to
Mrs. Schmechet 1s death?
A. Ycs, I have.

11: 28: 10 13
11:28:1214
11,28:1515
11,28,1816
11:28,2217

J: 1 : 2 8 : 2 5 18
11 :28, 2919
11,28,3120
11:28:3521
11:28:3922
11:28:43 23
11,28,4724
11:28,5025

A.

No, I wouldn't say that.

What was it, if you can recall, that
causes you to wonder about that? Just in
general? Was it the pi!! count? Was it the
level of toxicity found in her blood?
A. Just -- though I don't have a complete
recollection of the report, as it's been some
time that l reviewed it, I did note lhat the
levels -- on the toxicology report, the level of
methadone was within therapeutic range and the ;.
level of hydrocodone wus ul or -- at the higher
end of thernpeutic range or higher.
Q. Did you attempt to break down the
investigation) the coronets report, the autopsy
. ,.,•........ ,, .. ,., ..... ' ..,...,.,,"''''""·''''' .··,_., ...,,,.
Q.

24
(208)

345-9611

M

&

M COURT REPORTING SERVICE,

INC.

(Pages 90 to 93)
(208)

345-8800

(fax)

1.

.f.

C "/
)

1

Page 94
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11:28:57 2
11:29:00 3
11:29:02 4
11:29:18 5
11:29:25 6
11:29:27 7
11:29:29 8
11:29:31 9
11: 29: 3310
11:29:3411
11:29,3712
11:29:3913
11:29:4414
11:29:4815
11:29:4916

11, 29: 5817
18
11:30,1319
11:30:1420
11:30:1921
11:30:2122

11: 30: 26 23
11:30:3324
11:30:3625

report, in tem1s of calculating the number of
pills that she had been taking? At any point··
A. I did not.
Q. -- in time? I1m going to hand you what
I've marked as Exhibit No. 3, and I'll represent
to you that this comes from the Idaho
Administrative Code, and its the Rules for
Li censure of Physician Assistants.
A. Okay.
Q, Have you ever seen this document
before?
A. I believe) when I applied for a license
in the state of Idaho, this was part of the -the packet that I received, yes.
MR. HIPPLER: Do you have a copy there,
Counsel 1 for me?
MR. COMSTOCK: (Handing document to
Mr. Hippler.)
Q. (BY MR. COMSTOCK) ln terms of your
practice as a PA within the state ofldaho, at
various points in time did you ~- were you called
upon to study the Rules for Licensure of
Physician Assistants?
A. Was I called upon to review the rules
of --

Page 96
11:31:47 1
11:31'51 2

11:31:52 3
11:31:55 4
11: 31: 56 5
11:31:59 6
11:32:04 7
11:32:07 8
11:32:08 9
11:32:1110
11:35:4511
11: 35: 4812
11:35:5013
11:35:5314
ll.:35:5715
11:36:0016
·11: 36: 0417
11:36:0718

11:36:1019
11:36:1620
11:36:1921
11:36:2222
11,36:2523
11: 36: 2924
11:36:3325

document is '04 or 03.
THE WITNESS: Can you repeat the
question or can she read it back, please?
MR. COMSTOCK: I think what we'll do at \
this point in time is 1 since I've been advised by
;.
the videographer that we need to change the tape,
we 1ll take a short recess and change the tape.
THE VIDEOGRAPHER, This is the end of
Tape No, I; off the record.
(Recess held.)
THE VIDEOGRAPHER: On the record.
Q. (BY MR. COMSTOCK) Mr. Byrne, I'm no .
directing this question -- and we are back on the
record, having changed the videographer1s tape,
This question is not directed to the Rules for
Licensure that I had you look at. Frankly, I'm
not sure if those are 2004 or 2003 rnles.
The question, though, is stilt before
you, and that is, as of September of 2003, was it
your understanding, as a PA practicing in the
states of Idaho, that you needed to do so under a
written agreement with the physician who was
providing the supervision?
A. I believe there was documentation that
was provided to the State Board of Medicine1 as
1

Page 97

Page 9S
11;30:37 1
11:30:39 2
11 :30 :40 3

11:30:41

4

11:30,48 5
11:30,51 6
11:30:54 7
11:30:59 8
11:31:04 9
11:31:1010
11:31:1111
11:31:1312
11:31:1413
11:31:1714

11:3).:2115
11:31,2216
11'31,24 17
11:31:2718

ll.:31:2919
11;31:33 20
11:31:34 21
11:31:38 22
11:31,4123
11:31:43 24
11:31:4.525

Q, Yeah; did you ever study these at any
point in lime?
A. I believe J reviewed them a.t ~" at some
poinl1 yes.
Q. With respect to practicing as a PA in
the state of Idaho under the supervision of a
physician in September of 2003, was it your
impression that there needed to be a written
agreement between you, as the PA, and the
supervising physician in order for your Hcense
to be effective?
MR. HIPPLER: Are you refen-ing to the
provisions that have a 2004 date next lo them,
Mr. Comstock?
MR. COMSTOCK: 1 haven't represented
one thing or the other, Mr. Hippler, with respect
to the exhibit. I've got a question pending in
front of the Witness that deals specifically with
his understanding in September of 103.
MR, HIPPLER: I'll object to the extent
i1 cal Is for anything which relale -~ relates to
the document not in effect in 2003,
MR. COMSTOCK: The question didn't call
for him to relate it to the document, and the
reason 1asked that was, I don't know whether the

11:36:37 1
11:36:41 2
11:36:46 3
11:36:50 4
11:36:54 5
11:36:57 6
11:36:59 7
11:37:05 8
11:37:09 9
11:37:1310
11, 37: 1511
11'3'/,:;012
11:37:2313
11:37:2514
11:37:2715
16
11:37:2817
11:37:2918
11:37:3119
ll.:37:3220
11,37:3521

11:37 :39 22
11: 37: 45 23
11: 37 :48 24
11: 37: 5125

required by them1 for that working relationship
between the physician assistant and the
supervising physician.
Q. As you recall those documents -- and
whether the Board of Medicine will give us those,
documents or not~ I don 1t know -- but as you
\
recall them; do they get so specific as ro define
when Dr, Dille has to approve the actions that
you 1re taking on behalf of a patlent?
In other words, can Dr. Dille come back
in a week later and simply sign off on a chart1
or is there something that would define how soon:
after your decisions he needs to review that?
MR. HALL: Object to the fonm of the
question.
MR. HIPPLER: Join.
MR. COMSTOCK: It's a poor question,
but it's still a good one,
THE WITNESS: Again, I don't have a
specific recollection of the fonn or the
documentation, but to my recollection, there was
a section that tatked about the physician
ovc:rsccing the physician assistant and chart
review and such. And that's -- I don1t have a
speci fie rec aII there.
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11:38:09 5
11.:38:13 6
11:38:16 7
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11: 38: 24 9
11:38:2510

11:38:2811
11:38:3012
ll:38;3413

11:38:3714
11:38:3915
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Q, (BY MR. COMSTOCK} Y m1 1ve told me that 11: 40 : 59 1
you remember visiting with Dr. Dille about
11: 41: 02 2

cei1ainly had other medical problems and some

Rosalie Schmcchel on that Monday, although
there's nothing in the chart which would indicate
that happening. Did you talk with Rosalie -with Dr. Dille about Rosalie Schmechel on Tuesday
when you changed the medication up to as much as
15 rnil!igrams twice per day?
A. I don't have a recollection ofa

3

could have caused problems, but l don't have any

4

information-" other infonnation in reference to
that.
Q. What were those other issues?
A. She had high blood pressure; she was a
smoker.
Q, Anything else?
A. I think that the recm·d indicates i1er
past medical history.
MR. COMSTOCK: Cnn f have this marked
as the next exhibit in !ine? What arc we up to,

conversation on Tuesday.
Q, So in terms of Rosalie Schmechd and
conversations you had with Dr. Dille about this
patient, you recall one conversalion and that
conversation occurring on the Monday following
her initial presentation to the client?

11:38:5418

To the best ofmy recollection, yes.
Q. Did you dictate the letter, tha1 ls
contained in the record marked as Exhibit l, to

11:38:5919

Dr. Harris?

11:38:5217

11:39:0020
11:39:0421

11:39: 10 22
11;39:1123

11:39:1224

11:39:1525
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A,

A.
Q.

Yes.

And thal letter is at page 13 tinder

tab 5?

A. Yes.
Q. Would that have been diclation that you
did on September 26th, or sometime thereafter?

11: 41: 07
11: 41: 11
11 : 41: 14
11, 41: 15
11: 41: 18

s
6
7

11:41:20 8

11:41:23 9
11:41:25 10
11:41:2711
11:41:3312
11:4:l.t34 13
11:41:3614
11:41:4615
11:41:50 16
11:41:5117
ll:41:5218

11 :41: 55 19
ll:4L57 20
11: 42: oo 21

other health issues that, I guess, potentially

6?
COURT REPORTER: Yes.
(Exhibit 6 marked.)
Q. (BY MR. COMSTOCK) !'ve handed you what i
we've marked as Exhibit No. 6. Ts that a copy of
yout· Curriculum Vitae whk:h you provided to
Mr. H~!l, which has now beenprnvided tome?

A.

11:42:0122

Q.

11 :42: 02 23
11: 4 2: 04 24
11: 42 : 06 2 s

Q.

A.

Yes, it is.
Isthatcurrent?
Yes, it is.
Are there any additions, changes, or

deletions that you believe would be necessary-to

Page 99
2

A. This letter would have been dictated at
the same time or just after I finished the-~ the

3

other dictation, the history and physical

4

examination.
Q, Now, the date on the letter is

11,39,19 1
11:39:21
11:39:28
11:39:30
n,39,32
11,39:34
11:39,38

s

~age 101

11:42:08
11:42,09
11:42:18
11:42:32
11:42:41
11:42:47

1

make it accurate?

2

A. There actually is. From probably -['
for about two months in between January alld March~
or April of'05 1 I worked fill-in at a local
t
family practice clinic in Spokane. lt1s actually
a-· Community Health Association of Spokane ls

3
4

5
6

6

September 26th, and so my obvious question is,

7

you know, was this transcribed and prepared for
your signature by September 26th, or was it
likely sometime later?
A The dictation was, in fact, September
26th, which is indicated. I would say that the
transcription was subsequent to that..
Q. Even though the letter bears the date
of September 26?
A. That's when it was dictated, yes.
Q, Have you formed an opinion -- and I'll

11:42:50 7

Schmeche!?
A. No.
Q. Do you think she died from something
other than methadone and hydrocodone toxicity?

11:43:3319

11:39:43 8
11:39,46 9
11:39,4810
11:39:5111
11,39,5512
11,39:5913
11,40,0114
11:40:0315
11: 40: 20 16
11:40:2317
11:40:2618
11:40:3119
11:40:32 20
11:40:3621
11:40:38 22
11:40:46 23
11:40:4024
11,40,5425

11:42:52 8
11:4.2:58 9
11:43:0110
11:43:0711
11:43:0912
11:43:1013
11!43:1214
11:43:1615
11:43,1816
object to my own question. Have you formed an 11:43:2617
11:43:301.8
opinion relative lo what killed Rosalie

A. As I sit hcrc1 I guess I don 1t have the
information that I would need to accurately
respond to that question. Mrs. Schmechel

11:43:3620

11: 43: 38 21
11 : 4 3 : 4 3 22
11: 13: 4 s 23
11: 43: 52 24
11: 43: 54 25

the name of this facility. It provides health
care for indigent people within the community,
people that don't have health insurance. And
that's -- that's not on here. And Jim not sure
why, but it's not.
Q. Any other additions, corrections, or
deletions?
A J'll just take a second to review it.

Q. Sure.
A. (Reviewing document.) My ldaho license
is designated as an inactive \icense 1 but I do
have a license within the state of Idaho as a
physician assistant. lt1s just an inactive
license because l don't have a supervising
physician in the state of Idaho. And the same

would ho!d for rny athk:fo; trainer registrntion,
as I don'! have !I supervising physician in the
state of Idaho,
So those are both essentially inactive,
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11:44:02 2

11: 44: 11 3
11:44:15 4
11:44::19 5
11:44:22 6
11:44:25 7
11:44:28 8
11:44:31 9
J.l, 44: 3510

11:44:3611
11:44:3812
11:44:4113
11:44:4314
11,44:4815
11:44:5216
11:44:5917

11:45:0318
11: 45: 1119
11:45:1720
11:45:2121
11:45:2322
11,45:2623
11:45:2724
11,45:30 25

though I do have those licenses,
Q. Other than the lawsuit involving
Mrs. Wil!iams 1 husband and this particular
lawsuit, have you been named as a defendant in
any other cases that would relate to medical -provision of medical care and services?
A, Not to my recollection.
Q. Have you ever had your license as a PA
investigated, suspended, or revoked at any point
in time?
A. No, sir.
Q. Other than teslifying here for this
deposition and testifying for a deposition in
that Williams case, have you testified, eithei· by
deposition or in a court of law, relative to
provision of medical care and services?
A. Yes, There were two other occasions
where I was called as a witness in the
prosecution of two criminal cases, and that's the
only time that I've ever been in a courtroom,
And I dontt believe at that point that I gave a
deposition, l was just-~ I was called to
testify.
Q. Okay, and l won't go into that. Those
are criminal matters that probably relate to a

Page
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11:45:56 8
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11:46:0110
11 :46: 0411
11:46:0912
11:46, 13 l.3
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11:46:2015
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11:46:4621
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with him in reference to Mrs. Schmechel and the
changes that I made to her treatment plan.
Q. When did you firsl learn, if you
remember~ that Mrs. Schmeche! had passed away?
A. I think it was on or about October 3rd.
Q, So it was shortly after her death,
which was recorded as being October 2nd; correct?.'.
A. I believe those were the dates, yes.
Q. Who di{l you learn from?
A. I believe I was told by Christy Davies,
our office administrator,
Q. Di<I you then talk to Dr. Dille?
A. I think at some point in time we did
'
talk, yes.
Q, When did you talk to Dr, Dille?
A. I don 1t have a recollection of the
specific date or time,
Q, Where were the two of you when this
conversation took place?
A, We were in our office.
Q, And did you talk about Rosalie
Schmeche! and the care thal was provided to her?
A, I believe we had a discussion, yes.
Q. What did you talk about?
A. I don 1t have a specific recollection of

Page

103

patient and what happened with a patient, I'm
assuming; correct?
A. They were related to -- one was to a
patient that falsified information in a work comp
isst1e, and the other was a-~ actually a
vehicular manslaughter case when -- I was working
in an emergency room when this event took place.
Q. Any other testimony that you've given 1
either by way of deposition or in a court of law?
A. Not that I can recall at this time.
Q, Have you ever been asked by a law firm
thal Joes work, 8l!Ch as my firm does from time to
time, to review the conduct and activities and
services of another PA to determine whether or
nol that PA met the standard of care?
A. No.
Q. Have you talked wilh any of the
Schmechel family since Rosalie Schmeche!1s death~
A. No, I have not.
Q. Have you told me all of the
conversation that you had with Dr. Dlflc relative
to Mrs. Schmechc!?
A, 1 believe I indicated that I didn 1t
recall word for word the conversation, but that I
did indicate to you that I had had a conversation

11:48:12 1
11:48:16 2
11:48:18 3
11:48:21 4
11:48:25 5
U:48,26 6
11:48:29 7
11,48:33 8
11:48:36 9
11:48:4010
11:48:4211
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11: 48: 4913
11:48:5114
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11:49:0922
11:49:1223
11:49:1424
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the conversation. And part of the conversation
may have been, you know, that she had passed
away. And that was about it, because I didn't
really have any other information available at
that time, nor did he,
Q. At that time was it known to either of
the two of you that Rosalie Schmechel had died,
according to the autopsy report, from methadone
and hydrocodone toxicity?
A. No,
Q. When you talked with Dr. Dille, was
there any concern ofyourS relative to whether or
not she had died because of the provision of
medical care that you had provided to her?
MR. HALL: Object to the fonn.
MR. HIPPLER: Join.
TI-IE WITNESS: You know, my -- details
of the conversation, I don1t recall. It was just
basically that we had had a patient that I had
seen and_ that she had passed away and I didn't
have any other information at that point in time,
and that was really the extent of it.
Q. (BY MR COMSTOCK) Were any of the
chart notes that I had you go through, both
handwiilten and dictated and then transcribed 1
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2

signed by you after Rosalie Schmechef s death?
A. That's possible, I1m not sure when the

3

-- what the time frame was for those documents t< 11,51:50 3

4

come back from the transcriptionist and the date

5
6
7

11:51:56 5
of her -- of her death,
11:51:58 6
Q. Who was providing the transcription
services, if you know? I mean, as the PAyou ma 11,52:02 7
11:52,04 8
not have any idea of the --

1

8

9
ll:50;0110
11, 50, 0311
11,50:0812
lJ.,50,0813
11:50,0914
ll:50:1015
11:50,1116
11: 50: 13 17

11:50,1518
11: 50: 1719
11:50:1920
11:50:2221
11'50:2922
11:50:3123
11:50,3324
11,50:3625

1

11: 51: 45 1
11:51:47 2
11:51:54 4

r don't have any idea.

11:52:04 9
Q, Okay, Were you interviewed by anybody 11:52:0610
11: 52: 07 J.1.
from the coroner1s office relative to
11:52,1012
Mrs. Schmechel death?
11:52:1213
A. No.
11: 52: l.614
Q. interviewed by anybody from the
11:52:2015
sheriffs office?
11,52:2416
A, No.
11: 52 :2617
Q. Did anybody come and talk to you
11:52:3118
relative to investigating the cause of Rosalie
11:52.3419
Schmeche!1s death?
'.J.l.: 52: 35 20
A. No.
11:52:3821
Q. Other than talking with Dr. Dille, did
11:52,4022
you speak with anybody else about Rosalie
Schmechc! and the care and provision of medical 11:52:4423
11:52:4724
services you had given to her?
11, 52, 50 25
A. Not to my recollection.

A.

hydrocodone?

A

I reviewed the-· the documentation.
Okay, And that's how you learned?
A. Yes.
Q, After you reviewed that documentation,
did you do anything to investigate the matter
further yourself?
Q.

A. No,
Q. Did you go back to the chart and review
the chart again?
A. I have reviewed the chart subsequently,

Q. And that's a bad question. I meant as
a result of your reviewing the autopsy as opposed:

to trying to get ready for this deposition,
A. l don't recall specifically; l'm sorry.
Q. Other than the attorneys involved in
representing you 1n this matter, have you
discussed the alleged cause of Rosalie
Schmechel's death with anybody?
A. No,
Q. Rave you had any conversation with
Dr, Dille regarding the cause of her death after
you learned that it was being linked to methadon

and hydrocodone?
A. l don't recall specifically.
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Q. When did you learn that the cause of
her death was being linked to methadone and
hydrocodone?
MR. HALL: Object to the form.
THE WITNESS: l don't have a specific
recollection of that date.
Q, (BY MR. COMSTOCK) Was it -- if you
remember, was it before or as a result of the
filing ofa petition for prelitigation screening

in these matters?
A. Could you restate that for me --

Q,

Sure.
A. -- or repeflt that?
Q, What l really want to know is whether

Page 109 ,

11:52:54 1
11:52:55 2
11:52:58 3
11:53,02 4
11:53:04 5

Mr. Byrne, you did learn that -- that the death
was being allegedly linked to methadone and

THE WITNESS: Okay,
MR, COMSTOCK: We can either have these

11:53:09 8

gentlemen ask questions tf they choose to do so
while I do that, or we can go off the record

11:53:11 9

briefly,

11:53:06 7

Whatis your pleasure, gentlemen?
MR. HIPPLER: We'll go off the record,

11:53:1310
11:53:1511
11:53:1613

l guess,
MR. HALL: We'll just go off the

11:53:1714

record,

11:53:1612

linked to methadone and hydrocodone before the 11:55:4817
11:55:5718
point in time when 1 you know, this litigation
11:55:5819
process sta1ted and the prclitigation was filed.

-w

to take just a moment to go through my notes and
~- but l do think Pm done.

11:53:05 6

you learned from some source in the Twin Falls 11:53:2015
community that the cause of her death was being 11:53:2116

A. Again, I don'l haven specific
recollection of that sequence of events or the
time the time lherc,
Q. At some point in time, though>

MR. COMSTOCK: I believe those are all
the questions I have. At this point I would like

11:56:0020

11: 56: 03 23.
11:56:0722

11:56:1023
11:56;1324
1l :56: 14 25

Tl-IE V!DEOGRAPHER: Offlhe record.
(Recess held.)
THE VJDEOGRAPI-IER: On the record.
Q, (BY MR. COMSTOCK) The last questions r;
have for you relate to a kind of just
administrative matter, and it involves questions
of insurance, Did you have a policy ofinsurance
tha! covered you for your provision of medical
care and services ln effect at the time you were
treating Rosalie Schmeche!?
A. Yes,

28
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Page 112

Page 110

And to your understanding, is that

Q,

11:56:16 1

one which covers the clinic itself? Or do you

11:56:27 4

know'?

11:56:4811

A I believe it is independent, yes. res
a policy under my name,
Q, As l review the care that you provided
Rosalie Schmechel, it would look to me as thoug
~ . . and this is more lawyerly w- that everything
you did was within the scope and course of your
nonna! duties as a PA working for Dr. Dille and

11: 56: 5212

the institute, Can you think of anything that

l1: 56: 5513

11:57:0517

you might have done, relative lo Rosalie
Schmechcl, that would fa!! outside the nomrnl
realm of your duties that you would provide to
any patient?
A No, sir.

11:57:0818

MR COMSTOCK: Okay, Those are all

11:56:27 5

11:56:31 6
11:56:35 7
11:56:39 8
11:56:43 9
11:56:4-610

11:56:5714
11:57:0115
11:57:0316

11:57:0819

time.

MR. HALL: I have no questions.
TI1E VlDEOGRAPHER: Off the record.
(Deposition concluded at 11 :57 a.m.)
(Signature requested.)
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1

2

REPORTER'S CERTJFICATE
l, EMILY L. NORD, CSR No. 695,

,

3
4

Certified Shorthand Reporter, certify;
That the foregoing proceedings were

5

taken before me at the time and place therein set
forth, at which time tile witness was put under
oath by me;

6
7

8
9

That the testimony and an objections

'

made were recorded stenographically by me and were ·'.

10

thereafter transc1ibed by me, or under my direction;

11

That the foregoing is a true and correct
record of all testimony given, to the best ofmy

12

15
16

ability;
I further certify that I am not a
relative or employee of any attorney or party,
nor am I financially interested in the action,

:

IN WITNESS WHEREOF, I set my hand and
seal this _ _ day of May, 2006.

19
20
21
22
23
24
25

EMILY L. NORD, CSR, RPR
Notary P11blic
P.O. Box 2636
Boise, Idaho 83701-2636

..

"

My Commission expires November 5, 20 ! !,
. ...,,..... .. _..,, ..., ,., ......,., . ..... _,,,.,., •..
..............,...... ,., .... "'.. ,..
' • """'"'''"'" ,,-,vA,-,
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CERTIFICATE OP WITNESS
I, THOMAS J, BYRNE, P.A., being first duly
sworn, depose and say:
That l am the witness named in the foregoing
deposition, consisting of pages ! througli l IO;
that I have read said deposition and know the
contents thereof; that the questions conrnined
therein were propounded to me; and that the
answers contained therein are true and correct,
except for any changes that l may have listed on
the Change Sheet attached hereto,
DATED this _ _ day of
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MR. HIPPLER: No questions at this
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o'<.>uthern Ida.ho Pain & Rehabilitation Institute
Climon L. Dille, M.D.
Michael f;(. Schabacker, M.D.

236 Martin Street
TWIii Falls, ID 83301
2()8,733-3181 ph
208-733-3)/iQfax

Provider contract
As of the date of:

/

It

I 1/ IO /

,

2001, this contract wlll become effective.
J
The Plrysician Assistant, Thomas J. Byrne hereafter to be known as employee will be entering into a provider agreement
with the Southern Idaho Pain & Rehabilitation hlstitute hereafter to be known as employer.
SALARY:
1:he employee will be paid on an holll']y basis of $45.00 per hour. After January l, 2002, the employer
guarantees at least 3:t hours per week. Prior to that date, the eniployee will be paid on a per diem basis, Aftirr 90 days of
full time employment the employer and employee w!l) review hourly salary and performance at that time and consider a
possible monthly salary or changes i11 rate of hourly salary.
HEALTH INSURANCE BENEFfTS: On January l, 2001, the employee and family will be eligible for lrealth insuraitce
benefits, The appropriate fo1ms must be filled out by the employee in order for the employer to apply for said insurance.
A medical savings account will be set up ln the employee's name for the patient to use for medical expenses relating to
non-covered health bendits, vision, dental etc. The amount placed in the account will be 75% ofthe maximum deductible
for the family.
RETIREMENT BENEFrfS: Toe employee is eligible for retirement benefits after 1000 hours of employmet,t. The
accounts are set up on January!" annually. The employer contributes the maximum amount for this. The employee is also

free to set up payroll deduction accounts and other investment plans on his own. The emph:,ye:e is eligible at any time
during his employment to discuss investment options with our financial counselor as a benefit to the company,
VACATION: The employee is eligible,.for 2 weeks (80 hrs) of vacation time within the 1" year of employment. This time
will not be rolled over into the next year unless previous arrangements have lleen made, Thfo will be reviewed annually
for negotiation of more time.
SICK SALARY: The employee is elisfble for 1 week (40 hrs) of sick time. Further time for surgeries, or extended
illnesses will be reviewed on an individual basis. Notice for sick time needs to be as quickly as possible to arrange for
coverage,
PROFESSIONAL FEES: The employer is responsibfo to pay annual dues for malpractice insrn·atice, NATA dues, lditlto
license and any Physician assistant licenses.
MEDICAL EDUCATION: The employer highly recommends to the employee to remain current on changes in medicine.
If a conference or education seminar comes up that the employer or employee wishes to attend, it will reviewed on a case
by case basis for funding, time scheduling etc,
By signing this contract, I agree to the above statements, with the understanding that this contract will be revfowed on
April 1, 2002.

/9-01
Date

EXHIBIT

Southern Jdaho Pain & Rehabilitation Institute
Clinton L. Dille~ M.f).
236 Martin Street*496 Shoup Ave E
Twin Falls, fl) 83301
208-733-3181 ph
208-733-3168/ax
August 28. 2001

JOB DESCRJPTION FOR PHYSICIAN ASSISTANT (PA) SERVICES
IN1TTAL EVALUATION
The physician assistant employed with Southern Idaho Pain Institute will be utilized in
the initial evaluation for patients seen in this facility. Tbese patients stem from a
physician referral b3se and also patient self referrals. They wlll require a full history and
physical on it1itial visit and will be documented with appropriate findings and
recommehdations. This wiJl include the ordering of appropriate tests and prescribing of
tnedication8. These results will be reviewed by the supervising physician to determine
and confirm findings and form a treatment plan for the patiei1t ·
·
RE-EVALUATION

The PA will be utilized in the re-evaluation of existing 'patients for medication
management & renewal and recommendations. for further treatment within our facility.
The PA will perform appropriat<' system exams based on the patient's chief complaint.
Upon this exam, the physician assistant will recommend the type of therapy and/ot
procedure that the supervising physician will review and perfomi.
SURGICAL ASSlSTANT
The physician assistant wiH assist the supervising physician with cases presented in our
surgery center. These cases will include but are not limited to, epidural procedures under
fluoroscopy, epidurograms, discograms, stellate ganglion blocks, lumbar sympathetic
block$ and Medtronic intrathecal trials. The ,,upervising physician will train (he PA to
assist him on aII of the above procedures.
MINOR PROCEDURES
The PA wil! perform several small office based procedures based on the medical findings
on clinka! exam within this facility, These include, but are not limited to; trigger point
injections, small joint injections, occipital injections, and manipulations,

DELEGATION OF SERVICES AGREEMENT
DEUiGATION OF 81::IWICES AGREiM.eNT
A t>e!egatlo11 of S$rvlcet Agrc,omont ia to be maintained at eael) prai::tlce site 1 at the addreati ot record of the
supi,rvlsin9 pllya!olan and at the BMrd of Medicine. The Dol&gation ·of Sel'\llce$ Agreement j3 o written doo~nt
mutueUy agr~&d upon and -aigned end datsd by the physic!an aiutistant end supervislnt, phyi,:Jclan that lists the
physician assiatal'lt' o training, experience and education and. definoe the working relationship ~nd deleg~tlon of
duties batweel'l. tho supervising physician and the physician -~~l:£lt1mt att flpeoifiad bV BQard rule. 'rh& Board at

Medinine will review the written Delegation of Servlcas Agrqement end may review job de90rlptlori.s_ polii::y
statement$, or other dooumanta that define tht1 fl)sp0Mlbllltl1;ts of the physician as.')iatent !n thi, practlo& setting,
and may re~uira st.ioh changes as needed to aohiave oomp!ianca With thane rules and to safeguard th& public.
The following mutt be b;glbl&, Uso ~ddltl6~al ihosb if neca111!1ry. SUBMIT YOUR DELEGATION OF SERVICE$
AGREEMENT TO THE BOARD WITH YOUR APPLICA'rloN Fon LICEN8URE AND WffH ANY CHANGE IN PRACTICE
OR SUPSAVISION.

Phy.$iclan Assistant N.ame;_ _-+~~-..:....s,;---.,,__,__..;,....,,_"*~:.--"":,,,,...:r;..,_.._..,_.L......_ _ _ _ _ _ _~
Supervising Physician Name:~-~c::.,....;;...;...---'-.c;-"---,~'--..---"'-"--c;;-.G-.w;........:_--;.-_,_,.;~----,__.-Altemate Suparvising Physiclan(t} Nam a (s):_--'~~...2:..-u...,,.._...£....._:.,..r.--=~.=::::...,..L.c..~%..---...:/M
__•....:0:::..:...,_ __

:::·.~1 ;;-/4_JJJ

PRACTICE Slit:(S):

l

I
1·

l
!?.~30L
2, Name of Feoitlty:_ _ _ _ _ _ _ _ _ _..,..__ _,____,;..__ _. . ; . _ _ , _ ~ - · - - - - - - - - - - . · ·~ddre.ss: _ _ _ _ _ _~ - - ~ - - - - - - - - - ~ - - - ~ - - - - ~ - - ~ - - - ~ -
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THE FOI.LOWINS CQRE CQMPETl:NCY MEPICAL AND SURGICAL SEr!tVtCE$ ARI; APPROVeD FOR ALL IDAHO

rna

UCENSED PHYSICIAN ASSISTANTS.
supervising phy$lotan may ra.qvest Board ravtaw and approval of
speolatized procedures not Jiste\';I ln the core oornpatenr.:ies by cQmpfetln9 Form 6 Page 5,

.
"

Administration of medications
Anoscopy

•

•

•

•
"
•
•

•

•
•

•
•

Rw4/04

.

. .,

Apply/remove casts & splints
Ass:iit in ottic0 procedures & surgt'lfY
Assist in surgery
SladdEir catht:iterlzatton

•

Advanced Cardlao Llfe Support

•

CL!A waived lab prncedures
cc;insultation with ref erra-1 to approprie.t~
health car!,'! resources
Di~therrny/Ulttasound
Fulguration/cryQtherapy superficial lesions
Ganglion cyst aspiration
Incision & Drainagll
lngrow11 toenail removal

"'ii

Non-ablative la$&r procedures
Joint l~3eot\ons/aspiration
Laceration r-epalr tmd management
Local anesthesia including digital block
Menagern-0nt of slmpla frectures exeluding
rnd1.1ctions

•

•

•

•
•

•
•

Naso9astria tube insartion and removal

Order durabfa medical equipment
Perform pulmonary function te:it
Skin cir .subcutaneous excision/biopsy
Superflaial foreign objei;;t rernovaf
Treatment of thrombosa.d hemorrhoids
Vanipunoture
Wound management

form 6 Pag& 1

I
\
I
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DELEGATION OF SERVICES AGREEMENT
PRESCRIPTION AUTHORITY
A physician asslstaot who wishes to apply for prescription writing authority ~hall submft an application for such
purpose to the Board of Medicine.
The drug categories or specifio legend drugs and controlled drugs, Schedul& ll through V that may be prescribed
shall be consistent with the regular preserlptlva practice of the supervising physician,
Grodu11t8 p/Jy/1/clan 11ss1,m1,1ts shall not ba 1111tltkld ta fs11.11& llny pll1k¢ptlo1111.

Please tlst the drug natagorieu of specific legend drugs and oontroll&d drugs that will be prescribed,

.,,,

7i2rc"T /-,:- t'4> ,r.

~f'

~

I

....

Note, Tha phf/$1Clan. Mflstant · wtrh spproll8d prascrfptlv11 authol'lt'I ~om tli<> lfoard of Madfclne r,;r Scheduh) n
through V drug* mwst obtaftt reg1'rt,,.tlon ftom tJw Federal Drug l!nforo11m1111t Adminlatratlan and th11 Jdaht;> lJ"4rd of
Phsrm11cy. Form, and a link to thfl DEA may hs flCCfl!ts11d an tbs Board of Pharmscy',; W/Jbs/tB at

www.accw/dt,ho.w,lbap,
MEDICAL SERVICES REVIEW
Please des¢rlb$ the procedures or protocols for periodic r~view of a representative sample of record& and e periodic
review oi the medical servloe• being provided by the physloian assistant. This review shall also Include an
eva!ua\lon of adharenot1 to the Delegation of Service$ Agreement,

~

~~H+c

~- r1.'

Noto: Graduttti, phy1tlclsn aYslstllnts nro (l)qufrer/ to h•v•
Rev. 4/04

(f

.

WfJ9kly rocord rovfew by their quporvfsfng pbysiman,

DELEGATION OF SERVICE:$ AGREEMENT
ACTIVITY AND LOCATION
Plaase list the specific activities and patian.t service$ whioh will be porformed by the physician assistant and the
·
specific locations and facilities Ii'\ which the physician assistant will funoUon.

::;: e f'

/'f-·?' I- 1 ,/-,,- -t:, ,. ,/.

'

-·-

'
DIRECTION AND CONTROL
Please describe the methods to be used to ensure re$pon$ible direction and. control of the aotMties of the physician
assistant Including an on-site visit at least monthly, regularly soh-,duled conferences between the supervising
physician and the physiolan assistant, and eva!lablllty of the aupervlsing physlolan to tho phy$!Clan a•slstant in
parson by telephone at thl$ practice site,

5

t"'{"

&t:. ""C!.' ,;,..,,,(
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a

Rev. 4/04

Form

Paga 2
r": •·'1
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Dlrection and Control
The methods to be uood to insure responsible dlrection_ aud eontiol of the acliv.ities of the ph)'llioian
assistant whioh ,bllll provide for an on·site visit at l"*'<! monthly, reg,,J,,tly !lbheduled wnlbtences between
!l!e Sltp<n'islng physician and the physician ~ t , and availability oftbe nupervW,,g phyn!Clllll to the
physician a.sistant in person or by telephone,

Please de~Jt:,e how llils will be =mplish«d ut this prac~ll'I ,;ite;
As they physician US6iBlnnl's supervlsing physiclm:! I will be avi!llable for collUUltatfon, guidance, and
s!lpervision on most business days, in my infrequent ahsonces n s«iorulru:y supervising p\zysioian will \,e
11vaill!b!e.
l will pm:forn, at !""81 monthly periodic chart and ca,,: rev!ows, and wm wo!k wlth my phynician assistant
to cstablish m:ld maintain muttwlly ~ upo/1 Jm>CUCO protocols & guidcl1-.

Emergency Procedures
Availablllty of the sui,,ervising physician to the physician 11BSistant Jn pef$0n or hy telephone and
prooeclures for providinf, backup for the physician !ll)$i6lant ln emergency situations.
Plel!Se describe how this wiU l?e accomp!ioblod m; this prn,:,tice am,
When a serJoi,.jy ill or il\iurnl patiellt present to South= l<lltho Pil!n ruJd R,:,J;abililllllon the physician
assistant will mltfate.stabllizixig care lllld malntaltt strict ad.her= to ACLS, ATLS, lllld PALS su\delinell,
Tl:te physician assistant will move e,qieditiow,ly to 1mJ1sfor the= of1he patient to an appropt¼te
physician or physioiatl spocW.ist. A pru:mu:y or secondary phyeicillll will be a\'l>ilol:,\e 2~ hourn per day 1:o
provide consultlltion, smdruloo wd supervision to the pby8ician ru!Sistimt.

Addressing Sitn11tions Ontside the ~cope of Prn11tlce
Procedures for addressing situstioll!! outside the scope of practice o( ihe physlchro assistant.

Please dw:ribe how this will be occomplisbed at this practice aite
Should a situa1lon ()(X)llr tlw is outside the scope ofpmctice for the pb)'lllcliln assisint)t be will i.nlmNiately
contact a pri.ml,zy or secondary supervlsiug ph)'llician for coosuliation, guiUllllce and im,tru,;rtior,. The
patient's care will bo ""JlC(lie,1tly tnmsrerrod to an appropriate ph)l1'idan.

Prescription Authority

A ph;Ysicinn asslstuut who wish<"ll to apply for prewriptio!l mi ting ~uthorlty $hall submit M oppl!catlon for
such purpose to the Board of Medicine.
Tue drug categories or specific legend drugs and contl'Olled drugs, Schedule n throlljlb V !bat will be
p~cribed provided that the legend (hugs and controlled drugs shall be consisoont with the regular
prescrlptiv~ pmct\ce of the supervising physician.
Cl!l'rent p~ribmg privil~os, ,ww inclll!le Schedule 2, 2N, 3, ,N, 4 and S, Thfa ~henge =e after
applicatiQn and '\P!'lOYlll iliroug/,. lb.e l<Ulho B-Oard of Mclicine and Federol Drug Enforoemern
Admi.n.istrntion ~lines.

DEA II M.80480981
Issued 8/14/02
Expires 7/31/05

Delt1g11U1:m of Sertices Ag-ment.
&eh Jioo!ll!ed' physician assfollll:it "'1.ull malntai.tl a .:nrrent copy of 1M Deb,tp,tion of Se,-vloos (006)
Agr.em!l/lt between tlw ph)'llician U!18lstant and each ofhl,; or her•ilpetvilling pby,;iclm:lJI. This ag,ecment
.llb,;;\l not t,,;, sent I.<> the Boom, but = i be mmmalned on lite at ~ localion mwhlcl! the physidar,
llSSISUl!ll is prnctioiug, This agre,,ment shall be made i:mm;xllllicly available 1'> lhe Board ,ipon roqllel>t arui
sball lnelude:

Activity aud LOORtlon
A li>tillg of the ll)'Ocillc aotMtiO>l, will-Oh will be perfonned by 1he physician ll.'!Sislanl and tho specific
in which tho ph)l>lcian IIS/lIB!m!t will llu.,won.

Jocatlollll and fueillt!e,

f&AAtlon <>Uooi;e

Southern Idaho Pain and R,,bahilita1lon
236 Mat1in St.
Twin l'lllls, !dab<, 83301

Initial Eyj!)Ullljon of P!ltlents
The phy,riolm fll!~istani emp!oyi,d with Soothi,"tl;! !<Wm Pain &: Rel:mbillwtion will be utilized in the initial
evalimtlon for pa~tt seen ln tltl• .illcillty. Tb.ea.e Jllfflenlll 3tlrol irom a phy!!iclim refenal i,..., and ,ilso
patient se!f ll:f=!s, Pali1Wts wUl requlnrn full history and p)lysiw on initial vlmt. Perunmt iindingx will
be doo\tn,lented m;d N>OOttm:1.,..datious made. 'l'lll, recommondallons will be
by lhi, supervising
phylllcitm w conflrro .li.t>dllll!ll ru:id det.et'ttrln,, a ~ t pl1111.
0

""""'"';,ii

R&·Eva!Jllliirul

The l' A will be u!iJiz,,d in th<; "7-eVrullallon of ox:i~ Jllffle!l~ :fur ~ ~ & mwwal tlfid
remmn\eodmlons f.br further ll'ellltnimt within our !1w!lily. Tho PA wl!l petfurm "l'Pl'Ojlrin!e system=
l,,,sed on !l:le Plfflent's cllief complniul. Upon fhls eiwn, will recomm¢nd -thezype of therapy aod/,;r
procedure that ls needed, The sUp<1tViliing phyrliellm will review &:Id pecl\,nn llll.d lndi~

$u,rg;cal Assistant
TJ,~ physician mlii!llnt will MS!st llw supenising physielall with p ~ In our Slml<llY """ll<o:,
These C8ll<!$ will incln<le but w:e nQ\ limited to, epiducal ~ s ~ .tl~l?Y, t p i ~ ,
disoogl'lllll.!l, s«ollate gIDJglim.1 blookll, lUlllOOt ~pa!hotio 'blocks and Medlll:>nm ~ twls. Toe
suporvfal.ng physlcilm will lnlln the l'A to l!Mi!lt him oo .U of !he ai;Qve procedures.

Minor ~

The PA -will perform several small office booed J)ro<1<)dll!'e!I blllled on tho mediCld ~ on cllnicru exrun

within this :111\Jlll!y. These itwlude, '(,µtore not lintl~ tu: trigger point miootions, mUllljol.nt li\ioctions,
occipital mJeclJoru,, and manlpulatiou,.

fi:~will assist in

lllllllaging and evruoofulg J)lltients for physiool therapy wltbm our fuoility,

!Jeneml Quidl'Jm
Tue Pbys!cl,m A..,.ls\ot\llS ~ . bnck&round l1ll6 i,xpen"""" mm him q;,,,lified to func1ion in !his
C11pfi(lify. HTu pl'f!fltle<: will bi, augme!lted by 24-hour btwlrup and S\l!lport from hi{; derugrurted J>tUlllllY ""d
seco~dacy ,mpe,.visll;t_g Physician.

P'eriodio revlew of tt represoo!lllive llll!:llple of !1000.-d:l .md a periodic i:evlew of tho medlcul ~ being
provided by tru., plzy,,iclan assltru1nt. This wvl.nv sball Jlloo Include an eva!uotton of adhorence 1n the
dcleijllllim of ecn-ices ~ e n i
Pl- desctibe how this wlll be l\Ct:Omplll!hod at thi• ptaQtk:,: looatl,:,n:
AJJ the prinlaly ouJl()fl'ising pbyrucJ..o, l wiU perform p!lrlo&c ®rJrt m-i- !ll!d
ovid\W.lio.llll of patlonts
seen by the p!t;r,l!clru:i MsisnmL In nddltlon, l or a •eoondll!y oup¢rvi5lng phyl!ioirui will be ,rvllilllble 23
hours a day to pr-Ovide the pbyll!cilm ""1iil!Ulllt whl, medleal guldilnce !ll1d "1lpervi•ion.

=

'

Lipman, Arthur

*

July 5, 2007

IN THE DISTRICT COURT OF THE FIFTH JUDICIAL DISTRICT
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EXAMINATION
BY MS. DUKE:
Q. Dr. Lipman, good morning. My name is
Keely Duke. We were just introduced off the record.
We're here to take your deposition today, And thal
deposition will be taken -MS. DUKE: I assume, Counsel, we can
stipulate it will be taken pursuant to the Idaho
Rules of Civil Procedure?
MR. FOSTER: Yeah.
Q, (BY MS. DUKE) If you could slate your
foll name for the record.
A. Arthur G. Lipman.
Q, And where do you reside?
A. Salt Lake City.
Q. How long have you lived here?
A. Be 30 years next month.
Q. As I understand it when we were talking
Page

1
PAGE

I

ARTHUR G. LIPMAN, PHARM.D.,
called as a witness, being first duly sworn, was
examined and testified as follows:

Page 3

3 I Notice of Deposition
4
4 2 Curriculum Vitae of Dr. Lipman
4
4
s 3 Affidavit of Dr. Lipman
6 4 Supplemental Affidavit of Dr. Lipman 4
7 5 Second S\.!pp!emental Affidavit of Lipman 4 .
B 6 Typed notes of Dr. Lipman
4
9 7 6/7/05 letter to Dr. Lipman from Margie
Rosenberg
4

15

PROCEEDINGS
(EXHIB!TS-1-THROUGH-7 WERE MARKED.

off the record, you were raised in the East?
A. Correct.
Q. Okay. And where was that?
A. Massachusetts.
Q, Based on infonnation contained within your
curriculum vitae, I've noticed that you've been
deposed a couple of times, so you're obviously
familiar with this wonderful process.
A, Yes.
Q. I'll just go through a couple basic ground
rules which are important just to have on the record
here.
If I ask you a question that you don't
understand, will you please let me know?
A, Yes.
Q, And if you're answering my questions, I'll
assume that you're understanding them. Okay?
A. Yes.
Q, It's also impo11ant tl1at you and ! not

5

'

talk over one another as best we can. It's sometimes

difficult for me nut to cut you off, not meaning to,
bu! to think you're done with your answer and, in
fact, you're not, So please let me know if I cul you
off and that you have more to say.
And same for me wilh my questions. A lot
25
2
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of times you're going to know exactly what my
question is, and in good old American conversation we
always finish one another's sentences. But if you
could try to let me get the question out for the ease
of the court reporter here and also for cleanness of
the record.
As I understand it) you 1ve been (1eposed
six times? Would this be the seventh?
A. I can't recall the exact number.
Q. Okay.
A. Approximately.
Q, Maybe around five to ten?
A. In the last two or three years, yes.
Q. Okay. And what I've done -- I guess we
can do a little bit of the house cleaning first -- is
I'm going to hand you what's been marked as Exhibit
Number 1 to your deposition. And that is the Second
Amended Notice of Taking Deposition Duces Tecum of
Arthur G. Lipman, Pharm,D. And as I understand it,
you have seen a previous one of those, but you had
not actually seen Exhibit 1.
A, Correct.
Q. Okay. What I'd like to do and what we did
with respect to Exhibit l is delineated certain
documents. We went through your curriculum vitae and

l

2 as well, which is: "A copy of any and all

2

correspondence, medicals records or other materials

3

provided to you by plaintiffs or plaintiffs' counsel
or which you provided to plaintiffs or plaintiffs'
counsel." I would assume that any of those types of
documents are here as well.
A. Correct,
Q. And then the third section discusses items
that relate just generally to the case of any
statements you've made or anything like that that
relate to the case. I would assume that all of those
are here today as well.
A, Yes. You saw my typewritten notes.
Q, And your notes> yes, Your curriculum
vitae, I have a copy of what I believe to be, which
is item No. 4i your most current cuniculum vitae
which is marked as Exhibit 2, if you want to just
confirm for me.
A. Well, this is a dynamic document so-Q. l understand.
A. This is reasonably up-to-date, I've had a
few things since then. Nothing that would
substantially change anything that I'm doing here.
Q. Anything related to issues that are in
this ease with respect to methadone or anything like

4
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delineated certain documents, some of which we may be
able to obtain through, you know, our medical
sources, but others thal will be more difficult.
And so, if you could, I guess, take just a
glance through that list and you'll see what we're
looking to. And then I can ask you some questions
about it.
A. Yes.
Q. Okay. So let's start ,with item No. I,
which was: "All medical records, charts, reports or
other documents reviewed by you or in your possession
pertaining to the medical care and treatment of
Rosalie Sehmechel." You have brought all of those
documents with you here today, correct?
A. Correct.
Q. And with respect to this case and your

15
16
17 retention in this case, is it fair for me to assume
18 that every piece of paper or document that you have
19 reJated to this case is here in front ofus in these
20 three stacks?
21
A. Correct.

22
Q. I would assume there's no e-mails, nothing
23 like that?
24
A. Nothing that I've kept.
25
Q. Okay. And that, l think, would cover item

,
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that?
A, Well, I am frequently invited to speak
around the world on various topics. I don't know
if -- Twas just in Brazil last month. That's not-·
well, this actually only has invited presentations
through 2004. Surprises me, So this is an older
version.
Q. Okay.
A, I've had a number of invited presentations
at international pain meetings since then, but my
opinions and the science -- it reflects the current
science, but my opinions have not changed from what's
reflected here.
Q, I understand. Would it be easy for you to
provide an updated cuniculum vitae?
A. Sure.
Q. Okay,
A. If I get an e-mail requesting that, I'll
be happy to respond.
MS. DUKE: Perfect. We'll ask for that,
Mr. Foster, if you could do that. And we will mark
that updated CV as Exhibit Number 8 to this
deposition.
MR. FOSTER: Send me a letter.
MS. DUKE: You need a letter for that? l
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mean --
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MR. FOSTER: Yeah.
MS. DUKE: Okay. Well, it's Exhibit 8 to
the deposition.
Q, (BY MS. DUKE) With respect to item No. 5,
we asked for copies of the following, and the
following were items thal we noted in your curriculum
vitae. And [ guess what I'd like to do is talk to
you about each of those from the standpoint of
whether you would have a copy of those referenced.
And we might be able to more quickly do
that by just saying, you know, you do keep a copy of
the materials that you'll provide at various
symposiums and lectures that you provide.
A. Not necessarily,
Q, Okay. And so what we'll do is go through
item 5 here.
MR. FOSTER: You want to go through each
oneofthese?
MS. DUKE: Correct.
MR. FOSTER: Why?
MS. DUKE: And see if -MR. FOSTER: Why?
MS. DUKE: To see ifhe has them in his
possession, ifhe knows ifhe does or doesn't.
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literature, the Medline indexed journals in which
['ve published from my CV, and those will give you a
good handle of the major medical textbooks in which
I've published on opioids. Warfield,
W-a-r-f-i-e-1-d, which is a Harvard University
based -- Harvard Medical School based book; Tollison,
T-o-1-1-i-s-o-n, which is another leading textbook; a
couple of books that I've published myseU: Those
will give you a good handle on what my positions are
on this, and it's all public record.
Q, (BY MS. DUKE) Okay.
A. And I'm happy to discuss any of these in
whatever detail you'd like.
Q. No, That's helpful. You indicated you
had slides, that when you go to a presentation,
you'll pull from these approximate 5,000 slides to
cover whatever it is that you're going to discuss.
A. Right. The 5,000 may not he an exact
number. I don't know. I -Q, Sure. l understand.
A. I have several hundred presentations which
I've sorted over time, and I adapt from those.
Q, And what we would be looking for with
respect to these requests would be hand011ts, slides,
whatever you want to ca:11 them, related to issues in

Page 11

1
MR. FOSTER: Why don't you just send me a
2 letter, and I'll find out from him and you can cut
3 out about an hour of the deposition that way,
4
MS. DUKE: It's not going to take that
5 long, Mr. Foster, and it's my deposition.
6
MR. FOSTER: So that's really the way you
7 want to do it'/ You want to go through each one of
B these and ask him ifhe has a copy?
9
THE WITNESS: I may expedite this by
1 o stating that l have copies of the books in which
11 l've -- which I've written. l have copies of most of
12 the books in which I've written chapters. I only
13 have single copies of those. So they're in my
14 personal library. These -- most of these are
15 available through any standard health sciences
16 library, academic medical library, and could be
1 7 obtained there. ·
18
You have a number of items here which are
19 not particularly important, such as Grand Rounds at
20 various hospitals. l certainly don't keep those.
21 Invited presentations, I don't -- I have probably
22 5,000 slides in my computer which I sort according to
2 3 what presentations I'm doing, and l don't keep copies
24 of those.
25
l would refer you to the first tier
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this case, such as the use of methadone) for
instance,
A. I'll be happy to refer to the appropriate

publications from my CV on anything to back up what
I'm talking about today, if that would be helpful to
you.
Q, That is helpful in a way, but what you
might believe backs you up our experts might feel
differently or they might feel certain things that
you have done actually support them. And so that's
why my question is much broader versus just saying,
Tell me what you're relying on, which I will ask you,
But that's why I'm expanding it to this, you know,
this database you basically have of information that
you can compile when you go and speak in San
Francisco at the International Pain Symposium.
That's the kind of information I'm looking for.
So with respect to the preparation of
handouts for those types of things, what l would be
interested in obtaining is any information that you
have in those slides related to methadone.
A. Well, J'm not really willing to share
those slides. Those are my personal property. I
don't copyiight them, but this is my own intellectual
property and this is not infonnation that I pass out
. . . . . . . , ,. . .
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routinely. I am happy to refer you to the published
papers and firs( tier journals, which will-· or the
published textbooks, both of which are available
through standard medical libraries as back-up.
And I think that my credentials and my
federal consultationships and such speak to my
expertise in this as opposed to the people who you
obtained as your experts.
Q. And I'm not in any way trying to disparage
your experience or anything like that. I think
you're misinterpreting what I'm saying, What I'm
saying is we'd like information and, quite frankly,
we're entitled to information that you have put out
there in the public, whether it be through literature
or be it through a slide at a presentation that you
shared with people at a lecture related to methadone.
A. And if you ask specific questions, I'm
happy to respond to those with specific answers,
Q. Well, and so with respect to methadone, do
you have slides contained within your database that
involve the use of melhadone in chronic care nonmalignant patients?
A. Yes.
Q, We would be interested and are requesting
acopyofthoseslides.
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pay him to get you things that you can get otherwise.
MS. DUKE: Okay, Mr. Poster, I think that
you're not understanding exactly-MR. FOSTER: I think I fully understand.
MS. DUKE: No. If you'd please let me
finish, I let you finish, Mr. Foster. If you'd let
me finish.
MR. FOSTER: l think I fully understand.
MS. DUKE: The issue is we're looking for
things that were disseminated -MR. FOSTER: I know what the issue is.
MS, DUKE: That were disseminated -MR. FOSTER: I know what the issue is.
MS. DUKE: ·- at his lectures,
MR. FOSTER: And you can get them off his
CV.
MS. DUKE: Mr. Foster, please settle down.
MR. FOSTER: You can get them off his CV.
MS. DUKE: Settle down.
MR. FOSTER: I'm not -- don't tell me -MR. HIPPLER: Can we no( talk over each
other? One person at a time,
MS, DUKE: Just let me finish.
MR. FOSTER: Steve, hold your water.
Your--

:·
~----'-'-------------------1----------------------""
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A. Again, I'd be happy to send those to you
electronically, if you'd just send me an e-mail
message regarding that.
MR. FOSTER: Wait a minute. Wait a
minute.
THE WITNESS: Okay.
MR. FOSTER: Are you going to pay him to
do this?
MS. DUKE: I think it's your obligation to
provide it, Mr. Foster.
MR. FOSTER: I don't think so.
MS. DUKE: Well, then, we can-·
MR. FOSTER: So if you want to get this
stuff, you move for a Motion to Compel.
MS. DUKE: We!J, let me ask you -MR. FOSTER: Because this has now become
oppressive because you're asking him to take a
considerable amount of time to give you information
that you can get from the public sector from his

16
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20 publications. So-~ no. Just wait a minute. So
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21 he's not going to do this unless) one1 [ see them

21

first; and, two, you pay him to take the time to do
23 that because Pm not asking him to do it You re
24 paying him for his time in his deposition here today.
2 5 That's not my obligation, It's not my obligation to

22
23

22

1

24
25

MS. DUKE: Let me finish.
MR. FOSTER: First of all, this notice is
invalid because you didn't give reasonable notice for
this. So you shouldn't even be going through the
thing.
MS. DUKE: I ask can whatever I want.
MR. FOSTER: You should go to court and
ask the judge if this is reasonable notice.
Secondly, he's fully willing to give you
what you want but not in this context. If you want
these things and ifl determine that they're
discoverable, you're going to pay him for getting
those things.
MS. DUKE: Are you done?
MR. FOSTER: Because that's not his
obligation.
MS. DUKE: Are you done?
MR. FOSTER: And it's not my obligation to
pay for them.
MS. DUKE: Are you done?
MR. FOSTER: Say whatever you want. Are
you going to ask him any questions?
MS. DUKE: Are you finished so that I can
actually say something?
MR. FOSTER: Go right ahead,

5
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MS. DUKE: Okay. What we're discussing
is not as siniplistic as you 1re attempting to
characterize it, Mr, Foster, The infonnation that
we're seeking> I undetstand that we can make an
effort to obtain texts. I understand we can make an
effort to obtain chapters out of medical books that
have been disseminated through a publisher. What I
am talking about and I think what Dr. Lipman and I
had an understanding with respect to what was being
discussed are materials that he will compile for the
numerous and various lectures that he provides, you
know, on these topics, specifically methadone in
chronic care nonmalignant situations, and he's
indicated that's something he can do.
Whether the cost of it is something that
you want to bicker about and have us go to the court
for, that's a separate issue. What I'm trying to
establish at this point, assuming all of the issues
related to cost are handled, is if you're willing to
undertake that endeavor, whatever it may entail, to
obtain those materials.
THE WITNESS: Perhaps I can, again,
expedite this process in the interest of everybody's

24 time, Pm here for one reason and one reason only

1

2 5 and that's to present the science that backs up my

1

2
3
4
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THE WITNESS: Anything I send I would send
through Mr. Foster.
MS. DUKE: And nor would I ever ask for
that, Mr. Foster. I know what the rules are.
THE WITNESS: And I'm happy to provide
this. I'm not providing opinion. I'm providing
science.
Q. (BY MS. DUKE) I understand. Sol guess
an example would be when we are talking about these
slides, I note that you've gone to the worldwide pain
conference several years in San Francisco?
A. No. That was one international thing.
Which number are you on?

11
12
13
14
Q,
15
A. Oh, yeah. That was called the Worldwide
16 Pain -- that's the world society of pain clinicians
17 meeting.
18
Q. Correct.

w.

19
A. Yeah. I was asked to present that
20 particular topic, That was seven years ago. I would
21 not have that set of slides.
22
Q. I understand that. But what I'm asking is
23 just that's the kind of material we're looking for is
24 when you're asked to go and speak at something like
25 that.
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positions. I believe that I have a good grasp of the
science and that I do have some slides that express
these, many of which are referenced -- some of which
are referenced in papers that I've published in
referee journals, and I'd be happy to provide that.
All I need is a simple request, an e-mail request,
and I will provide those electronically.
I don't expect that I'd provide an
extensive amount of infonnation beeause you really
need some very specific information having to do with
tho, pharmacokinetics of methadone. That's what's
pertinent to this case. This was a tragic outcome.
It hurts me greatly to see this type of thing happen.
Unfortunately, it was highly avoidable:
Q. (BY MS. DUKE) Okay. And I understand
your position with respect to that. But going back
to the documents and whatnot, what type of time
commitment do you think it will take you to identify
slides and materials that you have that are related
to the use of methadone in a chronic care nonmalignant setting?
A. It will take me less than an hour.
Q. Okay. Thank you,
MR. FOSTER: Don't send anything to them
unlil you send it to me.
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A. Absolutely,
Q. That's just so we're on the same page,
A. And the key is you want the slides that
explicitly relate to methadone pharn1acokinetics and
dosing, and r ean get those together.
Q, All right. lfwe could, whal did you do
to prepare for your deposition today?
A. I looked through the notes that I have
of which you have a copy. I looked through the
affidavits from defense experts which I recently
received and the disclosure of what was to be said
by-· or what was to be presented by defense experts.
And then l had a brief meeting this morning with
Mr. Foster.
Q. With respect to your meeting with
Mr. Foster this morning, how long did you two meet?
A. Less than an hour.
Q. And during that conversation, what was
discussed between the two of you?
A. Simply reviewed the records and my ·
opinions about the experts' statements and the
disclosure of experts' testimony that you folks
provided.
Q. Okay. Anything else that you and he
discussed that you can remember the specifics of?
"
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A. I think we reviewed a few of the time
relationships and what occurred.
Q. And what are you referencing there?
A. The number of days that Mrs. Scl1mechel
received methadone, and we discussed the doses that
she received.
Q. And with respect to that, what have you
concluded were the days she received methadone and
the dosage she received each of those days?
A. That she was prescribed the methadone on a
Friday; presumably she began it Friday night or
Saturday, most probably Saturday; that her dose was
titrntcd up again Sunday and Monday and then probably
again Tuesday; and that she received the methadone,
as I recall -- we didn't talk about this -- but l
recall it was either six or seven days in total that
she received the medication.
Q. And what do you understand the doses to
have been on Friday through Thursday?
A. Well, there's extremely poor documentation
and there's conflicting information presented in
Mr. Byrne 1s records, the prescriptions that were
written and the labeling that was on the
prescriptions from The Medicine Shoppe pharmacy and
his testimony. So the documentation of what was done
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Q. Twice a day. And then what do you believe
it was titrated up to?
A. Mr. Byrne said in his testimony that he
instructed her 5 to 10 milligrams but that the
prescription label explicitly read 10 milligrams.
Now, this is outside of the standard of practice of
the Federation of State Medical Boards of the United
States, which is the parent body to all medical
boards, both allopathic and osteopathic, including
the Idaho State Board. And the original 1998
statement in 2002, I believe, was changed to a mo<lel
policy in which there's a call for explicit
instruction to the patient.
Now, the fact that Mr. Byrne testified
that he told the patient one thing and that he wrote
another thing on the prescription causes me some
concern. That's not my major concern, That1s
indicative of less than optimal care and one might
argue below the standard of practice.
My major concern that l believe is well
below the standard of practice and is clinically
unacceptable is to titrate the drug up, to increase
the dose with the rapidity with which he did that.
Q. Okay. And the question was: What do you
understand the titration to have been, the actual
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is not of high quality.
The initial dose, as I understand it from
the testimony, was twice daily, dosing probably of 10
milligrams of methadone. And l have absolutely no
objection to that. 1 note that four of your experts
all said that they had no objection to that, that
that was a very reasonable starting dose. They're
incorrect in that pharrnacokinetically it should have
been given three times a day, but that's not a risk
factor for toxicity. That's a risk factor for lack
of efficacy because of the duration.
My problem is that the titration was so
rapid, that the dose was increased on a daily basis.
Of explicit note none of your experts addressed that
in any way, which suggests to me either that they did
not receive full records, or if they did receive full
records, that they didn't pay much attention to them
because my concern is not the initial dose. My

lO
ll
12
13
l4
15
16
17
18
19 concern was the rate of titration,
20
Q. And the rate of titration being what?
21
A. That the dose was increased on a daily
22 basis the first few days of therapy.
23
Q. So you believe she started at I 0
21 milligrams on either Friday or Saturday.
25
A. Twice a day.
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milligrams?
A. That the patient was told that she could
take between 10 and l 5 milligrams, one to one-and-ahalf I0-rnilligram tablets up to three times a day by
Monday or Tuesday.
Q. And we'll come back to that, obviously.
Any other specifics that you recall you and
Mr. Foster discussing during your meeting this
morning?
A. l think that presents the flavor.
Q. And have you spoken to Mr. Foster at any
other time prior to today?
A. On the telephone.
Q, Are those telephone conferences reflected
in what I've marked as Exhibit Number 6, which it
looks like is your complete compilation of notes?
A. Yes, April 6th, also April 30th.
Q. All right. Do you recall just the general
nature of what you and Mr. Foster discussed on April
6th?
A. I believe that all of our conversations
related to my reaction to the testimony provided by
Dr. Dille and Mr. Byrne and the dosing regimen for
the medication that was used.
On April 301:h it was a teleconference that
•
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5

was held between Mr. Foster, two of his physician
experts, and myself.
Q. Okay. And who were the physician experts?
A. One was Dr. Steve Lorden in Salt Lake
City, and I can't recall the name of the physician in

6

Idaho. I'm sure Mr. Foster can.

7
8

conversation?

1
2
3
4

9

Q.
A.

Q.

3
4

5

6

7

And what was the nature of the

8

9
10

The·· our opinion of the care that was

10 provided by Mr. Byrne for Mrs. Schmechel.
11

1
2

Do you recall any details in that April

11

12 30th discussion?
13
A. My position, of course, is that the
14 medication was titrated too rapidly. Concern was

12
13

15 expressed, as I recall, by the physicians about the
16 documentation that Mr. Byrne requested. And there
17 was discussion of the standard of practice and the
18 commonality or differences between Utah and Idaho.
19
Q. Any other specifics that you recall?
20
A. Again, I think that reflects the flavor of

15
16
17
18
19
20
21
22
23
24
25

21
22
23
24
25

the conversation.
Q. And so, as l understand it, in Exhibit 6,
that reflects the time that you've spent on this case
from the time that you were initially contacted by
Mr. Comstock's office and up through yesterday?

14

international meeting in the last week and a half,
and I haven't put those in yet.
Q. Okay. At least we'll be much more updated
than Exhibit 2.
A. And, again, I don't think it's going to
reflect •• a couple of book chapters but really
nothing that would change any opinions.
Q. Okay. But with respect to your training
and whatnot, if you could first just describe for me
what your practice is.
A. Training or practice?
Q. Practice right now. Then we'll get into
the training to -A. ['m professor of pharmacotherapy at the
University of Utah in the College of Pharmacy and
adjunct professor ofanestl1esiology in the School of
Medicine. My practice is as director of clinical
pharmacology at the Pain Management Center, which is
the refeJTal center for the five-state lntermo·untain
Region.
Q. And as the director of clinical pharmacy
at the University of Utah-·
A. Clinical pham1acology at the Pain
Management Center.
Q. At the Pain Management Center?

Page 27

Correct.
And I'm trying to recall what your hourly
3 rate is. What is it?
4
A. Four fifty.
5
Q. Is it 450 per hour regardless of whether
6 you're traveling to Idaho for the trial or you're
7 sitting in the courthouse waiting for trial? I mean,
8 is there some different charge for trial testimony?
9
A. No difference between testimony, record
1
2

A.

Q.

10 review, and consultation.
11

Q.

And deposition?

12
A. Time is time, And deposition. And that
13 will be my charge for this morning also.

Q.

Have you already been paid?
A, No. I haven't presented a statement.
Q. Okay. !fwe could·· obviously, Exhibit 2
17 is a little older. But we'll have Exhibit 8 that
14

15
16

18 provides your most current, at least as of today-19
A. Okay.
20
Q. -- curriculum vitae.
21
A. Oh, as of two weeks ago.
22
Q. Or as of two weeks ago.
23
A. I haven't updated it.
24
Q. There we go.
25
A. Jive just been to two, one national, one

•.
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CoJTect.
ls that related or affiliated to the
University of Utah?
A. It is. It is of University Health Care,
which is the hospitals and clinics of the University
of Utah.
Q. How long have you held that position?
A. Well, I started ·• I was actually one of
the founders of the Pain Management Clinic 28 years
ago on a part-time basis, and I think I was named
with that particular term about 12 years ago. Could
be 15.
Q. And what are your job duties and
responsibilities in that position?
A. I'm involved in the active teaching and
training of medical students, anesthesiology
residents, and other residents who rotate through the
service, and pain management fellows. Those are
trainees for the subspecial!y board of pain
management. I also have undergraduate doctor of
pharmacy students, post-doctoral pharmacy residents,
and my own post-doctoral research fellows who rotate
through the service.
My responsibilities are to teach
appropriate phannacotherapy. I see patients two days
A.

Q.

8
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l
a week on consultation from the attending physicians
2 who are requesting my assistance in defining
3 appropriate phannacotherapy for their patients. I
4 explicitly recommend medications, commonly opioids,
5 medication regimens educate patients, and provide
6 consultation to staff.
7
Q. And so twice a week is the frequency in
8 which you see patients?
9
A. l see patients Tuesdays and Wednesdays.
1 o I'm involved in research, teaching and administration
11 other days.
12
Q. And with respect to an average number of
13 patients that you'll see every Tuesday and Wednesday
l.4 each day, what do you think an average is?
15
A. Well, there are two ways in which I see
16 patients. One is on formal consult, and I'll have
1 7 typically two to four patients each day that I'm in
18 clinic who I'm asked to see on a tertiary consult.
19 These are difficult advanced patients in whom the
20 physicians are explicitly seeking help.
21
When I have students and residents on
22 clerkship, I'm in clinic more oflen and will see
23 patients more frequently because that's a teaching
24 role for my students and residents. And they will be
25 seeing patients also infonnally. We may see six or
1

1
2
3
4

·5

6
7
8

9

10
11

12
13
14
15
16
17

18
19

2o
21
22

23
24
25

a simple form which gives me prescriptive authority.
Q. So Utah Jaw, if you fill out this simple
form, you could have prescriptive authority?
A. Correct.
Q. That's not something that you've done?
A. By choice.
Q. And so you are unable in Utah, based on
that choicef to prescribe medications to patients,
correct?
A. Using the legal term "prescribe," you arc
correct. Rather, my role is to teach people, to
teach physicians and physicians-in-training how to
prescribe.
Q. Okay. Would you agree that with respect
to your treatment of patients, that practice is
limited to pharmacology workup?
A. No.
Q. Okay.
A. l consult with the interdisciplinary team.
We have what we call team staffing where the
interdisciplinary team of physicians, psychologists,
physical therapists, and pharmacotherapists meet
first thing in the morning and go through all of the
new patients having been seen in the past week on
that pa11icular day or by that particular attending
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eight patients a day in that setting.

Q.

Okay.

A. I also get a large number of telephone
calls and what we call cribside consultations where a
member of the medical staff will say, Hey, Art, can
you help me with this particular patient problem?
Those typically happen two or three times a day when
Pm in clinic.
Q. Okay. And so, as I understand it,
obviously, you're not a medical doctor,
A. That's c01Tect.
Q, You're not a physician assistant.
A. No. I'm a doctor ofphannacy.
Q. Right. And under Utah law you're not
pennitted by law to prescribe medications.
A. That's not true.
Q. Okay.
A. Under Utah law under the Collaborative
Practice Act I have full prescriptive authority if I
seek that. I make a point of not seeking that
because I think that my far more important role is to
teach physicians in training, ranging from medical
students to subspecialty follows, the proper way to
prescribe. And they learn more if they actually do
the prescribing with my consultation. I can fill out

Page 33

1 physician, and we also carry out a good review of
2 continuing patients. And that's very much of an
3 interdisciplinary interaction where we discuss all
4 aspects of care. And there's complete input by all
5 members of the team.
6
I've been on medical school faculties
7 first at the Yale University School of Medicine in
8
the I 970s and at the University of Utah since I came
9 here now for well over 30 years arnj have been
10 teaching medical students and trainees how to
11 optimally use medication during that full period of
12 time.
13
Q. Okay. But taking aside an
14 interdisciplinary type treatment of patients, you
1s know, meetings that you might have with other medical
16 professionals who are providing treatment, what is
1 7 the time spent with you being the primary care
18 provider for a patient with respect to the provision
19 of pharmacology services?
A. I'm sorry. I don't understand your
2o
21 question.
Q. Let me try to think ofa better way to say
22
2 3 this. With respect to direct interaction with
24 patients -- so T1m not talking about conversations
25
A. Correct.
-M
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Q, -- with other providers who might be
seeking guidance or your opinions with respect to
treatrnent.
A. Uh-huh.
Q. -- how frequently do you aclually do the

hands-on patient evaluations?

A, Each Tuesday and Wednesday.
Q, And is that on your own or is thal with a
student?
A. Both. If l don't have a student on
service, l still have palients. I have a schedule of
clinic -- it's listed as pharmacotherapy clinic -just as each of the attending physicians has his or
her clinic listed, and I come into clinic and have my
schedule.
Q. And if you could just provide an example,
then. If you were going to be there on your own,
let1s say you don 1t have a medical student that1s
there with you on that Tuesday or Wednesday and you
have a patient scheduled on your pham1acotherapy
schedule, what would you be doing for that patienl?
A. Initially, I'd evaluate the patient's pain
intensity and complaints to validate what has been
reported to other members of the team because

25 consistency of report is important in an inter-
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through the attending physician for future
consultation as needed.
Q. And so do you examine the patient?
A. J take a history. I don't physically

examine them. Certainly, if we need to assess vital
signs, if I want lo know what the impact of the

patient's care is on heart rate and such, we have all
that information, which is typically taken by a
medical assistant or a nurse when the patient first
comes into clinic. So l have access to that.
Q. Sure,
A. And, of course, I'm working off the very
same medical record. My notes go in the same record
as the physicians, physical therapists, and
psychologists. So we all have access to each other's
notes. We eaCh have a section in the chart. And,
clearly, I'm not going to redundantly do what's
already been done by a physician or a psychologist.
But frequently in this setting the patient will
report things to one clinician which are actually
more aj)prop1iate for another, but, for some reason)
the connection is not there, And, therefore, I often
will be told things that are important for the
physical therapist or the physician or the
psychologist to know and vice versa, which is why

3
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disciplinary setting. I'll take a complete
medication history, current and past medications,
including nonprescription medications, dietary
supplements. I review sleep pattems 1 diet, use of
substances such as alcohol, caffeine, illicit drugs,
tobacco. I assess patients' compliance with their
treatment regimen, detennine who all of the
prescribers are who are seeing the pa1ient, including
both primary care and consultation physicians and
other presclibers, and then I come up with a drug
therapy management plan. I educate the patients.
l then typically meet with the other
members of the interdisciplina,y team, just as all of
the other providers in the clinic do on a routine
basis, and together we develop a h·eatment plan.
We then meet with the patient and share
the treatment plan because it's important for the
patient to be comfortable with the plan for the
patient to be compliant with it.
[ often will see patients on follow-up if
there is complexity in their pharmacotherapy. If
it's straightforward and it's simply required
education, I will often opt not to see that patient
again because of the limited number of hours that I
have to see patients, But l'm always available
..
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it's truly an interdisciplinary service.
Q, But from the standpoint of the physical
examinations of patients, that's done by other
medical professionals, and you have the benefit
through the notes of their work-ups?
A. Absolutely. l certainly could do this if
necessa,y. Advanced practice pharmacists, pharmacotherapists frequently do that. But since it's
already done, there's no need for me to do that.
Q, All right. And as I understand it, you do
not provide medical diagnoses for a patient's
condition?
A. Frequently I will come up with
identification of drug treatment or drug-induced
adverse effects, or I will identify problems with
sleep hygiene, for example, which in my note will
explicitly recommend that this be evaluated by the
psychologist, or I will identify the patient
presenting with what sounds like myofoscial trigger
points, in which case refer the patient to the
physical therapist to manage that.
So frequently I'm identifying patient
problems. Diagnosis, again, is a tenu of art. We

23
24 refer to it more as an assessment. But it's all
25 really the same thing, and that's all shared in the

10

CitiCourt, LLC
801.532.3441

(Pages 34 to 37)

i'

'

Lipman, Arthur

*

July 5, 2007
Page 40

Page 38

1
2

3
4
5

6
7
8

9
1o
11

12

13
14
15
16
17
18
19
20
21
22

23
24
25

1

interdisciplinary team staffing, which, as I
mentioned, is held each morning.
Q, Okay. But with respect to a specific
diagnosis for a patient as to whether they're

2
3
4

suffering from fibromyalgia, I mean, is that a
diagnosis that you make, or is that made by someone
else within your interdisciplinary n·eatment team?
A. That's a very interesting question and
it1s not a yes or no question because fibromyalgia is
a very complex syndrome. So it might not be the best
example. But I would often identify because of what
the patient shares with me particular behaviors which
would be more suggestive of1 for instance, a
somatization disorder or an affective disorder as
opposed to a physical disorder. And because of what
patients share with us and because of the training
that we have and the -- what's often referred to in
ounerrns of art as role blurring that occurs since
patients determine what they're going to tell to
which clinician, I often will be identifying key
issues that will contribute to the final diagnosis.
TI1e diagnoses are not made by one
individual in this setting. They're actually made by
the interdisciplinary team at team staffing. And not
infrequently the physical therapist will say to the
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attending physician.
Q. Well -A. Chronic pain is not a medical emergency
that you -- for which you intervene quickly. lt's
clinically important to move step-wise and closely.
I will frequently advise the patient of a change to
be made. l will then advise the physician what I've
told the patient.
Q. And that's where I'm getting to is the
timing of that.
A. And the physicians explicitly ask me to do
that. And the reason they refer patients to me -one of the main reasons they refer patients to me to
see the patients is to make those adjusunents.
Q. That's what !'m getting to -A. Correct.
Q. -· is with respect to those adjustments,
those aren't something that you go to the physician
and say, Hey, before I tell the patient that I'm
going to do this, I want to run ii by you first. Or
there are times when you do that, there's times when
you don't do that?
A. The latter is correct.
Q, Okay.
A. There are times that it's very important
Page 41

Page 39

1 physician, No, that1s not con-ect. In my examination
2 I found such-and-such, which is,_ which rules out
3 what you're looking at as a potential diagnosis. So
4 final diagnoses typically come out of the team
5 setting rather than one individual.
6
Q. Okay. With respect to treatment, do you
7 actually initiate pharrnacotherapy treatment to a
8 patient, or do you make a recommendation to a medical
9 provider with respect to the initiation of a therapy?
1O
A. Both. I will very frequently change the
11 patient's medication regimen. I will frequently
12 recommend additional medications, in which case I go
13 to the responsible physician, discuss the case, and
14 recommend that the physician write the appropriate
15 prescriptions which almost invariably is done.
16
But quite commonly I will change the
17 patient's dosing schedule based on the pharmaco18 kinetics of the medication and the patient's reaction
19 to it, write the note accordingly, instruct the
20 patient, and then inform the physician, for which the
21 response is invariably, Thank you, that helps a lot.
22
Q. Okay. And so you actually ':'ill adjust a
23 patient's medication without first getting approval
24 from the attending physician?
25
A. Well, I do this in collaboration with the
1
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that we speak, for example, to the psychologist about
changes before making them because of the
psychosocial implications. If it's a straightforward
phannacokinetic issue, the physicians typically defer
to me as the expert in clinic for that, and they come
to me for help and ask me to do that.
Q. And you certainly don't need their
approval to do that within the regimen that you have?
A. Well, I -- I have blanket -- I have a
priority blanket approval to do that. I'm being
requested to do that.
Q, And then once you make those types of
changes on your own, you'll infonn the interdisciplinary team of, you know, I went ahead and
increased the OxyContin to 20 milligrams every 12
hours?
A. Absolutely. And I wiite a note
accordingly which goes in the medical record.
Q, So do you actually make the decisions of
what medications cenain patients will actually be
on?
A. Often.
Q. But you've got to go to somebody and say,
rm recommending X for patient Y. I need you to
prescribe that to patient Y?

11
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A. Well, again, I don't have to. I choose to
because 1 see my role as a senior faculty member to
teach.
Q. I understand.
A, So I could easily do this without
involving the othermembers of the team, but then I'd
be abrogating my responsibility as a professor.
Q. Okay. So my question was -- and I'm not

meaning it in a have because you're not pennitted to
do so, You've made a choice not to fill out what you
call simple paperwork to have the ability to write
prescriptions. And so if you decide that you're
going to put a patient on something, you have to go
to someone else and say I need you to write thfa up
1

15 for me, correct?

A. Frequently what I'll do, just in the
interest of time, is I'll actually write the
prescription, then run it by the attending physician
or the fellow, if it's a senior fellow who already
knows the patient, saying, This is what so-and-so
needs. And they say) Thank you very much, sign it)
and it goes in the chart.
Q. But you don't sign the prescriptions?
A. That's correct. And, again, that's by my
25 choice.
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commonly which result in their making the changes
accordingly,
Q, And when you get a cribside or telephone
type call, you re making a recommendation based on
them reaching out to you, the physician reaching out
to you and saying, you know, What do you think about
this, Dr. Lipman, and you saying, I would recommend
doing X. That would be a recommendation that you're
providing to those medical providers, correct?
A. That's correct. Frequently they'll call
and say, Here's the situation. l'd like your
opinion. Do you think you need to see this patient?
Sometimes, if it's complex, I'll say, Yes, put the
patient on my schedule. Other limes it's just going
to be a question on how to adjust the dosing regimen
to optimize desired effects versus adverse effects.
Q, And so in your clinic if you -- well, do
you use methadone?
A. Absolutely.
Q, And you'll use it in a nonmalignant
chronic care setting?
A. Absolutely.
Q. And when you use methadone and you see a
patient on a Tuesday and you place that person on
methadone, would you follow up with tl1at patient or
1
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Q, So with respect to your clinical role at
the pain clinic, you do make decisions as to what
medications to place a patient on'?
A. Yes.
Q, What dosages should be used with a
patient?
A. Yes.
Q, What titration of those dosages is
appropriate?
A. Yes.
Q, And then you provide follow-up care to
those patients?
A. If indicated. And for the record, I am
not doing this routinely for all patients. I'm asked
by the physicians to see the more difficult patients
with whom they are having difficulty.
Q. How many patients a week do you think you
do those things for?
A. Well, as I mentioned, I see two to four
patients a day on Tuesdays and Wednesdays, When I
don't have a student or resident in my service, that
number will increase by a factor of two to three, and
also more days per week when I do have a trainee in
service. I also receive telephone calls commonly
from members of the staff and ctibside consultations
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would someone else?
A. Could be either.
Q, Okay.
A. The point is that the team will follow up
with the patient. And more often than not I will
actually define what the dosing regimen would be, the
rate of titration, and then we would discuss the
patient at the next team staffing to assure that all
members of the team are aware of the issues that
should be monitored.
Q. But the patient will start that regimen
prior to that conversation with the interdisciplinary
teami correct?
A. There will nonnally be an informal
discussion among the team members in the clinical
conference room that we all work out of. There will
be a fonnal staffing of the patient and completion of
the interdisciplinary team note within the next week.
Q, Okay. And when you do that, and, again,,
just using as an example someone that you'll place on
methadone, what would be the follow-up protocol with
respect to a patient that you place on methadone?
A. Well, the important issue is that
methadone is a medication that takes up to IO days to
reach steady state serum levels. That's the level -'

12
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the point at which the amount going into the body is
equal to the amount going out of the body. There has
been an alarming increase in the number of deaths due
to methadone, which, as you know, has been well
documented in the literature, most recently in
Morbidity and Mortality weekly reports. However,
this problem has been in the literature since the
1990s. And, indeed, in one ofmy publications in the
journal Oncology in the late l 990s I desctibe the
phannacokinetics of this in some detail with a
graphical presentation of how the serum levels
increase.
The biggest concern that I have is that
the physicians not titrate the drug too quickly
because of the risk of respiratory depression
occurring prior to the patient achieving the desired
effects.
Q. But going back to my question, if you were
to start a patient on methadone, what would be the
follow"up protocol to see that patient again?
A. We would nonnally give the patient a
limited amounl of medication, advise the patient to
call if there's any question, and schedule the
patient to be reseen in the clinic usually in two
weeks,

MR. FOSTER: Before we go on, let's go off
the record a second.
(A discussion was held off the record,)
Q. (BY MS. DUKE) Okay. So if you could go
5 into your medical education and background.
6
A. I have an undergraduate degree, a
7 Bachelor's degree in pharmacy, from the University of
8 Rhode Island. I have a Doctor of Pha1macy degree
9 from the University of Michigan.
10
Q, And the Doctor of Pharmacy you obtained in
1
2
3
4

11
12
13

14
15
16
17

18
19
20
21
22
23

24
25

1968?

A. At that time it was strictly a postgraduate degree with a major research phase. That
now has become the entry level degree for phamiacy in
the very recent past, but it's a very different
degree now from what it was at that time.
Q, Okay. But you obtained your Doctor of
Pharmacy in '68?
A. Yes.
Q, Okay, And I noticed when we looked
thro\lgh your curriculum vitae a number of honors that
you have, academic appointments, teaching coordinator
positions, professional experience, pharmacist
licensure.
A. That's because I'm old.
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9
10
11
12
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16
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Q. And when you say 1imited medication,°
would that be like a two-week supply?
A. Correct.
Q, Whatever supply to get them to the next
visit that you want them to have?
A. If we have a patient who we feel is
compliant and who has been taking opioids in an
adherent manner, then we may give a month's supply.
That s not the issue, and that1s not the issue in the
case of Mrs. Schmechel. The issue is the rate at
which the medication was increased.
Q. And, trust me, we're going to definitely
get there. I promise that ..
A. I trust you completely.
Q. ·· you're going to get to talk about that.
Are there times where you will take a
patient off of OxyContin and put them on methadone?
A. Certainly.
Q. Okay. And I think-- I mean, I'm trying
to do this in a logical structure, so we'll gel to
your opinion so we1re not jumping all around. So I1m
going to switch gears on you real quick and we 1ll
come back to this.
If you could,just give us a general
description of your medical education and background.
11

1
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16
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18
19
20
21
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23
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Q. With respect to all of those, I just want
to make sure there1s no significant or relevant
update that you feel we can talk about today since
we're actually here for your deposition.
A. l was just designated university
professor. Big deal, you know. In academics you get
honors in lieu of salary,
Q. Other than that, any other achievements?
I guess I should limit that to professional
achievements.
A. Things are always happening. They're not
really significant. You reach a point-- I was just
appointed as a member of a study section, which is a
peer review panel for federal grants for the agency
of Health Care Research and Quality, but I have a
number of those NIH appointments on there already.
Ifs just more of the same.
Q. If you could, I understand that you've
been in Utah for 30 years, or almost 30 years next
week.
A
Next month.
Q, Or next month.
A. I'm underoatl1.
Q. But if you could just describe what your
practice has been over tl1e last ·· you know, well,

13
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l?age 50

4
5

since 1968, of what you did after you obtained your
Doctor of' Pharmacy.
A. In 1968 I accepted a commission in the
U.S. Public Health Service, and I spent two years on
active duty in the Indian Health Service. I

6

maintained my commission and am now a senior inactive

7

reserve officer in the Public Health Service, consult
with the Surgeon General periodically,

1
2
3

8

1 made the decision to move into academics
9
10 after that and accepted a position at the Yale New
11 Haven Medical Center with the title of drug
12 information director, and in 1971 was invited to join
13 the faculty of die Yale School of Medicine,
14 · explicitly in the Department of Surgery where l
15 taught and did research until I was made an offer I
16 couldn't refuse by the University of Utah, Made the
17 decision to come here for no more than five years, to
18 leave New Haven for Salt Lake City, discovered it was
19 a wonderful place to live, and after 10 years J
20 retired from the chainnanship of the department for
21 which I was brought here to create a new clinical
22 department in the College of Pharmacy. I went
23 overseas, got my research back up, and have been
24 doing pain and palliative care work ever since.
The rest of what I do is written in
25

1
2
3
4

5
6
7
8
9

10
11.
12
13
14
15
J.6
17
18
19
20
21
22
23
24
25

board certified a dog some phannacists have taken.
That's the Diplomate of the American Academy of Pain
Management, which I consider a silly credential. So
that's the only one that 1 would be technically
eligible to take.
Q. And then just broadening that out to the
Pham1,D. world, not necessarily specializing in pain,
what tyPes of board certifications are available in
that?
A. Oh, there are a number of boards:
Oncology phannacy, psychiatric pharmacy. As!
mentioned, there's a board certified pharmacothempy
specialist, which is the primary care board, if you
will, or the basic board. These have been
established in the last 10 or 12 years. And the
young graduates who have gone through residency and
fellowship typically take those today.
Q. And tl1en do you obtain privileges like a
physician would when you practice at a hospital? Is
that something that you have to go through?
A. It varies from hospital to hospital.
Typically, once you receive an appointment on the
hospital staff and you're accepted by the clinic
staff, that takes care of it. There's not a
privileging process such as there is forphysieians.

Page 5 J.
1
2
3
4

5
6

7
8
9

10
11

12
13
l4

excruciating detail in the document in front of you.
Q. Are there any board certifications that a
Doctor of Pharmacy has or that you have?
A. There are now. At the time that l trained
there were not. There's .. there are things such as
board certified phannacotherapy specialist and such.
I actually serve as consultant on a number of the
board examinations and such. But because I'm one of
the •. in the days that l received my Doctor of
Phannacy degree, there were only five universities in
the country that granted the degree. It was strictly
post-graduate, very small numbers, and those things
didn't exist then. So I was literally one of the
founders of the field that was then called clinical
pharmacy. Now it's more commonly called
pharmacothernpy. So I've never taken any of those

15
16
17 board examinations.
1B
Q. And what are the board certifications that
19 exist now with respect to the type of work that you
20 do?
21
A. There's nothing $pecifically related to
22 pain.
23
Q, Okay.
24
A. Nothing that's broadly respected. There
25 is one board, which I would not take, that literally

..
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Q, Okay. Then if we look at almost the rest
of your curriculum vitae, if you could,just any
literature or publications, you know, whether it's
textbooks, medical articles, journals, treatises that

you've authored or participated in the authming of
6 with respect to issues related to this case that you
7 feel are relevant and pertinent.
A, Well, you have my textbooks. There's the
8
·9 Pain Management Primary Care, which 1 was requested
1:
10 to do five years ago or so, which is written for
5

;,

11. primary care physicians and other clinicians as

12 opposed to pain specialists. And that gets into
13 issues such as the risks of methadone. My chapters
14 in the Warfield book, in the Tollison book.
15
l was one of the chairs of the panel that
16 wrote the American Pain Society Principles of
J. ') Analgesic Use in Acute Pain and Cancer Pain, the most
18 recent edition. Now, that does not expHcitly
19 include nonmalignant pain, but there is a large
20 amount of transferability of the methadone section
21
22
23
24
25

..

from chronic cahcer pain to chronic nonmalignant
there. 1 was on the Federal Clinical Practice
Guideline appointed by the secretary of HHS that

wrote both the acute and cancer pain management
guidelines published in '92 and '94, respectively, by

................,.. ,,,,,,.,..
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1
2
3
4
5

the Departmenl ofHealfh and Human SeiYices. There
are numerous other chapters in my CV, but probably
the American Pain Society Principles and the most
recent textbook and textbook chapters summarize the

infonnation nicely.

6

By definition textbooks and book chapters

7
8

are a review of the literature. They1re not original
research. I have not done original research in

9

methadone, per se. I've done a lot of original
researc.h with other opioids. But the principles of
pharmacokinetics apply across opioids. They differ
greatly. TI1at is, the pharmacokinetics differ
greatly among the opioids. But in order to do the
research that I did, for example, on the
phannacokinetics of Sufentanil, the same principles
would apply there as they did in methadone.
Q. Any others that you think would be
relevant or pertinent to the issues in this ease that
you haven't already stated?
A. No. r think that pretty much summarizes
il. Hopefully, there's a consistency in what I've
written over the years.
Q. With respect to your opinions in this
ease, are you relying on any specific piece of
literature or journal with respect to issues in this

10

11

12
13
14

15
16

17
18

19
2o

21
22
23
24
25

Page

Q. Okay.
A. You can't talk about methadone in
3 isolation. You have to talk about methadone as one
4 of the range of opioids that we use clinieally.
5
Q. But other than this slide set on
6 methadone, there's no other item that you could
7 identify here that you would be taking the jury
8· through or referring to?
9
A. You know, I've written so much over the
10 years it's hard to remember. lfyou refer to my
1

2

11 textbook for primary care cliniciansi whatever we
called the silly tbing, I coauthored the chapter on
13 opioids with one ofmy former post-doctoral fellows.
14 I think that's what I did. And I'm sure l discussed
15 methadone in there. l don't recall the details.
16
Q. Okay.
l7
A. There's a -- there's not one thing that
18 ['d refer on. I'd refer on 30 years of experience
19 and consultation and literature and expertise.
2O
Q. And I'm just trying to get to the heart of
21 the matter, if there's any that we're relying on,
22 because we would obviously want to review it.
23
A, Certainly. And those are the things I've
24 cited.
25
Q. Okay.
.
12

55

1

case?

2

A. Well, realize, all I do is pain and
palliative care, and I read this literature
regularly. I contribute to this literature
regularly. I edit a journal that is Medline listed
that publishes this type of literature regularly.
And, therefore, I'm continually updating my knowledge
base based on what's published. But there is not a
particular reference that I refer to. I've written
numerous chapters in some books that summarize my
understanding.
Q. And what's the journal that you edit for?
A. Journal of Pain and Palliative Care
Pharmacotherapy.
Q. But, as you sit here today, I understand
that there's a breadth ofinfonnation and
publications that you've been involved in that do
relate to methadone. But is there any one or two or
three, or however many, that you would be walking a
jury through saying, you know, here's what I've said

Page 57

lO
11
12
13
14
15
16
17
18
19
2O

A. l certainly would refer to the Grey and
Caravati Morbidity/Mortality weekly reports paper
from January 21st or 23rd of 2005, albeit that
occurred after Mrs. Schmechel's event. But it
summarizes the previous decade ofliterature, And
that's an important summation of the problem.
Q. And what is that called, Grey and
Caravati -A. They were the two authors. Todd Grey is
the chief medical examiner of the state of Utah.
Marty Caravati is the medical director of our Poison
Control Center, which is part ofmy departmeot. And
they-· l think Caravati was the first author.
Morbidity and Mortality, MMWR -· it's available on
the Web -- publication of the Centers for Disease
Control and Prevention of the Public Health Service.
H's a major publication of reportable diseases and
medical events. And the lead article in that
January -- third week of January 2005 was on deaths
due largely to methadone legitimately prescribed for

21 here or here 1s what someone else has said with

21

patients with chronic nonmalignant pain.

2 2 respect to methadone?
A. No. You will be requesting my slide set
23
21 on methadone, and that will pretty much summarize
2 5 what I talk about.

22
MR. HIPPLER: Keely, if! may, just so I
23 can clarify, is that what you previously referred to
24 as the MMW Utah report on methadone deaths?
2s
TI{E WITNESS: Yes, yes.

3
4
5
6
7
8

9
10
11

12
13
l4
15
16

17
18
19
20

I

1
2
3
4

5
6
7
8

9
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5
5
7
8

9
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n
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14
15
16
17
18
19
20
21
22
23
24
25

MR. HIPPLER: Okay, Thank you.
THE WITNESS: You can easily find it just
by Googling.
MR. HIPPLER: [ have.
THE WfTNESS: Yeah. Good.
Of note, Todd had actually discussed this
with me as a clinical observation that he had made
from the autopsies he was doing over a year before
that was published. But I do want to stipulate that
was, of course, published after 2003,
Q, (BY MS. DUKE) Right.
A. But it reviews years of experience. And
there was literature, and [ gave you the example of
what I published in· the journal Oncology in the late
nineties that's in my CV on the pharmacokinetics of
methadone in there and the risk oflethality if it's
titrated up too quickly.
Q, I know we talked earlier about your April
16th and April 30th conversation with plaintiffs'
counsel's office, and you had indicated that on the
April 30th conversation you spoke to Dr. Lordon and
another Idaho physician with respect to this case,
Other than those two individuals, have you spoken to
any other experts retained by the plaintiffs in this
case related to this case?

1

A.

Oh. When we do --

2

Q.

-- literature that --

3
4

s
6
7
8

9
1o
11

12
13
14

15

16
17

18
19
2o

21
22
23
24
25

A. -- medical education, we always have to do
disclosures of companies with whom we ve consulted,
Q, Right.
A, And we're on speakers' bureaus, And so
I've consulted with most of the companies that are in
the pain management field simply because I've
published in tl1e area. That's pretty normative for
the thought leaders in the field.
Q. And l understand, And that's why -- I
mean, Glaxo SmithK!ine was one of them,
A. l did some research with them a few years
ago, a couple years ago,
Q. And what was that research?
A. It was with a peripheral opiate antagonist
for opiate-induced constipation.
Q, Janssen Phamiaceutica?
A. l did some consultation with them. I
can't remember. I think it was probably related to
their transdermal opioid.
Q. McNeil?
A. I'm on a speakers' bureau with OrthoMcNeil, and I've consulted with them and did research
when it was part of J&J and when Alza was handling
1

Page 59
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4

5
6
7

a
9
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15
16
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2O
2l

22
23
24
25

A. I spoke to Dr, Vorse at one point. And
that's all I can recall. I don't think there was
anyone else, But all of my conversations are listed
on the notes that you have.
Q. Okay.
MR, HIPPLER: Keely, can we take a
two-minute break?
MS, DUKE: Oh, sure.
(A short recess was taken,)
MS, DUKE: Back on the record.
Q, (BY MS. DUKE) With respect to grants and
honorariums that you've received, I noted through
some research that you ve received a number of grants
and honorariums from a number of different companies,
and I'm going to read some off and just ask if they
ring a bell.
Abbott?
A. l can't remember what I did with them,
Q. Okay. Endo'/
A. How many years ago was this?
Q, I have no idea, It was just a list.
1

A.

Is that~- I'm not sure where that 1s

corning from.

Q.

some--

I pulled it off the fntemct off of

•
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their iontophoretic fentanyl patch, We did some
studies on that.
Q, Merck?
A. Merck, I consult with them "- did consult
with them when they were in the nonsteroidal antiinflammatory business and now do some speaking with
them on prevention of post-herpetic neuralgic with
their new shingles vaccine.
Q. Novartis?
A. Novartis has a COX-2 selective nonsteroidal anti-inflammatory, lumeric oxid, I
consulted early in clinic,il development on that.
Q. Okay. Pfizer?
A. Pfizer, I've been involved in Celecoxib
consultation speaking,
Q. Farossia, does that ring a bell'/
A. l don't know,
Q. No idea what tlrnt is.
Purdue Phanna?
'
A. They are obviously heavily into opioids,
OxyContin,
Q. Has that been research that you've done
for them or -A. I was -- I spoke to them, I consulted with
them, and I was heavily involved in the OxyContin
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product liability defense.
Q. What do you mean by very involved in the
liability defense with respect to OxyContin?
A. There were a number of egregiously
offensive plaintiff suits against OxyContin that had
absolutely no scientific basis, and 1 was involved
in, among other things, Doberting out one of their

4
5
6
7
8 major witnesses and providing the science upon which
9 OxyContin was based. OxyContin was marketed
10 terribly, but it was -- it's a good product and
11

12
13
14

1.5
16

17
18
19
20
21.
22
23
24
25

product liability on it is silly.
Q, And then UCB Pharma?
A. l actually did some studies on the antiepileptic that they were looking at in neuropathic
pain.
Q. Have you done any research or anything
like that for methadone's producer, Methadose Tyco?
A. No. 1 did one consultation with one
company that was interested in marketing methadone,
but l can't even remember the name of the company.
Q. And when you say a consultation, what is
involved in that?
A. Advisory board. They'll bring six to ten
thought leaders in from around the country, around
the world, and sit you down in a hotel for a day or

Page 64
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enough science to make intelligent decisions.
Q. Okay. With respect to other testimony, we
talked just briefly earlier about other work that
you've done in other cases. And at least in the
research that I did, it looked like you had four
medical malpractice cases that you've been involved
in plus this one. ls that a -A. Well, you've got a listing. I've only
started keeping records on this two or three years
ago.
Q. Okay.
A. The vast majority of work that I have done
has been defense. I've done very little plaintiffs
work. I feel ethically that if I'm going to be a
strong advocate of opioid therapy, which 1 am, and
I'm on the record nationally and internationally as a
strong advocate of using opioids and using them
aggressively when clinically indicated, if I'm going
to do that, then J foci l have a moral obligation
also to speak up when 1 think opiates are being used
dangerously or inappropriately.
So probably three-quarters or fourthfifths of what I've done has been defense of
physicians or clinics or hospitals in their opioid
use when there have been unanticipated, unavoidable

4
5

6
7
8
9
10
11

12
13
14
15
16
17
18
19
20
21
22
23
24
25

two in typically New York to really brainstorm what's
happening with the medication and what its potential
uses, adverse effects, and regulatory issues are.
Q. And was that in the last five years, ten
years?
A. Last five years, l believe. 1 cannot even
remember the name of the company. I don't even know
who markets methadone now. It's probably somebody
who markets methadone.
Q. I think it's Tyco is what the PDR said.
A. It wasn't Tyco.
Q. It's not? Okay.
A. At one point it was Mallinckrodt, and this
was AA Pharma, or something like that.
Q. Okay. And then with respect to any other
grants, anything notable to this case -A. No.
Q. -- with respect to -A, People don't fund research on methadone.
It's a generic drug. The NIH will lypically not fund

research on something that's commercializable 1 and
the phanna industry will not fund something unless
it's going to be a patented product, which ls one

reason that the research, the science on methadone)
has been so slow to come out. Bui now we do have

•.

'
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adverse outcomes of opioid therapy, frequently
wrongful death, allegations of wrongful death. And
only a small percentage has been plaintiffs.
4
Q. And have you ever been involved in a
5 medical malpractice case that involved methadone
.6 other than this one?
7
A. l honestly don't recall. It's possible.
8
Q. How about morphine?
9
A. I'm sure I1ve been involved in morphine
10 cases. I know J1ve been involved in meperidine
11 cases.
12
Q. And do you recall being involved in a
13 pretty significant plaintifi's case that involved
J.4 morphine that went to trial?
15
A. One in Wisconsin?
16
Q. Yes.
17
A. l think, yeah. J make a point of both
18 physically and mentally shredding the file as soon as
19 I'm done with a case and I've got other things to
20 think about. And J recall it was in some small town
21 in Wisconsin, I think right on the -- was it the
22 Mississippi River? And beyond that I can't recall a
23 thing.
Q, Okay. None of the details of facts of
24
25 that case that you recall?

:i
;

;:
~

'
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I don't even recall the outcome of it.
And I think you've already answered this
question with some of what you just said. But do you
keep any copies of depositions ~A. No.
Q. -- that you have in other cases?
A. No. I look forward to shredding the file
in front of me right now.
Q. Okay. Do you register with any type of
legal service or referral agencies, anything like
that, with respect to your services as an expert?
A. No. You see, phannacy is the second
oldest profession in the world. Prostitution is the
first. The second is fine for me. I don't need the
first.
Q. Okay.
A. l consider that grossly offensive, and l
think anybody who does that type of thing ought to be
taken out, drawn and quartered. But l don't have any
opinions on that.
Q. l was going to say you don't feel strongly
about that at all, do you?
A. That's one reason l enjoyed Doberting out
a colleague in Federal Court who was just selling
himself as a plaintiffs' whore on the OxyContin
A.

Q.
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Q.

But you don't recall here?
But I don't recall in this case.
Q. I would assume you don't have any
acquaintance with their finm other than this case,
though, or the people at their firm?
A. l believe that's the case.
Q. And with respect to ptior testimony, does
it sound tight to say that you've testified in Utah,
Wisconsin, and Ohio with respect to vatious cases
A.

,,

that you 1ve been in an expert position?
A.

!!

Q.

And Atizona -Okay.
A. -- California. Those are what come to
mind. Georgia. Georgia. Sorry.
Q. Okay. Where was the OxyContin case where
you Doberted out the witness; do you remember?
A. He was Doberted out in Oklahoma Federal
Cou1t.
Q. When was that case?
A. Oh, three or four years ago. There were
over 370 OxyContin cases, not one of which was lost.
One we settled without prejudice because it was an
AG's case in West Virginia. Everything else was -MR. HIPPLER: Off the record.
(A discussion was held off the record.)

i,
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cases. l shouldn't say that on the record, but
that's how l feel.
Q. Okay. Have you worked with plaintiffs'

1
2
3

4
5
6

counsel's firm before?

4
5
6

MS. DUKE: Okay. Back on the record.
(BY MS. DUKE) Have you ever been sued for
medical malpractice?
A. No.
Q. Okay, And this is a standard question we
ask. It's not meant to offend you in any way. Have

7

you ever been convicted of a crime?

7
8
9
10
11
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This finn?
Q. Co1Tect.
A. You know, I think I was called about
another case, and l have no idea what the status of
that is. And I don't know -- l can't recall which
one came first. And I don't even know what's
happened on the other case.
Q. Is that another methadone case?
A. I don't believe so, but I don't recall.
Q. Do you know if it's in Idaho?
A. I'm not sure. I assume so. The only
reason l know that is because when I was going to
pull up my file to bring it here, that there was
another one there that was -- that was named. But l
have no idea what's happened to the other case.
Q. Any idea how plaintiffs' counsel's finn
located you?
A. No . They-.. I usually ask that question, .
and usually they say that they were referred by a
physician who I helped to a·ain or they found my name
in the literature.
A.

·,

Q.

A. No.
9
Q. Okay. What were you asked to do in this
10 case?
11
A. I was asked to review the use of the
12 methadone and provide my opinion as to whether it was
13 approptiate and within standard of practice. I
14 should say methadone and other opioids that this lady
15 received.
16
Q. And l would assume that's what you've
. 17 done .
18
A. Yes.
19
Q. You had made a comment earlier, and now
20 that we're really into your opinions with respect to
2l. methadone, that the research has been slow with
22 respect to methadone. I guess what do you mean by
23 that and why has it been slow?
24
A. Methadone has been available since the
25 I 940s and in this country since the l 950s. lt was
8

'

j

'
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actually developed as an alternative to morphine in
Germany at the build-up to World War I! when they
didn't have access to morphine because of the stuff

4

going on _in Europe. And from day one it s been an

4

excellent analgesic. 1110 problem is that, as you
know, there's a 17-year patent life on drugs as other
products; and,_therefore, it is by definition a
generic drug. And there's not a source of funding
for the research, particularly in the pham,acokinetics. This has taken place. It's taken place
because there's been a need for it. And it really
evolved more from initially clinical observation and
then the research that came accordingly. But you
don't have big phanna or the NIH, which are our two
major sources of fonding, available to support this
wo.,'k. Therefore, the work was not available. We
didn't have good phamiacokinetic data on this drug in
the fifties and sixties or even the seventies. ll
wasn't really until the l 980s that this started to
become available. By the mid- J990s we did have the
data, Had it been a new drug coming out, we would
have had the data within a couple of years.
Oxycodone is a drug that's been available
since 1915 in this country. It wasn't until
OxyContin was developed that the data were done --
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A. I-le was my student in the B.A. program at
Utah, which is the irony. And I know Chris, and he's
a leader in P.A. pain management. Dr. Cox, Dr. Hare,
Keri Fakata, who was my post-doctoral fellow, and
Dr, Bender, l believe.
MR. FOSTER: Binegar.
THE WITNESS: Binegar. All of whom
commented correctly that a starting dose of 10
milligrams twice a day was a conservative dose for an
individual who had been receiving OxyContin at a dose
of250 milligrams every eight hours plus short-acting
hydrocodone. Absolutely conect statement. The
problem is that none of them commented in their
affidavits on the titration schedule, which is the

15 issue here,
16
Now, whether that is because they did not
1 7 see the full record or, if they received it, did not
18 review it, or they were asked only to comment on the

19 initial dose, I do not know. But I have no argument
2 o with what each of them said there. They're

completely correct.
lf, however, any of them was asked under
2 3 oath to comment on tile appropriateness of the
24 titration, l can assure you of the individuals l
2 s know, that they would agree with my opinion that this
21

22
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was used.

5

The point is we have the infom1ation now
on methadone and it's got to be used accordingly.
Q. I've done my best to sort through the
disclosures that were provided by plaintiffs' counsel
with respect to what you will testify to and the
bases for those opinions based out of your affidavits
as well.
A. Uh-huh.
Q. And I guess what I'll do is just have you

6

A.
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medication was titrated much too rapidly. If they
did not reach that conclusion, anyone who did not
reach that conclusion is either ignorant or dishonest

in his or her answer.
I don't know the level of sophistication

of some of the experts. r do know the level of
sophistication of some of them. The ones who know
the medication and know its pharmacokinetics will
clearly tell you, as will anybody knowledgeable about
this medication, that you cannot safely increase the
dose of methadone rapidly. And the reason for that
is, as I mentioned to you earlier and as l published
in that Oncology article, is that it takes several
days to reach steady state.
Now, two or three of the experts commented

~6 on the dose conversion from Oxycodone to methadone.
1 7 The literature is very clear. The expert opinion is
18 very clear on this that we don't have good conversion

19 data on methadone. This is one of the problems with

Sure,

2O
Q. So if you want to go ahead and just, you
21 know, as you feel best with respect to describing it,

2 O the medication. We have very conflicting data.
21 There is universal agreement among the lmowledgeable

22

22 individuals that·there is a huge amount ofinter23 patient variability in response to different opioids,

23

what are the opinions that you hold in this case?
A. Okay. There were four of your experts:

2 4 Chris
2S

Q.

v~

,.

Page 73

the data were generated because the FDA insisted that
this new fom1 of Oxycodone had to have phannacokinetic studies. And we now have superb infomiation,
which we didn't have for the first 70 years that drug

14
15 provide a description of what your opinions are in
16 this case, and then we'll go through those and I'll
1 7 follow up with any that I'm curious about to see
18 whetl1er you have an opinion or not.

I

I can never remember his last name.

2q

and that mandates when we're rotating from one opioid

Kotenstette.

2s

to another -- and Dr. Hare, who is a friend and

'
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1 colleague, explicitly talked about opioid rotation in
2 his affidavit -- when we rotate from one opioid to
3 ·another, we always give a lower dose of the new

medication.
Ten years ago Dr. Kathy Foley, one oflhe
6 leading physician phannacologists in this area in the
7 world .. she's at Memorial Sloan-Kettering in New
8 York, another old friend -- suggested a 20 percent
9 reduction. With methadone today the general
10 consensus is that we should probably have closer to a
4

5

11 50 percent reduction.
12
The reason that we must reduce the dose of
13 the new opioid to which we're rotating is there is

incomplete cross-tolerance to the respiratory
depression. But the more important finding, which,
again, any knowledgeable person can speak to, and
this is work thal has largely come out of Dr. Gabriel
Pasternak's laboratory at Memorial Sloan-Kettering -Gab is a neuropharmacologist/neurologist. I last
spoke to him about this about three weeks at a
meeting in New York -- is that genetically we're all
different. There are many different subsets of the
opioid receptor, [n genetics we refer to these as
24 slice variance. So 1 may be more responsive to
25 morphine. You may be more responsive to methadone.
14
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morphine that's easy. Morphine has a half-life ..
that's !he time it takes for the body to eliminate
half of the medication. The half-life of morphine is
two hours. The half-life of oxycodone immediate
release tablets is two hours. So in ten hours
literally it would be safe to increase the dose. How
do we routinely increase the dose on these? For
convenience, once a duy. You couJd do it twice a
day, but we do it once a day. That makes very good
clinical sense. It's consistent with the science.
Methadone, conversely, and tbis is well
published in the literature, can have up to a 10-day
time to reach steady stale because your half-life can
be up to 60 hours. It's typically around 30, maybe
40 hours. Now, what that means is that you have to
wait a much longer period before you can safely

jncrease the dose,
At a recent opioid thought leader
conference the docs around the table were all asked,
How often will you increase methadone? And the
answer consistently among these six or seven thought
leaders was once a week. We don 1t increase methadone
more than once a week. Now, that's today in 2007.
We didn't know as much about this in 2003 when
Mrs. Schmechel received this medication. And it was
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Steve may be more responsive to Oxycodone. Byron ma
be more responsive to hydrocodone. It's just this is
our genes, what we get from our parents, And it has
to do with different densities of these receptors
and, therefore, different responsiveness.
Now, what this comes down to is that you
cannot ever safely convert a patient from opioid A to
opioid B at an equally analgesic dose knowing that
that's safe a priori. lt may well be, and in the
majority of cases it will happen. But in a
significant portion of patients, maybe 15 percent of
patients -- I don't know the number, but that might
be a good guess, and Gab Pasternak agrees with me in
our most recent conversation it's probably 15
percent, or at least that1s a starting point
you're going to get into real big trouble because
somebody .is going to be exquisitely sensitive to drug
B who was not very sensitive to drug A.
Now, that's why the teaching -- and this
is what I have taught for many years to students in
medkine, in physician assistants 1 and in phannacy,
is that you have to make these conversions very
conservatively. But most importantly -- this is the
key -- you have to do dose increases after you have
reached steady state sernm levels. Now, with
u~
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fairly common in 2003 to increase the dose every
three or four days, not every day. Maybe once every
day, but not every day. Where's the science?
Where's the mortality data that supports this? The
article in MMWR which clearly documents the number o :
deaths.
Now, there were deaths due to other drugs,
but methadone was way up there, Why was methadone
way up there? Because Medicaid programs in Idaho,
Utah, and other states, and third-pa1iy payers went
to the primary care docs and said, Hey, OxyContin is
very expensive, We don 1t want you using OxyContin
until you've at least tried something cheap. And the
docs had all been saying to the monitors who called,
Well, what's cheap? They'd say methadone. And so
the doc would use methadone and titrate ii the way
that these physicians had typically used morphine,
'
increasing the dose every day, which, as I said, for
morphine is fine. And guess what? A bunch of people
woke up dead, which is why Todd Grey came to me in
2004 and said, How come I'm seeing all these patients
coming in to my medical examiner 1s office on the
fourth to sixth day of methadone therapy when they've
died when they're getting this prescribed drug? And
I said to him, Absolutely understandable according to

20

(Pages 74 to 77)

CitiCourt, LLC
801.532.3441
-~ ~'.J .~.

n

l. ,, ..., -

Lipman, Arthur

*

July 5, 2007
Page 80

Page 78

the pharmacokinetics. And then you have the
publication. Now, the -3
Q. The publication being the 1999 -4
A. No, the 2005 thing that he wrote.
5
Q. Oh, okay.
6
A. Now, what is the standard of practice?
7 The Federation of State Medical Boards has been very
8 clear on this. When you go to your doctor, you
9 absolutely want your doctor to understand the drug
10 that he or she is prescribing. The standard of
11 practice is that if the physician does not understand
12 both the phannacodynamics, which is the mechanism of
1

2

13 action, and the phannacokinetics, whjch is the way
14

15
16
17
18
19
20
21
22
23
24
25

that the body disposes of the drug, what we call the
fate of the drug in the organism, if your doctor
doesn't understand that, that doctor has no place
prescribing that drug. The standard of practice says
that the doctor bas to find that out. How do you
find it out? You read the package labeling, which is
not the best source, but it's the one that's approved
by the FDA,
Physician assistant has absolutely the
same obligation under the Physician Assistant
Practice Acts of Utah and ldaho and all other
jurisdictions. And the physician assistant has an

we need to use in a lot of people. And I'm not
interes.ted in any witch hunts. I'm not interested in
3 any chasing people down. l'rn interested in improving
4 the way that we treat patients in pain. And this
5 tragic event was avoidable if there had been an
6 appropriate titration.
7
Does that mean that Mrs, Schmechel would
8 not have died of something else9 I don't know, I
9 can only comment on the medical probability, the
10 scientific probability that the way in which she was
u titrated on her methadone -- and 1can calculate out.
1

2

12 We have computer simulation, very accurate computer
13 simulation programs which will actually plot out how
14

a drug is going to be disposed of in a body. You and

15 I dispose of drugs by the same laws of thermodynamics
16 and mechanics that regulate how a waterfall or steam

17 engine works. This is the scienceofpharmaco18 kinetics. Most physicians don't know tl1e science of
19 phannacokinetics. They get a couple lectures in
20 medical school. That's all. They're not pharmaco-21 kineticists. That's not their job. We have a whole
22 group of scientists who do that full time for a
23 living. We know the laws ofpharmacokinetics. We
,
24 know the pharrnacokinetics of methadone. We know tha '
25 a lot of people will get methadone too rapidly, and
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additional obligation to consult with his or her
supervising physician, and the supervising physician
has a legal obligation and a standard of practice
obligation to assure that the P.A. under that
physician's supervision is knowledgeable in what lie
or she is prescribing.
Now, I was involved with the American
Academy of Physician Assistants in writing the whole
defense for which most jurisdictions have allowed
P.A.s to prescribe opioids. I wrote the original
curriculum, which is used now by most P.A. programs
in the country for teaching pharmacology to P.A.s,,
and I taught in the P.A. program at Yale and at Utah
until Utah -- Utah till about live years ago, Yale
from '70 or '71 till the late seventies when I moved
to Utah. So l've been involved in P.A. education and
practice and helping to define these standards of
practice. They have the same obligations as the
physician, pl11s the supervisory physician has
additional obligation, which is the problem here,
Let me be very frank and open. This is a
tragedy. I feel terrible when this happens, and I
feel terrible (a) for the patient and her survivors.
I also fbel tenible for society because it scares
other people away from using a good medication which
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they usually get away with it. But, you know, every
once in a while they don't get away with it. It is
the absolute obligation, and the standard of practice
is very clear on this, of the physician to know the
PK, the pharmacokinetics ofdrugs that he or she
prescribes. Same for a P .A, And, tragically, that
science was not applied in this case.
Now, the temporal relationship, the time
relationship of her dosing, of her titration and of
her death, are such that there is a high probability,
certainly far greater than not, that methadone was
the major contributing factor to her death, Had she
been a robust, healthy individual with no a priori

respiratory impairment, which, of course, she had

with her obstructive sleep apnea, chances are that
she may have survived this, That doesn't single out
methadone. There's nothing worse about methadone
1 B than any other opioid.
19
If she died of a -- largely due to a

2 o cardiac arrhythmia 1 as one of your experts contends,

21 which is a possibility but a lower probability than
22 respiratory depression, then methadone would have
23 actually been a contraindicated medication because,
24 as I'm sure yot1 1re aware from your research,
2 s methadone has been clearly implicated in some
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significant cardiac rhythm dist11rbances leading to a
recent FDA Dear Doctor notice that went to every
prescriber in the country •• or an FDA -- l should
say an PDA safely bulletin, rather, that was
published recently on EKG interval changes with
methadone. l don't believe that was the case.
But if the defense is that it was a
cardiac arrhythmia, you've got a whole new area of
exposure there that hasn't even been explored, And
the dose that she received and the duration at which
she received it, I think that that's highly
improbable that that was the major contributor. I
think the major contributor was direct respiratory
depression due to accumulation. Patients will
increase the dose of medication when they're getting
little effect, not enough. Thafs intuitive. Any
intelligent person would do that unless they are
explicitly warned that that's potentially lethal,
which it is with methadone. And that explicit
warning not only was not given by either Mr. Byrne or
Mr. Dille, but she was instructed to continue to
increase her dose. Go ahead and take l O to 15
milligrams and increase it. That's scary,
I have stopped physici,ms who have written
orders like that when they've come to my attention,
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'
a F1iday, because you know the rule. The problems
always happen alter 5:00 p.m. on Friday, You
start·· when we taper patients, when we do things
like that, we invariably start them on Monday or
Tuesday, no later than Wednesday so that we at least
know where we are by the weekend. But l'm not overly
critical of him for that. l think it was an unwise
decision. l think it showed a lack ofclinical
sophistication. Certainly, with a drug like
methadone that has a very vatiable phannacokinelic
pe1i111eter it was a dumb thing lo do.
lfhe hadn't titrated it loo quickly, if
he told her, This is the dose to take and don't
increase it at all until at least Tuesday, I wouldn't
be critical ofit.
Q. Okay. So let me just take that part of
,
il, though, switching her from the OxyContin to -A. That's fine.
Q,
to the methadone and doing it on a
Friday. r understand what your training is with
folks, but is that something you're saying is below
the standard of care?
A. I wouldn't pick on that.
Q. Okay.
A. We have much more important things to
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and I've gone and warned the physicians and said, you
know, that's a wonderfol order to wtite if you would
like to end up in a malpractice defense, which is
much more effective than telling them it's dangerous
to the patient.
That's basically my opinion. We could
spend hours teasing it out ofme, but that's what I
have to say about it. And I can produce the
mathematical models and the graphics that will
clearly demonstrate this. I hope that saved about an
hour.
Q, Okay. Let's go through these and further
flush them out. We'll see how well l did. First of
all, I guess, just so J understand what you're not
critical of, first of all, is the use of methadone
here. You're not critical of that.
A. No.
Q. Okay. Are you ctitical of the switch from
OxyContin to methadone?
A. No.
Q. No. Okay. Are you critical of Mr. Byrne
making the switch on thal Friday?
A. I have taught for over 20 years you never
start an opioid on a Friday, you never change an
opioid on a Friday, and you don't change the dose on
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address.
Q. Okay. So then let's move on from that
portion and then go to the dosing. You indicated IO
milligrams was fine. You're not ctitical of that
from a-A. Well, I'm critical of it clinically. It
should have been three times a day, but I would not
have had strong objection to 5 milligrams three times
a day. I might even be comfortable with 7-1/2
milligrams three times a day. Clinically, it was
wrong to prescribe it twice a day, In your experts'
affidavits they did not address the efficacy. 1l1ey
only addressed the safety, I'm sure that's what they
were asked to address because that's the basis of
this case. It was indicative of ignorance of the
pharmacokinetics of the drug, It's a huge red flag
to anybody looking at pharmacokinetic issues. But
I'm not concerned about the safety of l O milligrams
twice a day initially,
Q. And ifit had been 5 milligrams twice a
day, again, that's not necessarily a criticism. You
might not agree with that approach.
A. It would be inefficacious, but it wouldn't
be dangerous. Now, there is an inherent danger in
lack of efficacy. And that is when people don't get
22
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pain relief from taking two pills, what do they
typically do? They take three. If they don't get
enough relief with three but they're starting to get
a little bit, what do they do? They take four.
Welt, with methadone, that's ve1y, very dangerous.
Sol guess there is an inherent risk, but
that's not the major risk. The major risk was the
titration schedule.
Q, Okay. But looking at that, and we'll get
to the titration schedule, ifit had been 5
milligrams twice a day or if it had been I 0
milligrams twice a day, as 1 understand it, that's
not what you would have done, but you're not saying
that's below the standard of care; is that correct?
A. That not what a knowledgeable clinician
would have done, but it was not -- it was below the
standard of care for efficacy, not for safety. The
basis of this lawsuit is safety. It is noteworthy
that there had been several very high profile
criminal suits as well as civil suits for lack of
adequate pain relief, the Chen case in California
being the most notorious, which I'm sure you know
about. So it was below standard of practice, but it
was an efficacy, not a safety issue.
Q, So is that an opinion that you'll render
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of the blood. So you've got a reabsorption
phenomenon occurring from the urine back into the
bloodstream. So as people's renal function, kidney
function decreases, the drug sticks around longer.
This was a relatively young woman with
other morbidities, but renal failure was not one of
those.
Q, What other morbidities did you note?
A. Well, obviously, she had obstructive sleep
apnea. She obviously had some significant lower limb
edema, discoloration. She apparently had some
decreased cardiac function.
Q, On that Friday that Mr. Byrne saw
Mrs. Schmechel, what was your understanding of, first
of all, what he determined would be her treatment

regimen?
A. He reasonably determined that it would be
appropriate to rotate to an alternative opioid since
she was not obtaining optimal or desired results from
the OxyContin. He also determined that he would
decrease the dose of her amitriptyline. Clinically,
I would consider that an unwise decision. He should
have rotated her to desipramine, but that's beyond
the level of sophistication that I would expect in a
primary care physician assistant.
Page 89
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at trial?

A. If asked, l would.
Q. Okay. And so with respect to twice a day

4

versus three times a day. as I understand it it s

5

your opinion that if you're going to prescribe
methadone, it should be three times a day, not twice
a day?
A. Well, it's not just my opinion. It's the
science.
Q. But that's your opinion -A. Yes.
Q. -- in this case?
A. Yes, for a patient with good renal
function. And this lady's renal function was
perfectly adequate.
Q. And what's your basis for that opinion?
A. I refer you to my chapters.
Q. But if you could just provide an
explanation.
A. This drug is eliminated through the
kidneys. If your kidneys are functioning
inefficiency, then by defini lion the drug will
recirculate through the body. The kidney is the
valve that lets the -- lets the body eliminate what
is dissolved in the blood. The urine is the filtrate
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Of particular concern to me is that he had
a lady who he knew had obstructive sleep apnea and
had been treated by a dually boarded physician,
boarded both in sleep medicine and in pain medicine.
Now, your experts opined that it is the
prerogative of any clinician to determine which prior
medical records that clinician will seek. That's an
absolutely true statement in the broad generic sense.
But when you have a patient who you're putting on a
profound respiratory depressant, which an opioid by
definition is, particularly when it's a new opioid to
that patient, and when this patient has been under
the care of a physician with this type of credentials
previously and the patient comes !o you as a
relatively low level •• well, as a midlevel
practitioner, whereas the patient had already been at
a tertiary level practitioner with the dual
subspecialty boards, it is certainly unwise and, in
my opinion, below the standard of practice no! to
obtain the records from that other clinician.
Q. And why is that?
A. Because this is a patient with multiple
morbidities who has been under the care of a
special -- a dual subspecialist for relatively
complex disorders who has a severe chronic pain
'
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disorder, which is by definition very difficult to
treat, who is coming to the new clinician, Mr. Byrne,
not because of dissatisfaction with the prior doctor
but because of geographic convenience. Very
reasonable thing. rt's not only good medical
practice, it's just plain common sense and intuitive
sense that you would want to get the opinion of this
other specialist so that you will get a more complete
history.
Of note, in the records that I reviewed
there was concern expressed by, I believe, a plimary
care physician of Mrs. Schmechel, or was it a
cardiologist, about her not being able to
particularly well tolerate the pressures -- the CP AP
pressures that Dr. Vorse had ordered.
As I'm sure your aware, as any clinician
is well aware, a CPAP is a relatively uncomfortable
device, and noncompliance with CP AP and ill-fitting
masks is a very common confound. It's absolutely
essential for any clinician to know that the patient
is compliant with the CPAP, is tolerating the CPAP,
is using ii as prescribed, not simply to know that it
was ordered. Yet, in the simplistic reductionist
affidavits that your experts presented, they
indicated that there's no problem with using an
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medications. I know that she had a cardiologist, I
believe. I know she a primary care physician. The
concern, obviously, that any knowledgeable clinician
would have is respiratory depression from the new
opioid because of the incomplete cross-tolerance when
changing from the OxyContin to the methadone.
Q, But it's Dr. Vorse's records th.at you 1re
critical of Mr. Byrne not obtaining?
A. At least her opinion. I'm not saying he
needed to get medical records, I'm saying he at
!east needed to communicate with her, if not medical
records, at least, you know, how's she doing? What
are the concerns? I mean, these are conversations we
have in our clinic with referring physicians every
day, and not just referring physicians, but prior
care givers for patients who come to our clinic,
Q, And he should have had that conversation
with her or obtained her records prior to making any
change to her treutment, correct?
A, Certainly,
Q, Okay, With respect to Dr. Verse's
records 1 have you reviewed those records?
A. Yes.
Q, And do you believe that you have a
complete copy of those records?
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opioid i11 a patient who has obstructive sleep apnea
as Jong as the patient is on CPAP,
Well, that's an absolutely true statement
as far as it goes. But the essential part of this
that would clearly come out in trial, if asked, is
does everybody wear the CP AP mask easily? ls it
everybody compliant? ls it essential to know whether
the patient is compliant with and tolerating the CPAP
before determining that it's adequate to support the
patient's respiratory function dming sleeping hours?
That's not addressed. And I don't know whether
Mrs. Schmechel was able to use her CP AP properly. I
don'l even know if she felt thal she should continue
using her CP AP when she changed her care from
Dr. Vorse to Mr. Byrne. So these are all confounds
that really concern me,
Q, Okay. And with respect to that, as your
opinions pertain to records from another provider1 as
I understand, it's Dr. Vorse that you felt Mr. Byrne
should have at least called and had a conversation
with and/or obtained her medical records?
A. Correct.
Q, Okay, No other physician?
A. That's the one of most concern to me
because Dr. Vorse had been the person prescribing the
..
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A.

I believe so.
Was there anything in her records that you
believe would have changed the course of what was
done?
A, Possibly, The bigger issue·· the biggest
issue is Dr. Vorse's records were -- reasonably well
documented the fact that this lady had a severe
chronic pain disorder, She had degenerative joint
disease. Her pain was not going to be cured. Her
pain was going to be managed at best. And the goal
of-therapy, as Dr. Vorse documented it, and indeed as
the testimony supports, was to make her as
comfortable and as functional as possible with the
recognition that she was going to have significant
chronic pain the rest of her life.
Now, this was impo11ant information for
any o1her clinician addressing Mrs. Schmechel's pain
to have in hand before making any decisions. I have
no idea, because of the paucity of the documentation,
the very poor quality documentation of Mr. Byrne
that -- you know, what was discussed with her.
There is a clear standard of practice
here, As l mentioned earlier, the Federation of
State Medical Boards in the United States has
published initially model guidelines, now model

Q,
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policy on use of controlled substances for management
of chronic pain. You can find thoseon FSMB.org, the
publications, policies. It's public info11nation -evety state medical board in the country has those -that clearly spell out what should be documented in
the record. 1t wasn 1t done. So there 1s not enough
infotmation from Mr. Byrne's records for me to know
what he actually discussed with the patient.
I'm fu11her concerned that Mr. Byrne's
documentation is terribly inconsistent. What he
wrote on the prescription, what he says he told the
patient, what the family says he told the patient
differ. And this is well below the standard of
practice because patients get confused easily. There
has to be a consistency in what they're told in
writing and what they're told verbally and what their
support system is told ifwe want a potentially
dangerous medication to be used with the best
possible safety.
Q. Let's go back to Dr. Vorse's records. Is
there anything in her records that, in your mind,
should have caused Mr. Byrne not to start her on the
dose that he did?
A. Not the starting dose, no.
Q. Okay. Is there anything in Dr. Vorse's
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that you believed Mr. Byrne should have had.
A. The history of medications that the
patient received, how she responded to them) the
difficulty in managing her problems, and the
difficulty in managing her sleep apnea. Those are
the major issues that I recall. There may be other
minor issues thal I might find ifl were to go
through the records again.
Q. Are you aware, in reviewing Dr. Vorse1s
records, if Mrs. Schmechel did not adequately or
accurately provide an oral history to Mr. Byrne
related to what she had been on, you know, as her
pain regimen over the last couple of years?
A. He did not document a long-tetm pain
regimen. He documented what she was on presently.
And he did -- and what she reported there to him,
what Mrs. Schmechel reported to Mr. Byrne was
consistent with what Dr. Verse's records reflected.
What is not documented in Mr. Byrne's records is the
difficulties that Mrs. Schmechel had had with her
CPAP previously.
Q. Okay. So other than the difficulties tl1at
she had had with her CPAP previously, is there
anything else contained in Dr. Vorse's records that
you believe Mr. Byrne should have known?
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records that you believe Mr. Byrne should have
identified related to increasing the dose of the
methadone?
A. Yes, the issue that -- well, the fact that
CPAP had been ordered and that there were variable
pressures. Several months ago since I read
Dr. Verse's records. And my recollection now, which
may not be complete, is that there were concerns
about her sleep apnea management, and there certainly
were concerns about how well her pain could be
managed.
A critical issue in chronic pain is
patient expectation. \Vhen patients go to a new
clinician, they always go with a new hope. I've got
a new provider. Can 1 get better care? That's
perfectly appropriate and reasonable and
understandable. ll's very impot1ant that Mr. Byrne
have a realistic picture of what a well-trained pain
specialist has learned in, I believe it was several
years of treating this patient. If you don't know
the history, you're going to make the same mistakes
over again, to quote Santayana. And he didn't obtain
the information that he should have obtained.
Q. But that's what I'm trying to get to is
what information is contained in Dr. Vorse 1s records

:,
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A. Well, he needed to know how she had
responded to the opiates over time and how the doses
had been titrated. The biggest issue is what are
reasonable expectations of care. His records do not
reflect that in any way,
Q, And so when you say that he had no idea of
how she was titrated on other medications, would that
be, for instance, the OxyContin?
A. Yes.
Q. What other medications?
A. She also was taking a hydrocodone
acetaminophen which he immediately increased from a
7-1/2 milligram hydrocodone dose to a 10-milligram
hydrocodone dose. That's not a major issue, and I'm
not critical of that, per se. But it would have been
very helpful for him to know what her history was
there. Had there been an increasing trend, had she
been on a higher dose to which she had responded
bet1er pain-wise but had had adverse effects, which
would have resulted in Dr. Vorae lowering the dose.
The more history that we get with a chronic pain
patient, the more we understand the gestalt and the
better we can manage the patient's care,
Q. With the hydrocodone, thafs not a
criticism, though, that you have saying that that was
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a breach of the standard of care for him to increase
the hydrocodone, correct?
A. Co1Tect.
Q. Okay. You've talked about missing
documentation and inconsistent documentation. I'd
like to take those two items and separate them out
and first talk about missing documentation. In
talking about that you had talked about the FSMB.org

site.
10
A.
9

Correct.

11
Q. Do you know what Idaho provided for with
12 respect to documentation in these types of situations
13

14
15
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25

in 2003?
A. I don't. I assume (hat Idaho, like most
jurisdictions in this part of the country, simply
adopted the FSMB model policy, or some significant
part thereof. Many state medical practice acts do
not go into lot of detail, and then the legal
standard de facto becomes what is published by the
PSMB. And so lam working under the assumption that
that would be applicable since the Idaho State Board
of Medical Practice, or whatever it's called in
Idaho, is a member of the Federation of State Medical
Boards.
Q. Okay. But you don't know that for

1
2
3

4
5

6
7
8
9

clearly spelled out in that document.
Q. (BY MS. DUKE) And which areas do you feel
that he was lacking in with respect to his
documentation regarding Mrs. Schmechel?

A.

His notes are very, very cursory) very

outlined. He indicates what she was on previously,
that she wasn't responding to it adequately. The
pain is not quantified using any of the standard pain

quantification instruments that we use. TI1ere1s no

10 statement of expectation. And there's no statement
11 of his having disc\JSsed the risk/benefit ratio with
12 her of using this medication.
13
Again, that's recollection. It's a while
14 since I've looked at his records.
15
(EXHIBIT-9 WAS MARKED.)
Q. (BY MS. DUKE) I've handed you what's been
16
17 marked as Exhibit Number 9 to your deposition, and
18 !'II represent to you that this is a copy of the
19 medical chart kept by Southern Idaho Pain and
20 Rehabilitation Institute that was provided to us. ls
21 this the chart that you reviewed?
22
A. Yes.
Q. Those are all the documents that you had?
23
24
A. Yes.
,
25
Q. And if we turn, first of all, to-- see
r,

1----'----'---"--------------+----"---------'----'---------t>>
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certain?
A. No.
Q. And in 2003, September of 2003, what did

15
16
17
18
19

the FSMB model policy provide with respect to the
documentation in a scenario such as Mr. Byrne seeing
Mrs. Schmechel?
MR. HIPPLER: Object to the form. I
believe in 2003 it was guidelines, not policies.
Q. (BY MS. DUNE) Or guidelines.
A. No. Jt was policy in 2003. It was
changed. In I 998 was model guideline. I believe
2002 was the year it was changed to model policy.
But it's the same document. Policy is just a much
stronger document within the taxonomy of the
Federation of State Medical Boards.
. There are eight explicit things that are
desc1ibed there. I can't recite them verbatim off
the top ofmy head. They're in the document.
Specifically, complete medical history, a complete

2o
21

description of all interventions, discussion of
risk/benefit ratios) consultations that are obtained

s
6
7
8

9

10

n
12
l3
l4

22 or are going to be obtained 1 obviously any

23 interventions, which would be what he did document,
24 what he prescribed, and plan for fo]low-up care.
25 Those are the ones that jump out at me. But this is
., ••
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the little Dille 00 numbers?
A. Yes.
Q. Okay. If you turn to Dille 00 -A. Eleven.
Q. -- 11, it looks like you're there. And
then also to Dille 15 and l 6 along with the pain
questionnaire of 17 through 20. In looking at those
documents, which I understand to be the primary
substantive documents that contain information tl1at
was relayed to and from Mr. Byrne and
Mrs. Schmechel -A. Correct.
Q, -- if you could point out what you believe
is inadequate. And take your time to read those. We
can go off the record, if you'd like, just to refresh
your recollection.
A. Okay.
Q. Okay. So based on your review of those
records, what do you believe is lacking, if anything,
from the standpoint of Mr. Byrne's documentation
regarding his initial evaluation with Mrs. Schmechel?
A. The major issue which is directly relevant

23 to this case is discussion of risk/benefit ratio 1

.

2 4 which is explicitly described in the Federation model
2 5 policy. He states here in his plan that he is going

•.:•·cv;,, -,, . .,
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to discontinue OxyContin, start her on methadone I0
milligram q 12 titrated from 5 milligram up to a
maximum of J5 milligrams within the next 72 hours, l
don't see any statement in here about the lisk of
increasing more rapidly. l don't see any clear plan
of titration. He says titrated dose from 5 to a
maximum of 15, Is that five twice a day? Five three

8

times day? Five four times day? Over the next 72

9

hours? No discussion of the risk ofrespiratory
depression, no discussion of the issue of incomplete
cross-tolerance, which is what presents the risk to
her. This is specifically the issue that l believe
led to her demise,
Q. Any other items that you believe were left
out that should have been put in?
A. Well, it would have obviously been very
useful, as f have described, to have a more complete
history from Dr. Vorse. We have history of present
illness, past medical history. He mentions that
she'd been under the care of Dr. Vorse for pain
management. He doesn't mention anything about her
being under the care of Dr. Vorse for her obstructive
sleep apnea.
Let's look in here and see. Chief
complaint. I'm looking for comorbidities.
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Page 104

on page 11.
Q. Right. He also says sleep apnea light
before that.
4
A. I'm sorry?
5
Q. He also says sleep apnea right before
6 that.
· 7
A. Right, Yeah. So -8
Q. Okay. So that is documented?
9
A. I did see that previously. So that's -- I
10 guess that's why I didn't react to it previously. I
1

2
3

am 1 however, surprised that it's not in the typed
12 summary because the typed summary~- normative
13 medical practice is we rarely, if ever1 go back and
14 read the handwlitten notes which are the basis for
11

15
16
17

18
19

20
21
22

23
24
25

the dictated or typed summary. We always go back and
read the typed summary previously. So was it in the
record? Yes, Was it where itbelonged--whereit
was needed in the record for future review? No.
One could argue that.
Q, With respect to these criticisms that you
have of documentation, the failure to document
something in and of itself, obviously, does not cause
hann to the patient, correct?
A. No. Failure to document unfortunately
often does cause hann because at future visits we
Page 10s

Page 103

Neurological. What do we have under respiratory?
lsn't that interesting. Nothing. All systems

2

reviewed and otherwise unremarkab1e? This is
incredible. l hadn't picked this up until you

3
4

brought it to my attention. There's nothing about

5

6

her sleep apnea here under respiratory review of

7
8

symptoms, directly relevant to this case,
There's a very incomplete history on her
diagnostic studies. She had had sleep studies, at
least one complete one, nothing previously, and
that's not mentioned at all. I'm absolutely--well,
let me say I'm very surprised to see that there's no
mention in here at all of her sleep apnea, which says
to me he took a very incomplete history.
Q. Okay. Any other criticism of his

6
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1

16 documentation?
17
A. Those are the ones that I see at this
18 poinl.

19
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,

1
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don't have the information we need.
Q. Well, let's take Mrs. Schmechel. In her
instance any of the failure to document, as you call

them, none of those caused her injuries} correct?
A. This is a different question than you
asked me previously. I believe that her death was
due to too rapid titration of methadone. Failure to
document is not what caused the death.
Q. Right,
A. It was the way the methadone was titrated.
Q. Okay. That's what I'm getting to. So you
might have criticisms as to not including something
in the records, but at the end of the day that's
certainly not what you're saying led to her ultimate,
you know, death.
A. Y cs, I was answering the question you
asked, which was whether tile note was within standard

18 ofprnclice. And my answer was no. Now you 1re

(Witness confers with Mr. Foster off the
record.)
A Counsel refers me to page Dille 11 here,
but l'm reading the typed summary, which is what
people typically would look at. Okay. Had epidural
injections, low back pain, Dr. Vorse. Okay. He has
CPAP and has it down stable on his handwritten notes

19 asking a different question, is the failure of that
·2 O note to meet standard of practice causation here, and
2 J.

the answer is no.

22
Q. Right Okay. So now going to what you
23 understand Mr. Byrne discussed with Mrs, Schmechel
24 regarding the risks, benefits, alternatives
2 s available, what's your understanding of what
... , ...
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conversation occurred?
A. Well, r don't have a good understanding
because I have inconsistent records. I have his
saying one thing in testimony and his writing
something else in his note and his writing something
else in his the sam·e as the note as what he wrote
on the prescription, which says to me that there is
either an intentional or unintentional inconsistency
in what he is saying, He did not document the
concems that l would have. l write notes on this
type of thing regularly. I always put down, under
plan, explicitly discussed with the patient the risk
of this medication and the importance of adhering to
the presctibed regimen and not taking additional
doses. That's standard of practice. You are
required to both educate the patient on that and to
document what education you gave to the patient.
Q. And do you have an understanding as to
whether or not he has testified in this case that he,
in fact, did have that conversation with
Mrs. Schmechel on that Friday?
A.. Well, as I have said more than once
previously, what he wrote and what he said I find
inconsistent> and now I'm concerned about that. I
don't know what he said to Mrs. Schmechel.
WM

Q. But other than that, are you critical of
what he told Mrs. Schmechel regarding the initiation
of the therapy that he would be instituting on that
Friday?
A. Yes.
6
Q. Okay. And what is that criticism?
7
A. That the titration was inappropriately too
8 rapid.
9
Q. Any other criticism of what he has
10 testified that he told her on that Friday regarding
ll the initiation of therapy that he was providing?
12
A. Initiation is not the issue, It1s the
13 continuation that1s the issue. And I don1t recall
14 anything else at this point.
15
Q. Based on your reading of the records,
16 based on your review of Mr. Byrne's deposition, what
17 did you understand to be his initiation of therapy
18 with respect to methadone and then his titration of
19 that drug over the next couple of days?
20
A. Initiation> as I understand it, was at 10
21 milligrams twice a day, although his testimony says 5
22 to l Omilligrams. His testimony also said that the
23 patient could increase it to as high as 15
24 milligrams. And, indeed, in his -- l don't recall if
25 it was testimony or records, I think it was
1
2
3
4
5
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Q.

19

Have you read his deposition?
A. Yes.
Q. And what do you recall him saying in his
deposition as to what he discussed with
Mrs. Sclunechel regarding the treatment plan that he
was initiating for her on that Friday?
A. My recollection is that he told her what
she should take and that she shouldn't exceed that.
But what he told her to take was a rapid titration
from what he said was 5. What he wrote was 10 to 15
milligrams twice a day, that she could increase that
to three times a day. And I have some recollection,
this may be incoITect, that he also talked at some
point about four times a day -- that may not be
coITect -- of taking her methadone, and that she
would titrate up basically on a daily basis.
So if she started on Saturday, she could
go up on Sunday, go up again on Monday.
Q. All right. But you do understand that

20

it's Mr, Byrne's testimony that he had a conversation

1
2
3
4

5
6
7
8

9
1O
11

12
13
14

15
16
17

18

21 with Mrs. Schmechel in that regard?
22
A. Yes.
23
Q. I understand that you're ctitical of that
2 4 not being written in the notes,
25
A. Yes.
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testimony, he said that in a conversation with her
two or three days hence that he had approved
increasing it to 15 milligrams. J think that answers
the question.
Q, Okay. So it was your understanding that
she was to start at l Omilligrams a day?
A. Yes, twice a day. Not once a day, twice a
day.
Q. And then to titrate up -A. Daily.
Q. And what did you understand -- for
instance, if she were to staii on Friday at bedtime,
what did you understand he communicated to her with
respect to what she should do Saturday?
A. Pm not clear on that because, again, J1m
finding inconsistency. I saw a prescription record
from The Medicine Shoppe that indicated a 30-day
supply of90 tablets, and the mathematics says that's
three tablets a day for 30 days.
From what he said or what I read in the
documentation, I understand that he told her that she
could titrate up from 5 to 10, 10 to 15, perhaps from
two to three times a day, maybe to four times a day,
in a daily manner, in a very rapid step-wise manner.
Q. But you would agree that's in his
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1
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documentation and also in his deposition?
A.

I believe so.

3
Q. And so ifwe look, then-- I mean,just
4 based on what your evaluation is as to what she was
5
6
7

s
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to do, what did you understand that she should do
Friday? Let's say she takes an evening dose. What
should that evening dose be?
A. Ten milligrams.
Q, Saturday?
A, Ten milligrams twice a day.
Q, Sunday?
A. I'm not clear whether it was an hicrease
to three times day or whether it was an increase to
l 5 milligrams twice a day or maybe even 15 milligrams
three times a day. That's where I don't have a clear
picture,
Q. And what makes you think that he increased
her to three times a day?
A. The fact that he ordered 90 tablets for a
30-day supply. And, again, I'm sorry, my
recollection on this is not crystal clear. But I
thought there was a mention at some point of
increasing the frequency to three times a day, I may
be incorrect.
Q, Okay. And please, you know, if you'd like

1
A. Yeah.
2
Q. •• that you had thought that he had
" 3 increased that to three times a day, and l guess l
4
would like you to show me where you believe that says
5
that.
6
A. Okay. I may have drawn that conclusion
7 from the fact·· from the prescription .. the
8 pharmacy printout that listed 90 tablet.s for 30 days.
9
Q, Well, you'd certainly agree that they're
10 10-milligrnm tablets.
11
A. Yes.
12
Q. And if she's ultimately going to take 15
13 milligrams a day, that would require·· or twice a
14 day-- excuse me.
15
A. Fifteen milligrams twice a day requiring
16 three tablets, that's correct.
17
Q. Exactly. Okay, So other than··
18
A. So may be the case. But it's the total
19 number of milligrams of drug. Because of the long
20 half-life, this drug will, by definition, accumulate.
21 lf it were a shorter-acting drug such as morphine or
22 oxycodone, not OxyContin but short-acting oxycodone,
2 3 taking it two or three times a day would make a
2 4 profound difference in the elimination from the body
2 5 because of the short half-life, With its long half-
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to look at the records, you can certainly look at the
records we've already guided you to. You can also
look at the ··
A. And feel free to guide me ifl'm incorrect
on where it should be.
Q. The 29th and 30th. For instance, let's
take the 29th, which is at Dille 0013. That says, "l
spoke to Ms, Schrnechel today in reference to her
medication change to methadone. She was doing well.
I advised her to go ahead and increase her methadone
to 10 milligrams at bedtime and 10 milligrams

12 daytime.' 1
13
A. This is one of the areas where I have
14 confusion because on Friday J believe his records
15 said he told her to take 5 to 10 milligrams of
16 morning and evening. And I understood she was taking

17 that, When I look at Dille 0012 dated 9-30, she's
18 taking 10 milligrams a.m., 15 milligrams p.m., and
l 9 advised her to titrate dose on a variable dose
20 between 10 and 15 milligram a.m. and 10 to 15
21 milligram p.m, This is the rapid titration to which
22 I refer.
23
Q, l understand that, but l'm on something
24 different at this point. With respect to the dosing
2 5 frequency, you've alluded a couple oftirnes ..
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life, whether you take a total of 30 milligrams as
one, two, or three doses a day, the net effect of
what's remaining in the body is going to be very

similar. So from a toxicological perspective Ws
the same.
Q. Okay,
A. So, as I said earlier, I may have been in
error on the three times a day. That was an
assumption I made.
Q. Okay. And I just wantto make sure that
there's not something I'm not seeing that you're
seeing, and J want you to show me it if you believe
that she was on three times a day.
A, Sure. That's why we're here,
Q. All right.
A. Okay.
Q. So based now upon your review, it looks
like he was continuing to have her on a course of
twice a day with varying milligrams.

2O
A. And 1 again, that1s concerning to me
21 because of the relatively short duration of the drug

22 in the first few days of therapy. Because of the
variable kinetics, this is a drug that after a week
24 or so would probably work fine twice a day in many
25 patients, not in everybody, but in many patients,
23
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But in the first week of therapy it's a much shorter

4
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1

milligrams, let's say that that was the course of

2 action he look, and he said, I want you to take 15

2 duration.
3
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That would also cause me concern from the
risk of her taking additional doses, which we do not
know whether that was the case.
Q. Right.
A. But that certainly would have been
consistent with her demise.
Q. And l was going to ask you about that
because l saw it in your disclosure. You certainly
don't know whether or not she followed Mr. Byrne's
instruct.ions or if she increased her hydrocodone and

13 her methadone, correct?
14
A. CoITect.
15
Q. It would be speculation for any ofus to
16 testify to that?
17
A. It would be. But r did express concern,
18 and, again, you can help if I'm missing something
19 here. I'm only interested in getting the truth out.
20 And that is whether he explicitly cautioned her not
21 to exceed the prescribed dose.
22
Q. Okay. Do you recall reading his
2 3 deposition?
24
A. l do, but l don't remember the details.
25 lt was a while back.
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milligrams of' this twice each day, would that be
something that you would be critical of him from the
standard of care standpoint?
A. I'd be more concerned about 15 twice a day
on 30 a day than I would be initially 20 a day. Nol
a black-and-white issue.
Q. Okay.
A. I would want to see documentation in the
record on why he did that.
Q. You're saying you would be more concerned.
But does that mean that you would be critical of him
from the standpoint of 15 milligrams twice a day is a
breach of the standard of care period?
A. There's not a clean cutoff here between
one and the other. If! wanted to be as hypercritical as I could be, I would be more concerned
about starting with the drug on a Friday. I'd be
more concerned about giving her a month's supply.
Neither of those by itself is outside of standard of
practice. If you take each of these elements
individually, which is what you do and what you're
supposed to do, and try to dissect them and say is
this a violation of standard of practice, is that a
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Q. Okay. But ifhe were to testify that he,
in fact, did inform her that it's very important that
you don't take over the amount that I've prescribed
you, you would feel that that's reasonable for him to
tell her, coITect?
A. I would think it's essential for him to
tell her that. But at the same time it's essential
for him not to prescdbe an amount that would have
been potentially excessive.
Q. Ifhe had started her off on 15 milligrams
a day -- excuse me -- 15 milligrams twice a day, once
in the morning, once in the evening) would you be
critical of that?
A. That is not a black-or-white issue. This
is a shades-of-gray issue, I'd be more concerned
about starting her on 30 milligrams a day than 20
milligrams a day. As l mentioned previously, we do
not have good dose conversion numbers for methadone.
It's uniquely difficult. It's a uniquely difficult
drug to convert from other opioids, which is why wise
clinicians do this very conservatively. And that
was, indeed, what the IO milligram initially was as
Dr. Hare and Dr. Binegar stated in their affidavits.
And I concur with that.
Q. But ifhe were to have started her at 15

I
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2

violation of standard of practice, those are
perfectly reasonable and appropdate questions.

3 You're asking me as an experienced pain clinician who
4
5
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7
8

9
10
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16
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teaches this and who does this whether the overall
care was within standard of practice, whether the
entire package that you put together was one that
presented an unreasonable risk to this patient. My
conclusion is yes) it di.d present an unreasonable
risk to the patient.
Now, has it ever been done with patients
not having adverse outcomes? Of course 1 it has,
But, tragically, this patient did have the worst
possibly adverse outcome. And everything in this
pattern of care points to the fact that it was the
way in which this medication was used that was the
major contributor to her death.
Q. Okay. And !understand that that's your
opinion. But with respect to ifhe had initiated her
at 15 milligrams twice a day, as I understand it,
that is not something that you would be here saying
that's a breach of the standard of care; is that
correct?

You 1re asking me, again, to assign a yes
24 or no answer to a gradation issue. [ would bernore
25 concerned aboutsta11ing heron 15 milligrams twice a
23

A.
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l day than l would be on starting her on IO milli&>rarns
2 twice a day. I think the 10 milligrams twice a day
3 was a reasonable dose. Would 25 milligrams a day or
4 30 milligrams a day be grossly unreasonable? I can't
5 answer that yes or no. I would be less comfortable
6 with that. I am comfortable with What be did -7
Q. Okay. So -8
A. -- initially.
9
Q. .. as you sit here today, you do not have
l O an opinion whether that would be a breach of the
11 standard of care or within the standard or care to
12 have started her on 15 milligrams twice a day and
13 just kept her on that?
14
A. I'm not trying to be difficult and I
15 understand what you're asking and l understand why
16 you're asking it. And l can't answer that question.
1 7 What l can state unequivocally is that the risk to
18 this lady of giving -- of starting at 15 twice a day
19 as opposed to lO lwice a day would have been markedly
2 O greater and would have caused me more concern,
2l.

Q.

But, beyond that, I would assume tliat you

22

can 1t answer my question?

23
24
25

A. That's correct.
Q. Okay. With respect to the titration, now
that we have it cleared up that it was kept at twice

1
2
3
4

because, as l mentioned earlier, the half-life of the
hydrocodone is only two homs, 1.9 hours to be exact,
and, therefore, it would be eliminated from the body
rapidly.

5

So it's a matter of~- and, again, we can

6
7

show this graphically -- it's a matter of her serum
level going up gradually. I'm sorry, of her
analgesia going up gradually and her respirato1y
depression going up more quickly.
MR. HIPPLER: Before you go on, I was
going to do this earlier, and l apologize for not
having done that. Can I have a standing objection as
to foundation with regard to the qualifications of
the expert? I don't want to interrupt you every
time. I'll just have a standing objection.
Q. (BY MS, DUKE) Would itbe any different
from the standpoint of the graphs you're talking
about-- and have you prepared any of those graphs al
this point?
A. No.
Q. Okay. Would it be any different with
respect to the graphs that you're talking about
potentially doing if you have a patient titrate up
from 10 to 15 milligrams? You know, you've got them
on 10 milligrams for the first couple of days, and
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a day, describe for me what your criticism is with
respect to the titration that Mr. Byrne advised
Mrs. Schmechel to follow.
4
MR. FOSTER: Object to the fom1. Go
5 ahead.
6
THE WITNESS: My objection to the way he
7 did this, my concern abo11t the way he did this is
8 that he increased the dose on a daily basis when the
9 level of analgesia had not yet maximized. Now, when
10 you keep increasing the dose, you are by definition
11 seeking more pain relief and you are by definition
12 inducing more risk of respiratory depression. 1t is,
1

2
3

13
14

15
16
17
18

therefore, incumbent upon the clinician to not
increase the dose until the maximal effect from
the -- maximal analgesic effect from the dose has
occurred. If you do that, if you increase the dose
too rapidly, your rcspirat<,ry depression exceeds the
target, gets you into risk when you have not yet
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then, let's say, day three you bump them up to l 5
milligrams. Would the graph be any different from
that titration example versus just starting the
patient on 15 milligrams, or would the levels be tbe

s

same?

6
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A. No. lfyou started the patient initiaJly
on 15 milligrams twice a day and continued it for two
or three days at 15 milligrams twice a day, yournet
area under the curve, which is the geometric
representation of how much drug is in the body, would
be greater than if you started at l O and then went to
15. The concern I have, however, is not just the
area under the curve. It's the rapidity of the
increase. Because it will take several days to reach
the optimal analgesia from the twice daily dosing
that this lady was receiving. Therefore, you don't
really lmow what your target is. If you keep

18 increasing the dose and your increases are occuning

19 reached the m_aximum analgesics dose.

19 more quickly than the peak of the analgesia is

2 o·
Therefore, it is incumbent upon him to
21 increase the dose of methadone slowly. Had he

2 O occuning, then you basically can go past your
21 desired effect and get into the toxic range. That's
22 the inherent risk of methadone.
23
Q. How many increases do you believe
24 Mr. Byrne advised Mrs. Schrnechel to undertake?
25
A. My understanding is that he advised her

22 increased the methadone every four days, for example,
2 3 and had allowed her to use more of her short-acting
24 hydrocodone for break-through pain to keep her
2 5 comfo11able, that would have been far, far safer

I
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that she could increase the dose on a daily basis.
So if she started her first dose on Friday evening,
as you have suggested, that she could then increase
on Saturday, increase again on Sunday, increase again
on Monday. And he gave her a sliding scale of going
10 to 15. So if she started at 5 -- which is what he
contended, although that's not what either his
prescription label or his records documented -- ifhe
started her on 5 and then she went to l Othe next day
and 15 the next day, that's a very rapid increase.
In pha,macokinetics we never deal with numbers. We
deal with percentages. The body and any
thermodynamic machine only relates to percent
increases. This is a JOO percent increase. This is
the correct increase after you reach steady state
serum levels. This is a potentially fatal increase
before you reach steady state serum levels. Again,
five half-lifes to reach steady state serum levels.
Half-life of this drug, be conservative, say it's 40
hours. Say it's 30 hours. That's 150 hours. So
five, six, seven days, that's the right time to
increase the dose.
Now, this is a lady who was -· did have
some respiratory tolerance to the medication -- this
is not analgesic tolerance, This is respiratory
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A. And as we've discussed earlier, everything
is risldbenefit. There is an inherent risk in the
use of every drug. It's our job to minimize the
risk, to optimize the benefit. And that wasn't done.
Q. Okay. So let me try to step back just a
little bit by that qualification that you just
provided. One increase in the dose would have been
okay from the standpoint of Mrs. Schmechel's
treatment. It's the multiple increases withh, a
tight time frame that you're critical of?
A. Exactly. One increase, obviously, would
be more dangerous than no increase, but we're trying
to optimize analgesia, And we're accepting a certain
amount of inherent risk.
Q. And that would be something that·· you
know, an increase> that one increase would be
something that you would feel -- we're walking a fine
line here. It's still within the standard ofcare to
do, but it's not within the standard of care to
increase multiple times over a six-day period?
A. l would agree with that.
Q. And with respect to that, when you talk
about the chart -- and I might need you to just draw
one out as a sample because when you're talking about
over and under, I don't really understand what you're

:'

f
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tolerance .. because she had be on the oxycodone and
the hydrocodone previously. And, therefore, I would
be comfortable being a little bit more aggressive in
titrating her up. That's why I say every three or
four days would be reasonable. Had she been opiate
naive, no less than five, preferably seven days would
have been appropriate,
MR. HIPPLER: Can we take a break?
MS. DUKE: Sure.
(A short recess was taken.)
MS. DUKE: Okay. Back on the record.
Q. (BY MS. DUKE) l'm going to try to ask
this in an artful way that hopefully makes sense.
But with respect to this titTation issue that you've
testified to, it's my understanding that your
cdticism is that the first titration should not have
occurred until at least three or four days after the
initiation of the methadone with respect to
Mrs. Schmechel. ls that accurate?
A. Correct.
Q. And in -A. Or at least the second and third
titration. You might increase the dose once if she
didn 1t have any sufficient response.
Q. Okay.
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referencing. So I'll give you a fancy piece of
yellow paper here.
E
·''
A. I'm sorry. I can't do it. It's not legal
size.
Q, That's right.
A, Okay. We're looking at the serum
concentration, which is Cs here> and we're looking
at -- let's see. She was dosed twice a day, so let's
put in 12-bour increments on the horizontal axis.
Q, So the horizontal axis is the time?
A. Exactly.
!'
Q. Okay,
A. So this is time 0, this is time J2 hours,
24, 36, etc. So the first dose·· Now, let me start
by showing you something about methadone. The dose
response curve on morphine or any other opioid is
going to look something like this, It's taken, it's
absorbed, it's distributed, it's eliminated.
i
Methadone, however, has a curve that looks like this.
Q. And that would be the long half-life,
correct?

A. The long what we call beta elimination
half-life. 111is can go out to 72 hours. So the
curve on the methadone here is going to look like
this. Now, you have to add up the area under the
,.... ,.
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curve, if you remember your eighth grade geometry.
Q. I tried to forget it.
A. And so lhe nel serum level is going up
like this.
Q. With the dotted lines?
A. Right. Now, because you're adding under
the curve of the overlapping areas, you're getting
multiple overlaps. So lhe next one is here, and
you're getting contribution of three doses to this.
Q. Okay. And so when you do this dotted
line, is that the area that's contained -A. Exactly.
Q. -- within the overlapping curves?
A. Exactly.
Q. All right.
A. Now, the issue is that the - this will
keep going up for a period as long as ten days. If
the patient is increasing the analgesia in this time
frame, our -Q. And "this time frame" being the 24 to -A. To 36 hours to 48 hours -Q. -- 36 to 48 hours.
A. -- within the first three days, for
example. If the patient starts increasing the dose
within that first three days while our analgesic
0
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drugs for quite a while, been on the OxyContin for
quite a while, The OxyContin that she took now, now
we're 24 hours since her last dose of OxyContin.
111al's really wearing off. So there's almost no
residual effect left from lhat. And she probably
needs a little bit more analgesia. l would be much
happier giving her more hydrocodone, the short halflife drug, rather than increasing the methadone after
24 hours, but l'm not going to be stupidly obstinate
and say that, Oh, no, you can't increase it at all.
Scientifically, technically, I should say lhat. But,
you know, clinicians you've got to cul some slack.
You've got to -- we're trying to deal with real
people who are in real pain, which is the situation
here. So I'm not going to object to that, and I'm
trying to be very reasonable here,
But, boy, when you do it a second time and
a third time in that short time period, you're
setting yourselfup for risk, particularly in a
patient with a history of obstructive sleep apnea.
There's nothing uniquely toxic about methadone with
her history ofobstructive sleep apnea. This is
going to be true of any opioid that's increased
sooner than five half-lifes. But the beauty is that
with morphine, you've reached that five half-lifes

,
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effecl is still going up because when we've
reached steady state, then it's going to be level.
By definition the respiratory depression is also
going up. Now, you cannot assume that at this point
that this -Q. Being 48 hours?
A. Being 48 hours -- that this lady has
reached optimal analgesia because the net effect is
still going up. So if you increase the dose at that
time -- let's say 24 hours is when he did increase
the dose. If you increase the dose at 24 hours, it's
terribly premature because you have not yet reached
the maximal analgesia for the two doses that have
been given in that 24-hour period. It just takes the
body longer to reach that point.
Therefore, increasing the dose here will
obviously give you more analgesia. It will also give
you more risk of respiratory depression. But when
you've not yet reached the maximal analgesia from the
doses that you've already given, this is a very
premature thing to do.
Now, why did I qualify your statemenl a
couple minutes ago? Why would l nol have objection
to his increasing the dose once in Lhat firsi couple
of days? Look, this is a lady who's been on the
0

-
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well within a day. And with most of the other
commonly used opioids, with Dilaudid, with
hydromorphone, you've reached it within a day. You
haven't reached it "" you're probably four days out,
five days out with methadone. And that's the uniqne
lo xi city of methadone. Use methadone. It's a great
drug. But, damn it, know what you're doing before
you use it.
Q. With respect to this chart, if you were
tow~ let's not assume that there's a titration that
occurs in that first six days. Let's assume that
you're started on l Omilligrams and you stay on l 0
milligrams that entire six days.
A. Twice a day.
Q. Twice a day.
A. Preferably three, but twice a day.
Q. Do the serum levels change?
A. Yeah. The net serum level keeps going up.
Q. But what's the difference in the change
between the serum levels if you were to titrate up,
let's say, from 5 milligrams to l O milligrams or just
have the patient start on l O milligrams?
A. You're going to change the slope of the
curve, the rapidity with which it goes up.
Q. Okay. Can you describe that for me? l
...
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think that's what I'm not understanding.
A. The issue is that if she remained on just
IO milligrams -- here I'm showing -- I'm not showing
any increase in dose, I'm showing the same dose
being given. And because with each subsequent
dose -- and I'm not drawing this exactly. Remember
that the curve looks more like this. It's got a long
asymptotic tail. So the next one comes like this.
The next one comes like this. Well, as you can see,
you're getting each dose adding to the net serum
level with continued contribution from prior doses.
So four doses ago still has a minor contribution.
Four doses. Three doses ago has an even bigger
eonttibution. Two doses ago has a big contribution.
Current dose has a huge contribution. You give a
fifth dose you've still got some contribution with a
half-life of even 72 hours. That's a very
conservative three-day half-life. It's longer than
that. But even ifit were 72 hours, you'd have
contribution of six doses on a twice daily schedule.
And this is straightforward pha1macokinetics. This
is not questioned. TI1e science of this is -- this is
black and white.
What's not .black and white is whether
she'll respond better to methadone than oxycodorie or

l
what is incumbent upon -- what should have been
2 incumbent upon Byrne was to say, Hey, I can 1t
3 increase the dose this quickly. Yeah, f have might
4 have done it before and gotten away with it,
5 particularly in somebody who has complete respiratory
6 competence. But if I do this, I'm really increasing
7 the risk of getting ahead of where l want to be,
8 which means too much respiratory depression. So I'm
9 going to control her with more of the short acting.
lO
When you give her a boat load of
11 hydrocodone, that's just fine because that's going to
12 clear quickly. It's going to get out of the body.
13 It won't accumulate. She could take hydroeodone
14 literally every four hours. Could take six doses a
15 day of her hydrocodone. She wouldn't accumulate it
16 because she'd be peeing it out as quickly as she'd be
1 7 taking it in if she took six doses a day. But with
18 methadone you've got it sticking around for 96 hours,
19 100 hours, 120 hours. So you have all of these prior
2 0 doses contributing to her serum level.
21
Q. Is the respiratory effect greaterifyou
2 2 were to start her on l 5 milligrams versus titrate her
2 3 up to 15 milligrams?
24
A. Well, by definition you'd have more total
2 5 drug conttibuting to her effect. So if you started
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vice versa because of her genetic variability, what
we call genetic polymorphism. But what is clear is
3 she will be accumulating the amount because of the
4 long half-life and the contribution of multiple ptior
5 doses. So her serum level is creeping up. Her
6 respiratory risk is creeping up.
Q. And that's what I'm trying to understand
7
8 is with respect to the respiratory risk. Let's say
9 you start a patient on 5 milligrams. You titrate
10 them up to IO over the first 24 or 48 hours. You
11 titrate them up to I 5 -12
A. So you're going here -1
2

13

14
15
16
17

l.8
19

2o
21

22
23

Q.

-~ versus --

A. -- here, here. You're changing the slope
of the curve.
Q. Okay -- versus just having them on 15
milligrams the whole time. The difference would be
in the slope of the curve?
A. Well, we're adjusting the patient's
therapy [n response to how they respond to the
therapy. If we adjust the dose of methadone because
of less than desired analgesia, which is what clearly
was being done, this is being done out of unequivocal
ignorance because leaving the dose the same would
still result in increasing analgesia. Therefore,
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her at 15, you'd get up to a higher serum level
sooner. So, yeah, there's a little bit more inherent
respiratory tisk. The concern is not the starting
dose. The concern is increasing the dose before you
know that the analgesia has optimized because every
time you increase the dose, you're going to increase
the respiratory depression. Now, remember, the
analgesia is going to take days to optimize, but the
respiratory depression happens immediately. TI1at's
why people end up on day four, five, six on methadone
waking up dead, which is a term of art in our field.
Q. I understand. And all opioids have a risk

J

of respiratory depression correct?
1

A. Absolutely. But the key is you've got to
be at steady state before you increase the dose. And
you can do that daily or even twice a day with most
other opiates.
Q. Would you agree that respiratory
depression rarely presents a clinical problem to
patients receiving chronic opioid therapy due to
tolerance for the respiratory depression?

22
A. ('Rarely 11 is a very non-quantitative word.
2 3 Respiratory depression happens frequently to patients
24
24 taking opioids in the first week of opioid therapy
25
25 and it happens -- this is one ofour terms of art-,
'-,,,···=···•··=·""==~=~~~-=CC7C==··•••~··~•····~···~·=~~~=,-"""''"=====~··~·~o='"~"''~••··=•~•·•. ·.=•~·•···=·····==c=\•
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not infrequently in patients who are changed from
opioid A to opioid B, even though they have some
respiratory tolerance to opioids from opioid A.
As I said earlier, there is not complete
cross-tolerance, tolerance reforring to the
respiratory effect, not the analgesic effect.
There's not complete cross-tolerance, very well
documented in the literature, w),ich is why the norm
today is to reduce by -· we woukl -- 50 percent
reduction. As I said, you could find Kathy Foley's
classic paper that says 20 percent reduction. So
why? Because you do not have full protection.
So when she was changed from OxyContin to
methadone, she did not have the protection against
respiratory depression that she would have had had
she been continued on OxyContin.
Q. Okay.
A. The rule of thumb is start low, go slow.
Critical with methadone.
Q. Would you agree that after five to seven
days of regular scheduled dosing, patients become
tolerant to opioid-induced respiratory depression'?
A. Yes.
Q. With respect to what you were just talking
about on the opioid rotation, if you're taking a

1
2
3
4

5

6
7
8
9

1o

11
12
13
14
15
16
l7

18
19
2O
21
22
23
24
25

reasonable starting point. There's no magic number.
We don't know the answer. But that's okay,
Q. Okay. f'll let him write his note. Let
me just -A. You're asking that question in the context
was that appropriate starting dose. Yeah, it was a
reasonable stai1ing •• it was as reasonable as any
other sta11ing dose.
Q. What ifhe had done it three times a day
like you indicated should be done?
A. Ten three times a day?
Q. Yes.
A. I would have preferred 5 three times a day
because, you know, unfo1iunately, I see everybody
else's mistakes. So [ have a bias toward the
negative. I would have been more comfortable with 5
three times a day. I wouldn't necessarily raise a
huge red flag had she been started on l Othree times
a day if she'd been left on that for a week before
there was any increase. !t would have been safer,
however, for her to be on 5 three times a day with
more of the hydrocodone for break-through,
Now, he did increase the hydrocodone in
the number of milligrams, but he decreased it in the
number of tablets, and that was not right. Because
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13
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patient off of the OxyContin, as I understood your
testimony to be a while ago, that the equal analgesic
tables, you know, they're a guide, but they're
certainly not a this-is-what-you-have-to-do?
A. They're population averages, J would not
say they're a guide. They're specifically population
averages. So if we take 500 patients, on average
that would be the equivalent dose. But you or Steve
or Byron or l may have very different responses from
the average.
Q. And so what I was going to ask you is:
What's the equal analgesic dose, you know, from
OxyContin to methadone, in your opinion?
A. Well, that's a very difficult question.

15

Number one, we don 1t know the answer to that even

15

16
17
18
19

with population averages. The literature is
incredibly diverse. J usually use a -- well, you'll
find literature ranging from a two-to-one to a fourto-one ratio with morphine. And Oxycodone is 25
percent more potent than morphine. So you're going
to find a very variable listing.
Furthennore, you'll find difference in the
literature according to the initial dose the patients
were on. I don't have any objection lo her being
started on IO milligrams b.i.d. That was a
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the hydrocodone is going to give you a short blip.
It's going to give you a short additional analgesia.
She didn't need a greater amount of additional
analgesia. She needed to have the ability to get
that more frequently because that's on top of the
methadone that's already on board.
Again, that reflects lack of knowledge of
pharmacokinetics. That's okay. Primary care P.A., I
don't expect him to be a sophisticated pharmacokineticist. But I sure as hell expect him not to
prescribe a medication for which he doesn't know the
appropriate titration.
You put Dille on the stand and ask him how
rapidly he'd increase -- under oath ask him how
rapidly he would increase methadone, and I would bet
my house that he would not say every day. lt's not
much of a house.
Q. With respect to these titration increases,
how many increases do you understand that Mr. Byrne
advised Mrs. Schmechel to do?
A. My understanding is that he advised her
that she could increase the dose on a daily basis at
least Saturday through Tuesday.
Q. And what's the range that you understand
he indicated that could be done?
..... ,.. _,, .. , .. .,,.,....,, .. , ........., . ,... ,,..
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A. Well, ifhe said you can go from 10 to 15,
I would extrapolate that to being either a five-

milligram increase each time or a doubling each time.

Page 140

1 standard of care if you were to go up from 5 to I 0
2 milligrams?
A. One increase would not be below standard
3
4 of care, Now, I'm having trouble differentiating
5 standard of care from causation.
6
Q. And let me ask you that since we're there.

Either way it would scare me.
Q. lfhe had started her on 5 and then
indicated that she could increase up to JO on
Monday-- so she's gone Friday evening, Saturday,

7

What do you understand standard of care to mean as

Sunday increased to l 0) as I understand it, thats

8

it applies in Twin Falls, Idaho in 2003?
A. This is what is considered to be
appropriate and acceptable medical practice.
Q. And how is tha.t determined, as you
understand it?
A. Very softly. ft's not a nice crisp black
and white issue. It's -- J don't believe it's
community standard. I don't believe that Idaho law
now supports community standard. I think it's more
national scientific standard, And l would defer here
to the scientific literature, the Federation of State
Medical Boards, the American Pain Society documents,
of which I'm an author of some, Federal Clinical
Practice Guidelines, of which I'm an author of some,
standard textbooks, of which I'm author of some, And
they all consistently say with methadone you've got
to titrate slowly.
Q. With respect to it being whether a

not something you would -A. On Monday or on Sunday?
11
Q. On Monday. It's my understanding that
12 whether it was Sunday or Monday, that initial
l3 increase is not something that you have a criticism
10

of?

9

1O
11
12

13

15
A. Well, you know, you bring this up again,
16 and l have to qualify my statement again. I would
17 not do that, I would not consider that to be optimal
18 therapy. You're asking me, again, to make a judgment
19 on a very gray issue as a black-and-white issue, and
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r know why and I understand the law and I understand
the issue of probability. Is it more probable than
not that she would be at greater respiratory risk
with a doubling from 5 to JO? You bet it is. ls it
safer? Is it clearly much safer to have stayed at 5
until you reach steady state before going to l 0?

21

22
23
24

25
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Absolutely, Would l, as a clinician, as somebody who
teaches people how to do this, have a few hairs on my
head go up on end if somebody had made one increase
4
in the first 24 to 48 hours? Probably not. But I
5 would have said, Hey, you know, that's it. You don't
6 do another increase until at least five more days,
7 You're pushing it right now, And make sure that this
1

2
3

8

patient understands that there's a risk, there1s a

9

real risk with this.

10
Also, if this patient has a preexisting
11 risk factor for respiratory depression, which by
12 definition obstructive sleep apnea is even with CPAP,
13 nobody can say that because she'd on CPAP, she's

14 clear. That's absolutely untrue. She's much safer
taking CPAP with CPAP than if she hadn't had CPAP,
but she still has an increased risk, Our lady was
overweight. That's an increased risk factor. Of
course, that contributed to her obstructive sleep
apnea. She had some cardiac dysfunction, That
20 increases her risk. How much? I don't know. Let
21 the cardiologists fight that one out. This is a lady
22 who had risk factors. This is a not a lady in whom
23 you're aggressive in titrating up methadone.
24
Q. But with respect to an initial increase,
2 5 that would not be something that would be below the
15
16
17
18
19

11
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1 national or community standard of care, you know, if
2 we were to inform you that a community standard care
3 is actually what's required in Idaho, how would you
4 define what the appropriate and acceptable standard
5 of care would be for Twin Falls in September and
6 October of2003?
7
A, Since the majority of physicians
8 practicing in Idaho went to medical school in Utah
9 and since the majority of anesthesiologists
10 practicing in Idaho did their residencies in Utah, I
11 would say it's what's being taught at the University
i2 ofUtah.
13
Q. Okay, And I understand that you have
14 spoken to Dr. Vorse about the standard ofcare. ls
l 5 that accurate?
16
A. You know, I don't -- I remember talking to
l 7 her about the patient. I don't know that we talked
18 about standard of care. I know that we talked about
19 standard of care with· the other Idaho
20 anesthesiologist whose name I can't recall.
21
MR. FOSTER: Flinders.
22
THE WITNESS: Flinders. Thank you.
Q. (BY MS. DUKE) Let me hand you Exhibit 4,
23
24 if you could just read that.
25
A. Okay. Then we did talk about it.
····,·,< ··'
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Q. So I've handed you your supplemental
affidavit of Arthur G. Lipman, Pharm,D., and it
indicates that you did speak with Dr. Vorse -A, Yes.
Q, -- with respect to the standard of care in
Twin Falls in September of2003 regarding
Mrs. Schmechel?
A. Actually, we did, because we talked about
whether or not the care that she received was within
appropriate guidelines, which is the standard of
care. So, yes, that is true,
Q. Did Dr. Vorse provide any statements to
you or make any statements as to whether she felt the
care provided to Mrs. Schmechel by the Southern Idaho
Pain Institute fell below the standard of care?
A, I.don't recall.
Q. Rather, it sounds like you and she just
had a general discussion of, you know, l really think
there's nothing different from what you do in Utah
than what I do here in Sun Valley?
A. Oh, sure, That was the case, and I've had
that conversation with both her and with
Dr. Flinders. And the other issue is that we were
talking specifically about Mrs. Schmechel and about
what was necessary in her care and about •• you know,
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from Twin Falls?
A. Yes.
Q, You understand that's a different

community?
A.

Yes.
Did she tell you how she felt she was
knowledgeable with respect to the Twin Falls
standard?
A. Yeah. There's Idaho State Medical
Society. There's Idaho anesthesia group, These
people talk with each other. They meet periodically.
In fact, they usually meet over in Sun Valley.
Q, Those are things she told you?
A, I know they meet in Sun Valley because
I've spoken to the groups up there. But she told me,
yes, that she talks with the other people in the
state.
Q. And that she believed she was familiar
with the standard of care?
A. Yes.
Q. Then you talked to Dr. Flinders, as l
understand it.
A, Yes.
Q. With respect to Dr. Flinders, what was
your purpose in talking to him?

Q.
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and Dr. Vorse, as I recall -- and as l say, this was
how many months ago. l don't recall the exact
details, July 2005. That's two years ago -- two
years ago? ls ti1at right? The issue is that, you
know, how rapidly can you titrate up methadone? You
can't. You've got to go slow, And when you've got a
patient who's already got respiratory disease, you've
got to be even more conservative, It's better to err
in the interest of being conservative and using a
short-acting medication to cover her. That's most
probably what we talked about.
Q. Okay. Do you recall for certain what was
discussed?
A. J know that we talked about what is
reasonable care and the risks of methadone. I'm
quite -- l do believe that we also discussed the
wisdom of using a shatter acting as opposed to a
longer acting. That would be my recollection, Let
me clarify that, Using more of the shorter acting
rather than increasing the dose of the methadone.
Methadone is fine if used properly.
Q. And did you understand where she
practiced?
A. In Ketchum.
Q. And do you understand how far away that is
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A, Well, it was Dr. Flinders, Dr. Lordon, and
I were on the call to basically see ifwe agreed on
the pharmacokinetic and scientific issues and whether
the standard of practice was the same in Idaho and
Utah. Now, on that, of course, as far as the
practice of pain medicine and anesthesiology,
Dr, Lordon as a Utah practicing anesthesiologist and
Dr. Flinders as an Idaho practicing anesthesiologist
were able to compare notes on that. And they
certainly agreed and l concurred. But it was their
agreement that the standard was me same.
Q. Okay, And if you look at Exhibit 5, which
is your second supplemental affidavit, it's my
understanding -- well, stdke that,
Does Exhibit 5 accurately reflect what
you, Dr. Lordon, and Dr. Flinders discussed? I think
it starts about paragraph 5.
A. It does. Yes. Yes, One of lhe questions
was what did they as practicing physicians think was
necessary in records to be obtained for the patient.
And they both felt very strongly that they would not
treat a patient such as Mrs. Schmechel without
getting infom1ation from the previous treating --

prior treating physician, in this case Dr, Vorse.
Q. f m putting sheets away as we re done so
1

1
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we can finish here.
You indicated, when we were having you
articulate your opinions in this case 1 you were
talking about the titration schedule, and you
testified that there is a 50 percent reduction for
methadone today.
A. I'm sony?
Q. There's a 50 percent reduction for
methadone today when they rotate the doses.
A. Well, that's common practice among thought
leaders in the field.
Q. Does that mean if you're on the 60
milligrams of -A. Let me clarify. That's not just
methadone. That is when converting from opioid A to
opioid B -Q. B, okay.
A. -- using the dose equivalency tables, that
you would not convert at an equivalent dose. You
would convert at half the equivalent dose.
Q. And that applies for all opioids?
A. Yes.
Q. Including methadone?
A. Yes.
Q. And so today if you're on 60 milligrams of

1

concern. It's part of the entire gestalt, again, but

2
3

ies not the major concern.

Q. And I know it's difficult per what you're
saying to necessarily take those out piece by piece,
5 but, obviously, I need to from my standpoint. When
6 we do look at the issue of -7
A. Had the titration been appropriate, the
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monitoring would not be an issue.
Q. Okay. Explain that to me.
A. Had the dose not been increased on a daily
basis in those first few days, I would not have been
concerned about the level of monitoring tliat was
provided. If we're going to increase a drug like
methadone that quickly, I'd want to have the patient
in a closely monitored situation. We would not
increase the dose that quickly. It's never necessary
to increase the dose of methadone that quickly. We
have alternative drugs to use ifwe have to increase
it quickly.
Q. Okay. Soifhehadstartedheron JO or
15 milligrams twice a day, what monitoring would you
have expected would have been required by the
standard of care for him to do?
A. We'd certainly want to know within two
days how she was doing as far as her comfort level,
Page 149
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OxyContin and you're going to start a person on
methadone, you'd be looking at 30 milligrams?
A. Well, no, because those are not a

one-to-one conversion.
Q. Okay.
A. But I'd be looking at 50 percent of the
equivalent dose. The problem with methadone is we
don1t have a nice clean equivalent dose, We have one
for morphine. We have one for hydromorphone, for
oxymorphone, for hydrocodone. We don't have one for
methadone. So when we don't have it, we have to err
toward conservatism, which is -- and I have -- again,
IO milligrams twice a day was a very reasonable
starting dose. Was it the right dose? Nobody knows.
ls it a reasonable dose? Absolutely. But you've got
to give it five days at that dose before you know
what the net analgesia and respiratory risk is going
to be before increasing it,
Q. With respect to your opinions in this
case, are you in any way critical with respect to the
monitoring that Mr. Byrne provided to Mrs. Schmechel?
A. I'm not really completely clear on the
monitoring. That's not my because there appears
to be some disagreement as to whether or not certain
conversations took place, That's not my major
vv
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as far as any side effects. We'd want to -- and my
understanding is that he did do this, you know, that
there was some communication. We'd want to make sure/'
the patient knows how to reach him, if necessary,
should she have any difficulties. That's often a
real issue over the weekend, but it sounds like he
may have been able to make himself available.
Monitoring is not the issue, as 1 said.
lfthe dose had stayed consistent at that starting
point, then I think his communication with her was
perfectly adequate. He could not judge difficulty
she's going to be getting in very well over the
telephone. He would have to see her. He would have
to check her respiratory function, check whether
she's sedated, whether she's cognitively impaired,
issues like that, which is often difficult for the
patient to subjectively determine.
Q. So if it hadn't been for the titration,
his monitoring was fine?
A. Yes,
Q. And then with respect to the titration and
monitoring, what monitoring should he have done given
the initiation and titration of the therapy that he
was providing for her?
A. I don't think he could safely treat her
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the way he treated her with the daily -- with the
daily increases. That could not be done safely no
matter what monitoring he did on an outpatient athome patient. That would have required inpatient
hospitalization, totally cost ineffective, clinically
inappropriate.
Q, And so it would have required inpatient?
A, Yeah, which is not going to be done. It's
not going to be paid for by any insurance plan. So
he should have not increased the dose of the
methadone and given her more of the short acting to
cover her.
Q. Okay.
A. In case you 1ve noticed 1 rve been saying
that consistently,
Q, With respect to the dosing instructions
that he did provide her, l know we've talked about
those.
(EXHlBff-10 WAS MARKED.)
Q, (BY MS. DUKE) You've been handed what's
been marked as Exhibit Number l 0. Do you understand
these to be the written dosing instroctions that
Mr. Byrne provided to Mrs. Schmechel?
A. Very interesting. This is different than
what he wrote in his chart note. He wrote in his
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Mrs, Schmechel?
A. On this piece of paper, yes,
Q, Okay. So, obviously, you've seen these,
Exhibit I 0. And then you've also seen what he wrote
in Exhibit 9 with respect to dosing?
A. Can l take a look at that?
Q. Yeah. You have Exhibit 9.
A, Thank you, And that's page number -Q. Dille 16.
A. Thank you, Okay. "Will discontinue
OxyContin and start her on methadone IO milligram
q.12 titrated from 5 up to a maximum of l 5 over the
next 72 hours, 11 No, he did not write over the next
72 hours on the sheet that he gave her.
Now, reading this, I could read this and
say, Well, gee, if one-half didn't work and I can go
up to one-and-a-half and I take one-halfon Friday
evening, maybe I'll take one-and-a-half on Saturday
morning, 1 don't know if that's what she did, but
that would be consistent with what he wrote and gave
her. That would be incredibly dangerous. But he did
write over the next 72 hours,
I've seen patients clearly who have had
instructions to take their antibiotic one twice a
day -- had a police lieutenant. His instructions for
Page 153
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chart note decreased the amitriptyline to 50
mllligrams, and here he wrote decreased to 75,
another indication of poor record keeping.
"Methadone 1/2 - l pill every 12 hours,
May increase to maximum 1-1/2 pills every 12 hours,"
May increase over what period of time? Can you go
from one-ha If to 1- 1/2? That's a 300 percent
increase, 200 percent increase. Hydrocodone, three
to four a day is grossly inadequate. This is a
medication with a four-hour duration. When starting
methadone, especially when starting it at an
inadequate schedule of twice day, she should have had
that available six times a day, not three to four
times a day, He's putting her at major respiratory
risk by giving her higher peaks of the hydrocodone
less frequently rather than giving her lower peaks
more frequently that would not approach the toxic
threshold as much,
So that would exacerbate her respiratmy
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2 O risk because, remember, he increased the dose of that
21 by 25 percent. Dr. Vorse had her on 75 milligrams --

22 7.5 milligram, and Byrne changed it to 10 milligrams
2 3 of hydrocodone per dose,
24
Q. My question was: Are these the dosing
25 instructions that you 1ve seen from him to
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a serious infection, take one tablet twice a day for
a week, He took one at 8:00 in the morning and he
took the next one at 10:00 in the morning when he had
his next cup of coffee. He was following the label
on the prescription. He didn't understand that one
twice a day meant once 12 hours apart, which is
pharmaco- kinetically necessary for that antibiotic,
It would not -- an intelligent person could actually
misread this or could misunderstand this to think you
could just take a half. If that's not adequate, go
right to one-and-a-half. If this is what he gave
her, that 1s dangerous.
Q. Okay, And so if you look at this, Exhibit
l 0, 1 guess summarize what your criticisms would be
with respect to what he's written there regarding
methadone.
A, He didn't specify a timeline, and it was a
very rapid titration, And she could easily misread
this from going from one-half tablet or one tablet,
whichever she decided her first dose, and go right up
on the next dose to one-and-a-half.
Q. But you would agree that he provides a
timeline from the standpoint of saying every 12
hours, So that would be twice a day?
A. Thal he did, but he didn't say when she

.
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could increase and could she increase on the second

1

dose 12 hours after the first dose.
Q. Right. But this is different than your
police lieutenant example that you just gave.
A. Oh, yeah. I'm just pointing -- you
understand the analogy that I was making.
Q. I do, but l wanted to make sure it wasn't
one you're applying to what he did here.
A. Oh 1 no, no,
Q. S0-A. I'm just pointing outthat reasonably
intelligent thinking people can make very serious
mistakes in dosing ifwe don't give them very clear

2
3

instruction.
Now, the other issue that concerns me is

16 that the prescription bottle that she had said take
17 one tablet twice a day or one -- I don't know. No.
18 lt actually said 30 tablets. I haven't seen the
19 label. Do we have that label available? I
2o

21

22
23
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understand it was being requested. Because -Q. I don't have it with me.
A. -- it was for 30 tablets and it said on
the pharmacy printout 90 tablets to be taken in 30
days.
MR. FOSTER: One-and-a-half two times

A.

Well, he has no rationale for decreasing

it in his record. This is a lady who had spinal cord

issues, and she clearly had neuropathic pain.
Amitriptyline is not a drug of choice for neuropathic
5 pain, It's in the literature. It has too many side
6 effects. And there are preferred drugs, but that
7 class of drug is a drug of choice. If you're going
8 to use the drug, the optimal dose is 100 milligrams.
9 There's no rationale for his decreasing it that he
1 o documented. Ifhe pointed out that she had urinary
4

11 retention or blurred vision or dizziness or sedation
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or constipation, which are side effects of that class
of drug, then the correct thing would have been to
change her from amitriptyline to desiprarnine that has
one-quarter those effects, or the same efficacy. He
simply decreased the dose. Now, Hare and others were
not critical of that.
Q. And that's what l was going to ask you. I
mean, I understand that that might not have been the
approach that you would have taken, but you're not
saying that's a breach of the standard of care, are
you?
A. lt would be pushing it to say that's a
breach of die standard of care. Was it indicative of
unsophisticated, sloppy medicine? Yes.
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daily. That's what she told him.
THE WITNESS: So the label said
one-and-a-half two times daily.
Q. (BY MS. DUKE) Okay.
A. And the wlitten instructions say take from
one-half to one-and-a-half Now, does this mean that
she actually -- if she followed the label on the
presciiption bottle, which most studies of patient
adherence -- we used to call it compliance -- so that
the most telling instruction -- patients are
notorious for not remembering what they were told in
the doctor's office. And the most common thing that
they follow is the prescription label. So she may
well have started out at one-and-a-half right away.
l don't know.

15
16
Q. Okay, Any other criticisms with respect
17 to the methadone -18
A. I think that's enough.

19

Q.

20
21
22

A.

-- on Exhibit l 0?
No.
Q. And then with respect to the
amhTiptyline, I know that you testified earlier that
23 you were critical of him decreasing it, and rather,
24 he should have rotated her off of the amitriptyline
25 and put her on something different?
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Q.

not going to say it's a breach of the standard of
care. I'm going to say it's poor quality medicine.
If poor quality medicine is a breach of the standard
of care, I'll leave that to people more expert than I
in defining what is the standard of care.
Q. Well, and let me follow up on that. I
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But you're not saying that's a breach of

the standard of care, correct?
A. l can't answer it in that context so Pm

with respect to your opinions in this case,

with respect to the standard of care that applied in
Twin Falls, Idaho in September and October of 2003,
with respect to the treatment to patients such as
Mrs. Schmechel, based on your understanding of the
standard of care, would that have been a departure of
the standard of care to decrease the amitriptyline,
or do you know?
A. I don't know. J'll leave that one -Q. Okay.
A. -- as an unknown. Thank you.
Q. And then on the hydrocodone, with respect
lo increasing it to 10/500 -- I understand the 10 is
the hydrocodone part of it.
A. Correct.
Q. The 500 is the acetaminophen -- three to
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clear.

2

2

Q. Okay.
A. Patients frequently will tell us they're
doing better than they are for a variety of reasons,
including hopefulness on their part. I honestly
don't know what occurred here.
Q. Okay. But I guess what I'm getting to is
you have no reason to discount that, you know, she
reported that she was doing well to Mr. Byrne?
A. That she was doing better, that she was
getting some analgesia. I don't discount that.
Q. Correct. Okay. And, in this case, you're
not in any way alleging that she was drug seeking,
correct?
A. No, I'm not.
Q. And you ce1tainly have no reason to
believe that she was dishonest with Mr. Byrne -A. No.
Q. .. correct?
A. Correct.
Q. I didn't ask that very well. And you
agree that she was ready for a change in her pain

four times a day, you believe that's inadequate?
A. Absolutely.
3
Q. Because she could have had it up to six
4 times a day?
5
A. She would need it more frequently than
6 three to four times a day.
7
Q. But with respect to that, is that
8 something tbat you foe] is a breach of the standard
9 of care in Twin Falls, Idaho in September and October
10 of2003? And if you don't know, then that's your
11 answer.
12
A. I have to say I don't know because that's
13 a •• that's a legal call as opposed to a scientific

14

call. If you ask me is that quality medicine

4

s
6
.7
8

9
1o
11

12

13
14.

15 consistent with the science, the answer is no. I
16 need your help in defining whether that's a breach of
17

3

the standard of care.

15
16
17

18
Q. Now, you're aware that he followed up with
19 Mrs. Schmechel, Mr. Byrne followed up with

18
19

2 O Mrs. Schmechel on Monday and Tuesday, correct?
21
A. Yes.
22
Q. And that she was responding well to the
23 therapy?
24
A. I saw that noted that he telephoned her
2 5 and she said she was doing better.

2o

21

22

23 management regimen?
24
A. I believe she was requesting a change in
25

her pain management medicine -- regimen,
Page 161 ·
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Q. I mean, you certainly have no reason to
not believe that Mrs. Schmechel reported that she
felt that she was doing well on the medications,
correct?
A. Let me go back to our graphic. If,
indeed, she had stayed at the same dose, let alone
increasing it, and if she were here and those doses
would have brought the analgesia up to here, she
would have said, Yes, I'm doing better. But she's
still not at the maximum toxicity. So the toxicity,
even without any medication at all, and she was
taking additional medication, the toxicity would have
continued to increase.
Q, I understand, but my question is: You're
certainly not saying that there1s any reason to not
believe or trust what's contained in the medical
records when it's reported thal 1 you know,
Mrs. Schmechel -A. Said she was doing better.
Q -- said she was doing better?
A. However, there was a-~ there was
something from her family that they felt that she
was .. she had some problems that she was not being
forthright with them. Now, whether that related to
her lower limb edema or her general outcomes, l'm not

1
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Q. And that was because what she was on was
not working for her?
A. By her report. Now, Dr. Vorse's note
indicated that Mrs. Schmechel had been titrated to
what Dr. Vorse at that point-- this was months
earlier .. but at that point Dr. Vorse considered to
be -· provide a reasonable risk/benefit ratio, I
didn't know Mrs. Schmechel. I never interviewed her.
I can't make a judgment as to whether she was at a
reasonable treatment level. One ofmy serious
criticisms of Mr. Byrne is that he didn't discuss
this with Dr. Vorse before making tbe change, and he
di<ln'I know. ).)r. Vorse might have told him some
things that would have markedly influenced his
decision.
Q, And do you know any of those things that
could have markedly influenced the decision, or is
that just speculation?
A. That's speculation. But it's a reflection
on the clinical necessity of his having contacted her
before changing the regimen.
Q. But going back to my question two
questions ago, you do agree that she was ready for a
change in her pain management regimen?
A. She thought she was, yes.
.....
······"·" ,...., .....,_,, ...,....,.. "_.. ,,..,,.,,,,.- ··-···
•"','
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Q, And she certainly had a right to be
treated and to have someone try to get her out of

pain?
A.

Certainly.
Q, She was not opioid naive?
A, Correct.
Q. She had been receiving chronic opioid
therapy for several years?
A. But now I have to apply a little more
sophisticated phamrncology than I would expect
Mr. Byrne to necessarily be on lop of. She was not
opioid naive, but she was methadone naive.
Q. I understand.
A. That's an impo11ant difference.
Q. But she had been receiving chronic opioid

16 therapy for several years 1 conect?
A. Certainly.
18
Q. She had been on OxyContin for several
19 years?
20
A. Yes.
21
Q. And hydrocodone for several years?
22
A, Correct.
23
Q. Did she have pulmonary dysfunction?
24
A. She had respiratory impainnent. I'm not
2 5 in a position to comment whether she had pulmonary
17
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1
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4

as a medical provider that's a patient responsibility
to follow the advice of their practitioner?
A. Well, I think it's a dual responsibility
between the provider and the patient, and there has

5 to be an agreement. There1s an implicit contract.
And in many cases there s an explicit medication
management agreement attorneys advise us not to
s call it a contract·· which, in fact, Dr. Dille did
9 speak to in his testimony. It has to be two way, It
1 o can't be just one way. It is absolutely the
1

6
7

11

¥~

provider's responsibility to assess the probability

12 of the patient's adherence and to adjust therapy
13 accordingly.
14
Q. Right. But it's also the patient's
15 responsibility to follow their practitioner's advice?
16
A. As I said, it's a two-way obligation, yes.
17
Q. Okay. And certainly a responsibility the
1 B patient has is lo call or to contact the provider if

19 they have any questions or problems?
A. It is the obligation of the provider to
21 explicitly tell the patient to call if you have any
2 2 questions, and then it is ce,iainly the patient's
2 3 responsibility to do so.
24
Q. And it's also the responsibility of the
2 5 patient to report how they are doing in an honest
20
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dysfunction.
Q. Okay. Would you agree that in 2003 there
was no infonnation generally available to pain
management providers that there was any special
concern or problem with methadone in patients who had
obstructive sleep apnea versus any other opioids?
A. Correct. I qualify that by saying that
all opioids have the concern. Methadone is not a
different drug.
Q. Right. Okay. So OxyContin would have the
same concern?
A. Correct.
Q. Would you agree that ii was reasonable for
Mr. Byrne to believe that Mrs. Schmechel was
following his advice?
MR. FOSTER: Object to the fonn,
THE WITNESS: I cannot agree or disagree
with that because he had just met her. He did not
have an established relationship with her.
Therapeutic relationships take time to build. This
is another reason why it was important for him to
talk to Dr. Vorse to get her sense of whether
Mrs, Sehmechel was adherent with her physician's
inslructions.
Q. (BY MS. DUKE) Okay. But you would agree

Page 165
l

fashion so that the medical provider can accurately

2 understand what1s going on?
3
A. Certainly, And, again, it's the
4

5
6
7
8
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10
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17
18
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23
24

25

provider's responsibility to assess the probability
of the patient reporting that in an honest fashion
and adjust therapy accordingly.
Q. Would yon, based upon your review of the
records that you reviewed from Mrs. Schmechel,
believe that she was a patient who was compliant?
A. I believe so.
Q. With respect to the cause of death, I know
that you testified earlier that the cause of death is
uncertain, but that you believe some potential causes

,..

are more certain than others.
A. Yeah. l want to make sure that's in
context.
Q. Okay. I can just ask that.
A. Okay. Reas'k that.
Q. I was trying to ..
MR. FOSTER: I want to object to
something.
Q. (BY MS. DUKE) Yeah, exactly. I was
trying to cut to the chase, and l'll just ask you it
rather than do that, What's your opinion with
respect to Mrs. Schmechel's cause of death? Is that

.....,,,.:- ,,,-,,, ;,··.•,,••,, ,._,._ .,, .., .... -~·--"···· . - ...
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something you're rendering an opinion on?
A. Yes.
MR. HIPPLER: And I will object to that
one on foundation.
THE WITNESS: We've got everybody awake
now.
Yes. I can only do this on the
probabilities, on the pha,macological probabilities.
Ruling out other lethal morbidity which is
inconsistent with the medical examiner1s report and
the records that r read, I conclude that the most
probable cause, more probable than not, is the
accumulation toxicity of methadone causing
respiratory depression. Unquestionably her
comorbidities contributed to this. Unequivocally, it
is the provider's responsibility to consider
cornorbidities whenever prescribing a medication.
And, therefore, I conclude that the major causation
is methadone associated.
Q. (BY MS. DUKE) And so rather than just
adopting the pathologist's opinion, you have your own
independent opinion?
A, Oh, absolutely. Pathologist didn't refer
to pharmacokinetics, to risk of accumulation
toxicity. This is an area that I'm well aware, that

1
2
3
4

Q. Okay. But I guess what I'm trying to
understand, and maybe you just said this, but it's my
understanding that when you take blood out of someone
who's deceased and analyze it with respect to

5 methadone, you're actually going to see an increase.
6
A. Heart blood, not peripheral blood, f
7 don't recall -8
9

10
11

12
13
14

15
16
17
18
19
2o

21
22
23
24

25

Q.
A.

Peripheral meaning femoral or -Yeah.
Q. With respect to the blood here -- okay.
So what you're saying is you're not going to have the
increase in methadone in a deceased person's blood if
you're taking it out of the femoral versus if you're
taking it from the heart?
A. Yeah. You won'! see as much ofa shift.
Again, I'm going to defer on this to toxicologists.
Q. Okay.
A. I work with patients, not cadavers.
Q. Okay, Your patients are probably happy
about that.
A. They prefer to be patients than cadavers,
yeah.
Q. All right. So you would defer to a
toxicologist-A. Yes.
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1
2
3

I published in.
Q. With respect to methadone levels, is it
your understanding that when a patient expires and
4 they've been taking methadone, that the level of
5 methadone in their blood will actually increase?
6
A. Depends on which blood. You have central
7 blood and you have peripheral blood.
8
Q, Con-ect.
9
A. So there would be a central pooling
10 effect.
11
Q. And what does "central pooling effect"
12 mean?
13
A. Well, the drug is going to be in a higher
14 level in the central, in the heart blood. But you've
15 got to realize again that the scrum levels in a
16 living patient or posunorlem do not directly
17 correlate with clinical outcomes. Again) they're
18 highly variable, huge inlerpatient variability. So
19 the numbers that you have in -- what's his name?
20 Standard textbooks. The numbers that you pull out
21 there are, again) based on population averages that
22 may or may not apply to an individual. It's the
23 clinical course and the temporal relationships that
24 matter. And that's the basis ofmy judgment.
25 Certainly, they're supported by the findings on post.
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Q. ~- or someone else on that issue?
A. But of note, the postmortem data -- report
that I read is certainly consistent with what l would
have expected and what I concluded pharmacokinetically, It is not the basis ofmy
determination.
Q. And why do you say the postmortem data is
supportive of your opinion? I think that that's
under here somewhere.
A. Well, ifwe had very low methadone levels,
for example, that would have been inconsistent.
Q, Well, what were her methadone levels?
A. I'd have lo look in the report.
Q. I think that's right here.
A, Or is it this one?
Q, I knew it was under there. I just don't
know which one.
A. Yeah. It was femoral blood that he looked
at. And the conclusion which Dr. Grobin, the
forensic pathologist, reached was that it was
combined hydrocodone and methadone. That's
completely consistent with what I said earlier. I
didn't recall that, frankly. I read this a long time
ago. This was nol my determination. My
detennination was based on the science and what I
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read. But you recall that I talked about going to a
I 0-milligram versus a seven-and-a-half-milligram
hydrocodone dose getting a higher peak, which would
increase the risk. And as I look here at his
hydrocodone levels, they were significant. And he
sees it as a combined combination. He knows that the
methadone concentration is within the lower range of
no lethal concentrations. He did look a peripheral,
not heart blood, so central pooling would not be in
effect here. Jf anything, you'd lose some in the
peripheral because when it centrally pools, you lose
it from the periphery to the heart blood. So, again,
the Twin Falls County coroncrreport and the forensic
pathologist's report are consistent with what I
concluded based on the pharmacokinetics.
Q. Okay. But the question is: What did you
understand the level of methadone to have been in her
blood at the time of death?
A. He had a number there which I have to look
in the standard text to see if that's consistent.
Q. Okay.
A. My understanding is consistent with a
lower level of lethality.
Q. But as you sit here today, you don't know?
A. I did look that up at the time, and my
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blood in and of itself does not lead you to tl1at
conclusion) correct?
A. It doesn't lead me to the conclusion
because l'm not a forensic toxicologist. It may well
lead a forensic toxicologist to that conclusion.
From a viewpoint of pharmacotherapy pharmacokinetics, '
I've already concluded that. This supports my

contention.
Q. Right. But from your position, that
figure in and of itself is not enough to bring you to
your conclusion?
A. I did not base my conclusion on that
figure unto itself. I am not a forensic
toxicologist.
Q. And the hydrocodone level, is that the
same with that?
A. Same.
Q. Okay. And so when we read in these
repo1is that it says, you know, a lethal amount, that
doesn't mean that that in and of itself was the cause
of death. I mean, you could have a person, you know,
taken 15 milligrams twice a day and be hit by a car
and be killed because of that.
A. Sure.
Q. But have lethal levels of methadone and

Page 171

1
2
3
4

5
6

7

a
9

1o
11
12

13
14

15

16
17

18
19
20
21

recollection is that's correct.
Q. And when you say it's a lower level of
lethality, what does that mean?
A. Well, when we look at methadone deaths
reported in the literature, and there's a large
literature on this, we see a broad range of what had
been reported as levels found on postmortem
examination. A level of .3 nanograms that we had
here was certainly consistent with other reports of
lethal methadone doses, levels. That doesn't mean
that you or I could not have that level and be alive
and breathing, and that somebody else may have a
lower level and still die from it. It's not
definitive. That level does not by itself say -Q. Okay.
A. ·- that the patient died of methadone.
But add to that the level ofhydrocodone, add to that
the temporal relationship, the rapidity of the
titration, and you put it all together and you have
to -- I'm dealing with science and probabilities
here. And it says to me that the leading probable
cause, and certainly more probable than not, was

22
23 opioid toxicity, largely methadone) some contribution
24 by the hydrocodone.
25
Q. But you agree the methadone level in her

Page 173

·1
2

3
4

5
6

7
8

9
1o

11
1.2

13
14
15

16
17
18
19

2o
21

22
23
24

hydrocodone in their blood but not have that be the
reason for their death?
MR. FOSTER: Object to the form.
THE WITNESS: The best way that l can
answer that is by saying that did not-· I cannot and
do not conclude on the basis of that report alone
that methadone was the cause of death. I have read
autopsy reports that said that an opioid was the
cause of death when J agreed with that because the
clinical course and the phannacokinetics of the
opioid dosing was inconsistent with that being
causative.
ln this case this is strongly supportive
of what I concluded based on my knowledge of the
properties of this drug and the way it was dosed.
Q. (BY MS. DUKE) And so what are, I guess,
the factors that you considered in concluding that
you believe that she died as a result of methadnne or
hydrocodone or both?
A. Both, primarily methadone. Straightforward accumulation toxicity based on the
pharmacokinetics of the drug, that she was moving
rapidly toward both analgesia and respiratory

toxicity. Dose increases exceeded the safe time

25 interval resulting in increasing toxicity. She was
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probably pretty eomfo1table when she stopped
breathing.
Q. As l understand it in this case, you 1re
not saying that Mr. Byrne was not appropriately
trained or experienced as a physician assistant; is
that cotTect?
A. I don't know the answer to that. 1 don't
know-- I don't recall where he went to P.A.
training. As I recal1 1 it was some private program
back East. I've been involved in P.A. training from
the beginning. I'm aware of the incredible
variability of n·aining programs and particularly in
what the P.A. students learn in phannacology. I
conclude that he did not know enough about methadone
to use it safely.
Q. That l understand. Bui from an overall
global standpoint -A. I can't comment.
Q. Okay. You would agree that he was trying
to help her?
A. Absolutely.
Q. And that he certainly did not want this
outcome to occur?
A. Absolutely. And l would not support any
c1iminal action against him on the basis of what
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years ago or, more commonly, the people who teach
them their pharmacology were trained so much earlier
and. are not up-to-date. So we still have a lot of
people being taught out-of-date concepts. But the
real growth in the science of pain pathophysiology
'
and pharmacotherapy has been going on since the
1970s.
Q. (BY MS. DUKE) Do you believe that today
you !mow more about methadone than back in 2003 with :
respect to its use?
MR. FOSTER: Object to the form.
THE WITNESS: I have more data to supporr
'
what I believed then. 1 don't believe that my ideas
about methadone have changed at all between the late
nineties and now. The science was there in the late
nineties. We now have much more clinical
documentation of what the science supported at that
time.
Q. (BY MS. DUKE) And a lot of that clinical
documentation, you 1ve mentioned some ofit today) the
2007 FDA-A. Yes.
Q. -- issue with respect to methadone.
A. 2005 CDC.
Q. 2005 CDC.
Page 177,
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OCCUl1'ed.

·1

Q.

2

Do you believe he was trying to do what he
believed was appropriate based on his clinical
judgment?
MR. FOSTER: Object to the form.
THE WITNESS: Yes.
Q. (BY MS. DUKE) And··
A. So was Ted Bundy.
MR. HIPPLER: Move to strike.
MS. DUKE: Join.
THE WITNESS: Can I join that?
Q. (BY MS. DUKE) Taking the infom,ation and
knowledge that one may have had back in 2003 with
respect to methadone, you would agree that clinical
research in pain management is proceeding at an
unprecedented rate?
MR. FOSTER: Object to the fonn.
Q. (BY MS. DUKE) And important information
is continually coming to light with respect to pain
management?
MR. FOSTER: Same objection.
THE WITNESS: No. It's been moving at a
pretty good rate for about the past 20 years. 171e
problem is that the vast majority of clinicians in
practice today either were trained longer than 20
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A. But a lot of this occurred before 2003.
Q. But the publications related to
summarizing information you would agree were coming
out in the 2005, 2006, 2007?
A. No. I don't agree we that. There's been
more subsequent to 2003, but there certainly was
enough information out there prior to 2003 tha( we
knew what to do. Even the package labeling for
methadone cautions about slow titration and did in
2003.
Q. And, 1 guess, what do you define to be
slow titration in 2003 with methadone?
A. Well, by definition the time to steady
state serum levels. This is a pharmacokinetics l Ol
concept. I mean 1 there 1s a lot of sophisticated
phannacokinetics that gets into very extensive
mathematical modeling. We don't expect clinicians to
know that. We absolutely expect clinicians to know
the basic 101 principles. This is one of the very
early 101 principles.
Q. Okay. So how do you define it again? l
didn't get it all written down, slow titration.
-· A. You don't increase the dose until you 1re
at steady state serum level, five half-lifes, five
elimination half-lifes.
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Q.
titration
2003 as
A.

Q,

And would that definition of slow
with respect lo n1ethadone be the same in
it is today?
Yes.
Okay.

A. H's more visible today because of more
reports of death, but it w,is in the literature, it

was i11 the labeling, and it was in normative practice
in 2003,
Q. What was in the labeling was just slow

11 titration) correct?
A. Correct.
Q. Not a definition ofwhal that meant?
A. It's important to recognize that the
15 label, labeling, which, by federal law, is the
16 package insert from the FDC Act, that that is not
17 intended for the layman. Thal is intended for the
1s trained health professional. Again, I'm referring
1. 9 now to the federal law, code federal regulations.
2 D And it explicitly says that this is to be interpreted
21 by a trained health professional who has the
22 scientific understanding to know what it means.
2 3 Therefore, any trained, licensed health professional,
24 including a P.A., would, by law and by standard of
25 practice, be obligated to understand the principles
12
13
14
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Q. Okay. In providing your opinions, do you
believe that Mr. Byrne's actions rose lo the level of
reckless conduct?
A. I don't know the definition of "reckless
conduct. 11

Q,

That's what l was going to ask you is,

7 obviously, if you said yes, what do you understand
8 reckless to mean, So is it fair to assume that you
9 are not taking the position one way or the other as
10 to whether this was negligent conduct or reckless

11 conduct?
A. l can't take a position until the terms
are defined. I don't !mow what they mean.
Q. So at this point today you have not
15 rendered an opinion in that regard?
16
A. That's correct.
17
Q. Okay. The final opinion that l noted and
18 you've alluded to, l think, throughout your testimony
19 today is that Dr. Dille failed to supervise and
2 D should have corrected what Mr. Byrne did. rs that an
21 opinion you hold?
22
A. Yes.
23
Q. Okay. And if you could just explain that
24 opinion.
25
A. I found it interesting that this
12
13
14
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before using the medication.
Q. Okay. Other than the label or, you know,
the package insert, what other literature, to your
knowledge, was out there with respect to this concept
of slow titration with respect to methadone?
A. Standard medical textbooks, and f've given
you examples of several previously.
Q. If you could just give some examples.
A. Bonica, B~oMn-i-c-a; Warfield 1
W-a-r-f-i-e-1-d; Tollison, T-o-l-l-i-s-o-n. l wrote
the chapters on opioids in the latter two. I'm
editor for the whole pharmacology section of the new
Bonica. And the one other big one is Mel~ack,
M-e-l-z-a-c-k, and Wall, W-a-1-1. Those are the four
leading pain management textbooks.
Q. All prior to 2003?
A. Yes.
Q. Any other literature or documents that you
believe would suppo,t that position regarding slow
titration of methadone?
A. Everything that l've referred to earlier
in the testimony today.
Q. You mean of literature you've written
and -A. Yes.

1
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11

12
13
14
15
16

l7
18
19
2o

relatively complex patient, due to her comorbidities
and her long history of chronic pain that was not
well controlled, was not seen by Dr. Dille. Now, I
do know the law as ii pertains to physician assistant
practice. l do know that it's a collaborative
practice; that Dr. Dille has the responsibility to be
the supervisor, that he has a responsibility to
review the patient case with the P.A., which he did;
that he is responsible for countersigning the
records, which he did. I just found it surprising
that he was not more actively involved.
l found it totally unacceptable and
contradictory in his own testimony for him to state
that Mr. Byrne provided excellent care to
Mrs. Schmechel, and then he went on to criticize the
care in a few places. He was relatively soft in his
qualification, and l understand why. But he did
comment about the use of the methadone. l don't
remember all the details. l just remember the

contradiction between his use of the word excellenf
11

1

care and his further discussion.
I understand busy practice. I understand
23 what happens when P.A.s are physically remote from
24. the supervising physician. But I also understand the
25 law and the obligation of the supervising physician
21

22
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to be just that. And, unfortunately, I don't think
that really occurred to the necessary level in this
case.
Q, And based on those statements youtve made,
do you believe that Dr. Dille failed to meet the
standard of care in Twin Falls for a physician
practicing in 2003?
MR, HIPPLER: Object to the form.
Foundation,
THE WITNESS: I don't know that I can
speak to that. lam speaking specifically to his
supervision of Mr. Byrne's use of methadone. And I
feel it is highly probable, had there been discussion
of the methadone dosing piior to the way that it was
implemented, that there may have been some additional
consideration as to whether that was the appropriate
regimen.
Q. (BY MS, DUKE) You indicated that you felt
that there were items that Dr. Dille was not
necessarily suppoJ1ive of Mr. Byrne on?
A, That's my recollection,
Q, Okay, What do you recall those being?
A. 1 can't recall the exact statements, It
was in his testimony, I may have that in my notes,
Q, Okay, While you're looking for that, I'll
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Q. Okay. Any other areas where you feel that
Dr. Dille did not support -A. I think that was the one that jumped out
atme.
Q, If we look at your notes which are Exhibit
6, as I understand it, there 1s two versions of these.
One looks like it was a prior, and then you keep
adding to it.
A. Exactly.
Q. Okay.
A So could I suggest that we simply destroy
the earlier version?
Q, I just marked Exhibit 6 as -A Okay, With your pennission I'm going to
destroy my earlier version of this because I -- !his
I printed earlier and the computer note is
up-to-date, This is as of yesterday,
MR. HIPPLER: I prefer that that be
marked.
MS. DUKE: Yeah, You want it marked?
MR. HIPPLER: Well, yeah, If there are
earlier versions, I prefer we see the earlier
versions as well.
.,

THE WITNESS: Yeah, Everylhing that's in
25 the earlier version is in the later version.

/-------~---------------;----------------------~!:
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look through my notes here real quick.
A, I have it here,
Q, Oh, you're referring to Exhibit-·
A No, I'm sorry. I don't.

1
2
3
4

Q, -- 6?

5

A, Yes, He admitted that an increase to 30
milligrams by Saturday would be too rapid an
increase, which contradicts what T,J, Byrne said,
This is on page 29 of Dr, Dille's testimony, And
that's exactly what I concluded,
Q. Let's see, This is on page 3, Okay. [
see what you 1re talking about there.
A, Yeah, I mean, that jumped out at me in
the statement. It was after he had sald) quote, 11 he
handled the care in an excellent fashion," You know,
I -- I'll soften my prior statement that says that
reflects either unacceptable ignorance or dishonesty.
l was shocked by that statement. l think it reflects
denial. This was a tragic outcome and nobody is
minimizing the tragickness of the outcome, It just
is not -- it's just too dam bad that Dr, Dille was
not more actively involved because I -- from what he
said in his testimony and from what is clear to me
scientifically, that had there been a slower
increase, the risk would have been markedly lower.

6

7
a
9
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MR, HIPPLER: I understand, It gives me a
time perspective of your thought process,
MS. DUKE: I'm going to go ahead and have

it marked then.
1

·

THE WITNESS: Yeah. Nothing changed here,
Jt's just more of it.
MR. HIPPLER: That's fine,
(EXHIB!T-11 WAS MARKED,)
(A short recess was taken,)
MS, DUKE: Back on the record,
Q, (BY MS, DUKE) I understand during the
break you had an opportunity to talk to Mr. Foster
with respect to the reckless conduct question, Go
ahead and let me know what you want to say,
A As I said in my earlier testimony, I did
not recall the definition of"reckless," which is why
I couldn't answer it. Mr. Foster reminded me that
the definition apparently under Idaho law is that
Mr. Byrne should have-· either knew or should have
known that his action in this case, his prescribing
of methadone the way he did, could have caused
serious hann, I don't question that he didn't know
it. I state clearly that he should have known it.
That he was practicing outside of standard and
unlawfully by prescribing the drug without knowing
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1
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it, unlawfully because he's outside of the P.A.
Practice Act. And, therefore, that is consistent
with the definition of reckless as I understand it.
Q. And so, based on that definition, you
believe his conduct was reckless?
A. On that definition -- based on the
definition of something he should have known, yes.
That was defined for me earlier and l did put that in
one of my earlier statements. Still don't know what

9
1 o 11 negligent' 1 means.
11
Q. We've talked in great length as to your
12 opinions in this case. Have we adequately covered
13 the opinions that you hold in this case here today?
14

15
16
17
18
19
2o
21
22
23
24
25

A.

Yes.
Q. Do you intend to do any other work with
respect to the evaluation of this case prior to
trial?
A. Not unless asked to do so.
Q. And so with respect to any opinions that
you would intend to testify to at trial, they would
have been covered by us in this deposition today,
correct?
A. Ibelieveso.
MR. FOSTER: I'm going to belatedly object
to the form.
.
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grossly inappropriate based on the pharmacokinetics
and slow onset response.
And I would also have strongly recommended
converting her from amitriptyline to desipramine as
the drug of choice, nortriptyline as an alternative
because the fonner would have a 25 percent, the
latter 50 percent side effect profile of U1e
amitriptyline, not reduce the dose of the
amit1·iptyline. He was entirely appropriate to keep
her on her anti-inflammatory. She was taking Bextra
at the time. Other than that, I think his care was
okay.
Q. And other than what you've just testified
to, would you have done anything differently?
A. Well, more careful documentation, as we
discussed previously. But no. I think that's
reasonable.
Q. And with that addition, anything else?
A. Well, l would have preferred not to change
the dose on a Friday, but he saw her on Friday and
she was asking for help. So it's not unreasonable
for him to want to do something right away.
Q. Other than that, anything else?
A. I think that should do it.
Q. Okay. Well, I appreciate your time. I

Page 187
2
3

MR. HIPPLER: What was wrong with the form
just so we can correct it'?
MR. FOSTER: Well, it's depending upon the

4

examiner. I'm not casting aspersions.

5
6

Q. (BY MS. DUKE) What do you believe is the
course of treatment that Mr. Byrne should have taken
on that Friday with respect to Mrs. Schmechel?
A. Optimal care or acceptable care?
Q. Acceptable care. What you believe would
meet the standard of care, recognizing that there's
other items that would meet the standard of care too.
A. Start the methadone at the dose that he
did, don't increase the dose for at least four and
preferably five days, give Mrs. Schmechel an adequate
amount of hydrocodone to be taken every four hours as
necessary. I would have preferred to have -- rather
than go up from seven and a half to 10 milligrams,
change from seven and a half to five-milligram
tablets and allow her to take one to two. ll would
be entirely appropriate to titrate the short-acting
medication to response because you 1ll get a rapid
response and a rapid offset. But to absolutely not
allow any titration, that is patient determination of
the dose of methadone, in this case one-half to
one-and-a-half tablets being as ordered, which is

1

7
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rm just --

Page 189
1

might have a couple follow-ups after Mr. Hippler

2

finishes his examination> but I appreciate your time

3

today, Doctor.
A. Thank you.
5
EXAMINATION
6 BY MR. HIPPLER:
7
Q. Doctor, as you know by now from our
s conversations off the record, I represent Dr. Dille
9 and the Southern Idaho Pain and Rehabilitation
1 o Jnstiiute in Twin Falls, Idaho.
11
Have you ever been to Twin Falls, Idaho?
4

12

A.

13
14

Q. For what occasion?

Yes.

A. l gave Grand Rounds at the local hospital
15 on one or two occasions in the past.
16
Q. Does BYU have a physician's assistant
17 school?
18
A. I don't believe so, no. l believe
19 University of Utah is the only one in the state.
20
Q. We took a break after you said you didn't
21 know whether or not the conduct of Mr. Byrne in this
22 case was reckless, and then you came back in, and
23 Mr. Foster had apparently given you a definition of
2 4 "reckless." And based upon that, you indicated you
2 5 thought the care was reckless, correct?
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A.

Con·ect.
And the definition was that he knew or
should have known that he shouldn't have prescribed
as he did, correct?
A. That's my understanding.
Q. Okay. If the definition of reckless were
that he consciously disregarded knowledge that he
had, would you still feel the same with respect to
recklessness?
MR. FOSTER: Object to the form. That's
not the definition of "reckless." But go ahead.
THE WITNESS: No. l don't believe that he
did consciously ignore infonnation that he had. l
think he lacked the necessary information to function
within the law.
Q. (BY MS. DUKE) Do you believe that he knew
that he lacked the necessary information?
A. I don't know. I believe that was
Dr. Dille's responsibility as his supervisor to know
that. This is a specialized practice. This not a
primary care general practice.
Q. So I take it you don't believe that
Mr. Byme consciously disregarded the health or
safety of Mrs. Schmechel?
A. No, not at all.
Q.

1 boards to get that approved.
2
Q. And you understand that Mr. Byrne spoke to
3 Dr, Dille about the patient that he saw on a Friday
4 the next business day, which would have been Monday
5 after he initiated care, correct?
6
A. I believe that's correct. I recall seeing
'7 a note that was countersigned by Dr. Dille subsequent
8 to the medication being prescribed and the titration
9 regimen being initiated.
10
Q. Do you recall from the deposition of both
11 Mr. Byrne and Dr. Dille that that conversation took
12 place on the Monday following the Friday?
13
A. I don't recall the exact date.
J.4
Q. Okay.
15
A. J certainly accept that if that's what
16 you're telling me.
17
Q. And in terms of supervision .in a community
18 pain management practice where there are just a
19 couple providers, as in this case, do you believe
2 o that's a reasonable approach?
21
A. For this patient, no, for the reasons I
22 stated. This is a complex patient who had
2 3 significant comorbidities. And I do not place blame
24 on either party. I think it was a tragic
2 5 circumstance, but avoidable, had there been a
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Q. Do you believe that Dr. Dille consciously
disregarded the health or safety of Mrs. Schmechel?
A. Not at all.
Q. Now, the more you answer yes, the faster

s

we are.
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A.

Not at all.
(A discussion was held off the record.)
Q. (BY MR. HIPPLER) Do you understand that
physician's assistants in Idaho have, or did in 2003,
have the authority to see patients on initial
evaluation and to prescribe a course of treatment,
including Schedule JI narcotics?
A. Yes.
Q. Without a physician first approving that
course of conduct?
A. Yes. As a point of law, there is no such
thing as a Schedule ll narcotic. lt's a Schedule rr
controlled substance.
Q. Pardon me. You're correct.
A. Seven years oflaw school on my part. No.
l'mjustjoking. But yes. I'm well aware of that.
Q. Okay.
A. And I was actually instrumental in the

·5
6
7

s
9

1o
11
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13
14
15
16
17
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2o
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24 American Academy of Physician Assistants developing

24

25

2s

the protocol that they took to the state medical
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Page 192

protocol in place defining complex patients, the
necessity for consultation before initiating
phannacotherapy, especially an opioid in a patient
with pre-existing respiratory impainnent. I think
it's unfortunate that that had not been anticipated
and set up in written policies and procedures within
that clinic, which I don't believe existed.
Q. Do you understand such written policies
and procedures to exist in the majority of community
centers such as that in small towns?
A. I don't know the answer to that. I do
know that they exist in many clinics with which I've
interacted. I don't know if it's the majority or the
minority.
Q. Okay. Do you kuow whether standard of
care in Twin Falls, ldaho required such screening
protocols?
A. I don't know.
Q. And at'e you aware that Dr. Dille and
Mr. Byrne worked together for over two and a half
years prior to Mr. Byrne seeing Mrs. Schmechel?
A. I knew there was a longstanding
relationship. J don't recall the exact length.
Q. Do you have any reason to disagree with me
tliat Dr. Dille, through his work with Mr. Byrne, had
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Page 1%"

grown to trust Mr. Byrne's clinical judgment?
1 physical obstruction in the airway, correct?
A. No. No reason to disagree.
2
A. Correct.
Q. Okay. Now, I want to go back to what you
3
Q. As opposed to central sleep apnea, which
talked about in the very first part of your
4 is a depressed respiratory state generally, correct?
deposition where you talked about how you work
5
A. That's correct. But this all adds up to
6 impaired respiratory drive.
collaboratively with the collaborative team of
specialists that come together to treat patients at
7
Q. Right. Alid CP AP keeps open the
the University of Utah Pain Management Clinic. Okay? B respiratory tract to help prevent such occlusion,
9 right?
But as I understand it, that typically includes at
least a pain management physician?
1o
A. If it's being used at the proper pressure,
A. Correct.
11 if the mask fits properly, and if the patient is
12 compliant.
Q. Yourselfor another phannacologist?
A. Co-therapist.
13
Q. And you understand from Mr. Byrne's note
Q. Phann.D.?
14 that Mrs. Schmechel had indicated that she was using
A. Right.
15 CPAP and that she was stable on the CPAP?
Q. A psychologist?
16
A. That's a very difficult determination for
A. Correct.
17 a patient to make. This is my concern. We not
Q. And a physical therapist?
18 infrequently have patients referred to our clinic who
A. Con·ect.
19 are on CPAP. We will invariably consult with the
Q. Okay. lt might include other people
2 o primary care physician or the pulmonologist or the
depending on the patient?
21 other physician who initiated the CP AP therapy to get
A. It usually does. There are medical
22 a determination on the efficacy of the CPAP. A very
students, residents, other people who come in on an
2 3 large percentage, maybe even half of the patients who
as-needed basis.
24 are receiving CPAP or BIPAP therapy are not getting
Q. And you understand that in a community
2 5 an optimal effect from it. H requires periodic
Page 195
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2

clinic such as the Southern Idaho Pain lnstitute in
Twin Falls, those types of resources in practice

3

don't exist?

3

4
5
6

A. Of course. We're a tertiary care referral
center. In fact, we get the referrals from places
like your facility.
Q. What is it about Mrs. Schmechel's
obstructive sleep apnea that Mr. Byrne needed to know
before prescribing the pain medicine methadone
instead ofOxyContin?
A. Not methadone versus OxyContin. Before
changing opioid, because of the increased risk of
rnspiratory depression due to incomplete crosstolerance, it would be impo1iant for him to know that
she was compliant with her CPAP, that she was using
it at the proper pressures, and that she was getting
good control of her obstructive sleep apnea. As you
probably know, with sleep apnea patients will
actually stop breathing during the night. And
respiratory drive is markedly decreased by opioid.
This risk is by far greater in the first five days to
seven days of initial or changed opioid therapy than
it is after that first week, as I was asked in

4

1

7

B
9

10
11
12
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15
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17
18
19

20
21
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24 earlier testimony.

25

2007

Q. And obstructive sleep apnea is an actual
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follow-up and assurance that there's a good fit and
the patients understand how to use it.
I don't have any documentation to that
effect. 1 do have some documentation in Dr. Vorse's
notes that there was a problem at one time, but
things are doing better later on. But this is not
something for which we have a continuity of care
record because Mrs. Schmechel left Dr. Verse's care
when she converted over to the Twin Falls facility.
Q. So you don't have any information to
suggest that Mrs. Schmechel, at the time that she was
treated by Mr. Byrne, was not getting adequate relief
or treatment with her CPAP?
A. No, nor do I have infonnation that she
was.
Q. Okay. What Mr. Byrne had was infonnation
from Mrs. Schmechel that she was doing well with her
CPAP?
A. As I stated a moment ago, patients are
typically unaware of how well they're doing with it.
Patients with obstructive sleep apnea, as you may
well know, often awaken at night and have no memory
of awakening in the morning. We often get reports
from sleep partners that are completely different
from what the patient reports. So any knowledgeable
....,, ....,,.:,.,, ... ·····" ...... ,......
. ........
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1

clinician would not accept a patients subject report

1

2

of how well the CPAP is working. We want more
objective infonnation,
Q. And do you consider Dr. Hare a
knowledgeable and competent practitioner?
A. Yes.
Q. I take it you respect him as a clinician?
A. I've worked with Brad for 28 years.
Q. Do you have knowledge regarding the local
standard of care in the community of Twin Falls,
Idaho in 2003 of whether or nol a pain management
physician, before changing opioids, had to obtain

2

3
4

5

6
7

8
9

10
11

12
13 sleep study records or more specific secondary source
14 information regarding the patient's efficacy with
15 CP AP treatment?
A. That's a very complex question. The only
16
17 intelligent response l can give is that [ think it
18 would be foolhardy of any clinician to undertake
19 aggressive opioid therapy in a patient with multiple
20 morbidities, including obstructive sleep apnea, if a
21 CPAP was being used without obtaining at least an
22 outline of how well the patient has used and
23 responded to the CPAP from the initial prescribing
24 physician.
Q, So if Dr. Hare indicates that il was
25

3
4
5

6
7
8
9

.

Q. What do you mean by that? You don't
believe he would review that or you don't believe he
would have that opinion?
A. I don't believe, ifhe had read all those
records, that he would have that opinion.
Q. Okay. And ifhe had and he does, tllen you
would just disagree with him?
A. Disagree, correct.
Q. Sometimes clinicians can have reasonable

10 differences of opinions?
11
A. Absolutely.
Q, Now, you weren't there, obviously 1 when
12
13 Mr. Byrne talked to Mrs. Schmcchel, conect?
14
A. Correct,
15
Q. And you don't know precisely what he told
16 her, correct?
17
A. Correct.
18
Q. And, obviously, Mrs. Scl,mechel is not here
19 to ask that question of what she was told, correct?
20
A. Conect.
21
Q. So the only one that is here to tell us
22 that is Mr. Byrne, correct?
23
A. Correct.
24
Q. Do you recall that Mr. Byrne testified in
25 his deposirion that he gave strict instructions to
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appropdate and within the standard of care to

1

receive assurances from a patient that was utiJizing

2

a CPAP and doing well, that that complied with
standard of care, you would just disagree with that?
A. l don't know what records Dr. Hare
reviewed. I know I've worked with him for a long
time. I suspect that he had limited information
available to him at the time he made that
determination. That's a judgment call on my part.
!'m not sure that l would disagree with him. r 1hink
that we're probably coming from a different knowledge
of the case.
Q, Okay. Well, let's assume thal he's read
Dr. Vorse's records and read the sleep medicine

3

records from the studies and assume that he 1s read
the depositions and assume that he's read the medical
records of Mr. Byrne and the Southern Idaho Pain
Institute.
A. Well, that's a hypothetical that I don't
think applies,

Q. Because you don t think he s read that
1

stuff?
A.

24

Q.

25

A.

1

That's correct.
Have you talked to him aboul that?
No. I just know Dr. Hare very well.
••'•

.. , ..,,.,

4

5
6
7

8
9

Mrs. Schmechel that she was not to increase her
methadone beyond what he had prescribed without
talking to him first?
MR, FOSTER: Object to the form.
THE WITNESS: l recall his having said
that. l also share with you the dictum of clinical
medicine: !fit isn't documented, it isn't done.
And I looked explicitly for such documentation in the
record and found none.
Q. (BY MR. HIPPLER) Well, the truth of the
matter is that a lot of physicians in their own
clinic records use a shorthand method of
documentation, do they not?
A. l accept shorthand. I don't accept total
omission.
Q. Well, by "shorthand" I'm not talking about
a fonnal shorthand. I'm talking about use of
language that they know what it means.
A. There is nothing in there to suggest that
there was any such counseling given. If tllere had
been a simple notation such as standard counseling or

10
11
12
13
14
15
16
17
18
19
20
21
22 cautioned patient 1 I would have accepted that as a
23 shorthand. I don't recall having seen that.
24
Q. Take a look at Exhibit -- what exhibit are
25 the medical records?
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1
2

Q.

MS. DUKE: Nine.
(BY MR. HrPPLER) -- 9. Look at Dille

page 16.
A. Okay.
5
Q. And look under Plan.
6
A. Right.
7
Q. Tell me if I'm reading this correctly.
8 About a third of the way down under Plan it says:
9 "Today we had a lengthy discussion in reference to
1 O pain management and the benefits of long-acting
11 medications as well as periodically changing pain

Page 204

1

2

3

3

4

4
5
6

12 medications to avoid excessive dosing and adverse
13

14
15
16
17
18

19
2o
2 J.
22
23
24
25

effects from this." Do you see that?
A. Yes.
Q. Okay.
A. I see nothing there to suggest there was
any discussion of the risk of exceeding dose.
Q. Okay.
A. This reflects what was well disproven
medical care at that time, which is called preemptive
opioid rotation. It's completely ruled out as being
efficacious. There was some advocacy of that in the
mid-l 990s, the thinking being that ifwe rotated the
patient from drug A to drug B every six months or so,
that this would prevent tl1e development of analgesic

7
8

9
10
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the dose daily. So I don't see any shorthand or any
suggestion in here that he gave the necessary
counseling to the patient.
Q. Okay . .If Mr. Byrne testifies that it was
the standard within his practice and in the clinic to
document that he had a lengthy discussion regarding
pain meds and benefits, that that also includes
discussion of risks, would you find that unusual?
A. l'm sorry, I didn't understand, Ask it
again.
Q. lfMr. Byrne testifies that it is typical
for him to dictate in that practice that he had a
long discussion with the patient or had a discussion
with the patient regarding the benefits oflongacting opioids, that that included the risks as well
and, in particular, as had been explained to him by
Dr. Dille, to stress the 1isks of exceeding doses?
MR. FOSTER: Object to the fonn.
THE WITNESS: My recollection, and, again,
correct me because this is several months ago that I
read this, was that he said that's his normal
practice, He couldn't recall whether he had done
that with this patient ornot. But if I'm in error,

please correct me.

Q, (BY MR. HIPPLER) We'll just go with what
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tolerance. But that had been completely disproven,
So this reflects some out-of-date thinking. But,
that said, there were still some people who were
doing that type of preemptive rotation certainly into
the early 2000s.
But there's nothing here. That's
periodically changing pain medications to avoid
excessive dosing. Now, we certainly change from drug
A to drug B if the dose of drug A is already creeping
up to the point that we're getting excessive side
effects. But there's nothing here to suggest that
there was any caution given to the patient about the
danger of exceeding the prescribed dose,
And, additionally, let me add that there
was the slip of paper that Mr. Byrne gave to
Mrs. Schmeche!, said one-half to one-and-a-half
tablets. That's not acceptable. And it did not say
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you remember. That's fine.
A. But that's the reason we write things in
the chart, because we can't remember what we do with
patients in the past.
Q. Well, and so1netimes, as I was alluding to,
sometimes clinicians have a shorthand way of
reminding themselves that they did have a discussion
with the patient.
A. Correct. But, unfortunately, I don't see
that here,
Q, And if Mr. Byrne testifies that this is
his shorthand way to say that he talked about the
benefits of the medication, that the discussion of
benefits always includes a discussion of the risks,
that's a way of documenting it.
A. Well, ljust-MR. FOSTER: Objccl to the form.
Argumentative.
THE WITNESS: l had a different reading of

18 that you can -- you know you can increase the dose
19 even daily or every other day. It just said take

18

2 o one-half to one-and-a-half tablets. In his chart
21 note he indicated over 72 hours, but he didn't
22 indicate whether that could be done in the first 12
23 or 24 of the 72 hours or whether it could only be
24 done once every 72 hours. And it's clear from the
2 5 testimony that he advised her that she could increase

2 0 the testimony because, again) as I said, my

I

J.9

21 recollection is that he could not state that he
2 2 specifically discussed this with her. He could only
23 talk in generalities.
24
Q, (BY MR. HrPPLER) As I understand it, if
2 5 we were to boil down the crux of your opinion, it1s
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pnmarily Mr. Byrne having titrated upward her dose
on a daily basis?
A. Correct.
MR. FOSTER: Object to the fonn.
THE WITNESS: And this led to the now well
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described phenomenon of accumulation respiratory

6

toxicity.
Q. (BY MR. HIPPLER) Okay. You talked
earlier -- and you'll have to excuse me, I'm going
to jump around for more than Keely did because I'm
just picking up as opposed to having a game plan and
going start to finish.
A. l understand.
Q. We talked earlier about this certificate
or license that you could get if you filled out the
paperwork in order for you to write prescriptions.
A. Correct,
Q, Does that include Schedule II medications?
A. Yes. There's ample precedent of people
who have done this receiving their own DEA number.
As soon as you get the prescriptive authority from
your state board, then you apply to the DEA for a DEA
registration. And then you have Schedule II through
V prescriptive authority.
·
Q. Do you know whether Pharm.D.s in Idaho

7

8

9
1o
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25

has to sign off on that, cotTect?
A, If it's a new prescription, new
medication, then somebody who does have a license to
prescribe, a DEA number for a controlled substance,
would have to write the prescription, or would have
lo at least sign the prescription.
Q. And if it's just instructions on how to
take a medication they already have and there's not a
new prescription, then what would it be?
A. Then normally l would simply write in the
chai1 what recommendation l gave to the patient, I
would usually give the patient a written piece of
paper explaining what to do or ask the patient to
repeat back to me how he or she is going to take the
medication. And that would take care of it.
Q. And in those cases you don't review that
with the physician?
A. Well, we always review all of our patients
with the interdisciplinary team, but I don't have to
review in advance. This hasn't happened since
Tuesday of this week when I saw a patient that was
taking both a long-acting and short-acting opioid and
was not taking them on an optimal schedule. I went
through and educated the patient, had the patient
repeat back to me what was happening. The patient
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have that authority?
A. I don't know. I know that it's been done
in Nebraska and some other jurisdictions, Maryland
and others,
Q. And Utah apparently?
A. We have the mechanism to do it. And one
of my staff actually looked into that, and we do have
the mechanism. Bui I made an administrative decision
that it's more important that we teach others how to
do it.
Q, Do you know whether any Phann.D. in Utah
is licensed to prescribe Schedule II medications?
A. l don't know.
Q. So you don't know of any that are, I take
it.
A. Cotrect.
Q. Now, you talked earlier in your deposition
about how sometimes in clinic you would see a patient
and come up with a plan regarding the medications
they were going to take, or perhaps changing the
dosing of medications they were taking, correct?
A. CotTect.
Q, And just so that I'm clear, in order for

that to take effecti a physician, or at least a
2 5 physician 1s assistant or nurse practitioner, actually
24

::-::-:
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walked out very satisfied.
After the patient left, I advised the
physician of what I told him. The physician said,
Thank you very much. And then the front desk clerk
came in to talk to me later saying that the patient
had been on his cell phone with his wife and had just
called to say that in two years at the clinic this
was his most satisfying interaction because he now
for the first time really understood his medications,

It's an educational issue, and it s
1

18
19

critically important that patients understand how to
take these potentially toxic medications properly.
Q. And you also described on some occasions
where you would actually fill out a prescription and
then go have a physician sign it?
A. At times I do that just for expedieucy.
Q. And when you do that, do you go through
all of the underlying comorbidities with the
physician and other medications that the patient is

2o

on, or do your colleat,rues have enough trust in

16
17

21 understanding you to sign off/
22
A. Well, nonnally, we've seen the patient

23 already. Ifwe re making a change in a regimen)
1

24 then, obviously, we are already have that documented,
25 !fit's a new patient, the latter of what you reflect
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occurs. Certainly, I would have reviewed the
eomorbidities. !fl had a patient in whom I did not
have a complete medical record, either from the
referring physician or referring clinic that gave us
that background on comorbidities that we needed, th.on
[ would not recommend a change until we had done the

7

necessary workup at our own clinic.

3
4
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Q. Okay. But once you're satisfied and you

take it to one of the physicians, does the physician
typically have the same level of knowledge about the
patient as you do at that point when be signs the
prescription?
A. Sometimes would have more, sometimes would
have less.
Q. Okay. I take it there has to be some
trust with the physician of you in doing that""
A. Yes.
Q. -" based on his understanding of your
knowledge and working with you.
A. Yes.
Q, Okay. You talked about some labeling
requirements by the federation of"" or by somebody
with regard to the label on the prescription has to
24 correctly identify the dosing the patient is actually
25 going to take, correct?
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23

s

you aware of thal practice?
A, I am, and l also am aware that that is
insurance fraud.
Q. Okay. But you're aware that that happens?
A. Yes. I've never seen that happen with an
opioid.
Q. !'m not suggesting they do that.
A. And we're dealing "" methadone is a very

9 inexpensive medication, whereas the antHipemics are
10 very expensive. Yes, [ know that goes on.
11
(A discussion was held offtlie record.)
Q, (BY MR. HIPPLER) Now, we already talked
12
13 about this, that you weren't there when Mr. Byrne
14 explained the dosing-"
15
A. Of course.
16
Q. -" parameters to Mrs. Schmechel, correct?
17
A. Or course.
18
Q. And you talked about one of the ways that
19 you explain it to them is talk to the patient, have
20 the patient repeat it back, make sure they have a
21 good understanding of what it is you're telling them
22 to do 1 co1yect?
23
A. Correct.
24
Q. Okay,
25
A. But I also mentioned that if I'm changing
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A. This would nonnally come under the State
Phannacy Practice Act, that the label on the
prescription vial has to reflect what the prescriber
has written.
Q. Okay.
A. And that the standard of practice is that
what the prescriber has prescribed must be recorded
in the medical record. Now, that's -" the latter is
Federation of State Medical Boards. And ifa
physician prescribes something and does not record
that in the medical record, that is below the
standard of practice.
Q. Okay. So it would be appropriate, then,
for a physician to"- let's say he wanted a patient
to take 15 "- strike that. ['JI do this from a drug
l actually know.
Say he wanted a patient to take 20
milligrams of Pravachol. The patient had cost
concerns, so he writes a prescription for 40
milligrams of Pravachol and tells the patient to
break it in half and take it.
A. Okay.
Q. But the bottle might say take one a day in
order for the insurance to pay for 30 days' worth of
40 milligrams in order to get 60 days' supply. Are
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the regimen from what's already on the prescription
bottle, that [ give the instructions to the patient
in writing, clear and explicit, explaining what's
happening.
Q. And you don't know, for example, in this
case whether Mr. Byrne explained in detail to
Mrs. Schmechel on how to take the medication and then
gave her the handout as a shorthand version of what
he was saying that they were going to do on a longer
term basis?
A. Well, as I already testified, of course, I
don't know that. But as J already testified, what I
see here is different from what's in his dictated
note. Both of those differ somewhat from his
testimony. And what the patient has to go by, what

16 the patient is most apt to rely upon, is 1 number one,
the prescription label; and, number two, w1ilten
18 instructions,
19
Now, the prescription label appears to
20 have said one-and"a-halftablets twice a day from the
21 infonnation that Mr, Foster received what was
22 actually on the label, and that's in earlier
23 testimony. This says: "1/2" l pill every 12 hours,
24 may increase to maximum of 1-112 pills every !2
25 hours." We have three different conflicting pieces
17

.,, .... -'"•

... ,,,,,
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of infonnatlon; One, the verbal counseling; tvlo,
what is written here; and three, what is written on

2

1

the prescription vial. That's a recipe for disaster

3

on patient misunderstanding.

4

Q. Okay. The other thing that we have is our
notes from the physician on the 29th reflecting what
she was to start taking on that day, correct?
A. Did you say from the physician or from ·Q, From the physician's assistant.
A. Yes, yes. That's one of the three things
l referred to, So there are three different sets of
instructions. And I'm not sure -- I have, obviously,
no idea what Mrs. Schmechel came away understanding.
But my fear is that she was confused by getting
different instructions verbally and in writing on
this pad handwritten. And those both differ somewhat
from what was in the medical record. So I don't
know -- I don't know exactly what was said to her.
Q. Okay. The only one who can tell us what
was said to her is Mr. Byrne, correct?
A. Well, it's Mr. Byrne who wrote this note,
who wrote the note that's in the chart, and who wrote
the prescription that was reflected on the label. So
he generated three different sets of documentation
which is all different.
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the variability, correct?
A. Well, there are two factors. One is that
the published tables -- and I'm the author of the one
from the American Pain Society, for example -- are
population averages. So with one given patient you
don't know whether the patient is on the median, is
tucked in one corner of the bell-shaped curve or 01e
other corner. So they're just starting points, and
you have to titrate from those, which is why we must
staii conservatively. And, indeed, Mr. Byrne did
that initially.
The second issue is that methadone has
incredibly inconsistent reports on its dose
equivalents. Unlike all of the other opioids for
which we have fairly consistent population average
dose equivalents, we don't have that for methadone.
It varies greatly, which makes methadone a tricky
drug to use.
Q. So, for example, I might pick up a
textbook from 2003 that might tell me that metl,adone
is in an equal analgesic chart equivalent -- 10
milligrams of methadone is equivalent to 10
milligrams of OxyContin, and I might pick up another
book that tells me 20 milligrams of methadone is
equal to l Omilligrams of OxyContin.

::

:

1-----------------------f--~-----=-------'-------~~-I
Page 215
1
2
3
4
5
6
7
8
9

Page 217:

Q. But he can tel1 us what he told her and
what she reported to him the following Monday on what
she was doing?
MR. FOSTER: Object to the fonn.
THE WITNESS: r honestly don't know ifhe
can. l don't know ifhe can recall what he told her.
And my recollection is in his testimony he thought
that he recalled what it was, but I'm not sure that

7
8

he was sure,

9

10

Q, (BY MR. HIPPLER) Okay. Well, certainly,
11 if anybody can, it would be he because he's the only
12 one here.
13
MR. FOSTER: Object to the lorm as
14 argumentative.
15
THE WITNESS: ff anybody could do it who

16 is sti1J with us, he's the only one who could.
17
Q, (BY MR. HIPPLER) Okay.
18
A. But I can only go by the inconsistency of
19 what he documented.
20
Q. Now, I think you indicated and talked a
21 little bit about equal analgesic dosing charts.
22
A. Correct.
23
Q. And I think you indicated that it's
24 difficult to say precisely what an equal analgesic
2 5 dose is comparing OxyContin lo methadone because of

1

A.

Or it would actually be the other way

2 around. But your answer is correct. I mean, your
3

4
5
6
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statement is correct. And there is actually a
two-to-one variance that appears in the literature.
Jt typically is a half as much of methadone or a
quarter as much of methadone equivalent to morphine.
In other words, 5 to 10 milligrams of methadone being
equivalent to 20 milligrams of morphine is what you
typically find.
Q, So you're not aware of any equal analgesic
charts published between, say, 2000 and 2004 that
indicate on an equal analgesic basis that IO
milligrams ofOxyContin was equal to 20 milligrams of
Methadone?
A. There may be.
Q. Okay.
A. You know, as you said, there are a whole
bunch of charts that are out there, and they're quite
variable on methadone.
Q. Are you aware of any literature that was
out there in 2000 to 2004 that suggested that if a
patient was-~ when converting from one analgesic

22
2 3 opioid to another, that the patient was not receiving
24
25

adequate pain control on the previous analgesic, that
you could consider increasing the equal analgesic of
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the other dose by 20 percent?
A. What I've typically seen has been that
rather than do the 20 percent decrease, if the
patient is not getting accurate analgesia with drug
A, that you might convert at an equal analgesic
conversion, which is the equivalent of a 20 percent
increase, assuming that there should be a 20 percent
decrease lo begin with. And that was thinking that
was occuning back in the early 2000s. We've become
more conservative now because of reports. And as I
mentioned, it used to be 20 percent. Now we talk 50
percent. So I think your statement is reasonable.
Q. Would you agree with me that out there in
the general world of primary carry physicians and
sort of outpost pain management clinics, that the
standard of practice has evolved with regard lo
methadone from the late nineties and early 2000s to
today?
MR. POSTER: Object to the form.
THE WITNESS: That was a compound question
and it's two different questions. In primary care,
yes. In what you call outpost pain management
programs, no. I would disagree with that. Dr. Dille
is a boarded anesthesiologist who has taken
additional medical education in pain and has a clear

l

2
3
4
5

6
7
8
9
1O
11

12
13
14

15
16
17
18
19

2o
21
22

23
24
25

could not have used this medication 50 times
previously and patients did okay. But this is not
mystery stuff that's unknown, This is well-known
pharmacokinetics. And it was clearly the
responsibility of Mr. Byme, in my opinion, to know
these pham1acokinetics before using the drug. Jfhe
did not know them, which he obviously didn't··
because l don't believe he did this in any malicious
manner. I think he did it in a frighteningly
dangerous manner but out of ignorance, not out of
malice. And it was clearly, in my opinion,
Dr. Byme's responsibility .. Dr. Dille's
responsibility, as a supervising physician, to
ascertain that Mr. Byrne knew enough to use the drug
safely and assure that that was done.
Q. f take it you don't know what Mr. Byrne's
and Dr. Dille's experience with Mr. Byrne was with
respect to other patients who started on methadone
converted from OxyContin or other drugs?
A. Conect.
(A short recess was taken.)
Q. (BY MR. HlPPLER) Would you agree that if
Dr. Dille had instructed Mr. Byrne prior to having
seen Mrs. Schmechel in the course of his working with
him that whenever he puts a patient on methadone,
Page
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interest in it. He certainly was aware of this.
And, indeed, his testimony where he indicated that he
would not have titrated the methadone as quickly
reflects that.
You can't hang out a shingle and say

1
2
3
4

5
you 1re a pain management center and use methadone and 6
7
not know the pharmacokinetics of it full stop. So l
would not consider this facility a quote, "outpost,"
8
9
your word, pain management program. And their not
1o
understanding the phanuacokinetics of a drug that
11
they're using such as methadone I consider
12
unacceptable.
13
Q. (BY MR. HIPPLER) From your review of
14
Dr. Dille's deposition, l think what you're saying is
15
it appears to you from his deposition that he did
have an understanding of the phannacodynamics and
16
l 7
pharmacokinetics of methadone.
18
A. Yeah. I'm not talking about dynamics al
19
all. Pharmacokinetics, yes, I believe he did and
2O
does. I also believe that he provided inadequate
21
assessment of Mr. Byrne's knowledge base and/or
22
supervision~- and supervision of Mr, Byrne's use of
23
this medication in light of Mr. Byrne's clear lack of
24
knowledge of how lo use this medication safely.
Now, this is not to say tlrnt Mr. Byrne
25

221,

that he is to instruct the patient that taking more
than what is prescribed can be very dangerous and, in
fact, lethal would be an appropriate thing to tell
your P.A.?
A. Yes.
Q. You testified earlier that it was your
understanding that Mrs. Schmechel's renal function
was normal. What was your basis for that opinion?
A. No. I said reasonable. The medical
records, the history reflect that this was a
reasonably healthy person other than the specific
morbidities that were indicated. She did have some
cardiac insufficiency. But you have to have many
years of cardiac·· or several years of mild or a
very severe cardiac insufficiency nom1ally before it
would impact renal function.
Q. When you're talking about cardiac
insufficiency, are you talking about her
hypertension?
A. Well, hypertension eventually takes a role
in the heart. It causes some cardiomegaly. It
causes some changes in the fluid dynamics and>
obviously, can have an effect on the kidneys also.
But this was a relatively young woman. Forty-one?
Q. Sixty.
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A. Sixty? I'm sorry. Well, to me that's
relatively young, And every year it gets younger.
MR. FOSTER: I was going to say don't say,
Oh, God. She was on death's door.
THE WITNESS; No, no. But she was a
reasonably otherwise healthy person. The records do
reflect that. I'm sorry I didn't recall her age.
But you've got to have some significantly
impaired renal function before you're really going to
get a longer duration of methadone. You normally -ifwe have somebody who has severely elevated serum
creatinine, then we will actually frequently see
12-hour duration with methadone and see an eight-hour
duration with morphine. But I'll be 63 in a couple
weeks, and I'm -- my renal function is perfectly
normal and I have a -- I would require morphine every

1
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5
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7
8

actual prevalence of it is. It's been reported
relatively recently much more so than previously.
Q. And that's mostly been reported in
patients in methadone treatment programs who are

taking large doses 1 correct?
A. Well, it's actually been reported in
higher doses but for clinical purposes. And this is
most common in patients taking high doses such as we

9 use in cancer care. not the doses that we use
1 o typically in chronic nonmalignant pain.

If a patient

11 had a preexisting cardiac arrhythmia, however,
12 particularly QT interval disturbanctl or abnormality,
13 then methadone would be relatively, not absolutely,
14

but relatively contraindicated,

1 7 six hours to maintain analgesia. I would require

15
Q. And !just wanted to make sure that l was
16 clear about your statement about contraindication.
17 There was nothing apparent about this patient that

18 methadone every eight hours to maintain analgesia.
19
Q. (BY MR. HIPPLER) Is edema ln the lower

19

15
16

20 extremities a telltale sign of methadone toxicity?
21
A. No.
Q. Even with discoloration?
A. No, it is not, Certainly, would not be an
24 expected effect of methadone.
25
Q. And with any patient who is starting a new

22
23

1 B would have been known in advance --

20
21

22
23

24
25

A. Absolutely,
Q. -- suggesting she was contraindicated for
methadone.
A. Absolutely. As l stated, clearly
methadone was a very reasonable drug to try in this
patient.
Q, And if you don't feel qualified to answer
Page 225 ;
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opioid, in the first few days you might expect a
little bit of nausea, correct?
A. Correct.
Q. And that's not necessarily a dangerous
sign?
A. No. In fact, we routinely give patients
mild antiemetic to take for a few days when starting
an opioid.
Q. I wanted to address something that you
talked about earlier, and that is ff Mrs. Schmechcl
had a sudden cardiac arrhythmia, that methadone would
have been contraindicated, I think is what you had
said.
A. Well, methadone itself, typically in
relatively high doses, can cause a rhythm
disturbance.
Q. Prolonged Q?
A. Yes, PQ interval. Very good, You got
halfofit.
Q. Thought it was QT,
A. QT interval. Did T say CQ?
Q. You said PQ.
A. RSD. Bui the -- I'm sorry. The -- it's

this because you're not a physician and you're not a
cardiologist, !hat's fine. You canjust tell me
that. But is it not true that patients with occluded
4 vessels to the heart as well as cardiomegaly can have
5 sudden arrhythmias?
6
A. That is true.
7
MR. HIPPLER: Off the record.
8
(A discussion was held off the record,)
9
Q, (BY MR. HIPPLER) I apologize. I'm
1 o getting close. I'm just kind of going through my
1

2
3

11
12

notes here.

24 QT interval disturbance that can occur. It's been a

24

You talked about the amitriptyline and
Mr. Byrne's reduction of that. There were actually
two reductions of that. You thought there was a
contraindication, but when you look at the chart, is
it not true that ••
A. I didn't say a contraindication. I saw a
contradiction. l thought I saw in one place a note
reducing it from JOO to 50, another place a reduction
from 100 to 75. lfhe took it down step-wise JOO to
75 to 50, that's reasonable.
Q. Okay, That was my understanding of the
records, and l just wondered.
A, I don 1t think that1s a major issue. You

25 long day. It's not common. We don'! know whatthe

25

just asked me to comment on care.
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Q. ls amitriptyline a type of drug that you
can just stop cold without adverse side effects?
A, Not a good idea at all af\er being on it
for a period of time. That Jowers the seizure
threshold, can cause some rebound cholinergic
effects.
Q. So if you're going -A. Titration would be right. Titration down
would be correct.
Q. And if that's what he had in mind, that
would be the appropriate thing to do?
A. Yeah. l just don't understand why he was
going to eliminate that class of medication because
that's a drug of choice for neuropathic pain, and
this lady had a neuropathic pain, or neuropathic
component of her pain.
Q. Do you recall him discussing that in his
deposiHon, why he did that?
A. I don't recall.
MR. HIPPLER: Okay. Off!he record.
(A discussion was held off the record,)
Q. (BY MR. HIPPLER) I just want to go back.
Do you know for certain that BYU did or did not have
a P.A. program in the mid-nineties?
A I don't believe they ever had a P.A.
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Dr. Vorse said?
A. Nothing that I can recall right now,
Q, Okay, And! take it you noted that
Mr. Byrne was aware that the patient, in addition to
having had two prior surgeries on her back and
surgeries on her knees and pain in her knees
A. Yes.
Q. -- had a diagnosis of arachnoiditis?
A. Yes.
Q, And, in fact, he obtained imaging reports
to confirm that before sta11ing his therapy?
A. Yes.
Q. And I take it you would expect a
physician 1s assistant working in a pain management
clinic to understand that a patient with
arachnoiditis is going to have relatively severe
chronic pain?
A. Yes.
Q. And then understand that arachnoiditis is
not a curable disease state?
A. Con-ect.
Q. And that the typical goal with therapy
would be patient comfort?
A. Yes, as I stated earlier.
Q. And other than Mr, Byrne not expressly and
w-

'
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program.
Q, Okay.
A I'm quite sure they didn't have one,
Q. Jf they did, you certainly weren't
involved in teaching their -A. No,
Q, "" their students of pharmacology?
A No, not at all.
Q. Okay.
A They did have a nurse practitioner
program. Brent Willey was teaching phannacology dowr
there at that lime, but not P.A.
Q. Did you -- and Ms. Duke may have asked you
this, and l apologize if she did, but, as you
indicate, it's been a long day"" did you find any
inaccuracies in Mr. Byrne's documentation in tenns of
the history that he wrote out coupled with the
dictation? In other words, if you look at all these
documents as one chart together, the history that he
and the medical assistant wrote out of the vitals and
etc., the history and physical that he dictated as
well as the pain questionnaire that the patient
filled out, did you find inconsistencies between
those documents and Dr. Vorsi:1s records where the
infonnalion was just incmTect based on what

explicitly documenting that, you have no reason to
believe that he wasn't aware of that?
3
A. No. I think that's pretty implicit. What
4 Pm concerned about in documentation is the
5 information that he provided to the patient,
6
Q. Okay. And do you believe the standard of
7 care requires a physician's assistant working in a
8 pain management clinic to document everything that he
9 tells a patient regarding how to take the
1

2

,

1 o medications?

11
A. "Everything" is a very broad word. I
12 think it's -- the standard of practice does
13 dictate -- and this is not my interpretation. This
14 is the Federation of State Medical Boards, presuming
15 that.most P.A. boards would use !hat document. I'm
16 not sure in Idaho if P.A.s are under the medical
17 board or if they have a separate board.
18
But the definition of what interventions
19 are initiated and what instructions are given to the
2 0 patient, with a clear explanation of the potential
21 benefits and potential risks of the interventions, is
22 mandated in the federation model policy.
23
Q. That that he given lo lhe patient or that
24 !hat be documented in the chart'/
25
A. Documented in the chart,
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Q. And would it be sufficient to document in
the chart that, for example, quote 1 11 I gave a clear
indication to the patient the risks and benefits of
initiating the treatment therapy identified below"?
A. Thinking back to what the Federation
standard is, policy is, that it said specifically say
what are the risks and benefits. I would not expect
a reasonable busy clinician to write out a lot of
detail. I would expect an explicit statement that
discussed with the patient risks of or discussed with
the patient our standard protocol. What's done in
many clinics for medical/legal protection is they
have a simple policy statement in a policy and
procedure manual that says, This is what we will
discuss with patients. And then all a clinician has
to do is document in the record, I did our policy,
As defense attorneys, you're obviously

aware of that process and you 1re also aware that,
unfortunately, that often doesn't happen.
Q. One of the other things that some
clinicians might do, particularly in a small office
of a physician's assistant and a physician, is to
have a clear understanding through dialog with one
another and working with one another that we're
starting a patient on methadone or converting to
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as what a reasonably pnident physician in the same or
similar community does or would do, and if a good
number of physicians don't dictate in their own
office chart the specific risks discussed with
respect to a medication stai1ed, but simply a
shorthand indication that they had a discussion with
the patient about the risks or about the medication
and an understanding between them what that means,
that that could under that definition of standard

')

methadone. Here arc the things that you will discuss
with the patient.
MR. FOSTER: Object to the form.
THE WITNESS: Well, I understand what
you're saying. l don't believe that meets the
standard of practice,
Q. (BY MR. HIPPLER) And that's based upon

8

the Federation1s guidelines, correct?

1

3
4
5

6

MR. FOSTER: Object to the form.
THE WITNESS: I understand what you're
saying and we discussed this previously. I really
can't agree with that being acceptable unless there's
something documented, either in a policy and
procedure manual, a simple statement that's in the
file at U1e place. And in this particular case, I
saw absolutely no allusion in the chart to the risks
being discussed with the patient. This is a serious
issue, This is a potentially lethal issue. It's
something that cannot be done in a haphazard manner.
It1s got to be done in a routine consistent manner.
Most clinics will have a written
medication management agreement that they -- many
clinics would have a written medication management
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A. Conect.
9
10
Q. lt's not based upon necessarily what
11 actually occurs jn pain management clinics and
12 throughout communities such as Twin Falls?
13
A. I don't practice in Twin Falls, but I've
11 visited and consulted with and presented Grand Rounds
15 at many small community hospitals, and those are
16 often attended, almost always attended by the local
17 pain management physicians. And these are questions
18 that often come up and are always addressed in the
19 same way.
20
You and I both know that there ai·e things
21 that are done that are below standard of practice and
22 that oftentimes people get away with that. But,
23 unfortunately, when people don't follow standards of
24 practice 1 there can be serious adverse outcomes.
25
Q. Well, if we define "standard of practice"

(

care meet standard of care?
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agreement that explicitly spells out the risks to the
patient. It's typically signed by both the clinician
and the patient. The patient is given a copy to take
home. And this is to help protect the patient and to
point out that this is a two-way relationship. I
don't see evidence of the necessary information being
provided in this case,
Q. (BY MR. HIPPLER) One of the things that
was provided in this case and that Mrs. Schmechel
signed was a drug contract, correct?
A. Conect.
Q. And one of the things the drug contract
provides is that Mrs. Schmechel agrees that she will
not take more of the medication than is directed for
her to take -- we can disagree about what was
directed -- without first talking to the clinic,

'

con·ect?

A. Conect. My problem is that the direction
she had said one-half to one-and-a-half.
Q. That's the part I said we can disagree
about. And ifwe want to disagree about it, we'll be
here forever disagreeing about it.
A. Well, we'll agree to disagree. But just
the fact that they use a medication management
agreement or drug contract like that indicates that,
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1 place?
1 you know, this is not an outpost clinic, that they're
2
A. I don't know definitively what did occur.
doing some contemporary things.
3 I've seen Mr. Byrne's testimony that -- and,
3
Q. And in this case the clinic did obtain
4 actually, I think he had some documentation that he
4 from the patient an objective assessment of the
5 had conversations. I saw Mrs. Schmechel's family's
5 patient's pain level, correct?
6 report, I don't know. I'm not prepared to comment
6
A. As objective as you can be.
7 on that.
7
Q. The one to ten standard is about as
8
Q. And Mr. Byrne's documentation is with
8 objective as you can be.
9 respect to conversations on Monday and Tuesday,
9
A. Well, there are actually -10 correct?
10
Q. I've seen the crying faces and smiling
11
A. Correct. So over the weekend is when we
11 faces and -12
get
the"· her children spoke. Yeah. That's
12
A. Well, there are actually a lot better
13 correct.
13 things to do, but that's done, The zero to ten, not
14
Q. So I take it you're not taking a position
14 one to ten, zero to ten scale is typically and
15 with regard to the credibility of the varying
15 commonly done.
16 factorial accounts?
16
Q. Cenainly within the standard of care,
1.7
A. No,
1 7 standard of practice?
18
Q. Just so that I understand, is it your
18
A. Yes.
19 testimony that Mr, Byrne needed to speak with
19
Q. And you talked about the board ofphannacy
20 Dt. Vorse or review her records or both?
20 Federation -- or not board ofphannacy, This
21
A. One or the other, at least.
21 Federation of Medical Boards requiring that there be
22
Q. One or the other?
22 some documentation of consultations obtained,
23
A. Yes. I believe that he needed to get her
23 correct?
24
clinical
impression of what was going on.
24
A. Correct.
And that could have been through record or
25
Q,
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1 through conversation?
of records placed in the charts, evidence of
2
A. Yes.
consultations received from the imaging pmvider as
3
Q. ls it your contention that Mr. Byrne or
well as the orthopedic surgeon that had seen the
4 Dr. Dille violated any applicable statute or rule of
patient two weeks prior, -correct?
5 law in the state ofldaho?
A. That's correct.
6
A. No.
Q. You would agree with me that it was
7
MR FOSTER: I'm going to object to the
appropriate and, in fact, good practice for Mr. Byrne
8 fonn.
to get the 011hopedic surgeon's consultation record
9
Q. (BY MR. HIPPLER) One of the reasons that
to assure that there was no operative fix for
1
o
methadone
is sometimes used is because irts felt to
Mrs. Schmechel?
11 be an efficacious medication to give for neuropathic
A. Absolutely.
12 pain, correct?
Q. In your discussions with either Mr. Foster
13
A Yeah. There's not evidence to support
or anyone from his office or with anyone else, for
14 that. There were a number of speculations on that,
that matter, or in documentation you received other
15 and I've actually published in this area also. It's
than the depositions of Mrs. Schmechel's children,
16 a very -- one of the isomers of the molecule is a
have you seen evidence of a phone call between
Mrs. Schmeche\ and somebody from Southern ldaho Pair l'I weak NMDA antagonist. We know that NMDA antagonis ~
18 are useful in managing neuropathic pain. There1s
:
Institute on either the Saturday or Sunday after the
19 absolutely no real evidence that methadone is any
'
Friday visit?
2 o better than any other opioid for that purpose. There
A. As you stated, this is -- or as you imply,
21 was a speculation to that effect in the literature in
this is listed in the depositions from the children.
22 the late 1990s which could have influenced people
I'm totally unclear on that issue as to what
2 3 using it in 200}. Thinking thal it's a better drug
occurred.
24 than morphine or oxycodone or any other opioid is not
Q. Okay. And do you have an opinion as to
2 5 valid. It's just as good as tbe other drugs,
whether or not a phone conversation, in fact, took
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1 however 1 so theres no reason not to use it.
2
Q. Okay.
3
A. And it's cheap.
4
Q. ll certainly wouldn't have been
5 inappropdate in 2003 for Mr. Byrne working in a pain
6 management clinic to think that methadone might be a
7 good drug of choice for neuropathic pain?
8
A. There's no reason to think it's a drug of
9 choice. [t s certainly a reasonable alternative
1 o opioid. l have no problem with the selection of
11 methadone. I've been ve1y clear on that. I think it
12 was a reasonable choice.
13
Q. I take it you don't feel it was necessary
l4 for him to first try to increase her OxyContin to see
1 s if that worked better?
16
A. She was already -- she was not taking a
17 large dose. She was only taking 20 milligrams three
18 times a day, But that's sti!I a reasonably expensive
19 drug, and methadone is a lot cheaper. So for
20 economic reasons it would certainly be reasonable to
21 try her on methadone,
22
Q, It's at least, at a minimum, a matter of
2 3 judgment, professional judgment?
24
A. Yeah. Neither I nor anyone else on either
25 side of this case, to my knowledge, faults the use of
1
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anesthesiologists, r certainly concurred with what
they said. l don't remember much more detail about
it.
Q, So you don't remember whether it was a
general discussion or spedfic discussion related to
2003?
A. l suspect it was both.
Q. Okay. And do you recall what Dr. Flinders
indicated, if anything, about what his knowledge of
the standard of care in Twin Falls, Idaho was in
2003?
A. I don't recall.
Q. Or what his basis of -- or how much
contact he had with providers in 2003 from the Twin
Falls region?
A. That may have been part of the
conversation. Again, I don 1t have a recollection. I
do recall that he felt tliat there was fairly
consistent standard across the state of Idaho, and
thal it was consistent between Idaho and Utah.
Q. Okay. Do you know whether he practiced in
Utah?
A. I think he trained here.
Q. Okay. Do you know whef) that was?
A. I don't recall.
·
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methadone or the selection of the methadone, It's
the way that ii was used that I fault.
Q. And that relates, again, to the once-a-day
upward titration?
A. Correct.
Q. Are you knowledgeable enough about the
scoring of sleep apnea to kn.ow whether her scores
qualified her for severe or moderate sleep apnea?
A. No.
Q. You said you had a discussion with
Dr. Vorse. Did she indicate lo you a belief, not
with respect to the dosing i10w, but just a belief
that this patient should not have been on mctliadone?
A. Not that I recall.
Q. And when you talked with the physician in
Lewiston whose name 1 can't remember ~MS. DUKE: Flinders.
MR. FOSTER: Flinders.
Q. (BY MR. HIPPLER) -- Flinders, did you
talk with him generally about the standard of care in
Idaho, or did you talk specifically about the
standard of care in 2003?
A. The majorily of the conversation on the
standard of care was between Dr. Flinders and
Dr. Lord on since they're both practicing

2007

Q. Do you know when he started practicing in
Idaho?
3
A. No.
4
Q. Do you know whether it was before 2003?
5
A. I don't recall.
6
Q. As you sit here, do you have an
7 understanding of what the published therapeutic range
8 of blood concentrations of methadone arc considered
9 to be?
1o
A. J have tables to answer that question in
11 my office. l don't know them off the top of my head.
12 It's impottant to note again that those are highly
13 variable, and these are all based on population
14 averages. There's a huge standard deviation. The
15 serum level for morphine is published as 44 plus or
16 minus 65 nanograms, for example. So a mathematically
1 7 impossible range from what's actually been reported.
1s
Q. What do you mean "mathematically
11
19 impossible ra11ge ?
2o
A. Well, if 44 is your mean and it's plus or
21 minus 65, that puts it into the negative range. But
22 that1s because of the -- means versus mediums if you
2 3 want to play statistics.
24
Q. Sure. Do you know whether, according to
25 published tables, the 300 nanogrnms to milliliter was
1

2
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within the therapeutic range of published tables?
A. It's actually in the overlap range between
therapeutic -- high therapeutic, low toxic or low
lethal. There have certainly been deaths associated
with 300 nanogram levels. And there have been
patients who have been therapeutic at more than 300
milligrams -- nanograrns. So) again) that1s that
patient variability, So what we look for on those
type of data are whether it's consistent with, I
don't consider that to be at all pathognornonic or
diagnostic of methadone-induced death. And as I
stated earlier, l just found it consistent with and
supportive of the conclusions I've reached on
phannacokinetics.
Q. Do you have any knowledge or understanding
or belief that Mrs. Schmechel took more than 30
milligrams of methadone a day?
A. I don't.
Q. Do you }mow what the blood level of
hydrocodone translates to given its half-life in
terms of number of tablets?
A. Those are very difficult calculations to
do. Again, I have all the tables in my office on
what the blood levels are, what we typically see in a
therapeutic range, what we commonly see in the toxic
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developed full tolerance to the respiratory
depressive effects of methadone.
MR. HIPPLER: I'm just about done. Do you
have more?
MS. DUKE: No.
MR. HIPPLER: Let's go off the record
while I go through the rest of my notes here, I
think I'm almost done.
(A short recess was taken,)
Q. (BY MR. HIPPLER) You'd indicated at the
beginning of the deposition that you know Dr. Fakata.
In fact, she did her fellowship under you, correct?
A. Yes.
Q. And do you consider her to be a competent
and obviously well-trained Phann.D.?
A. Dr. Fakata did not successfully complete
her fellowship.
Q. And why is that?
A. She did not finish or publish her
research, which ii was a research fellowship. And in
her last several months in the fellowship she did not
perfonn -- the last quarter of the fellowship she did
not perform successfully, so she was never granted
her fellowship certificate. I'd rather not say
anything else about it. But, unfortunately, Keri
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range. But l don't know them off the top of my head.
Q, Would you agree that it appears that she,
within the four hours of her death, took at least
more than one narco?
MR. FOSTER: Object to the form,
THE WITNESS: I don't have a recollection
right now of -- l did look at that at one time, and I
don't recall. My attitude toward the hydrocodone, as
l said earlier, is that was contributory as opposed
to causative; that the methadone, in my opinion, was
the major problem. She could have taken significant
doses ofhydrocodone by itself. They would have
cleared. It would have been far better to take lower
doses more often than higher doses less often because
you want a lower peak serum level. But the m~jor
causative agent, in my opinion was the methadone
with the hydrocodone being an additive contributor.
Q. (BY MR. HIPPLER) For someone like
Mrs, Schmechel who had been on hydrocodone for years,
l assume she would have had a pretty good tolerance
to hydrocodone,
A. To the respiratory depression of
hydrocodone. I would make the same assumption, which
is another reason why l say I think it's only
additive, where she would not have had time to have
1
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turned out to be a huge disappointment.
Q, You did, however, publish a number of
articles and chapters with her, correct?
A. We do that with all of our fellows. One
of -- it's important for them to get publications
because most of them seek academic or other researchbased positions. And she's gone to work as
essentially a research assistant in a for-profit
private clinic,
Q. And with respect to Mr. Kotenstette, who I
think you also indicated you knew ••
A. Yes.
Q. -- from what you lrnow of him and his
reputation, is he considered to be a well-respected
and competent physician's assistant in pain
management?
A. I believe so, yes.
Q, TI1en just so that I understand because l
may be perhaps a little dense, but I just want to
make sure l understand tl1is and what you were saying
correctly, In terms ofrespiratory risk and
accumulation of methadone, would the respiratory risk
in a patient be the same, less, or equal in a patient
started on 15 milligrams twice a day and kept on that
until steady serum state was reached -- during that
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interval we're talking about the respiratory risl<; -versus a patient started on l O milligrams twice a day
and increased to 15 milligrams twice a day in the
first 72 hours?
A. It's actually a very complex question.
When patients have inadequate analgesia, they will
tend to frequently take extra tablets. If a patient
receives adequate analgesia, the patient is more apt
to be adherent with the prescribed schedule. l have
no information as (o whether Mrs. Schmechel was
adherent to the way it was prescribed, whether she
understood how lo take it, or whether not. All
things being equal, the more drug on board, the more
respiratory risk. So starting at l 5 milligrams and
maintaining that as opposed to titrating up to the
same total amount of medication could actually cause
more respiratory risk.
At the same time, if somebody sta11ing at
a lower dose is not getting adequate analgesic and,
therefore, starts taking extra doses, there can be
greater respiratory risk,

The biggest issue with methadone, however,
is not so much whether it was a l 0- or l 5-miltigram
dose initially. It's the fact that the dose was
taken every 12 hours and it would take
to a
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days, during that 10-day interval is their
respiratory risk greater, equal, or less than the
patient who starts at 10 milligrams every 12 hours
and then within 72 hours increases to 15 milligrams
every 12 hours?
A. The total area under the curve is the
driving factor for respiratory risk. So ifwe
calculate out the total amount of drug that the
patient received over that period of time, from which
we subtract that that has been eliminated already by
the body, we get the net answer. So it could go
either way for the reasons that I suggested.
The problem is that the patient has a
continuing risk until you've reached tolerance to the
respiratory depression, which is going to take a
period of time, perhaps seven to ten days. H could
happen within a week. But we don't know where we are '
if the dose is continually increasing.
\
Q, Okay. I want to go back to my question
because -A. But I can't answer that question because
i
it could go either way.
}
Q. Well, and I guess mathematically I'm
trying to understand that. Because ifwe start at 15
mllligrams twice a day and because of the longer
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hundred hours to clear. Therefore, with each
subsequent dose there is going to be additive and
ever increasing respiratory depression potential.
And the analgesia will actually lag behind that
respiratory depression potential. Therefore,
patients who think that they're doing well and are
feeling better can, indeed, shoot well beyond the
therapeutic target into the toxic, potentially lethal
range, even without taking additional doses because
of the residual effect of doses they've already
taken. And if the patient continues to take doses on
an eveiy-12-hour regimen, this tisk is going to
increase. And that's the reason that we don't want
to go beyond a conservative starting dose until we've
reached steady state serum levels.
Q. Okay.
A. I understand what you're asking and why
you're asking it, but it's not an easy question.
Q. Well, let me try it again because you
threw in some stuff that I didn't ask you. Okay?
l want you to assume that the patient
takes the medication in the doses that! described
and doesn't take extra. Okay? And l just want to
lmow about respiratory risk. lf a patient takes 15
milligrams every 12 hours and does so for, say,., . I0
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half-life those initial doses of l 5 milligrams twice
a day versus those initial doses at !O milligmms
twice a day and then increase to l 5 milligrams twice
a day, wouldn't it mean necessarily that there would
ii
be more respiratory risk under the curve, as you say,
mathematically?
\'
A, With which one?
Q, At 15 twlce a day,
,,
A. Starting at i 5 twice a day.
Q. Starting at 15 twice a day.
:,~
;a
A. Well, that's what it would appear
f
empirically. The question 1 have is whether the
l
dose -- if the dose started at 5 twice a day, low-end
conservative estimate, which we don't think was the
case, but it's conceivable that that was taken that
way, and then went up to 10 and then went up to 15,
then there's an escalating amount of drug going into
the body. In the same patient there's going to be
i
more risk with the l 5, What we don't -- starting
with the 15. What we don't know, however, is what
_l:
was the right dose for this particular patient. And
so we want to start conservatively and we want to
keep it there until we know what's actually
happening. If we're increasing the dose, we don't
ever really know what's a.ctually happening.,·,,.,-,., ....... ..,,.,
........ -- ..
-····
'
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Q. But from a mathematical perspective in
terms of amount of medication that is building in the
patient, there's actually more building starting at
15 ••
A. Yes,
Q. -· and continuing on a steady state than
these increases up to 15?
A. I understand your question. And the
answer to that is mathematically geometrically area
under the curve, yes.
MR. HIPPLER: 11,ank you. That's all !
have.
MS. DUKE: I have nothing further,
MR. FOSTER: We'll reserve our questions
for the time and place set for trial.
MR. HlPPLER: Well, let me go back. 1 do
have one more question just to make sure, house~
clCaning question.
Have you today, do you believe, fairly
expressed all the opinions you have as of today in
this case'(
THE WITNESS: Yes,
MR. HIPPLER: Thank you.
(EXHIB!T-8 WAS MARKED.)
(The deposition concluded at 4:55 p.m.)
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Ptofes$ional Reporter nntl Notary l'ubfa in and for
the S1ate ofU1ah, <lo her(!l)y cerli))';
Thn! ffl'lor In- being ezml\inaj, the w\1n1·-~~.

1

I

ARHltJR G. LIPMAN. J>H/\RM.ll .. wrm by me du!y:rworn 10
e !ell !he 1ru\h, 1\1c whale tru\h. and 1101hi'n11, bui (he
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nomy p11blk and then rctum 10 me fer filini; wi1h
15 Keely Duke, Esq.

l6

( fortl«:rcenffy 1hM 1um nol ki11 or
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